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Summary
The DNA damage response triggers a complex regulatory network to protect 
genomic integrity and promote cell survival by inducing effects such as cell 
cycle arrest, upregulation of dNTP synthesis and DNA repair. The Nucleotide 
Excision Repair (NER) pathway removes a broad array of DNA lesions by 
excising the damage with surrounding DNA and resynthesising the DNA using 
the undamaged strand as the template. NER consists of two sub-pathways 
that remove lesions from transcribed DNA (TC-NER), or from the rest of the 
genome (GG-NER). It has been proposed more recently that NER factors 
have additional regulatory roles in the DNA damage response.
The initial aim of the study was to identify a possible regulatory interaction 
between the Abf1 protein and the 19S proteasome. abfl and sug 
(proteasome) mutant alleles were employed to identify a functional interaction 
between the factors but a significantly altered mutant phenotype could not be 
identified.
The study proceeded to investigate a regulatory role of the Rad4-Rad23 NER 
complex in the DNA damage response via Rad7-dependent ubiquitination of 
Rad4. Previous evidence suggested that post-UV Rad4 ubiquitination has a 
regulatory role in DNA damage-responsive transcription.
Global analysis of gene expression revealed that genes involved in dNTP 
synthesis, including the Ribonucleotide Reductase (RNR) pathway, were 
misregulated in a strain unable to ubiquitinate Rad4. The study progressed to 
investigate the function of the Rad4-Rad23 complex in regulation of the RNR 
pathway.
It was discovered that constitutive activation or expression of the RNR 
pathway could suppress the UV sensitivity of the E3 ligase-defective strain, 
thus suggesting that the Rad7-E3 ligase has a role in regulating cellular dNTP 
levels in response to DNA damage. The Rad4-Rad23 complex binds at the 
DUN1 promoter, a positive regulator of the RNR pathway.
E3 ligase-defective mutant strains were also found to exhibit defective cell 
cycle progression in the presence and absence of DNA damage. This 
defective cell cycle progression is suppressed by upregulating the RNR 
pathway. This further supports a role of the Rad7 E3 ligase in regulation of 
cellular dNTP levels.
These results indicate a role of the Rad7 E3 ubiquitin ligase in regulation of 
cellular dNTP levels in the DNA damage response.
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1 Introduction
The study of biological pathways within cells aspires to elucidate the complex 
interactions required for cellular metabolism and survival. Although these 
pathways can be studied as separate entities, the subtle interplay between 
distinct biological pathways is of paramount importance, and with the 
emergence of global techniques to study genetic regulation the complex 
network of inter-regulated pathways is being revealed. This study aims to 
investigate specific aspects of several cellular pathways that respond to UV 
radiation, and how they function together in the DNA damage response to 
maintain cellular integrity.
1.1 Saccharomyces cerevisiae as a Model Organism
Saccharomyces cerevisiae, also known as budding yeast is a single-celled 
eukaryotic organism that has been used extensively as a convenient and 
powerful genetic tool. Many human genes were first discovered as yeast 
homologues, including regulators of the cell cycle, signalling proteins and 
factors involved in DNA repair. Yeast has also allowed significant progression 
in the understanding of processes such as regulatory mechanisms of 
transcriptional control and cellular metabolism.
Budding yeast cells replicate in an asynchronous manner, a process known 
as budding. This involves formation of the daughter cell as a protrusion on the 
surface of the mother cell during DNA replication. The process of budding and 
the yeast cell cycle is discussed in Section 1.6.
The S. cerevisiae genome consists of approximately 12 156 677 bp, 
containing about 6 000 genes, and organised into 16 linear chromosomes.
The yeast genome was the first eukaryotic genome to be fully sequenced, and 
is thought to be approximately 23% homologous to the human genome 
(en. wikiped ia. org/wiki/Saccharomyces_cerevisiae).
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1.2 DNA Damage
Cells are constantly being exposed to environmental damaging agents that 
can compromise the integrity of biological macromolecules. The damage can 
result from endogenous sources, such as the production of reactive oxygen 
species during normal cellular respiration, or environmental sources such as 
chemical mutagens or electromagnetic radiation. These can inflict damages 
upon polypeptides, lipids and nucleic acids, including the cell’s molecular 
blueprint, DNA. It is the damage of DNA that can be most detrimental, as 
damage replication can result in harmful mutagenesis, possibly causing 
metabolic defects or death in unicellular organisms and genomic instability 
leading to loss of genetic information in more complex multicellular organisms. 
This process of DNA damage leading to mutagenesis has a role in molecular 
evolution, and therefore affects genetic variation to some extent. A subtle 
equilibrium is required to allow genetic variation to develop, which drives 
natural selection, whilst maintaining the genomic integrity and stability of the 
organism, which requires repair of damage. In the absence of environmental 
damaging agents, a typical human cell must repair 10 000 damage events per 
day in its DNA, caused mainly by reactive oxygen species, a by-product of 
cellular respiration, and misincorporation of bases during DNA replication, 
recombination, or repair leading to spontaneous base changes (Friedberg 
2001; Peterson and Cote 2004).
DNA damage can adopt many different forms, ranging from slight molecular 
alterations at a single base to a double-strand break (dsb), whereby the 
backbone of both DNA strands are severed. These damages include 
deamination of cytosine, adenine, guanine or 5-methylcytosine, creating 
uracil, hypoxanthine, xanthine and thymine respectively. It should be noted 
that some of these products are not alien in normal DNA, so detection 
becomes more difficult and mismatching can occur during DNA synthesis 
(Friedberg 2005b; Lindahl 1993). Reactive oxygen species (ROS) and 
alkylating agents from endogenous sources can cause adducts such as 8- 
oxoguanine and 06-methyldeoxyguanosine (Hasty et al. 2003). Whereas 
some agents act as direct carcinogens, molecules such as benzopyrenes can
2
become a threat to DNA when metabolised by endogenous enzymes, which 
increase the solubility of the compound to facilitate excretion. However, this 
allows the compound to attack and attach itself to DNA, causing a helix- 
distorting bulky adduct (DeMarini 2004; Friedberg 2005b, 2006; Lindahl 
1993). The above-mentioned damages all cause distortion of the DNA double 
helix. Damaging agents such as ionising radiation, ROS and collapsed 
replication forks can cause single- or double-stranded breaks (ssb/dsb) which 
can cause more severe genome instability and chromosomal rearrangements.
1.2.1 UV Radiation and DNA Damage
The damaging effect of UV radiation on DNA has been recognised and 
utilised as an experimental tool for many decades. It was discovered in the 
1930s that although UV radiation posed a threat to living cells, they could 
survive through relatively large doses, however two groups introduced the 
notion of DNA damage/repair in the late 1940s (Dulbecco 1949; Kelner 1949). 
More specifically, this marked the discovery of photoreactivation, whereby the 
repair was dependent on post-damage exposure to a light source to activate 
the enzyme responsible. The UV radiation spectrum is categorised into three 
wavelengths; UV-A (400-320nm), UV-B (320-290nm) and UV-C (290-1 OOnm). 
Most organisms are subjected to UV radiation on a daily basis from the sun, 
however solar UV radiation reaching the Earth’s surface mainly consists of 
UV-A and UV-B, as the shorter wavelengths are filtered out by the ozone 
layer. DNA maximally absorbs UV at 260nm, so a 254nm germicidal lamp is 
used in laboratory irradiation to have optimum DNA damaging effects. UV 
radiation predominantly induces two major lesions, which are defined as 
cyclobutane pyrimidine dimers (CPDs), which constitute ~75% of total 
damage inflicted after UV-C exposure, or pyrimidine-pyrimidone (6-4) 
photoproducts (6-4 PPs), which account for ~20% of total damage inflicted 
after UV-C exposure. Both lesions involve the covalent linking of adjacent 
pyrimidines (Mitchell 1988). Other UV-induced damage includes 
purine/pyrimidine hydrates, thymine glycols, DNA cross-links and strand 
breaks (Friedberg 1995; Ichihashi et al. 2003).
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CPDs are frequently formed in DNA exposed to UV radiation and involve two 
adjacent pyrimidines becoming covalently attached by a cyclobutyl ring 
formed by saturation of the C5=C6 double bond (Figure 1.1A). This stable 
conformation causes a distortion of the DNA double helix and is defined as a 
bulky adduct. The thymine dimer CPD was first discovered in the 1960s, and 
was found to be induced by exposure of cells to sunlight and a hindrance to 
DNA metabolic processes such as replication and transcription (Setlow and 
Carrier 1964). The thymine dimer was later discovered to be the most 
frequently occurring CPD, which are found in the following ratio; T-T: C-T: T- 
C: C-C = 68:13:16:3 (Mitchell et al. 1992). CPD induction is greatly influenced 
by nucleotide sequence. A 5’ pyrimidine enhances the probability of CPD 
formation at adjacent thymines (Gordon and Haseltine 1982). CPD induction 
is also highly dependent on conformation and organisation of chromatin. The 
arrangement of DNA within and between nucleosomes can greatly influence 
CPD formation in both a positive and negative manner (Thoma 1999).
4
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Figure 1.1 - Molecular Structure and Conformation of a UV-induced CPD
and 6-4 PP A. UV radiation causes two adjacent pyrimidines to form a 
cyclobutane dimer by denaturing the C5=C6 bonds. B. UV radiation causes a 
heterodimer to form between an adjacent Cytosine (at C4) and Thymine (at 
C6). Figure adapted from (Friedberg 2005b).
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Pyrimidine-pyrimidone (6-4) photoproducts (6-4 PP) are also UV-induced 
lesions formed between adjacent pyrimidines, and are rather less common 
than the aforementioned CPDs. 6-4 PPs account for 15-30% of UV induced 
lesions (Mitchell and Nairn 1989). 6-4 PPs most commonly form at cytosine 
bases located 3’ to a pyrimidine. The most abundant 6-4 PP forms between T- 
C adjacent bases, which occurs much more frequently than C-C and T-T 
bonds (Mitchell et al. 1990). UV irradiation causes formation of a covalent 
bond between C6 of the 5’ cytosine and C4 of the 3’ thymine (Figure 1.1B). 
This crosslink causes a major helical distortion to the DNA, resulting in a bend 
of 44°, a far greater disturbance than that inflicted by a CPD (Pearlman et al. 
1985). Unlike CPDs, 6-4 PPs are mostly found in linker regions, and inhibited 
by nucleosomal DNA as suitable bending cannot be achieved.
1.3 DNA Repair
To cope with the plethora of possible DNA lesions, an extensive range of DNA 
repair mechanisms have evolved. These repair systems each deal with a 
subset of lesions, allowing very specialised and DNA efficient repair to occur. 
DNA repair pathways can be divided into two main categories based on their 
molecular mechanism; direct repair and excision repair. Direct repair acts on 
the damaged DNA to simply reverse the lesion, retaining the original DNA 
components, whereas excision repair machinery removes a stretch of ssDNA 
flanking the lesion either at the base or nucleotide level, and synthesises new 
DNA in its place. Some repair mechanisms require a dsDNA template from a 
homologous chromosome to function so can only occur after DNA replication 
but before mitosis in haploid organisms, whereas other mechanisms can 
occur at any stage of the cell cycle. Most operate best when the cell cycle is 
arrested and checkpoint activation facilitates this.
1.3.1 Direct DNA Repair
The most primitive method of DNA repair is simply to directly reverse the 
offending lesion. Three systems of direct repair are photoreactivation, repair 
of alkylation damage and removal of single-strand breaks.
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Photoreactivation is a mechanism for removing UV-induced CPDs and 6-4 
PPs using energy from visible light. It is utilised by many species, excluding 
humans but including yeast, plants, some bacteria and some mammals such 
as marsupials (Yasui et al. 1994). A range of photolyases exist, each enzyme 
specific for a certain lesion, which use energy derived from blue light to 
separate dimerised pyrimidines, thus correcting DNA helical distortion (Weber
2005).
Minor alkylation of DNA can also be repaired by direct reversal, a pathway 
evolutionarily conserved from bacteria to humans. Products of the mutagenic 
agent N-methyl-N'-nitro-N-nitrosoguanidine, which include 06-alkylguanine, 
can be repaired by the 06-alkylguanine-DNA alkyltransferases, which can 
remove alkyl groups ranging from methyl to benzyl. The 06-methylguanine- 
DNA methyltransferase enyzyme operates by transferring a methyl group 
from guanine in DNA to a cysteine residue within the enzyme (Olsson and 
Lindahl 1980; Pegg 2000). The proteins that facilitate this type of repair 
cannot be considered true enzymes as they become permanently inactivated 
once repair has been catalysed. This class of proteins are also known as 
‘suicide enzymes’. These alkyltransferases have been found to repair both 
DNA and RNA.
In the event of a single strand break in the DNA backbone, which can be a 
result of exposure to ionising radiation, a nick can form whereby no 
nucleotides are removed. This can be reversed by religation of the 3’ hydroxyl 
and 5’ phosphate by a DNA ligase (Friedberg 2005b). However, if the nick 
progresses to loss of nucleotides or a more severe lesion, additional repair 
apparatus is required.
1.3.2 Excision Repair
Lesions that disrupt the DNA structure more severely cannot be simply 
reversed, and require a suitable repair system. Several excision repair 
pathways exist to deal with a wide variety of damages, however all pathways
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include the following stages of repair: lesion detection, invasion and excision, 
and DNA synthesis and ligation. In general, rather than just undoing the 
damage, excision repair removes the offending DNA containing the lesion, 
and resynthesises new DNA using the non-damaged strand as a template. 
The 3 main excision repair pathways are mismatch repair (MMR), base 
excision repair (BER) and nucleotide excision repair (NER).
1.3.3 Mismatch Repair
The semi-conservative replication of DNA can on occasions introduce 
mistakes in nucleotide matching to the template strand. This results in 
mismatched bases, which if replicated are a source of mutagenesis. Certain 
DNA sequences are more prone to introduction of mismatched bases during 
replication or recombination due to the presence of repetative or palindromic 
nucleotide tracts, which can form secondary structures and pose a challenge 
to the replicative machinery (Friedberg 2005b). Mismatched bases can also 
be the result of base damage. Deamination of 5-methyl cytosine, a common 
base variant in silenced DNA, produces thymine, thus creating a T-G 
mismatch. MMR can also recognise victims of base oxidation and methylation 
(Modrich and Lahue 1996). MMR systems require highly sensitive detection 
systems, as they do not identify bulky chemical adducts or major helical 
distortions, but they must detect mispaired bases and discriminate which base 
is incorrectly paired. Once damage is identified, excision and resynthesis can 
occur in a similar manner to other excision repair pathways (Brown 1999; 
Friedberg 2005b; Jiricny 2006; Jun et al. 2006). MMR is conserved from 
prokaryotes to eukaryotes, however the complexity and number of proteins 
involved has increased dramatically over evolutionary time (Jiricny 2006). 
Eukaryotes use the MSH and MLH proteins to conduct MMR, whereby the 
MSH proteins bind to mismatches and promote ATP-dependent repair, and 
MLH proteins form heterodimers with a variety of proteins to activate MSH 
proteins. Defective MMR in humans has been implicated in hereditary 
nonpolyposis colorectal cancer (Kunkel and Erie 2005).
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1.3.4 Base Excision Repair
BER acts upon bases with non-bulky chemical adducts. The first stage of 
BER requires removal of the inappropriate base to produce an abasic site. 
Specific DNA glycosylases are employed for this, which each recognise and 
cleave a certain type of damaged base. Some damages are fairly common, 
for example the presence of uracil, xanthine, hypoxanthine or the oxidation 
products 8-oxo-7,8-dihydroguanine and 5-hydroxycytosine, so relatively few 
DNA glycosylases are required to remove the majority of damaged bases, 
however many different DNA glycosylases exist (Fromme et al. 2004;
Seeberg et al. 1995). Following cleavage of the damaged base, the abasic 
site is removed by specialised nucleases, and the DNA is resynthesised and 
ligated (Friedberg 2005b).
1.3.5 Nucleotide Excision Repair
Bulky DNA adducts cannot be repaired using MMR or BER so nucleotide 
excision repair (NER) is employed, which is able to correct a far broader 
range of lesions, including BER-repairable lesions. The extensive array of 
lesions NER can repair is due to its mode of damage recognition. Instead of 
detecting the damage itself, NER is thought to identify distortion in the DNA 
structure to indirectly detect damage, which allows repair of many diverse 
lesions using relatively few enzymes (Nouspikel 2009). NER in eukaryotes 
involves the combined effort of more than 30 peptide factors on naked DNA in 
vitro, and most of these factors are highly conserved across species. Defects 
in the genes involved in NER are responsible for several human cancer- 
susceptibility syndromes, including Xeroderma Pigmentosum (XP), 
Cockayne’s Syndrome (CS) and Trichothiodystrophy (TTD).
1.3.5.1 NER in Prokaryotes
NER in bacteria was first discovered in the 1960s, when DNA lesions were 
found to be removed, along with a short flanking region, and the region was 
resynthesised following excision (Boyce and Howard-Flanders 1964;
Hanawalt and Haynes 1965; Setlow and Carrier 1964). Genetic studies soon
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identified the genes involved in the repair process as uvrA, uvrB and uvrC 
(Howard-Flanders et al. 1966). uvrA and B are known to be induced by the 
SOS response (Janion 2001) (Figure 1.7). The multi-step prokaryotic NER 
reaction requires the ATP-dependent formation of an UvrA dimer (Mazur and 
Grossman 1991), which proceeds to form a complex with UvrB. This complex 
recognises, and loads UvrB onto sites of DNA damage (DellaVecchia et al. 
2004). UvrC is recruited to DNA- and ATP-bound UvrB and performs the 3’ 
and 5’ incisions, then dissociates from the damage site. UvrD (DNA Helicase 
II) is required to remove the 12-13-base oligonucleotide, and DNA polymerase 
I fills the resulting gap (Caron et al. 1985; Husain et al. 1985). The repair 
process is concluded by ligation by DNA ligase. Although very little sequence 
homology is present between the uvrABC genes and eukaryotic NER 
machinery, the overall molecular mechanism and range of identifiable and 
repairable damage are strikingly similar (Truglio et al. 2006).
The NER pathway has two distinct sub-pathways, one operates on damage in 
transcribed DNA, and the other addresses damage in non-transcribed DNA 
including silenced DNA, and the untranscribed strand of gene ORFs. This 
division allows prioritised repair of transcribed DNA thus minimising synthesis 
of defective mutant proteins. Evidence of these separate pathways can be 
seen in prokaryotes. Transcription-coupled NER (TC-NER) requires the 
mutation frequency decline (MFD) factor, which uses a DNA-dependent 
ATPase activity to dissociate stalled RNA pol II at DNA damage. Once the 
transcription complex is disrupted, MFD aids recruitment of the UvrABC 
complex (Selby and Sancar 1993).
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1.4 NER in Eukaryotes -  Saccharomyces cerevisiae
The factors involved in yeast NER can be organised into three main 
categories:
1. Core Factors: RAD1, 2, 4, 10, 23 and 33, and components of the TFIIH 
complex(RAD3, TFB1, 2, 3, 4, SSL1 and 2). Deletion of any of these 
factors produces mutants that are completely defective in NER, and 
produces a moderate to severe UV sensitivity.
2. TC-NER Factors: RAD26, DEF1 and RAD34 (for TC-NER of Poll- 
transcribed genes only). Deletion mutants are only defective in TC- 
NER. RAD28 has also been implicated in TC-NER.
3. GG-NER Factors: RAD7, RAD16 and ABF1. Mutants in these genes 
are defective in GG-NER.
Mutants defective in either TC-NER or GG-NER generally exhibit less 
sensitivity to UV radiation than core factor mutants. The NER factors can be 
isolated in distinct complexes.
Similar to E coli, NER in yeast also involves progressive recruitment of 
proteins to DNA damage loci in an organised, ordered fashion to allow 
efficient damage removal and repair, however eukaryotic NER is more 
complex and involves over 30 proteins. It can be separated into 5 distinct 
steps: damage recognition, open complex formation whereby DNA helicases 
form a ‘bubble’ structure, dual incision, excision of damage, and repair 
synthesis and ligation.
1.4.1 Damage Recognition
Damage recognition is an important and varied stage in NER, due to the wide 
range of DNA lesions, each inflicting varying degrees of helical distortion. It is 
the damage recognition stage that differs most between TC-NER and GG- 
NER, as TC-NER recognition factors identify stalled RNA polymerase to 
initiate repair, whereas GG-NER detects the damage itself, most likely by 
detecting DNA helix distortion. As previously described in prokaryotes, TC- 
NER occurs at a significantly faster rate than GG-NER in order to
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preferentially maintain the integrity of transcribed DNA and to recover RNA 
synthesis that is generally shut-down in response to DNA damage.
1.4.1.1 RNA Polymerase-Independent Damage Recognition
Recognition of DNA damage in GG-NER is thought to require the Rad4- 
Rad23 recognition complex, Rad 14 and RPA. Rad4 has been found to 
preferentially bind to DNA containing NER-repairable lesions, which is thought 
to be the first, and rate-limiting step of NER (Friedberg 2005b). Rad4 stably 
binds the non damaged strand of DNA and flips out the damaged nucleotide 
by insertion of a p hairpin structure (Min and Pavletich 2007). Virtually all 
cellular Rad4 is bound to Rad23, whereas Rad23 exists in a >10 fold excess 
over Rad4, so can function alone, or in combination with other factors in other 
cellular processes via interaction with the proteasome (Dantuma et al. 2009; 
Ghaemmaghami et al. 2003). It is thought that the initial binding of the Rad4- 
Rad23 complex facilitates recruitment of NER factors, however the process of 
damage recognition and NER activation is not well understood.
It is also known that Rad4 becomes ubiquitinated by the Rad7-Elc1-Cul3 E3 
ubiquitin ligase complex, and subsequently degraded following DNA damage 
induction, however the role of Rad4 degradation in NER activation or the DDR 
is not yet understood (Gillette et al. 2006). The human homologue of Rad4, 
XPC is also ubiquitinated in response to DNA damage, however it is not 
degraded (Bergink et al. 2007; Sugasawa 2006). It appears that Rad4 
ubiquitination, and not Rad4 degradation is required for its role in the DNA 
damage response, as Rad4 stability does not affect UV survival (Gillette et al.
2006). The role of the GG-NER complex is further explored below (Section 
1.4.6). Another factor thought to be involved in DNA damage recognition is 
Rad33, a proposed homologue of human Centrin2. Rad33 has been 
implicated in both TC-NER and GG-NER by binding to and modifying Rad4 
(Figure 1.2) (den Dulk et al. 2008).
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1.4.1.2 Transcription-Coupled Damage Recognition
Recognition of damage in TC-NER requires recruitment of TC-NER specific 
factors to the site of stalled RNA polymerase however the process of factor 
recruitment is poorly understood. TC-NER in humans requires CSA and CSB, 
for which the yeast homologue of CSB; Rad26 has been identified (van Gool 
et al. 1994). CSA and CSB recruit NER factors to the stalled polymerase, and 
once the damage has been repaired transcription can resume. The 
mechanism in yeast is not as well understood, however it is known that Rad26 
recruits Def1, which brings about Rbp1 ubiquitination (Figure 1.2).
In order to access the damaged DNA the transcriptional machinery must be 
disassembled, which is seen through targeted degradation of Rbp1, the 
largest subunit of RNA polymerase II (Malik et al. 2008), however it is not 
clear if RNA polymerase degradation is necessary for TC-NER to occur. 
Identification of E3 ubiquitin ligase complexes that targeted Rpb1 allowed two 
distinct pathways to be identified; TC-NER and Rpb1 ubiquitination. It is 
thought that Rpb1 degradation may occur to ensure DNA repair when TC- 
NER fails or is delayed (Svejstrup 2007). Rpb1 ubiquitination may be a 
general mechanism to manage any stalled transcriptional polymerase rather 
than a DNA damage-specific response. Another explanation is the idea that 
elongation of the ubiquitin chain provides a time frame for TC-NER to occur. 
When the ubiquitin chain reaches the critical length, Rbp1 is degraded and 
GG-NER must occur instead (Daulny and Tansey 2009).
Rad26 becomes phosphorylated by the checkpoint kinase Mec1 in response 
to DNA damage and this is required for efficient TC-NER to occur. This 
provides a link between DNA repair and the DNA damage checkpoint 
response (Taschner et al.).
TC-NER has been observed in both RNA pol II and RNA pol l-transcribed 
genes in yeast (Verhage et al. 1996). Rad4 is only involved in TC-NER in 
RNA pol II transcribed genes, however a gene that shows homology to Rad4, 
termed Rad34, has been implicated in pol I TC-NER. This suggests that the
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two proteins act on different parts of the genome, however they cannot 
compensate for each other as shown in rad34 mutants (den Dulk et al. 2005).
1.4.2 Open Complex Formation
Following damage recognition the surrounding DNA is unwound to form an 
open complex or bubble structure. This allows the repair machinery to access 
the damaged region. TFIIH, recruited by the Rad4-Rad23 complex or stalled 
polymerase, is responsible for DNA unwinding. The Rad3 and Rad25 subunits 
have 5’-3’ and 3’-5’ helicase activity respectively. Both genes are essential, 
and are also known to have a role in transcription via their helicase activities 
(Guzder et al. 1994; Higgins et al. 1983; Naumovski and Friedberg 1983; Park 
et al. 1992; Qiu et al. 1993). The bubble structure spans across approximately 
30 nucleotides, and is stabilised by RPA, Rad 14 and Rad2 proteins (Prakash 
and Prakash 2000) (Figure 1.2).
1.4.3 Dual Incision
The boundaries between ssDNA and dsDNA provide targets for the incision 
machinery, aided by the RPA and Rad 14 proteins. Rad 14 has been isolated 
in a complex with the Rad 1-Rad 10 nuclease, which is thought to help target 
the nuclease complex to target the damage (Guzder et al. 2006) (Figure 1.2). 
Both Rad2 and Rad 1-Rad 10 complexes possess endonuclease activities. The 
first incision is conducted by Rad2 3’ of the damage, followed by 5’ incision by 
Rad 1-Rad 10. The typical length of the excised oligonucleotide is 25-32 bases. 
Rad 1-Rad 10 also has a role in mitotic recombination, separate from their role 
in NER (Rattray and Symington 1995).
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1.4.4 DNA Excision
Excision of the damaged fragment requires further enzymic activity, which is 
thought to occur in GG-NER by the Rad 16 subunit of the Rad7-Rad16-Abf1 
trimeric GG-NER complex (Figure 1.2). Rad16 has been found to generate 
superhelical torsion in an ATP-dependent manner, which is thought to 
facilitate displacement of the excised strand (Yu et al. 2004).
1.4.5 Repair Synthesis and Ligation
Following excision of the damaged strand, the genomic DNA is left with a 
stretch of ssDNA, which would leave the genome vulnerable to nuclease 
attack if not refilled. Repair synthesis requires the formation of another protein 
complex involving the DNA polymerases 5 and e, along with the accessory 
factors PCNA, Replication Factor C (RFC) and RPA. The repair process 
proceeds like normal DNA synthesis, using the non-damaged strand as a 
template. Finally the gaps are sealed by the Cdc9 DNA ligase, thus restoring 
intact dsDNA (Wu et al. 1999) (Figure 1.2).
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Figure 1.2 - Nucleotide Excision Repair in S. cerevisiae NER in yeast requires the 
sequential recruitment of factors to the site of damage in order to maintain intact 
DNA. Following production of bulky lesions the damage must be identified. Damage 
recognition occurs differently in transcribed (TC-NER) and non-transcribed (GG- 
NER) DNA. Following damage recognition the DNA is unwound, the damaged strand 
denatured and excised, then repair synthesis and ligation occurs to provide intact 
dsDNA. Modified from (Dantuma et al. 2009).
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1.4.6 The Role of the GG-NER Complex
The role of the Rad7-Rad16-Abf1 GG-NER complex in NER is only partially 
characterised. It is known to have a role in post-incision events of NER (Reed 
et al. 1998) and in excision of the damaged DNA strand via Rad16’s SNF2- 
like ATPase activity (Yu et al. 2004). The complex is also thought to have a 
role in DNA damage recognition (Guzder et al. 1997, 1998), and in other 
cellular processes such as UV-dependent histone H3 acetylation (Teng et al. 
2008) and chromatin remodelling via Rad16’s ATPase activity.
The GG-NER complex forms an E3 ubiquitin ligase complex that ubiquitinates 
Rad4 in response to UV and triggers its degradation (Gillette et al. 2006; 
Ramsey et al. 2004). Although no human homologues of the yeast GG-NER 
complex factors exist, XPC (the human homologue of Rad4) becomes 
ubiquitinated by an E3 ligase complex known as UV-DDB containing the 
human NER factors DDB1 and 2, Cull4a and R od. This complex binds to 
chromatin following UV irradiation, is involved in GG-NER, and has been 
observed to facilitate post-UV reversible ubiquitination of XPC, revealing a 
non-proteolytic regulatory activity of XPC ubiquitination. (Pintard et al. 2004; 
Sugasawa 2006; Willems et al. 2004). The UV-DDB complex is also known to 
target histones H2A, H3 and H4, which has been suggested to have a role in 
NER activation. (Kapetanaki et al. 2006; Wang et al. 1997b)
The DNA-binding component of the GG-NER complex was found to be the 
general regulatory factor Autonomously Replicating Sequence (ARS) Binding 
Factor 1 (Abf1). Abf1 was originally discovered as a DNA replication factor, 
but has since been identified to have roles in transcription, both as a silencer 
at the mating type loci, and as an activator or repressor at gene promoters 
affecting over 100 genes, chromatin remodelling and DNA repair. Non-repair 
functions of Abf1 are discussed in Chapter 3.1.
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It is known that the DNA binding capability of Abf1 is required for efficient GG- 
NER to occur (Reed et al. 1999). It is also known that this DNA binding 
function is not required for the Rad 16-dependent chromatin remodelling 
activity of the GG-NER complex (Yu et al. 2004; Yu et al. 2009).
1.5 The Ubiquitin-Proteasome System
The ubiquitin-proteasome system (UPS) has two main cellular functions, a 
general housekeeping role via targeted degradation of damaged or defective 
proteins, and a regulatory role by ubiquitination of functional proteins, thus 
influencing their activity or targeting them for degradation. The action of the 
UPS is of paramount importance for many aspects of cellular metabolism and 
maintenance of cellular integrity. Proteasomal and proteasome-like structures 
have been discovered in prokaryotes, archaea and eukaryotes with varying 
complexity in their structures.
The basic principle behind the UPS involves tagging damaged proteins, and 
proteins no longer required with the highly conserved 76-amino acid protein 
ubiquitin. Covalent attachment of a polyubiquitin chain allows identification of 
the targeted protein by the proteasome, which subsequently binds to and 
degrades the protein. The UPS is a major cellular mechanism for targeted 
degradation of cellular proteins.
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Figure 1.3 - The Ubiquitin Conjugation Pathway and 26S Proteasome 
Structure Ubiquitin is activated and transferred from E1 to E2 conjugating 
enzyme, then an E3 ligase facilitates ubiquitin tagging of the required protein, 
and subsequent ubiquitin chain formation resulting in targeted degradation. 
The 26S proteasome consists of a 20S proteolytic core flanked by two 19S 
regulatory complexes. Figure adapted from (Murata et al. 2009).
The ubiquitin gene is translated as a chain of ubiquitin monomers, or an 
ubiquitin conjugated to ribosomal protein (RB). Free ubiquitin is liberated by 
the action of deubiquitylating enzymes (DUB), which can be used in the 
progressive ubiquitin conjugation pathway. Ubiquitin is activated by E1 
enzymes, which form a high energy thiol-ester bond between ubiquitin’s C- 
terminus and the E1 cysteine active site, in a reaction that requires ATP 
hydrolysis. The activated ubiquitin is transferred to an E2 (ubiquitin 
conjugating enzyme), and subsequently transferred to a specific E3 ubiquitin 
ligase. E3 ligases exhibit a high level of substrate specificity, and must be 
able to interact with the target substrate to transfer its ubiquitin. There are two 
major classes of E3 ligases, RING-type and HECT-type. RING-type E3 
ligases bind to the E2 and substrate simultaneously to facilitate ubiquitin 
transfer, whereas HECT-type E3 ligases form a thiol-ester bond with the E2- 
bound ubiquitin before transferring it to the target substrate. Covalent
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attachment of ubiquitin occurs at lysine residues of the target substrate 
(Murata et al. 2009).
The eukaryotic 26S proteasome is a dynamic structure, but its most well- 
characterised and possibly its most common conformation involves a central 
20S proteolytic core subcomplex, flanked on each end by a 19S regulatory 
subcomplex. As a whole this 26S complex is responsible for recognition of 
ubiquitin tagged proteins followed by unfolding and degradation (Pickart and 
Cohen 2004) (Figure 1.3).
The 20S proteolytic core is a 700kDa complex comprised of 4 heptameric 
rings forming a barrel structure. 14 gene products are required for the 
cylindrical structure of the 20S, a1-7 and pi-7. p1, 2 and 5 are the catalytic 
subunits, whose Thr protease active sites line the lumen of the barrel. The 
rings are stacked in an appa formation, which create a-ring 13A pores at 
each end providing selective entry into the catalytic chamber (Baumeister et 
al. 1998) (Figure 1.3).
The 19S regulatory complex can be further separated into 2 subcomplexes, 
the lid and the base structures. The 19S identifies targeted proteins, has a 
role in unfolding, and mediates entry into the catalytic chamber. The base 
structure contains a hexameric ring of AAA-family ATPases, which are 
involved in ATP-dependent protein unfolding and ubiquitin binding. The 
hexameric ring sits proximal to the 20S 7a ring (Smith et al. 2006). These 6 
ATPases (Rpt1-6 aka Sug proteins) along with 3 non-ATPase subunits (Rpn1, 
2 and 13) form the entirety of the base structure. (Figure 1.3)
The remainder of the 19S forms the lid structure, however the function of most 
lid subunits is currently unknown. Some subunits have exhibited a 
deubiquitylation activity, which requires the metalloisopeptidase activity of 
Rpn11. The Rpn10 subunit has a ubiquitin interaction motif (UIM), which can 
bind polyubiquitin chains (Figure 1.3).
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It has been shown more recently that the 26S proteasome does not always 
adopt the previously described 19S-20S-19S formation, and proteasome 
composition is in fact extremely dynamic (Demartino and Gillette 2007). Cells 
can alter proteasome frequency and subunit composition in response to 
environmental conditions (Glickman and Raveh 2005; Lecker et al. 2006). In 
some cases, other regulatory complexes than the 19S can bind to the 20S a 
rings. Although these alternative complexes clearly have a function in 
proteolysis, many do not have ATPase activity, or ubiquitin-binding capability 
(Rechsteiner and Hill 2005). It should also be noted that 20S structures have 
two separate a rings capable of binding regulators, so two different structures 
can bind to the same 20S. Additional to the main proteasomal subunits, 
associated proteins also aid efficient proteolysis. Several proteins with 
polyubiquitin chain binding ability have been identified including Rad23, Dsk2 
and Ddi1. These are thought to act as shuttle proteins, which transport 
polyubiquitinated proteins to the proteasome for degradation without being 
degraded themselves (Schmidt et al. 2005). These proteins contain UBA 
domains, to allow interaction with ubiquitin, and an N-terminal UbL domain, to 
facilitate interaction with the Rpn1, 10, 13 and Rpt5 19S subunits. These 
subunits can also interact directly with polyubiquitin chains.
Deubiquitination is an important stage of proteasomeal proteolysis. Aside from 
deubiquitination before degradation, it has also been suggested that the 
protesome may salvage some proteins by deubiquitinating and not degrading. 
This implies an active role of the proteasome in determining protein fate 
(Guterman and Glickman 2004).
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1.5.1 Non-Proteolytic Regulatory Activity of the UPS
Aside from its canonical role as a protein degradation machine, the UPS also 
has non-proteolytic roles in transcription and DNA repair
1.5.2 Discovery and Characterisation of the SUG genes and alleles
During an investigation to reveal novel Gal4 transcriptional co-activators, 
factors found to exhibit a genetic interaction with Gal4 were later discovered 
to be AAA ATPase subunits of the 19S proteasome base (Swaffield et al. 
1992).
The GAL system in yeast presents an elegant feedback loop, which allows 
induction of genes required for galactose metabolism when a suitable 
alternative carbon source (e.g. glucose) is not available. Gal4 is a bona fide 
transcriptional activator, which is inactivated under non-inducing conditions by 
interaction with the Gal80 repressor, but still thought to be bound to DNA. 
Upon induction, which occurs when galactose is the sole available carbon 
source, the Gal3 inducer facilitates dissociation of Gal4 from Gal80 by 
sequestering the repressor in the cytoplasm (Peng and Hopper 2002). Gal80 
removals triggers binding of the TATA binding protein, and subsequent 
initiation of transcription of GAL genes (Johnston 1987; Traven et al. 2006). 
GAL gene transcription is increased by a thousand fold under inducing 
conditions (Figure 1.5B). The structure of Gal4 resembles a typical 
transcriptional activator, as it contains an N-terminal DNA-binding domain and 
a C-terminal acidic activation domain.
Deletion of 28 amino acid residues from the C-terminus of Gal4 reduced its 
activity to 3%, which prevents cells from growing on galactose media. This 
truncated protein, known as gal4D, could still bind GAL promoters, but had 
dramatically reduced GAL gene transcription, a consequence of the deleted 
activation domain. Overexpression of the mutant protein can sufficiently 
increase transcription to allow limited growth on galactose media.
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The SUG1 (SUpressor of Gal phenotype 1, mutant allele sug1-1) mutant 
allele was found to increase Gal4-mediated transcription to 55% of the WT 
level in the Gal4D strain (Figure 1.5D). This suppression was specific to the 
gal4D truncated mutant, which suggested that the identified proteins did not 
act as typical transcriptional co-activators (Swaffield et al. 1992). Sug1, now 
more commonly known as Rpt6, is a component of the 19S proteasome base, 
and more specifically is an AAA ATPase (Swaffield et al. 1995). Members of 
this group share a conserved 230bp AAA domain (Figure 1.4) which contains 
Walker A and B nucleotide binding motifs (Walker 1982).
Another 19S base AAA ATPase SUG2 (mutant allele sug2-1) mutant allele 
restored GAL transcription to 70% of the wild-type level in the Gal4D strain 
(Russell et al. 1996). It was also found that Sug2 binds directly to the 
activation domain of Gal4 (Chang et al. 2001). Sug1 and 2 are not redundant, 
and both proteins are required for full proteolytic activity of the proteasome 
(Russell et al. 2001).
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Figure 1.4 -  Domain Organisation of Sug1 and Sug2, and their location 
in the 26S Proteasome
1.5.3 A Non-proteolytic Role of the 19S Proteasome
The association of these ATPases with the proteasome suggested that 
defective proteolysis due to loss of Sug activity could be the cause of the
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suppressed phenotype. Reduced proteolysis leading to accumulation of the 
less potent Gal4D transcriptional activator, or another protein(s) could be 
responsible for reinstating transcriptional activation, as overexpression of 
Gal4D can partly suppress the defective growth on galactose phenotype. 
However, proteolysis-defective mutants did not suppress the Gal4D 
phenotype, which clearly indicated that defective proteolysis was not the 
cause of Gal4D suppression, and the molecular mechanism of transcriptional 
co-activation has subsequently been deduced (Nalley et al. 2006; Russell and 
Johnston 2001). The suppressive effect varies between different mutant 
Sug1/2 alleles with different point mutations, and an elevated level of gal4D 
protein was found in non-suppressive alleles such as sug1-20. This 
suggested proteolysis was not responsible for the altered transcriptional 
regulation of GAL genes.
Specific Sug1 mutant alleles were also found to suppress a temperature 
sensitive phenotype of a strain containing the cdc68-1 mutation (Xu et al. 
1995). WT Cdc68 protein is required for the transcription of many genes and 
has been found to interact genetically with the transcriptional elongation 
factors TFIIS and Spt4. (Orphanides et al. 1999) Cdc68 also plays a pivotal 
role in the Gi/S cell cycle transition in S. cerevisiae. It was found that the 
sug1-1 allele did not have a suppressive effect on the cdc68-1 mutant 
phenotype, but another allele, sug1-20, which had a mutation in a more highly 
conserved residue in the AAA domain, was able to restore transcription of 
Cdc68-activated genes. This shows another allele-specific effect of the sug 
mutants. It should also be noted that sug1-1 in an otherwise WT genetic 
background shows no significant visible phenotype whereas sug1-20 in an 
otherwise WT background exhibits severe temperature sensitivity, a further 
example of allele-specificity.
Cdc68 co-immunoprecipitates with the 19S, suggesting a physical interaction 
(Ferdous et al. 2001). Cdc68 is a known transcriptional elongation factor and 
it was discovered that the mutant sug alleles had an elongation defect from 
their sensitivity to 6-azauracil (6-AU), an agent which causes a severe growth 
defect in elongation-defective strains by reducing intracellular GTP levels. In
24
vitro studies showed that elongation was inhibited by introduction of a Sug1 
antibody or by heat-inactivation of a sug1-20 mutant allele, but the defect was 
rescued by addition of purified 19S (Ferdous et al. 2001). This effect did not 
involve proteolysis, as addition of lactacystin, a potent inhibitor of proteasome- 
dependent proteolysis, or mutation of subunits of the 20S core did not affect 
transcription. These discoveries revealed a second non-proteolytic role of the 
19S proteasome in transcription, this time regulating elongation instead of 
transcriptional initiation via Gal4.
1.5.4 Regulation Through Monoubiquitylation
A non-proteolytic function of the proteasome in transcriptional control was 
investigated. The proteasomal ATPases have a role in recruiting the 
chromatin-modifying SAGA acetyltransferase complex to promoters during 
transcription (Lee et al. 2005), and provide a link between histone H2B 
monoubiquitylation, which recruits the proteasome to the promoter region, and 
histone H3 methylation, which is abolished by Sug mutation (Baker and Grant 
2005; Ezhkova and Tansey 2004). However, none of these functions could 
explain the suppressive effect of the sug mutants, as the mutations are 
recessive.
The DNA binding dynamics of Gal4 was determined using an artificial GST- 
Gal4-VP16 transcriptional activator and purified proteasome (26S or 19S). It 
was found that the 19S was able to rapidly destabilise Gal4-DNA binding in 
the presence of competitor DNA via a direct interaction with the VP16 
activation domain using ATP-hydrolysis (Figure 1.5A). This involved a rapid 
on-off cycling mechanism, so was only evident in the presence of competitor 
DNA. This observation resolved the issue of Gal4D suppression by 19S 
mutants, as 19S interaction with Gal4’s activation domain is required for Gal4- 
DNA dissociation and Gal4D lacks an activation domain. It remained unclear 
how Gal4 could maintain stable binding in order to activate transcription when 
required due to the constant presence of nuclear-localised proteasome 
(Ferdous et al. 2007).
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It is known that for effective proteasomal degradation to occur the protein 
substrate must be tagged by a K-48 polyubiquitin chain comprising of at least 
four ubiquitin monomers (Thrower et al. 2000). Monoubiquitination of certain 
factors has been shown to have a regulatory role, without targeting them for 
proteasomal degradation. The monoubiquitination event has been shown to 
increase the potency of some factors, including VP16 (Salghetti et al. 2001), 
and the human HIV-1 transactivator and CTIIA (Bres et al. 2003; Greer et al. 
2003), which shows the mechanism is conserved in higher eukaryotes. This 
dual function of the UPS in transcriptional control implicates the initial 
ubiquitination as a licensing event, activating the transcription factor to induce 
transcription, but also beginning its finite functional lifespan. The single 
ubiquitin allows ubiquitin chain formation which ultimately triggers 
proteasomal degradation. This model ensures an appropriate turnover of 
transcription factors, and controls their duration of function. This duration of 
function can be further regulated by the action and balance of deubiquitinases 
and ligases.
Two possible models have been devised for this phenomenon. The ‘timer’ 
model assumes monoubiquitination is the licensing event to activate the 
activator, thus driving transcription until the ubiquitin chain contains at least 4 
monomers and the activator is proteasomally degraded. This model was 
deduced using Gal4 (Gonzalez et al. 2002). The ‘black widow’ model 
suggests that activator ubiquitination occurs after transcriptional induction, 
and is a consequence of the RNA polymerase complex interacting with the 
activator, which is thought to tag the protein ready for ubiquitin-dependent 
degradation, based on a study conducted on the Gcn4 transcription factor 
(Chi et al. 2001). It is possible that different factors use different mechanisms 
for transcriptional control via ubiquitination.
The model transcriptional activator Gal4-VP16 was incubated with a HeLa 
nuclear extract and it was found that the DBD of the activator that was stably 
bound to DNA had been post-translationally modified with a single ubiquitin, in 
an ATP-dependent manner. This monoubiquitinated form was resistant to 
19S-mediated destabilisation. A Gal4 mutant designated Gap71, which has
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three point mutations in its DBD; S22D, K23Q and K25F, is unable to be 
ubiquitinated. It was found that this mutant was hypersensitive to 
destabilisation from DNA binding in vitro and in vivo under inducing 
conditions, where galactose was the sole carbon source (Figure 1.5E). Fusing 
Ubiquitin to the N-terminal of Gap71 can allow it to stably bind to DNA, which 
confirmed the conclusion that the presence of a single ubiquitin is required for 
stable DNA binding (Ferdous et al. 2007).
In the Gal4D mutant it was found that the 19S can still bind to the remaining 
part of the activation domain (Figure 1.5C). The increased sensitivity to 
destabilisation is due to its inability to be efficiently ubiquitinated both in vitro 
and in vivo, but like Gap71, an N-terminal genetic fusion of ubiquitin re­
established stable DNA binding. This suggests that a recognition sequence 
for the E3 ubiquitin ligase was also present in the activation domain, in 
addition to the 19S-interaction domain (Archer et al. 2008b). It was discovered 
that the covalently attached ubiquitin on Gal4 DBD interacts directly with the 
Rpn1 and Rpt1 subunits of the 19S base preventing dissociation from DNA 
via an allosteric process. The ubiquitin is thought to limit the interaction time 
between the proteasome and Gal4, therefore preventing a conformational 
change and activator-promoter dissociation (Archer et al. 2008a);(Kodadek).
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Figure 1.5 - Role of the 19S and Monoubiquitination in Transcriptional 
Control. A; Under non-inducing conditions (another carbon source other than 
galactose available) and in a W T strain, Gal4 transiently binds to GAL 
promoters, which is destabilised by the 19S. B; Under inducing conditions 
(galactose as the sole carbon source) and in a W T strain, Gal4’s DBD is 
monoubiquitinated by an unknown E3 ubiquitin ligase, which prevents 
destabilisation by the 19S, allowing GAL transcription to occur. C; In the 
Gal4D mutant the bound protein is more susceptible to 19S destabilisation 
and cannot be ubiquitinated, so GAL transcription cannot occur. D; In sug1-1 
or sug2-1 19S mutant in a Gal4D strain, GAL transcription is reinstated as the 
19S can no longer destabilise Gal4 binding. E; The Gap71 mutant cannot be 
ubiquitinated, so stable binding cannot occur and GAL transcription cannot 
occur.
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1.5.5 NER and the UPS
Many proteins contain domains that can interact with ubiquitin, known as 
ubiquitin-associated (UBA) domains. Many of these UBA-containing proteins 
are directly involved in the ubiquitin-proteasome dependent protein 
degradation pathway, however they have also been found in kinases involved 
in signal transduction, and in the NER protein Rad23. UBA domains span 
approximately 40 amino acids and have a conserved sequence from yeast to 
higher eukaryotes (Bertolaet et al. 2001). Rad23 contains two UBA domains, 
an internal and a C-terminal UBA domain, which are not required for its 
interaction with Rad4 and are dispensable for its function in NER (Masutani et 
al. 1997; Sugasawa et al. 1997). It is thought that these domains allow Rad23 
and similar proteins to act as scaffold proteins, to facilitate interaction between 
the proteasome and proteins targeted for destruction.
Many of these scaffold proteins also contain N-terminal ubiquitin-like domains 
(UBL) domains, which span approximately 80 amino acids, and although have 
limited sequence homology to ubiquitin, they adopt a typical ubiquitin fold 
(Walters et al. 2002). This further facilitates interaction with the proteasome 
(Schauber et al. 1998). In most cases, these domains can be replaced by the 
sequence of ubiquitin without affecting the protein’s function. The first UBL 
domain-containing protein discovered in yeast was Rad23. Other examples of 
UBL domain proteins are Dsk2 and Ddi1, which also harbour ubiquitin-binding 
domains. It was found that the presence of this domain was required for 
efficient NER (Hiyama et al. 1999).
Rad23 binds to the Rpn1 subunit of the 19S proteasome base (Saeki et al.
2002), an interaction required for its role in NER. Specific mutations in the 
19S base AAA ATPases can suppress the UV-sensitivity of Arad23 strains. 
This shows that in WT cells the 19S negatively regulates NER, and this 
inhibition is prevented by Rad23. When both activities are deleted NER is 
partly restored. This suppressive effect does not occur in Arad23 strains with 
proteasomal mutations causing severe defects in proteolysis, concluding that
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the proteasome has a non-proteolytic regulatory activity in NER via Rad23 
(Gillette et al. 2001; Russell et al. 1999).
Further interplay between the UPS and NER is evident by the E3 ligase 
activity of the GG-NER complex. The novel E3 ligase complex comprised of 
elongin Elc1, cullin Cul3, Rad16 and Rad7, which interacts with the complex 
via its SOCS (suppressor of cytokine signalling) domain (Gillette et al. 2006). 
One target of this E3 complex is the Rad4 NER factor, which functions in a 
complex with Rad23 in damage recognition. Contrary to initial reports that 
Rad4 accumulated in response to DNA damage (Lommel et al. 2002; Ng et al.
2003), it was found that Rad4 was ubiquitinated and subsequently degraded 
in a proteasome-dependent manner following UV radiation (Gillette et al. 
2006).
A rad7 mutant strain with two point mutations in its SOCS domain was unable 
to facilitate the DNA damage-dependent ubiquitination of Rad4. Surprisingly, 
this socs mutant exhibited no increased UV sensitivity compared to the WT 
strain, however additionally deleting RAD23 resulted in a mutant more UV- 
sensitive than the Arad23 RAD7* strain. These UV sensitivities could be 
partially suppressed by introducing specific 19S proteasome mutants. It was 
concluded that the Rad7 E3 ligase-dependent ubiquitination of Rad4 and the 
Rad23-19S proteasome interaction were functioning in two separate 
components of the NER response, the latter of which does not require de 
novo protein synthesis for effective CPD removal to occur. It was also shown 
that Rad4 ubiquitination but not its subsequent degradation was required for 
its role in the DNA damage response. These observations presented a 
potential role of NER factors and the UPS in the DNA damage response 
(Gillette et al. 2006).
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1.6 The Budding Yeast Cell Cycle
In order for cells to replicate efficiently a specific progression of events must 
occur in a meticulously orchestrated order. Evolution has resulted in 
progressively more elaborate mechanisms for regulating the cell cycle, 
however the underlying basis of cell growth-DNA replication-cell division 
remains a well-conserved process. Unlike many organisms, S. cerevisiae 
cells replicate asymmetrically. The process of bud emergence and maturation 
into a daughter cell facilitates fairly accurate estimation of cell cycle stage 
through microscopy, which is a powerful tool to investigate the eukaryotic cell 
cycle.
The eukaryotic cell cycle can be divided into 4 distinct phases; growth gap 
phase 1 (Gi), DNA synthesis phase (S), growth gap phase 2 (G2) and mitotic 
cell division (M). It is imperative that these phases occur only once per 
replication cycle, and at the correct time in order to replicate the genome 
once, thus forming a genetically identical daughter cell. Overall cell cycle 
regulation is governed by the progressive formation and dissociation of 
specific dimeric complexes involving a cyclin and a catalytic subunit, a cyclin- 
dependent kinase (CDK). S. cerevisiae has 9 cyclins (Cln1-3 and Clb1-6) and 
1 CDK (Cdc28) (Hartwell 1991), which heterodimerise at specific stages of the 
cell cycle. The catalytic activity of Cdc28 is only active when in complex with a 
cyclin (Evans et al. 1983). Cln1, 2 and 3 are known as the Gi cyclins, and are 
involved in progression though late Gi into S-phase. Deletion of all three Gi 
cyclins causes cells to arrest indefinitely in Gi (Cross 1990). The second class 
of cyclins are known as B-type cyclins, which refers to Clb1-6, of which Clb1-4 
are involved in assembly and maintenance of the mitotic spindle. These 
cyclins are active during G2 phase (Richardson et al. 1992). Clb5 and 6 are 
expressed earlier in the cell cycle, and are involved in S-phase entry and 
progression (Schwob and Nasmyth 1993). Although the cell cycle appears to 
be regulated centrally by these few proteins, the full complexity of regulatory 
pathways remain to be elucidated. Global transcription studies identified a list 
of 800 genes that have periodically varied transcription during the cell cycle, 
however this doesn’t account for additional factors and helper proteins, which
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may be activated by post-translational modification or complex formation 
(Spellman et al. 1998). Many of these gene promoters contain common 
elements, which bind transcription factors that are activated by cyclin-CDK 
complexes.
Spindle
Formation
Nuclear
Migration
Chromosome 
Segregation, 
i Nuclear 
\  Division
DNA
Replication
Cytokinesis
START
Cell Growth
Figure 1.6 - The Budding Yeast Cell Cycle Haploid yeast cells start in Gi, 
then progress to S phase to begin bud emergence and DNA replication. Bud 
maturation and nuclear migration occurs in G2, and spindle formation, nuclear 
segregation, division and finally cytokinesis occurs during M phase. This 
produces genetically identical mother and daughter cells. Adapted from 
(http://mpf.biol.vt.edu/research/budding_yeast_model/pp/).
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1.7 The DNA Damage Checkpoint Response
Cells under the threat of DNA damage induce a co-ordinated metabolic 
response to maintain genetic integrity and continue normal growth. DNA 
damage must first be identified to trigger the DNA damage response (DDR), 
which begins a signalling cascade causing checkpoint-mediated cell cycle 
arrest and DNA repair, or programmed cell death (apoptosis). Only when the 
damage has been satisfactorily removed or tolerated can the cell resume 
growth and replication.
1.7.1 The SOS Response in Prokaryotes
Perhaps the most primitive example of a cellular response to DNA damage is 
E. coifs SOS response system, which allows cells to survive significant 
amounts of DNA damage without compromising genomic integrity. The SOS 
response was first described in the mid 1970s by (Radman 1975). Two key 
proteins were identified, the LexA repressor, which remains bound to the SOS 
box of genes under non-inducing conditions, and the RecA filament inducer 
which binds to ssDNA following DNA damage. The SOS gene set includes 
over forty genes involved in protection, repair, replication, mutagenesis and 
metabolism of DNA.
Regulatory proteins are required for RecA DNA binding, as ssDNA binding 
protein prevents RecA binding when damage is not present. The RecFOR 
proteins are required to load RecA onto ssDNA gaps resulting from damage 
processing of lesions such as those induced by UV radiation, and RecBC is 
required for ssDNA created as a result of processed dsb. The LexA repressor 
is cleaved in response to DNA damage (Figure 1.7).
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Figure 1.7 - The Bacterial SOS Response The LexA repressor binds at SOS 
promoters to repress SOS transcription under non-inducing conditions. DNA 
damage is processed to form stretches of ssDNA, which becomes bound by 
RecA. RecA binding triggers LexA cleavage and activation of SOS genes, 
including LexA. Increased LexA transcription functions as a negative feedback 
loop, as does Dinl and RecX, which affect RecA filament stability. Adapted 
from (Michel 2005)
SOS gene induction follows a specific order, which begins with the uvrB, C 
and D genes, required for bacterial NER, followed more slowly by genes 
involved in homologous recombination repair. SfiA is also induced, which 
inhibits cell division, allowing repair to occur sufficiently. If damage persists, 
the mutagenic DNA repair polymerase Pol V is induced late in the SOS 
response as a final strategy to maintain the genome and promote survival.
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The SOS response is tightly regulated to avoid prolonged delay of cell 
division, and use of mutagenic error-prone polymerases. LexA is an SOS 
gene, which provides rapid termination of the response when damage is 
removed. The transcription of Dinl and RecX is also SOS-induced and 
negatively affects the stability of the RecA filament thus adding another level 
of SOS regulation (Janion 2008; Michel 2005). This regulation provides an 
effective feedback loop to reset the system when DNA damage is no longer a 
threat to cellular integrity.
Although the evolution of far more complex checkpoint responses in 
eukaryotes has superseded the SOS response, the bacterial system displays 
the importance of coordinating cell cycle arrest for DNA repair following 
damage from the simplest to most complex organisms on earth.
1.7.2 The Eukaryotic DNA Damage Checkpoint Response
Sophisticated surveillance mechanisms have evolved in eukaryotic cells to 
ensure damage to cellular components, particularly genomic DNA, is dealt 
with effectively. These pathways are also highly conserved between species, 
and have been well studied in budding and fission yeast, and humans. Unless 
otherwise stated the pathways described here correspond to the budding 
yeast S. cerevisiae system.
The DNA damage checkpoint response requires the co-ordination of several 
different metabolic systems within the cell, as many normal biological 
processes cannot continue in the presence of DNA damage (Weinert and 
Hartwell 1988). In general, the DNA damage checkpoint response triggers a 
kinase signalling cascade involving four main factors; sensors, transducers, 
mediators and effectors. Sensor proteins identify the damage, and convey the 
signal to transducers and mediators, which localise to the damage site. The 
signal is then passed along to effector proteins, which activate appropriate 
pathways that can initiate cell cycle arrest, DNA repair or programmed cell 
death. This ultimate response depends greatly on the severity and type of 
damage, and cell cycle stage (Niida and Nakanishi 2006). DNA checkpoints
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can also be divided into three stages; activation, maintenance and 
inactivation. These three stages are required for effective induction of the 
checkpoint response, allowing sufficient time for the necessary 
repair/maintenance processes to occur, and promoting re-entry into a 
proliferative growth cycle when it is ‘safe’ and viable to do so. This is achieved 
mostly by cell cycle control. Reviewed in (Harrison and Haber 2006) and 
summarised in Figure 1.8.
1.7.3 The Mec1 -Dependent Checkpoint Response
The eukaryotic DNA damage checkpoint response is coordinated by 
phosphatidylinositol 3’ kinase-like kinases (PIKK). The human PIKK are ATM 
(Ataxia-Telangiectasia Mutated), which functions primarily as a result of dsb, 
and ATR (Ataxia-Telangiectasia Mutated and Rad3-related), which responds 
to lesions producing regions of single-stranded DNA (ssDNA) (Abraham 
2001). S. cerevisiae also has two checkpoint PIKK. Mec1 (related to ATR) is 
responsible for the main checkpoint response, and is activated when ssDNA 
is sensed, a result of most if not all DNA lesions, however in most cases some 
processing is required to produce ssDNA. The other yeast checkpoint PIKK is 
Tell (related to ATM), which mainly detects blunt-ended or minimally 
processed dsbs. These PIKK have a conserved C-terminal catalytic domain, 
which usually preferentially phosphorylates lipids, however no lipid substrates 
of the PIKK discussed here have been discovered (Toker and Cantley 1997). 
Although both organisms have two PIKK that have similar functions they have 
several fundamental differences because human ATR and ATM both appear 
to have significant roles in the checkpoint response, whereas yeast Mec1 
plays a far superior role to Tell in the damage response.
1.7.3.1 Generation of ssDNA
ssDNA is an intermediate result of NER, BER, dsb repair and replication fork 
stalling, which is why it is the main target of M ed for checkpoint activation 
(Carr 2002). ssDNA becomes bound by RPA, the single-strand binding 
protein complex, which has a role in recruitment of checkpoint factors.
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Generation of ssDNA at dsb requires enzymatic processing of dsDNA. This is 
done via exonucleases or helicase/endonuclease complexes. The yeast MRX 
complex (comprised of Mre11-Rad50-Xrs2) is responsible for some of this 
processing, particularly in G2-synchronised cells (Diede and Gottschling 
2001).
1.7.3.2 Damage Sensing and Checkpoint Activation
The most upstream event of checkpoint activation is recruitment of the 
checkpoint PIKK to DNA, which triggers a signal cascade. When active, Mec1 
binds DNA as a heterodimer with Ddc2, and this interaction is required for 
DNA binding and occurs independently of DNA damage. It is not thought that 
Mec1 is activated by damaged DNA, but is simply recruited to damage sites 
by Ddc2 (Paciotti et al. 2000). RPA-bound ssDNA is required for Mec1/Ddc2 
recruitment, shown by ChiP using an RPA mutant that cannot interact with 
Ddc2 (Zou and Elledge 2003). It is unclear however whether the RPA-Ddc2 
interaction requires M e d , but the evidence currently supports a requirement 
of the heterodimer for binding RPA coated ssDNA (Ball et al. 2005; Melo et al.
2001). Ddc2 can bind directly to DNA via a region of basic residues, which is 
essential for DNA interaction and checkpoint activation, but not required for 
M ed interaction (Rouse and Jackson 2002). Eventual removal of the M ed- 
Ddc2 complex is imperative for release from checkpoint-induced arrest. It has 
been shown that overexpression of Ddc2 causes a permanant arrest, 
however overexpression of M ed does not produce the same effect (Clerici et 
al. 2001).
Rad 17, Mec3 and Ddd form a heterotrimer known as the 9-1-1 complex or 
checkpoint clamp. The 9-1-1 complex also has a pivotal role in checkpoint 
activation and cell cycle arrest and is loaded onto the DNA by the checkpoint 
clamp loader at dsb in an RPA dependent manner. The checkpoint clamp 
loader is composed of Rad24 with Rfc2-5, a modified PCNA clamp loader 
complex (Ellison and Stillman 2003). The 9-1-1 complex functions as an 
alternate damage sensor as it is recruited to damage foci independently of
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Mec1, Ddc2, Rad53 or Rad9 (Kondo et al. 2001). The role of the 9-1-1 clamp 
in checkpoint activation is not yet clear, but it is thought that it recruits 
substrates for phosphorylation by Mec1 because Rad53 and Rad9 
phosphorylation is depleted in 9-1-1 mutants (Emili 1998). It is believed that 
the Tell pathway is less dependent on the 9-1-1 complex, as Tell is still able 
to phosphorylate Rad9 and Rad53 in 9-1-1 defective cells (Giannattasio et al.
2002).
1.7.3.3 The Role of Tell
Although human ATM has a major role in checkpoint activation in response to 
dsb, yeast Tell has a secondary role in the checkpoint response. It is 
proposed that inactive Tell is sequestered in cells as a multimer, which 
blocks its kinase domain. Upon DNA damage, autophosphorylation and 
monomerisation activates T e ll. Tell appears to be recruited to blunt or 
unprocessed ends of dsb independently of RPA. DNA binding is facilitated by 
the MRX (Mre11-Rad50-Xrs2) complex, which is phosphorylated by Tell on 
the Mre11 and Xrs2 subunits in response to DNA damage (Grenon et al.
2001; Usui et al. 2006). Sae2 also regulates the action of MRX at dsb by 
stimulating its nuclease activity (Mimitou and Symington 2008). Following 
Tell-dependent checkpoint activation, Rad53 becomes phosphorylated and 
the same downstream pathway is triggered as in Mec1-dependent checkpoint 
activation.
Although Tell appears to respond differently to Mec1, they share some 
overlapping function, as increasing levels of Tell can suppress the sensitivity 
and lethality of Amec1 strains (Sanchez et al. 1996).
1.7.3.4 Signal Transduction Following Checkpoint Activation
Following detection of DNA damage, a kinase cascade transduces the 
checkpoint activation signal to affect the required target proteins. Rad53, a 
Chk2-family kinase, is the main signal transducer, and becomes 
phosphorylated in the presence of M ed and the adaptor protein Rad9. Rad9
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phosphorylation by Mec1 or Tell allows it to act as a scaffold protein, thus 
facilitating the Mec1 or Tell interaction with Rad53’s phospho-threonine 
binding FHA domains resulting in Rad53 autophosphorylation (Durocher et al. 
2000; Sun et al. 1998). Rad53 phosphorylation sites were identified by 
progressive mutation of TQ and SQ motifs. TQ and SQ motifs are a structural 
hallmark of DNA damage responsive proteins and present likely sites for 
phosphorylation (Traven and Heierhorst 2005). Rad53 contains an N-teminal 
cluster of TQ sites and a C-terminal cluster of SQ sites. Mutation of both 
clusters eliminates most phosphorylation by M ed in vitro. The signalling 
target Dun1 FHA domain interacts with the TQ cluster, and is not 
phosphorylated in TQ cluster mutant cells. Rad53 can also bind to its own 
FHA domain, thus allowing oligomerisation, and facilitating 
autophosphorylation in response to DNA damage (Lee et al. 2003). Full 
activation of Rad53 is also dependent upon nuclear import, which it achieves 
via interaction with the nuclear import factors Srp1 and Kap95. Without this 
interaction Rad53 accumulation does not occur fully following exposure to the 
DNA damaging agent methane methylsulphonate (MMS) (Smolka et al.
2005).
Effective function of the adaptor protein Rad9 in the checkpoint response 
requires homodimer formation via its C-terminal BRCT motifs (Soulier and 
Lowndes 1999). In addition to facilitating Rad53 phosphorylation, it is also 
required for Chk1 activation, however Chk1 does not have an FHA domain, so 
a different function of Rad9 facilitates Chk1 phosphorylation 
(Blankley and Lydall 2004). Rad53 is also activated in response to replication 
stress under non-DNA damage conditions. This activation requires Mrc1 
instead of Rad9, which becomes hyperphosphorylated in response to 
replication blocks (Alcasabas et al. 2001).
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Figure 1.8 - The DNA Damage Checkpoint Response in S. cerevisiae
ssDNA or dsDNA breaks as a result of DNA damage recruit the Mec1 or T e ll 
checkpoint kinases, which begin the DNA damage checkpoint response 
kinase cascade. The adaptor protein Rad9 becomes phosphorylated, which 
mediates Rad53 phosphorylation, which affects downstream targets. Dun1 is 
activated which results in elevated nucleotide pools. Inhibition of Cdc5 and 
APC/Cdc20 results in cell cycle arrest. Mec1 also activates Chk1, which 
activates Pds1 and further promotes G2 arrest. Figure adapted from (Harrison 
and Haber 2006).
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1.7.3.5 Checkpoint-Induced G2 Arrest
DNA damage checkpoint activation can arrest cell cycle progression in G2 by 
activating the anaphase inhibitor Pds1. Pds1 becomes hyperphosphorylated 
in response to damage, which requires Mec1, Rad9 and Chk1 but not Rad53 
(Cohen-Fix and Koshland 1997). During normal proliferative growth Pds1 
functions as an inhibitor of anaphase onset during spindle assembly. 
Progression into anaphase requires ubiquitin-dependent degradation of Pds1 
by the anaphase-promoting complex (APC) with Cdc20 specificity factor for 
mitosis to occur, however it only becomes hyperphosphorylated during the 
DDR. This Chk1 mediated phosphorylation prevents Pds1 from Cdc20-APC- 
dependent proteolysis in vivo. Achkl and Apds1 mutants exhibit a checkpoint 
defect, and display a significant degree of epistasis. Phosphorylation site- 
defective pds1 mutants are also strongly checkpoint defective, as Pds1 is not 
immune to ubiquitin-dependent degradation (Agarwal et al. 2003; Wang et al.
2001). Pds1 stability in vivo is also promoted by Rad53 by blocking the Pds1- 
Cdc20 interaction possibly by Rad53-dependent or protein kinase A (PKA) 
Cdc20 phosphorylation (O'Neill et al. 2002; Searle et al. 2004). Regulation of 
Cdc20 levels is also seen in the yeast S-phase and spindle assembly 
checkpoint to control cell cycle progression.
Although Rad53 is known to be an upstream regulator of Pds1, genetic 
evidence suggested that it had other downstream targets too, as the Arad53 
mutant had a more severe checkpoint-defective phenotype than Apds1 cells 
(Gardner et al. 1999). Rad53 is known not only to regulate anaphase entry via 
Pds1, but also to control mitotic exit, thus having a role in checkpoint 
maintenance as well as activation. It is thought to maintain CDK activity during 
the checkpoint response via inhibition of Cdc5, which normally promotes 
mitotic progression via inhibition of the mitotic exit network (MEN) inhibitor, 
the Bub2/Bfa1 complex (de Bettignies and Johnston 2003; Geymonat et al.
2003). It is probable, but as yet unknown if Rad53 has other cell cycle-related 
targets, however the combined Abub2Apds1 knockout is as checkpoint- 
defective as Arad53 cells. The null mutant of another known target of Rad53, 
the Dun1 kinase exhibits a similar checkpoint defective phenotype. This
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implies that it is downstream targets of Dun1 rather than other targets of 
Rad53 that contribute mainly to its faulty checkpoint response (Gardner et al. 
1999).
1.7.4 Regulation of Nucleotide Pools
Nucleotide pools become significantly elevated as a downstream effect of the 
DNA damage checkpoint response. This occurs by regulation of activity of the 
ribonucleotide reductase (RNR) complex, which catalyses the rate-limiting 
step of dNTP synthesis, the monomeric precursors of DNA. RNR upregulation 
is brought about by Dun1, a downstream effector kinase of the Mec1 
dependent DNA damage checkpoint pathway. Dun1 facilitates degradation of 
Sml1, the RNR inhibitor, which activates the RNR complex. Further regulation 
of the RNR pathway is explored in more detail in Chapter 5 and also see 
Figure 5.1.
Mec1 dependent Sml1 degradation is an essential process even in the 
absence of DNA damage, as elevation of nucleotide pools is also essential 
during normal S-phase for DNA synthesis. This phenomenon is evident in the 
rescued survival of Amec1Asml1 cells, whereas Amecl cells are inviable.
1.7.5 DNA Damage Checkpoint-dependent Chromatin Modification
The DDR also causes Mec1/Tel1 dependent phosphorylation of the histone 
variant H2AX, termed y-H2AX when phosphorylated. y-H2AX is found in the 
region flanking of dsb, approximately 50-1 OOkb in yeast and up to 1Mb in 
mammals (Shroff et al. 2004). Yeast cells that cannot synthesise y-H2AX are 
sensitive to DNA damage and display a mild Gi/S checkpoint defect (Downs 
et al. 2000). Its role in the DDR is thought to involve recruitment of the 
chromatin remodelling complexes Ino80, Rvb1, NuA4 and Swr1 to the dsb, 
however these do not appear to play a role in the checkpoint response (Pauli 
et al. 2000).
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1.7.6 The Gi/S Checkpoint
Following DNA damage, human cells can orchestrate a Gi arrest by activating 
the tumour suppressor gene p53, which affects many cellular pathways 
including cell cyle arrest, programmed cell death and general stress response. 
Yeast do not have a p53 homologue, but S. cerevisiae can also arrest the cell 
cycle in Gi in response to DNA damage. In order to trigger a Gi/S checkpoint 
and delay S-phase onset a threshold dose of ~30Jm'2 UV is required. S- 
phase delay can be reduced by exposing the UV-irradiated cells to visible 
light, thus allowing photoreactivation to occur, which suggests that the 
presence of CPDs have a role in Gi/S checkpoint maintenance (Goodin et al. 
1971). It was suggested that NER intermediates were required for Gi/S 
checkpoint activation, however due to the fairly large UV dose required to 
invoke the Gi/S checkpoint, the NER process is considered insufficient to be 
solely responsible for checkpoint activation (Neecke et al. 1999). It is most 
likely that the Gi/S checkpoint is also triggered by dsb or UV-induced DNA 
gaps rather than common UV-induced lesions. This was supported by the 
discovery of mutants that have a defective Gi/S checkpoint but are UV- 
resistant (Paciotti et al. 2001). The Gi/S checkpoint fails to be activated in a 
Arad 14 NER-defective strain so cells arrest during S-phase due to 
accumulation of replication/recombination intermediates (Neecke et al. 1999). 
It is thought that the Gi/S checkpoint is activated by Rad53-dependent 
inhibition of CLN1/2 transcription via Swi6 phosphorylation, thus delaying S- 
phase onset (Sidorova and Breeden 1997).
1.7.7 Cellular Responses to UV -  The Postreplication Checkpoint
Contrary to past belief, which considered the yeast checkpoint response as a 
cell cycle arrest between Gi/S or G2/M phases, it was discovered that this 
was only a response to relatively high doses of UV (>20Jm'2) that induced cell 
cycle arrest. It was found that a lower dose of UV (~5Jm'2) instigated a 
different response, termed a postreplication checkpoint (Callegari and Kelly
2006). It was proposed that this level of UV was more representative of 
environmental solar radiation. Although virtually all solar UV that penetrates 
the earth’s atmosphere is >290nm and laboratory UV lamps emit 254nm
43
radiation it was found that the same DNA damage was induced (Cadet et al. 
2005), and the same genes are required to survive the different wavelengths 
(Harm 1979).
Following a sunlight-comparable dose of UV, instead of arresting before S- 
phase, cells carried the damage through bulk DNA replication, then delayed 
cell cycle progression. The length of the second cell cycle was also found to 
be highly dependent on cell cycle phase at the point of irradiation. The first 
cell cycle after irradiation appeared to progress normally, but the second and 
third cell cycles were dramatically extended. This was also found to be the 
case in budding yeast, which did not exhibit delayed bud emergence, but bud 
emergence during the next cell cycle was delayed (Callegari and Kelly 2006).
During the postreplication checkpoint, the concept of damage bypass or 
damage tolerance is pivotal for cell cycle progression (Friedberg 2005a). This 
adaptation is also known as translesion synthesis (TLS), and involves 
switching between different DNA polymerases to cope with damaged DNA. 
These polymerases, among other TLS genes belong to the RAD6 epistasis 
group of DNA damage-responsive genes. Rad6 is an E2 ubiquitin-conjugating 
enzyme (Jentsch et al. 1987), which forms a complex with Rad 18, an E3 
ubiquitin ligase (Bailly et al. 1997). This complex targets PCNA for 
monoubiquitination at Lys164, a modification that allows an alternate 
polymerase to be loaded onto the DNA, allowing damage bypass (Hoege et 
al. 2002). PCNA can also be polyubiquitinated by the Rad6-Rad18 complex in 
order to function in error-free TLS. The Ubc13-Mms2-Rad5 complex is also 
required for PCNA polyubiquitination to activate the error-free TLS pathway. 
This complex also contains E2 ubiquitin-conjugating (Ubc13-Mms2), and E3 
ubiquitin-ligase (Rad5) activities, which target Lys63 of ubiquitin instead of 
Lys48. Rad5 can also interact with Rad18, which choreographs contacts 
between the two ubiquitin-conjugating complexes (Brusky et al. 2000). The 
Ubc13-Mms2-Rad5 dependent TLS pathway is error-free, and RAD30 
encodes a polymerase, which has a central role in the alternate error free TLS 
pathway. A third pathway also exists, which involves the REV1, REV3 and
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REV7 genes, but this pathway is error-prone and therefore mutagenic 
(Prakash et al. 2005).
1.8 The Current Study
The aim of the current study is to further uncover the complex interplay 
between factors involved in NER and the UPS. The main focus of this has 
been regarding the role of DNA damage-dependent ubiquitylation of the NER 
factor Rad4, resulting in its subsequent degradation. This follows on from 
work conducted by Gillette et al., which identified Rad7’s SOCS domain, and 
its role as an E3 ubiquitin ligase, and partially characterised the mutant 
phenotype of the psocs strain, which cannot ubiquitinate Rad4. This study has 
striven to further characterise the psocs strain, with regard to UV sensitivity 
and cell cycle progression, and to identify the role of the Rad4-Rad23 
complex in DNA damage-dependent global transcription.
Following identification of potential transcriptional targets of the Rad4-Rad23 
complex involved in the DNA damage checkpoint response, particularly the 
RNR branch of the pathway, the next objective of the study was to create 
mutants of these factors and use these genetic tools to further characterise 
the role of Rad7’s E3 ligase, thus uncovering its role in the DNA damage 
response.
The initial aim of the project focussed on another GG-NER factor, Abf1. It was 
speculated that interaction between Abf1 and specific subunits of the 19S 
proteasome had a regulatory role in DNA replication and DNA repair, 
dependent on A b fl’s DNA binding domain. This was conducted using various 
mutant alleles to identify phenotypic variations on the mutant strains.
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2 Materials and Methods
2.1 Storage and Growth Conditions
All equipment and growth media was sterilised appropriately by autoclaving, 
and all manipulations were conducted under aseptic conditions.
Yeast strains were grown, when required, in appropriate liquid medium at 
30°C or 25°C, and were stored for short periods on solid media at 4°C or RT. 
Yeast strain genotype and source are described in each corresponding results 
chapter.
Large amounts of cell culture were produced by growing a single colony from 
a plate in a 5ml preculture overnight to stationary phase, diluting this to O.D6oo 
of 0.1 in 50ml media and allowing it to grow for several population doublings 
but not reach stationary phase, then diluting appropriately into the required 
volume. The dilution was calculated empirically to achieve the required cell 
density for the following day.
For long-term storage, cells were grown in media to exponential phase, then 
frozen in 30% glycerol using liquid nitrogen and stored at -70°C. Prior to use, 
frozen cultures were streaked onto solid media, and allowed to grow to 
stationary phase.
2.2 Yeast Transformation
Yeast strains were transformed using the lithium acetate (LiAc)/single- 
stranded carrier DNA/polyeythylene glycol (PEG) method (Gietz and Woods
2002).
50 ml yeast culture was grown in YPD to mid/late log phase (O .D 6oo~0.6), and 
cells were harvested by centrifugation at 4 000 rpm for 3 minutes and washed 
in 50ml sterile water. Cells were resuspended in 15ml 0.1M LiAc and 1 x TE 
(0.1M Tris-HCI, 0.01 M EDTA), and incubated for 1 hour at RT on a Roller
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Mixer (Stuart). Cells were pelleted and suspended in a suitable volume of H2 O 
(100pl per 0.1 ODeoo). 10Opil cells were added to the transformation mixture 
containing 0.1M LiAc, 1 x TE, 50% PEG 3350, 15pl denatured salmon sperm 
carrier DNA, and a suitable amount of DNA, and incubated for 30 minutes at 
RT on a Mini LabRoller (Labnet). The mixture was heat-shocked at 42°C for 
15 minutes, and then cooled on ice for 3 minutes. 1ml sterile water was added 
before centrifugation at 4 000 rpm for 3 minutes, then the pellet was 
resuspended in 500jnl sterile water. 200pl of the cell suspension was spread 
onto suitable dropout media plates, which were incubated at an appropriate 
temperature for 2-3 days to allow colonies to form.
2.3 Rapid Preparation of Yeast Genomic DNA
Rapid preparation of yeast genomic DNA was employed to check the state of 
transformed cells during strain construction. Cells were grown from a single 
colony overnight in 5ml of appropriate media. Cells were then harvested by 
centrifugation for 2 minutes at 4 000 rpm in a benchtop centrifuge. The pellet 
was vortexed vigorously for 6 minutes with 300pl DNA lysis buffer, (4M Urea, 
0.2M NaCI, 0.01 M EDTA, 0.05%SDS, 0.1 M Tris-HCI) 200pl glass beads and 
200pl 1:1 phenokchloroform. The mixture was then centrifuged for 10 minutes 
at 13 000 rpm, and the upper aqueous layer was retained. To precipitate the 
DNA, 1ml 100% ethanol was added, and incubated at -20°C for at least an 
hour. The precipitate was spun for 10 minutes at 13 000 rpm and the 
supernatant discarded. The pellet was washed with 70% ethanol and dried at 
RT for 30 minutes. DNA was resuspended in 100pl water or TE.
2.4 DNA Manipulation
2.4.1 Yeast Colony PCR
Colony PCR was used to screen potential correct transformant colonies.
A small cell sample was picked from a single colony using a 10pl pipette tip 
and suspended in 12.5pl water. Then, in sealed 0.2ml tubes, cells were 
vortexed, microwaved on full power for 2 minutes, then vortexed again. The 
boiled cell suspension was used to make a 25pl PCR reaction mix (1x
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ReddyMix (Thermo) 0.16pM forward and reverse primer, to 25|al with ddH20). 
The PCR reaction was run and analysed using agarose gel electrophoresis.
2.4.2 PCR Conditions
Two PCR programs were used during this study, depending upon the 
predicted size of PCR product. For products <1.5kb, an initial denaturation 
step of 4 minutes at 95°C was employed, followed by 30 cycles of 40 seconds 
denaturation at 94°C, 50 seconds annealing at a temperature suitable for the 
primers used and 30 seconds elongation at 72°C, adding 3 seconds per 
cycle. The program was finished with a final elongation step at 72°C for 10 
minutes, then the temperature was reduced to 4°C to store the product.
In the program used for products <1.5kb, an initial denaturation step of 4 
minutes at 95°C was employed, followed by 5 cycles of 20 seconds 
denaturation at 94°C, 30 seconds annealing at 45°C and 40 seconds 
elongation at 68°C, adding 5 seconds per cycle. This was followed by 25 
cycles of 15 seconds denaturation at 94°C, 30 seconds annealing at a 
temperature suitable for the primers used and 60 seconds elongation at 72°C, 
adding 5 seconds per cycle. The program was finished with a final elongation 
step at 68°C for 8 minutes, then the temperature was reduced to 4°C to store 
the product. <1.5kb PCRs were conducted using the Expand High Fidelity 
PCR System (Roche).
2.4.3 DNA Electrophoresis
Agarose gel electrophoresis was employed on numerous occasions 
throughout the study to check the size, quality and quantity of DNA. A 1.2% 
agarose gel was mostly used, dissolved in TAE buffer with 1pl 10mg/ml EtBr 
per 100ml buffer. DNA samples were run with loading buffer (Fermentas) at 
10V/cm with an appropriate DNA marker. DNA bands were visualised using a 
UV transilluminator.
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2.5 Yeast Total RNA Extraction
The hot phenol method (Schmitt et al. 1990) was employed to extract RNA 
from yeast cells. 10ml yeast culture was grown to mid/late log phase (O .D 6oo ~  
0.6) and cells were harvested by centrifugation at 3 000 rpm for 5 minutes at 
4°C, and resuspended in 500pl RNA lysis buffer (10mM Tris-base, 10mM 
EDTA, 0.5% SDS). 500pl equilibriated phenol (pH 4.3) was added, and 
incubated for 1 hour at 65°C with regular vigorous vortexing. The lysate was 
then chilled on ice for 10 minutes, then lOOjul 3M NaAc (pH 5.2) was added, 
then the samples were centrifuged at 10 000 rpm for 10 minutes at 4°C. The 
top (aqueous) phase was then collected. 2 phenol extractions were carried 
out, by adding 500pl 1:1 phenol.chloroform, mixing, then centrifugation for 10 
minutes at 10 000 rpm at 4°C, then removing the top aqueous layer and 
repeating the process. Another extraction was performed using 
chloroform/isoamyl alcohol, and the final extract was added to 1ml 100% 
ethanol, and precipitated overnight at -20°C. RNA pellets were collected, 
washed and redissolved in 80pl ddH20 with 20pl 5x RNA loading buffer 
(0.16% saturated aqueous bromophenol blue, 4mM EDTA, 2.664% 
formaldehyde, 30% formamide, in 4x FA gel buffer (200mM 3-[N- 
morpholinojpropanesulphonic acid (MOPS), 50mM NaAc, 10mM EDTA, pH 
7.0)). RNA was stored at -80°C.
2.6 Formaldehyde-Agarose (FA) Gel Electrophoresis and Northern 
Blotting
The gel was prepared by melting 1.5% agarose in 1x FA gel buffer, and 
allowed to cool to 65°C, which was followed by addition of 1,8ml 
formaldehyde and 1jnl 10mg/ml ethidium bromide (per 100ml buffer). The gel 
was then poured and allowed to set, then 1x FA gel buffer was added, and left 
to equilibriate for 30 minutes. 20pl of each sample was loaded, and the gel 
was run for 2 hours at 70V, then briefly visualised using a UV transilluminator 
to ensure proper running and equal loading.
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Prior to transfer, a nylon based membrane (Genescreen Plus, PerkinElmer 
Life Sciences Inc) was soaked in water, then the gel, filter paper wick, 2 
sheets of filter paper and the membrane were soaked in 20x SSC (3M NaCI, 
0.3M Na Citrate 2H20 , pH 7.0) The transfer was assembled according to 
Figure 2.1, and RNA was transferred overnight. The RNA side of the 
membrane was irradiated with 254nm UV for 2 minutes to allow cross-linking 
to the membrane. The membrane was then rinsed with ddH20 , and rolled in a 
glass tube with hybridisation buffer (0.5M phosphate buffer, 7% SDS, 1% 
BSA, 1mM EDTA) at 65°C for 1 hour.
Weight (~500g)
Paper Towels
Glass Plate
Wet Filter Paper ^  Dry Filter Paper
q 6I I............ ^  Nylon Membrane
Solid Support i—  —  ^  Filter Paper Wick
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Figure 2.1 -  Setup of Equipment for Northern Blotting
2.6.1 Probe Preparation
A 50pl PCR reaction (1x ReddyMix (Thermo) 0.16pM forward and reverse 
primers) was conducted to amplify a 200-500bp fragment from the ORF of the 
required gene. A 5’ biotin-label was applied to the primer homologous to he 
non-transcribed strand. PCR reactions were checked for size and quality 
using agarose gel electrophoresis. 10pl of the PCR mix was added to 20pl 
streptavidin-coated Dynabeads (Invitrogen) in 2x BW (binding and washing 
b u ffe r-2 M  NaCI, 10mM Tris-HCI ph 8.0, 1mM EDTA), mixed by pipette and 
incubated at RT for 15 minutes, with occasional mixing. A magnetic particle 
collector (MPC) was used to extract the Dynabeads and discard the 
supernatant. The beads were washed twice with 60pl ddH20  and 
resuspended in 30pl 0.1M NaOH to denature the dsDNA. After 10 minutes
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incubation at RT, the MPC was used to discard the supernatant and the 
beads were washed twice with ddH20, then resuspended in 10jnl 1x BW. 2pl 
of non-biotinylated primer (10pM) was added, and the mix was heated to 
65°C for 2 minutes, then allowed to cool slowly to RT. Bound matter was 
retrieved and the supernatant discarded, followed by 2 washes with ddH20. 
The beads were finally resuspended in 17.2pl ddH20  and the following were 
added for radioactive labelling of the probe: 8pl 8x Sequenase reaction buffer 
(Amersham), 4jnl dATP buffer (0.1 mM dTTP, dGTP and dCTP), 2.8pl 0.1M 
DTT, 2pl a-[32P]dATP (6000 Ci/mmol, Amersham) and 6pl Sequenase mixture 
(1pl Sequenase in 5pl Sequenase dilution buffer, Amersham). This was mixed 
thoroughly and incubated for 10 minutes at 37°C. The beads were then 
collected using the MPC, and following 2 washes with ddH20  the beads were 
resuspended in 20pl 0.1M NaOH and incubated at RT for 10 minutes. The 
supernatant, containing the radiolabelled probe was then transferred to a new 
tube and checked for radioactivity.
2.6.2 Membrane Probing, Washing and Detection
The membrane buffer was removed, and replaced with 10ml fresh 
hybridisation buffer. The probe (in 20pl NaOH) was added to the buffer, and 
incubated in a rolling oven at 65°C overnight. The buffer was then discarded, 
replaced with washing buffer, (2x SSC, 1% SDS) and incubated for 30 
minutes. Washing buffer was then removed, replaced and incubated for a 
further 30 minutes. The membrane was then placed against a 
phosphorimager screen (Molecular Dynamics) and exposed overnight. The 
screen was scanned (Typhoon 9410, Molecular Dynamics) and visualised 
using ImageQuant software version 5.0 (Molecular Dynamics).
2.7 Yeast Whole Cell Extract (WCE) Preparation
100ml yeast culture was grown to mid/late log phase (O.Deoo ~ 0.6) and cells 
were harvested by centrifugation at 4 000 rpm for 5 minutes, and 
resuspended in 500pl cold yeast dialysis buffer (YDB -  20mM Hepes-KOH,
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0.01 M EDTA, 0.01 M MgSO^ 10% Glycerol, 5mM DTT, 1x proteinase 
inhibitors) with 500pl glass beads, and vortexed vigorously for 8 minutes at 
4°C (1 minute break for every 2 minutes vortexing to prevent tube heating up). 
The supernatant was collected, and protein content was quantified using the 
Bradford assay. (BioRad) WCEs were stored at -80°C.
2.8 SDS-PAGE and Western Blotting
Gel plates were assembled according to manufacturers instructions (BioRad) 
and gels were prepared. 10ml resolving gel (8% acrylamide, 0.375M Tris, 
0.1% SDS, 0.1% ammonium persulphate (APS), 0.06% N,N,N’,N’- 
tetramethylethylenediamine (TEMED)) was prepared per gel. Resolving gel 
was poured, and allowed to set completely. 2.5ml stacking gel (8% 
acrylamide, 0.375M Tris, 0.1% SDS, 0.1% APS, 0.06% TEMED) was 
prepared per gel, then was poured, a comb was inserted and the gel was 
allowed to set. The gel running tank was set up, and filled with SDS running 
buffer (25mM Tris-Base, 0.2M Glycine, 0.1% SDS). The comb was removed, 
the wells were rinsed and the samples were loaded. (20pg WCE, variable for 
IP samples) The gel was run at 100V for a suitable period of time, dependent 
on the size of the required protein.
A PVDF (Polyvinylidene Fluoride) membrane (BioRad) was prepared by 
submerging in methanol then water, and transfer apparatus was arranged 
with sponge supports, filter paper, membrane and gel in correct orientation 
(Figure 2.1). The transfer tank was assembled with a magnetic stirrer and ice 
pack, and filled with cold (4°C) western transfer buffer (25mM Tris-Base, 
15mM Glycine, 0.015% SDS, 20% Methanol). Transfer was run for 45 
minutes at 100V, then the membrane, with transferred proteins, was allowed 
to dry completely at RT in a sterile hood.
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Figure 2.2 - Setup of Equipment for Western Blotting Electrophoretic 
Transfer to Membrane
Before blocking, the membrane was returned to a hydrophillic state by 
submerging in methanol, then rinsing in water. Blocking was conducted 
overnight at 4°C in blocking solution (1x TBST (10mM Tris-Base, 150mM 
NaCI, 0.05% Tween) with 3% blocking agent (GE Healthcare)). The 
membrane was then rinsed briefly in 1x TBST, and then incubated for 1 hour 
at RT in blocking solution supplemented with primary antibody. This 
incubation was followed by 3x 10 minute washes in 1x TBST. The membrane 
was then incubated for another hour at RT in blocking solution supplemented 
with secondary antibody, then washed 3 times as before. The secondary 
antibody was designed to have an affinity for the primary antibody, and the 
ability to catalyse a luminescent chemical reaction via a Horseradish 
Peroxidase (HRP) domain. Detection was carried out using the ECL Plus 
western blotting kit (Amersham-GE), and the blot was visualised by 
chemilluminescence using autoradiography.
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2.9 Yeast Growth Curve
Growth curves were conducted on yeast strains to determine the rate and 
manner in which the culture grows. 5ml yeast cultures were grown from a 
colony overnight to reach early stationary phase. The cultures were then 
diluted to O D 6oo 0.1, and exact O D 6oo value recorded. O D 6oo values were 
recorded at hourly intervals for at least 12 hours using a spectrophotometer. 
When cultures reached O D 6oo 1 they were diluted 10-fold in the same media, 
prior to measurement of optical density, and the dilution factor was accounted 
for when plotting timepoints.
2.10 Yeast Growth Analysis via Serial Dilution
Yeast growth analysis was also performed using a serially diluted culture 
spotted onto solid growth media. This was employed to reveal differences in 
sensitivity to various environmental stimuli between yeast strains.
5ml yeast cultures were grown from a colony overnight to reach early 
stationary phase. Cells were counted, and cultures were diluted to 106 
cells/ml. A serial dilution was then conducted, using a dilution factor of 3, to 
create 9 suspensions of decreasing cell content. Using a template, 10pl spots 
of each dilution were transferred to plates. The cell counts were: 10 000, 3 
333, 1 111, 370, 123, 41, 14, 4.5, 1.5. Cells were allowed 2 days to grow, then 
photographed.
2.11 UV Survival Analysis
Cells were grown to late log-phase in appropriate media, then counted and 
diluted to 107 cells/ml. Further serial dilution then occurred in media to provide 
2 000 cells/ml. 100pl of cell suspension (200 cells) was plated on 2% agar 
plates containing appropriate media. Plates were then irradiated with a range 
of UV doses, including an untreated control. All UV doses were conducted in 
triplicate. Following UV irradiation, plates were kept in darkness and allowed 
to form colonies for 48 hours. Colonies were counted, and % surviving cells 
were calculated using the untreated average as 100%.
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3 Investigating the Role of a Possible Interaction Between 
the 19S Proteasome and Abf1 in DNA Replication and NER
The subtle interplay between different and diverse cellular pathways allows 
complex and coordinated regulation of metabolic processes required for 
survival and integrity of living organisms. A connection between the UPS and 
NER is well established, as is the relationship between the UPS and 
transcriptional control. The aim of this chapter is to investigate a possible 
regulatory function of the 19S proteasome in DNA replication involving the 
global regulator Abf1, a DNA binding factor that participates in multiple cellular 
processes including NER, DNA replication and transcription.
3.1 Introduction
The UPS primarily provides a highly efficient and specialised system for 
degradation of damaged cellular proteins and removal of regulatory protein 
factors to influence their regulatory activity. Aside from its canonical role in 
ubiquitin-dependent proteolysis, the 19S proteasome base subcomplex, more 
specifically the AAA ATPase subunits (Chapter 1.5, Figure 1.3), have been 
found to have a non-proteolytic regulatory role in transcription, both in 
activation and elongation, (Swaffield et al. 1992; Xu et al. 1995) and DNA 
repair (Gillette et al. 2001).
Another factor involved in a variety of cellular processes is Abf1, a ‘global 
regulator’. Abf1 was discussed previously as a GG-NER factor (Chapter
1.4.6), in a complex with Rad7 and Rad16, however the scope of Abf1 
function extends beyond DNA repair. Originally identified as a DNA replication 
factor, Abfl has since been implicated in such diverse processes as gene 
silencing (Wiltshire et al. 1997), transcriptional control of numerous genes 
involved in a diverse set of cellular processes such as meiosis (Gailus-Durner 
et al. 1996), sporulation (Ozsarac et al. 1997) and nutrient metabolism (Park 
et al. 1999), and Abf1 functions in NER as discussed previously (Chapter
1.4.6) (Reed et al. 1999).
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3.1.1 Abf1 -  A DNA Replication Factor
Abf1 was originally discovered as a DNA-binding protein that interacts with 
the B3 DNA element of Autonomously Replicating Sequences (ARS), and has 
a regulatory effect on DNA replication at certain sites in the genome (Diffley 
and Stillman 1988).
3.1.1.1 Autonomously Replicating Sequences (ARS)
The S. cerevisiae genome contains numerous defined cis-acting sequences 
dispersed throughout the genome that function as DNA replication origins, 
known as ARS (Clyne and Kelly 1997). ARS were first discovered as 
sequences that improved the efficiency of DNA transformation into yeast cells. 
They were found to allow a plasmid to replicate in a stable manner without 
integrating into the genome (Stinchcomb et al. 1979). It was then found that 
these ARS correspond to origins of DNA replication, and were spaced at a 
frequency of 32-40kb across the genome.
The structure of ARS are modular and variable, however they all have a high 
A/T content, and all contain the essential 11 bp ARS consensus sequence 
(ACS), which provides a binding site for the 6-subunit origin recognition 
complex (ORC). ARS also contain additional near-matches to the ACS that 
are dispensable for ARS function, but mutation of sequences flanking the 
ACS can affect ARS function. The ACS along with its immediate flanking 
sequence is known as the A-element. Although the ACS-containing element is 
essential for origin function it is not sufficient, and requires the action of 
additional ARS elements known as B-domains (Figure 3.1). The variable 
structure of ARS allows staggered initiation of DNA replication during S-phase 
to ensure efficient replication of the entire genome (Marahrens and Stillman 
1992).
The B-domain is composed of several short elements (B1-B4) that share very 
little sequence homology and are highly variable between ARS. The B1 
element functions with the A-element to bind the ORC, and the B3 element 
provides a binding site for ARS Binding Factor 1 (Abf1). Abf1 binding is
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required for specific ARS function, but not all ARS contain a B3 element or 
require Abf1 binding (Theis and Newlon 1997). There are numerous other 
proteins that bind to ARS, which have various regulatory roles in initiation of 
DNA replication. The precise function of the B2 and B4 elements is not 
known, however the B2 elements of ARS1 and ARS307 can substitute for 
each other. The B4 element of ARS305 cannot be substituted by any of the 
ARS1 B elements (Figure 3.1) (Yang et al. 1999).
ARS1 A BI B2 B3
ARS307 A B l B2
A B l B4
ARS305 M jy ■
B3-like A+Bl? ATR
ARS121 MM-----------------------------
Figure 3.1 -  The Variable Modular Structure of ARS. Four different 
genomic ARS are displayed here, revealing their varied modular structure and 
aligned according to the essential ACS sequence (tick marks below line). The 
A and B elements are shown, and ATR is the AT rich region present in some 
ARS. Figure adapted from (Theis and Newlon 1997).
3.1.2 Abf1 -  Transcriptional Regulator
Following its discovery as an ARS binding factor, it was soon evident that 
Abf1 was more than just a DNA replication factor. It is a site-specific DNA 
binding protein, and following extensive editing and redefinition since its 
original sequence was published, the currently accepted DNA binding motif of 
Abf1 is 5TnnCGTnnnnnnTGAT3 , deduced by in vitro selection 
(Beinoraviciute-Kellner et al. 2005). In addition to ARS, Abf1 binding sites are 
found at numerous other specific loci throughout the genome, including the 
mating type loci where it is required for transcriptional silencing, at telomere 
X-regions and in the promoter regions of many genes (Miyake et al. 2004).
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The function of Abf1 in transcription and DNA replication was characterised by 
the Campbell lab in 1992 (Rhode et al. 1992), which identified a variety of 
single-nucleotide mutant alleles in the N-terminal DNA binding domain. The 
most severe viable mutant allele (abf1-1) was found to have compromised 
DNA binding at the semi-permissive temperature (32°C) and DNA binding 
was completely abolished at 37°C resulting in cell death. Microscopic 
observation of these cells showed they were enlarged with small elongated 
buds, a phenotype resembling cells overproducing STE12, a transcription 
factor involved in pheromone response (Dolan and Fields 1990). The mutant 
alleles also exhibited reduced ARS function, DNA and RNA synthesis, and 
reduced plasmid stability in plasmids containing an Abf1 -dependent ARS.
The transcription of over 100 genes is regulated by Abf1 binding, thus 
impacting upon a variety of metabolic processes including carbon source 
regulation (Chambers et al. 1990), nitrogen utilisation (Park et al. 1999), 
sporulation (Ozsarac et al. 1997), meiosis (Gailus-Durner et al. 1996) and 
ribosomal function (Planta 1997), and also regulates its own expression 
(Miyake et al. 2004). Abf1 binding is only required for transcriptional initiation, 
and ongoing transcription can occur after Abf1 dissociation (Yarragudi et al. 
2007). Silencing at the HMR-E mating type locus is also mediated by Abf1 
binding, which occurs via nucleosome positioning (Zou et al. 2006). Abf1 is 
also reported to affect chromatin structure in ARS, acting as a boundary 
element to prevent nucleosome invasion of the A-element, allowing ORC 
binding and DNA replication to occur (Venditti et al. 1994).
3.1.3 Abf1 Structure and Function
The structure of Abf1 is that of a typical site-specific transcription factor, due 
to its N-terminal DNA-binding domains and C-terminal protein 
interaction/activation domains (Figure 3.2). The N-terminal domain has two 
essential binding regions, amino acids 40-91, which resembles a zinc finger 
metal binding domain, and residues 323-496, a basic region. Both domains 
are required for specific DNA-binding (Cho et al. 1995).
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The C-terminal portion has also been mapped extensively, and contains two 
essential regions: CS1 occurs between residues 624-628 and CS2 at 
residues 639-662. These were deduced via construction of various C-terminal 
truncation and alanine substitution mutants, some of which were found to 
have similar sensitivities to the N-terminal mutants described previously. It 
was also found that CS1 is required for transcriptional silencing and gene 
repression whereas CS2 is involved in transcriptional silencing and gene 
activation, stimulation of DNA replication and chromatin remodelling (Miyake 
et al. 2002).
DNA-binding domains C-terminal essential domains
abf1-1
C49Y
Figure 3.2 - Domain Structure of Abf1, Showing Location of abf1-1 Point 
Mutation
3.1.4 Abf1 -  A Promiscuous General Regulatory Factor
The high cellular abundance of Abf1, far greater than most other site-specific 
transcription factors, has placed the protein in a group known as general 
regulatory factors, of which three have been identified in S. cerevisae: Rap1, 
Reb1 and Abf1. These factors bind frequently throughout the genome, 
including at several gene promoters, and affect a multitude of cellular 
activities (Fourel et al. 2002).
In addition to its global DNA binding capacity, Abf1 is a promiscuous protein- 
binder, and its presence in a number of distinct protein complexes suggests 
Abf1 is a ‘hub protein’ (Luscombe et al. 2004). This indicates that the main 
function of Abf1 is to facilitate the formation of a variety of protein and 
nucleoprotein complexes. Abf1 has been found to co-precipitate with 
complexes involved in chromatin assembly and remodelling, notably the 
histone proteins Hta2 and Htb1, and the chromatin modifiers Rvb1, Rvb2 and 
Isw2. It has also been found in complexes with factors for transcriptional
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regulation (Mot1, Sth1 and Taf5), activity of RNA Polymerase I (Hmo1 and 
Rpc40) and III (Rpc34, Rpc53 and Rpo31) and mRNA nuclear export 
(Yra1)(Luscombe et al. 2004; Schlecht et al. 2008).
Another distinct Abf1-containing protein complex is the Rad7-Rad16 GG-NER 
complex, which has revealed the role of Abf1 in NER of non-transcribed DNA. 
This was initially shown in vitro by defective NER in a strain with depleted 
Abf1 levels, and the UV-sensitive phenotype of the DNA binding- 
compromised abf1-1 allele, which also implies that the DNA binding function 
of Abf1 is required for its role in NER (Reed et al. 1999).
3.1.5 Non-Proteolytic Regulatory Function of the 19S Proteasome
The 19S proteasome affects the DNA binding dynamics of the Gal4 
transcriptional activator, which regulates its ability to drive GAL transcription. 
This is discussed in detail in Chapter 1.4. It is known that components of the 
19S proteasome interact physically with Gal4’s activation domain, which is 
thought to promote destabilisation of Gal4 DNA binding thus preventing 
unregulated transcriptional activation (Ferdous et al. 2002; Ferdous et al. 
2007). This proteasome-mediated destabilisation of Gal4 from DNA was 
found to be inhibited by monoubiquitination of Gal4, allowing transcription 
initiation to proceed from GAL promoters for cells to utilise galactose as a 
carbon source (Archer et al. 2008b).
The regulatory activity of the 19S proteasome is not unique to Gal4, and like 
Abf1, the 19S has multiple interacting partners, with which it performs a 
variety of regulatory functions in cellular processes such as transcription (via 
Gal4 and Cdc68) (Chapter 1.5.3) (Swaffield et al. 1992; Xu et al. 1995) and 
NER (via Rad23) (Chapter 1.5.5) (Gillette et al. 2001). These overlapping 
functions could suggest interplay between the two factors. Gal4 and Abf1 
share the common structure of a typical transcription factor, featuring an N- 
terminal DNA binding domain and a C-terminal activation domain. They are 
both sequence-specific DNA binding factors and have a role in transcriptional
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control. The similarities between Abf1 and Gal4 structure suggest that the 19S 
proteasome could act upon them in a similar manner, by destabilising their 
DNA binding activity.
The following chapter aims to investigate a possible interaction between Abf1 
and the 19S proteasome. Firstly, a physical interaction between Abf1 and 
Sug1 was investigated by conducting a co-immunoprecipitation (Co-IP) assay 
in a WT strain. In order to investigate whether the physical interaction was a 
functional, genetic interaction or not, strains with abf1-1 and sug2-1 mutant 
alleles were constructed. Growth analysis of the abf1-1 sug2-1 mutant strain 
was performed to determine the effect on regulation of DNA replication. This 
was performed by serial dilution growth analysis on solid YPD plates and 
monitoring logarithmic growth of the mutant strains in liquid media. A UV 
survival assay was also performed to determine whether the Abf1-19S genetic 
interaction could affect AbfTs role in NER.
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3.2 Materials and Methods
3.2.1 Yeast Strains Used
Strain Genotype Source
W303-1A MATa ade2-1 trp1-1 leu2-3, 112 his3-11, 15 ura3-1 
can1-100
(Russell et al. 1999)
W T W303-1A S10-SUG1 (Russell et al. 1999)
sug 1-20 W303-1A S10-sug1-20 (Russell et al. 1999)
sug 2-1 W303-1A sug2-1 (Russell et al. 2001)
abf1-1
(JCA31)
MATa trplA his3A200 ura3-52 Iys2-801 ade2-1 gal 
abf1-1 HISS3
(Rhode et al. 1992)
abf1-1 W303-1A S10-SUG1 abf1-1 URA3 This study
abf1-1
sug2-1
IA/303-1A sug2-1 abf1-1 URA3 This study
Yeast Strains were used and stored as described previously, except the sug 
mutants, which were grown at 25°C, stored at RT and re-plated frequently. 
This was due to severe genetic instability resulting in an increased tendency 
to revert to WT when grown at 30°C or stored at 4°C.
3.2.2 Construction of abf1-1 and abf1-1 sug2-1 Strains
The abf1-1, sug2-1 and abf1-1 SUG2 strains were constructed using a two- 
step linear DNA transformation process, similar to (Toulmay and Schneiter 
2006), which exploits S. cerevisiae’s homologous recombination system 
(Figure 3.3).
3.2.2.1 Insertion of URA3 at the 3’ End of ABF1 ORF in abf1-1 Strain
A URA3 marker gene was inserted at the 3’ end of the genomic ABF1 
sequence in the original abf1-1 (JCA31) strain. Insertion was targeted to 
300bp downstream of the terminal codon to minimise defects caused by loss 
of downstream regulatory sequences. A 1.5kb fragment was amplified from 
the pRS306 plasmid (Sikorski and Hieter 1989), using primers with 20bp 
homology to the plasmid flanking the URA3 gene, and 50 bp overhang with 
homology to the sequence downstream of ABF1 ORF. This was transformed
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into the abf1-1 (JCA31) strain and transformants were grown on minimal 
media lacking uracil. Insertion was screened by colony PCR then confirmed 
by PCR amplification of genomic DNA from the newly constructed strain. One 
correct transformant was selected and a 500pl PCR was conducted to amplify 
the whole ABF1 gene with the downstream URA3 marker, using genomic 
DNA as a template. This provided a 4.2kb product, which was purified and 
concentrated into 30jnl H20  using the QIAquick PCR Purification Kit (Qiagen). 
The DNA was sequenced before proceeding to the transformation stage to 
ensure the presence of the abf1-1 (G146A) mutation.
a.
C URA3 ORFpRS306 (4.4kb)
Transformationb.
abf1-1 strain S. cerevisiae Genome:
URA3 marker
Homologous Recombination
d.
t = ~
J
<*-
P  PCR Amplification
4.2kb fragment for 2nd Transformation
Figure 3.3 - Two-Step Transformation Procedure -  Adapted From 
(Toulmay and Schneiter 2006). a: A URA3 marker was amplified from the 
plasmid pRS306, using primers with 50bp homology to ABF1 3’ UTR. b: The 
resulting URA3 fragment was transformed into an abf1-1 strain, which was 
inserted 3’ of ABF1 via homologous recombination, c: Genomic DNA was 
purified from the transformed strain and a 4.2kb region was amplified (d) and 
was transformed into sug2-1 and sug1-20 mutant strains. The abf1-1 mutation 
and URA3 marker were then incorporated into the genome via homologous 
recombination.
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3.2.2.2 Construction of abf1-1 URA+ Mutant Strains
This 4.2kb product was used to transform the sug2-1 and corresponding WT 
strain, and transformants were once again grown on media lacking uracil. 
Insertion was checked by colony PCR and prospective mutant colonies were 
replated onto new plates lacking uracil. Although the URA3 insertion may 
have been successful in the transformants, it was imperative that the resulting 
colonies harboured the abf1-1 mutation. Rather than sequencing every colony 
a higher throughput method was developed using the restriction 
endonuclease Mae III, (Roche) which recognises and cuts at 5GTNAC3 
sequences. The abf1-1 mutation creates a Mae III restriction site, not present 
in the WT sequence (Figure 3.4).
Mae! I I Restriction Site:
X
ABF1\
G T N  A C  
C A N T  G
G C G T T G C C C
C G C A A C G G G
abf1-1:
x
G C i G T T
C G C A A
A c c c
GiGG
-388bp
-241 bp 
-147bp
Figure 3.4 - Formation of Mae III digestion site in abf1-1 mutant, and 
result of Maelll digestion on 388bp fragment in abf1-1
Colonies were screened by extracting genomic DNA, then amplifying a 388bp 
sequence incorporating the abf1-1 mutation site. The fragment was digested 
using Maelll, then run on an agarose gel, which was photographed using UV 
light and the visible bands were analysed. Two bands (147 and 241 bp) 
confirmed the presence of abf1-1 whereas a single band (388bp) represented 
the WT sequence. Transformants displaying two DNA bands following 
digestion were sequenced.
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3.2.3 Co-lmmunoprecipitation (Co-IP) Assay
2pl anti-Abfl (Santa Cruz) was added to 400pg WCE in 500jal YDB, which 
was incubated on a Mini Labroller (Labnet) at4°C for 1 hour. 100pl 10% 
Protein A-coated Sepharose beads (Amersham) were added and incubated 
for a further 2 hours. The suspension was centrifuged for 10 minutes at 13 
000 rpm, and the supernatant was discarded. Beads were then washed 3 
times with YDB, and then proteins were incubated at RT for 1 hour in 30pl 1x 
SDS loading buffer containing 6M urea to denature protein complexes. Beads 
were then removed by centrifugation, and the supernatant was incubated at 
95°C for 10 minutes then used for SDS-PAGE and western blotting.
3.3 Results
3.3.1 Identification of a Physical Interaction Between Abf1 and Sug1
Prior to undertaking experiments to examine a possible functional interaction 
between Abf1 and the 19S proteasome, a Co-IP assay was employed to 
determine whether a physical interaction between the two factors existed. The 
presence of Sug1, a 19S proteasomal AAA ATPase, in an IP assay 
conducted using an Abf1 antibody was used to test the existence of a physical 
interaction. A whole-cell protein extract (WCE) was obtained from a WT strain, 
and protein complexes with affinity for an Abf1 antibody (Santa Cruz) were 
isolated using immunoprecipitation. Complexes were denatured by boiling in 
SDS loading buffer, and denatured proteins were separated by 
polyacrylamide gel electrophoresis. The proteins were transferred to a PVDF 
membrane, and the presence of Abf1 and Sug1 in the IP sample were 
detected by Western Blotting (Figure 3.5).
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Figure 3.5 -  Western Blot of anti-Abfl Immunoprecipitation Probed with 
A: anti-Abfl and B: anti-Sugl. An immunoprecipitation (IP) was performed 
by incubating W T WCE with anti-Abfl and Protein A beads. Co- 
immunoprecipitated proteins were run on a polyacrylamide gel and used to 
conduct a western blot. The blot was probed with anti-Abfl(A), then stripped 
and probed with anti-Sugl (B). The lanes represent proteins precipitated from 
the anti-Abfl IP (1 and 4), a Mock IP using no anti-Abfl (2 and 5), and 10|ug 
non-immunoprecipitated WCE (3 and 6).
Figure 3.5A displays the Western Blot conducted using the anti-Abfl IP 
sample, probed with the same Abf1 antibody for western blotting. This blot 
was conducted as a control experiment to ensure the Abf1 IP was successful. 
The intense band in lane 1 representing the 112kDa Abf1 protein confirms 
that the Abf1 IP was successful. The WCE sample in Lane 3 displays a band 
of an identical size to lane 1, which indicates the presence of Abf1.
The mock IP (Figure 3.5A and B, lanes 2 and 5) was conducted as a negative 
control. The IP conditions were the same for the mock as the actual IP but an 
equivalent volume of pre-immune serum was added instead of Abf1 antibody. 
Limited signal for both Abf1 and Sug1 is detected in their corresponding mock 
IP lanes (Figure 3.5A and B, lanes 2 and 5). This is most likely due to loading 
of the polyacrylamide gel, whereby some of the IP sample may have entered
50kDa
37kDa
Abf1 -
(112kDa)
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the adjacent well. Another possible reason for the faint protein band in the 
mock IP lane is unspecific antibody binding to another protein the same size 
as Abf1 or Sug1. However there is sufficiently higher signal strength in the IP 
(lanes 1 and 4) than the mock IP (lanes 2 and 5), which implies that the Co-IP 
was successful.
Figure 3.5B displays the same membrane as Figure 3.5A, however it has 
been stripped of Abf1 antibody and reprobed with Sug1 antibody. The intense 
band in lane 4 represents the 45kDa Sug1 protein present in the anti-Abfl IP 
sample. This suggests that there exists a direct or indirect physical interaction 
between Abf1 and the 19S proteasome, since Sug1 has only found to be 
present in cells as part of the 19S proteasome complex. The intense band in 
lane 6 displays the presence of Sug1 in the WCE sample, at the same size as 
lane 4. These results provide evidence that Abf1 physically interacts with the 
19S proteasome.
3.3.2 Investigating a Functional Genetic Interaction between Abfl and 
the 19S Proteasome via Phenotypic Analysis of Mutant Strains
The outcome of the Co-IP provided preliminary supporting evidence that Abf1 
physically interacts with the 19S proteasome. The study proceeded to 
investigate the function of this possible interaction by examining cellular 
phenotypes, thus determining whether a genetic interaction is occurring or 
not. ABF1 and the SUG genes are essential for cell viability, so in order to 
deduce the significance of their interaction a double mutant strain was 
constructed, using the abf1-1 and sug2-1 alleles characterised previously 
(Rhode et al. 1992; Russell et al. 2001). The abf1-1 mutant allele has 
defective DNA binding, and the 19S proteasome is known to disrupt stable 
DNA binding of factors such as Gal4. Introduction of the sug2-1 point mutation 
into the 19S proteasome was found to prevent Gal4-DNA destabilisation and 
thus promote stable Gal4 DNA binding (Figure 1.5). It was therefore 
speculated that the 19S proteasome may have a role in destabilising Abf1 
DNA binding, an effect that may be accentuated in the DNA binding-defective
67
abf1-1 mutant allele. It was therefore hypothesised that introduction of both of 
sug2-1 and abf1-1 mutations in one strain could stabilise Abf1 DNA binding 
and suppress the cellular phenotypes associated with the abf1-1 strain such 
as temperature sensitivity, slow growth and UV sensitivity (Rhode et al. 1992) 
(Reed et al. 1999).
3.3.2.1 Analysis of Temperature Sensitivity in abf1-1 sug2-1 Strains
Temperature sensitivity of the newly constructed mutant strains was observed 
to characterise the possible functional genetic interaction between Abf1 and 
the 19S proteasome. The temperature sensitivity of the abf1-1 mutant strain 
has been well documented previously. It results in a significant growth defect, 
visible at 30°C but more apparent at higher temperatures due to defective 
Abf1 DNA binding (Rhode et al. 1992). The sug2-1 mutant allele does not 
have a significant defective growth phenotype compared to the WT strain 
under normal conditions (25°C or 30°C) or increased temperature (37°C). 
Failed DNA binding in the abf1-1 mutant allele causes temperature sensitivity, 
so if the temperature sensitivity was reduced in the abf1-1 sug2-1 double 
mutant it would suggest that the 19S defect was improving the binding 
stability of abf1-1 to DNA and indicate a genetic interaction between Abf1 and 
the 19S proteasome.
In order to analyse temperature sensitivity, a serial dilution growth analysis 
assay was performed. abf1-1 and sug2-1 mutant strains were serially diluted 
in liquid YPD and spotted onto YPD plates, then allowed to grow for 2 days at 
a range of temperatures. The plates were photographed after 48 hours growth 
(Figure 3.6).
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Figure 3.6 -  Serial Dilution Growth Analysis of abf1-1 and sug2-1 
Mutants. abf1-1 and sug2-1 mutant cells were serially diluted in liquid YPD, 
then 10jal cell suspensions were spotted and grown on YPD plates at the 
stated temperatures (Panels 1-4). The plates were photographed after 48 
hours growth.
Figure 3.6, Panel 1 displays all four strains growing at the same rate at 25°C, 
which suggests that abf1-1 binds DNA normally at this temperature. This also 
confirms the consistent accuracy of cell counts and concentrations across the 
strains, which greatly aids comparative analysis between the strains.
Panel 2 exhibits growth rate variations between the strains, displaying the 
severe temperature sensitivity of the abf1-1 strain. This phenotype shows the 
same sensitivity as the original strain (abf1-1 (JCA31)), which helps confirm 
that introduction of the abf1-1 mutation has been performed successfully. This 
is also the case in Panel 3 and 4, which are lethal temperatures for the abf1-1 
(JCA31) strain, and the lethality is displayed clearly here for the abf1-1 strain. 
The sug2-1 strain exhibits no temperature sensitivity at any temperature 
investigated, which can be seen by comparing the sug2-1 strain to the WT 
strain in Panels 1-4. It appears that a slight suppression of the abf1-1 
temperature sensitivity may be occurring in the abf1-1 sug2-1 strain at 30°C, 
as seen in Panel 2. This could represent improved Abf1 DNA binding in the
69
abf1-1 sug2-1 strain, however the effect is weak. This observation is 
reproducible, but always appears as a subtle difference. If a suppression of 
abf1-1 temperature sensitivity is occurring in the abf1-1 sug2-1 strain it is not 
significant enough to rescue the lethality of abf1-1 at 33°C or 37°C, as shown 
in Panels 3 and 4.
These observations show that a slight suppression of the abf1-1 temperature 
sensitivity may be occurring in the abf1-1 sug2-1 strain at 30°C, however it 
does not rescue the lethality of the strain at higher temperatures. These 
results provide some indication of a functional genetic interaction occurring 
between the 19S proteasome and Abf1, however further growth analysis of 
the mutant strains is required to confirm the subtle effect seen in Figure 3.6, 
panel 2.
3.3.2.2 Growth Analysis of abf1-1 sug2-1 Mutant Strains
The abf1-1 sug2-1 strain exhibited slightly reduced temperature sensitivity 
than the abf1-1 strain, which could indicate a functional genetic interaction 
was occurring. In order to examine the interaction further, growth curves were 
performed on the strains to observe their rate and manner of growth. Strains 
were grown in YPD, and cell concentration was measured at hourly intervals 
(Figure 3.7). Numerical ODeoo reading are displayed in Appendix V.
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Figure 3.7 - Growth Curve of abf1-1 and sug2-1 Mutant Strains. WT, abfl- 
1, abf1-1 sug2-1, and sug2-1 strains were diluted to ODeoo 0.1 then grown in 
YPD for 8 hours at the stated temperatures (graphs 1-3). Cell concentration 
was observed at hourly intervals by measuring OD6oo using a visible light 
spectrophotometer.
Graph 1 in Figure 3.7 shows growth of all strains at 25°C, which unlike the 
temperature sensitivity analysis shows that the abf1-1 strains have a slower 
growth phenotype. This phenotype suggests that Abf1 binding appears to be 
less efficient at 25°C and not just at higher temperatures, although this does 
not appear to affect cell viability at 25°C, as shown in Figure 3.6, Panel 1.
The main interest of Figure 3.7 is Graph 2, which was intended to 
characterise further the suppression of the abf1-1 temperature sensitivity in 
the abf1-1 sug2-1 strain observed in Figure 3.6, Panel 2. The growth curves 
of Figure 3.7, Graph 2 show the sug2-1 strain exhibiting a slightly slower 
growth phenotype than the WT strain, but the abf1-1 and abf1-1 sug2-1
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strains appear to have precisely the same growth rate at 30°C. This suggests 
that the slight suppression of temperature sensitivity observed in Figure 3.6, 
Panel 2 by the sug2-1 mutation in the abf1-1 strain is not due to improved 
DNA replication, otherwise it would be expected that the cell cycle time, i.e. 
growth rate would be increased to a rate closer to the WT rate.
Figure 3.7, Graph 3 also fails to show suppression of the lethality of the abf1-1 
allele at 37°C in the abf1-1 sug2-1 strain, and also shows the slower growth 
phenotype of the sug2-1 strain. The abf1-1 and abf1-1 sug2-1 strains are 
unable to grow at 37°C.
From the results displayed in Figure 3.7, it can be concluded that the slight 
suppression of temperature sensitivity observed in Figure 3.6, panel 2 is not 
due to increased growth rate in the abf1-1 sug2-1 strain compared to the 
abf1-1 strain. This suggests that the genetic interaction between Abf1 and the 
19S proteasome does not affect the DNA replication defect caused by the 
abf1-1 mutation, so therefore may affect another specific function of Abf1 or 
the 19S.
3.3.3 UV Survival Analysis of abf1-1 and sug2-1 Mutant Strains
Abf1 and the 19S proteasome both have roles in NER (Reed et al. 1999; 
Russell et al. 1999). In order to investigate further the genetic interaction 
between Abf1 and the 19S proteasome a UV survival assay was conducted 
using the WT, abf1-1 and abf1-1 sug2-1 strains. This analysis was performed 
to deduce whether the Abf1-19S interaction has a functional role in NER, and 
thus characterising a genetic interaction between the factors. It is proposed 
that the functional interaction could involve the 19S proteasome affecting Abf1 
DNA binding stability. This hypothesis predicts that introduction of the sug2-1 
mutation in the abf1-1 strain could suppress the DNA binding defect of abf1-1, 
thus allowing it to bind DNA more stably thus improving NER efficency in the 
abf1-1 sug2-1 mutant strain. Logarithmically growing cells were exposed to a 
range of UV doses and allowed to form colonies for 48 hours. Colonies were 
counted and are displayed in Figure 3.8.
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Figure 3.8 - UV Survival of abf1-1 and abf1-1 sug2-1 Strains Cells were 
spread onto agar plates and irradiated with the stated doses of UV. Following 
2 days growth surviving colonies were counted and % survival calculated. 
Raw data values are presented in Appendix II.
It has been characterised previously that the abf1-1 allele causes significantly 
increased sensitivity to UV irradiation, which was one of the first indications 
that Abf1 was involved in NER (Reed et al. 1999). Figure 3.8 shows that the 
abf1-1 sug2-1 strain exhibits no altered UV sensitivity compared to the abf1-1 
strain. This suggests that the functional interaction between Abf1 and the 19S 
proteasome does not affect A bfTs role in NER.
3.4 Discussion and Further Work
The aim of this chapter was to deduce a possible functional interaction 
between the 19S proteasome and Abf1, thus revealing a novel role of the 19S 
proteasome in DNA replication, and further characterising Abf1 and the 19S 
proteasome’s role in NER. The Co-IP (Figure 3.5) provided evidence of a
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physical interaction between Abf1 and the 19S proteasome, which either 
suggests that the proteins are interacting directly, or are present together in a 
larger protein complex. This could be an example of Abf1 functioning as a hub 
protein, thus recruiting various protein factors to create a functional complex.
Having established the presence of a physical interaction between Abf1 and 
the 19S proteasome, strains with Abf1 and 19S mutant alleles were used as 
genetic tools to observe a functional interaction between the two factors. It 
was hypothesised that introduction of the sug2-1 19S proteasome mutation 
into a DNA binding-defective abf1-1 mutant strain could suppress the 
defective phenotypes caused by the abf1-1 mutation. It was speculated that 
the 19S was responsible for destabilising Abf1 DNA binding, in a similar 
mechanism as observed for Gal4 regulation (Archer et al. 2008a), therefore 
mutating the Sug2 19S proteasome subunit could prevent the DNA binding 
destabilisation activity of the 19S. It is known that the DNA binding activity of 
Abf1 is required for its role in DNA replication and NER, so the mutant strain 
was analysed phenotypically for growth rate and UV resistance to investigate 
a suppression of the abf1-1 defects in the abf1-1 sug2-1 strain.
It was found that combining the sug2-1 mutation in a strain containing the 
abf1-1 allele had a slight suppressive effect of the temperature sensitivity of 
the abf1-1 mutant strain at 30°C (Figure 3.6 panel 2), but was unable to 
suppress the lethality of the abf1-1 allele at higher temperatures (Figure 3.6 
panels 3 and 4). The suppressive effect at 30°C was experimentally 
reproducible, but always appeared as a subtle effect. This suggests that the 
Abf1-19S proteasome interaction can slightly enhance cell viability at the 
permissive temperature, possibly by improving Abf1 DNA binding stability.
The suppression of temperature sensitivity showed a possible functional 
interaction, but did not reveal what aspect of Abf1 or 19S proteasome activity 
was being enhanced. Analysis of logarithmic growth in the mutant strains was 
performed to reveal improved DNA replication, as defects in DNA replication 
cause delayed cell cycle progression resulting in slow growth. The growth 
curves of the abf1-1 sug2-1 strain showed no difference in growth rate to the
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abf1-1 strain (Figure 3.7), which would suggest that the Abf1-19S proteasome 
interaction does not have a role in DNA replication.
The UV survival analysis of the mutant strains was performed to identify 
whether the functional role of the Abf1-19S genetic interaction was involved in 
NER or not. Figure 3.8 shows no suppression of UV sensitivity caused by the 
abf1-1 mutation in the abf1-1 sug2-1 strain. This suggests that the functional 
interaction between Abf1 and the 19S proteasome does not have a role in 
NER. An alternative explanation of the results observed in Figure 3.7 and 
Figure 3.8 could be the loss of the sug2-1 mutation, as the sug alleles are 
known to be prone to reversion to WT. The starter colonies used for the 
growth analysis and UV survival assay had genomic DNA extracted and 
sequenced at the abf1-1 and sug2-1 mutation sites. The sequencing results 
showed that the abf1-1 and sug2-1 mutations were present in all samples, so 
reversion of the mutations is not the cause of the same growth pattern and 
same UV survival curve of the abf1-1 and abf1-1 sug2-1 strains. It has 
therefore been concluded that the Abf1-19S proteasome interaction does not 
have a significant function in NER or DNA replication.
The sug2-1 mutation was used in this study because it is known to prevent 
the 19S from destabilising Gal4 DNA binding, the mechanism that was 
proposed to be occurring for Abf1 too, however, alternative sug mutant alleles 
are known to behave differently. Certain sug mutant alleles can suppress 
phenotypes that others cannot, and vice versa. The sug1-20 mutant allele is 
known to suppress the transcriptional elongation defect of the cdc68-1 mutant 
(Xu et al. 1995), but does not affect Gal4 DNA binding stability like sug2-1 or 
sug1-1. Construction of an abf1-1 sug1-20 double mutant was attempted by 
introducing abf1-1 into a sug1-20 background. The mutagenesis was 
undertaken using the same method as used for the sug2-1 strain, however all 
prospective URA+ mutants lacked the abf1-1 and/or sug1-20 mutations. This 
could be due to the high reversion rate of sug1-20, or that the combined effect 
of the mutations is lethal. Whatever the cause, a stable double mutant could 
not be constructed, so allele specificity could not be investigated.
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Abf1 also has several functional mutant alleles, such as the C-terminal 
mutants characterised by (Miyake et al. 2002) These mutants can still bind to 
DNA, but have similar temperature sensitivity to abf1-1 due to defective C- 
terminal activation function. This could be a more suitable representation of 
the Gal4-Sug system mentioned previously, which also used C-terminal 
mutants (Swaffield et al. 1992). The DNA binding dynamics of the Abf1 C- 
terminal mutants have not been characterised previously, but this could be 
conducted using chromatin immunoprecipitation (ChIP) at various Abf1 
binding sites such as ARS and gene promoters.
An effect of the Abf1-19S proteasome interaction on DNA replication could not 
be identified by growth analysis, but it may be of interest to investigate Abf1 
occupancy at ARS using ChIP in the mutant strains. This would provide a 
more direct insight into Abf1 DNA binding stability, and could be performed at 
a local level on specific ARS or for a more comprehensive overview of global 
Abf1 binding, ChlP-chip analysis could be performed using abfl and sug 
mutant strains.
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The aim of this chapter was to identify and characterise a functional 
interaction between Abf1 and the 19S proteasome. A physical interaction 
between the two factors was observed via protein Co-IP (Figure 3.5), so 
phenotypic analysis of an abf1-1 sug2-1 mutant strain was conducted. A slight 
suppression of temperature sensitivity was observed in the abf1-1 sug2-1 
strain (Figure 3.6), however a suppression of the abf1-1 DNA replication 
defect via growth analysis (Figure 3.7), or the abf1-1 NER defect via UV 
survival (Figure 3.8), was not visible. Therefore, it appears that a functional 
interaction may exist between Abf1 and the 19S proteasome, which provides 
scope for further investigation in this area, however the functional interaction 
could not be characterised using the techniques employed in this chapter. 
Consequently, the study will now proceed to focus on another aspect of the 
function of GG-NER factors in the DNA damage response, thus terminating 
this specific area of research at this stage of the study.
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4 The Role of the Rad4-Rad23 Complex in Regulating DNA 
Damage-Responsive Gene Transcription
4.1 Introduction
Exposure of eukaryotic cells to DNA damaging agents instigates a variety of 
cellular responses, including a significant transcriptional response involving 
altered expression of a variety of genes throughout the genome. The intricate 
induction of stress responsive and DNA-damage responsive pathways at the 
transcriptional level is of paramount importance to maintain cell integrity and 
promote cell survival when faced with the insult of DNA damage.
4.1.1 The Rad4-Rad23 NER Complex and the DNA Damage Response
The Rad4-Rad23 complex is known to be an integral component of the NER 
pathway in Saccharomyces cerevisae and is thought to function in the DNA 
damage-recognition step of NER (Min and Pavletich 2007). Recently an 
important insight into the regulation of these early stages of NER was 
revealed, involving a novel function of the UPS (Gillette et al. 2006).
It was shown that UV irradiation triggered the UPS-dependent ubiquitination 
and proteolysis of Rad4, contrary to previous reports that UV-induced damage 
caused accumulation of Rad4 and its human homologue XPC, resulting in 
enhanced NER (Lommel et al. 2002; Ng et al. 2003). It has also been shown 
that the lower steady state levels of the Rad4 protein was not due to 
increased Rad4 proteolysis in the Arad23 strain because lower levels of RAD4 
mRNA were observed. This could suggest that reduced RAD4 transcription 
was the cause of lower Rad4 protein levels in the Arad23 strain rather than 
increased protein turnover, however this remained speculative as many 
confounding factors could also have an influence (Gillette et al. 2006). The 
ubiquitin ligase responsible for ubiquitinating Rad4 was discovered to be an 
E3 ubiquitin ligase containing the Rad7 and Rad 16 GG-NER factors with the 
Elc1 and Cul3 proteins, a function proposed in (Ramsey et al. 2004). Rad7
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contains a SOCS domain, which classifies the ligase complex as a cullin- 
based Elongin-cullin-SOCS box (ECS)-type E3 ligase. Rad7’s SOCS domain 
is essential for post-UV ubiquitination of Rad4.
A mutant strain was created that contained two point mutations in the SOCS 
domain of RAD7 (L168A and C172A), which specifically prevented UV- 
dependent Rad4 ubiquitination. This E3 ligase-defective mutant was denoted 
the psocs strain, as it contains the mutant RAD7 gene on a plasmid. The 
psocs strain was found to have no additional UV sensitivity compared to a WT 
strain, which initially suggested that post UV ubiquitination of Rad4 did not 
have a role in promoting UV survival, however, Rad23, which functions in 
NER in a complex with Rad4, contains an ubiquitin-like (UBL) domain, which 
is essential for its role in NER. It was investigated whether the presence of an 
ubiquitin-like sequence in the Rad4-Rad23 complex could affect its role in the 
DNA damage response by compensating for the lack of ubiquitinated Rad4. It 
was observed that the psocs mutant with RAD23 deleted, or the RAD23's 
UBL domain deleted strain resulted in increased UV sensitivity in these 
strains, significantly more so than the intermediate UV sensitivity of the 
Arad23 or rad23Aubl strains (Gillette et al. 2006).
4.1.2 Two Distinct Components Regulate NER
Rad23 is thought to function in NER by mediating an interaction with the 19S 
proteasome via its UBL domain, and antagonising the 19S proteasome’s 
inhibitory effect on NER. This has been shown by suppression of the Arad23 
strain’s UV sensitivity by introduction of the sug2-1 proteasome mutation 
(Gillette et al. 2001). It has been documented previously that two distinct 
components function in the NER pathway, one that requires de novo 
synthesis of protein factors and one that doesn’t (Al-Moghrabi et al. 2003; 
Waters et al. 1993). Using the protein synthesis inhibitor cycloheximide, it was 
deduced that the Rad23 and 19S proteasome’s activity in NER does not 
require de novo protein synthesis, whereas the other regulatory pathway, 
involving the Rad7-containing E3 ligase complex-mediated Rad4 
ubiquitination does require de novo protein synthesis (Gillette et al. 2006).
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This observation, along with the finding that RAD4 is expressed at a lower 
level in the Arad23 strain prompted the possibility that the Rad7-containing E3 
ligase complex-mediated Rad4 ubiquitination could play a role in DNA 
damage-responsive gene transcription, thus having a role in regulating NER 
via the pathway that requires de novo protein synthesis.
4.1.3 The Rad4-Rad23 Complex as a Transcriptional Regulator
The ability of the Rad4-Rad23 DNA damage recognition complex to bind 
damaged DNA has been reported, and it is known that the complex can also 
bind to non-damaged DNA. Recent evidence from our laboratory has 
suggested a role of this complex in transcriptional control. It has been 
revealed by our laboratory that the Rad4-Rad23 complex binds to the 
promoters of certain genes by ChIP analysis (Z. Zhou, unpublished data).
Furthermore, a recent study has suggested a more global role of Rad23 in 
transcription, however this somewhat dismissed the involvement of Rad4, 
concluding that Rad23 was not acting with Rad4. This role of Rad23 in 
transcriptional regulation was observed in untreated and UV-irradiated cells, 
and it was suggested that Rad23, in conjunction with the 19S proteasome 
influences numerous downstream effectors to control the transcriptional 
response to UV. The mechanism also involved the DNA binding transcription 
factor Mig3. Rad23 was implicated in both activation and repression of genes 
affected by the transcriptional response to DNA damage (Wade et al. 2009).
This chapter will investigate further the role of the Rad23-Rad4 complex in 
transcription, with particular attention to the role of Rad7-dependent Rad4 
ubiquitination in transcriptional control of the DNA damage response. It will 
also further investigate the role of Rad23 as a global regulator of transcription, 
as proposed by (Wade et al. 2009).
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4.1.4 Transcriptional Responses to DNA Damage in S. cerevisiae
Early experiments using high throughput screening methods to identify 
transcriptionally altered genes in response to DNA damage discovered 
several genes including the Damage INducible genes (DIN1-6) and the DNA 
Damage Responsive genes (DDR1-4) (Ruby and Szostak 1985). These 
global screens paved the way for more powerful microarray technologies, 
which continue to reveal that a significant proportion of the genome is 
differentially expressed in response to DNA damage.
It is thought that most, if not all DNA damage-responsive genes are activated 
as a downstream effect of the Mec1-Rad53-Dun1 kinase cascade. Three 
main transcriptional targets of this cascade have been identified (Fu et al.
2008). Activation of the RNR pathway via phosphorylation of the Crt1 
repressor by the Dun1 kinase results in elevation of cellular dNTP pools, a 
requirement for effective DNA synthesis. Regulation of the RNR pathway is 
discussed in more detail in Chapter 5.
DNA damage also induces transcription of PHR1, a photolyase that 
exclusively repairs UV-induced CPDs, however PHR1 transcription is induced 
by a wide range of DNA lesions. The promoter of PHR1 contains three 
regulatory elements, an upstream activating sequence (UAS) an upstream 
repression sequence (URS) and an upstream essential sequence (UES) 
(Sancar et al. 1995). Ume6, a transcriptional regulator involved in various 
metabolic pathways binds to the UAS and positively regulates PHR1 
transcription (Sweet et al. 1997). PHR1 transcription is negatively regulated 
by Rph1 and Gis1, which bind to the URS. Rph1 becomes phosphorylated by 
the DNA damage response signal transduction pathway, which causes 
upregulation of PHR1. PHR1 induction is dependent on Rad9, Rad17, Mec1 
and Rad53, but not Dun1, which suggests that the Mec1-Rad53 kinase 
cascade is responsible for Rph1 phosphorylation, but via an upstream or 
separate branch of the pathway to Dun1. Rad53 does not interact with Rph1, 
so an alternative kinase is most likely involved (Kim et al. 2002).
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The MAG1 base excision repair factor is also transcriptionally induced by a 
wide variety of DNA damages, however is only required for repair of a small 
subset of lesions. Another damage-inducible gene, DDI1 was found 
immediately upstream of MAG1. The expression of these genes is jointly 
regulated. The MAG1 promoter contains an URS and an UAS, which 
surprisingly lies within the DDI1 coding sequence. Another UAS regulates the 
expression of both genes (Liu and Xiao 1997). The transcriptional activator 
Pdr3 was found to bind to this UAS and induce MAG1 and DDI1 transcription 
(Zhu and Xiao 2004). The transcriptional activator, Rpn4, has also been 
shown to regulate MAG1 and DDI1 transcription, but it does not appear to 
bind the MAG1-DDI1 UAS. Rpn4 deletion does not affect MAG1/DDI1 
expression in pdr3 mutant cells, which suggests it functions upstream of Pdr3 
(Zhu and Xiao 2004).
4.1.5 The Current Study
The aim of this chapter was to investigate the role of the Rad4-Rad23 
complex in DNA damage-responsive global gene transcription following on 
from (Gillette et al. 2006), which presented evidence that suggested a 
possible role for the Rad4-Rad23 complex in transcriptional control. Global 
gene expression studies were performed in various mutant strains to identify 
genes with altered transcription both in untreated strains and strains exposed 
to UV radiation. The psocs strains were used to investigate the role of Rad4 in 
DNA damage-responsive transcription, because the psocs mutant specifically 
prevents post-UV Rad4 ubiquitination from occurring, and does not display 
the severe UV sensitivity of the Arad4 strain. Two sets of microarrays were 
performed in this study. The first set observed transcriptional alterations in 
Arad4, Arad23 and Arad4Arad23 strains in the absence of UV. These 12 
arrays are referred to as rad4/rad23 arrays throughout this study. The second 
set of arrays looked at the transcriptional response to UV using the 
psocs/rad23 mutant strains constructed in this chapter. These 30 arrays are 
referred to as the psocs/rad23 arrays throughout this study. All microarrays 
performed in this study are available for public use on the Gene Expression
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Omnibus (GEO) Database, the rad4/rad23 arrays at: 
http://www.ncbi.nlm.nih.gov/geo/querv/acc.cgi?acc=GSE11871 
and the psocs/rad23 arrays at:
http://www.ncbi.nlm.nih.gov/geo/guerv/acc.cgi?acc=GSE23204 
.CEL files are also included on the electronic Appendix IV CD.
4.2 Materials and Methods
Prior to investigation of global transcription, strains were constructed and 
checked for quality by observing UV sensitivity, which was required to confirm 
the sensitivity observed in (Gillette et al. 2006). The method of cell preparation 
and irradiation was also optimised prior to conducting microarrays to enhance 
the quality and accuracy of expression data acquired. For most analyses of 
DNA repair, it is common practice to UV-irradiate yeast cells in cold PBS. For 
the purposes of analysing global transcription, exposure to cold PBS would 
trigger a transcriptional response of its own, not related to the UV response. 
For this reason, a method of irradiating cells in minimal media was devised, 
and a UV survival assay was conducted to compare UV penetration in PBS 
versus minimal media.
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4.2.1 Yeast Strains Used
Strain Genotype Source
Arad4 BY4742: MATa his3Al leu2A0 ura3A0 
YER162C::KanMx4
EUROSCARF
Arad23 BY4742: MATa his3Al leu2A0 ura3A0 
YEL037C::KanMx4
EUROSCARF
Arad4
Arad23
BY4742: MATa his3Al leu2A0 ura3A0 
YEL037C::KanMx4 YER162C::HIS3
EUROSCARF
Arad7 BY4742: MATa his3Al leu2AO ura3A0 
YJR052W::KanMx4
EUROSCARF
pRS314-
pRAD7
W303-1A S10-SUG1 Arad7::LEU2 pRS314-RAD7 (Gillette et al. 2001)
pRS314-
psocs
W303-1A S10-SUG1 Arad7::LEU2 pRS314-RAD7 (Gillette et al. 2001)
pRAD7
sug2-1
W303-1A sug2-1 rad23::HIS3 pRS314-RAD7 (Gillette et al. 2001)
psocs
sug2-1
W303-1A sug2-1 rad23::HIS3 pRS314-socs (Gillette etal. 2001)
pRAD7 BY4742 pRS313-RAD7 This Study
psocs BY4742 pRS313-socs This Study
pRAD7
Arad23
BY4742 rad23::URA3 pRS313-RAD7 This Study
psocs
Arad23
BY4742 rad23::URA3 pRS313-socs This Study
4.2.2 UV Sensitivity Streak Test
Yeast cell cultures were grown from a single colony overnight in 5ml of the 
appropriate liquid media. They were then diluted to OD6oo = 0.1 in of 1ml 
media, and a streak of this cell suspension was drawn across an agar plate 
using a sterile cotton swab. The plate was then covered, and exposed to UV 
(254nm, 10Jm'2s"1). The cover was progressively removed over a 10 second 
period, so the streak of cells received an increasing dose of UV (0-100Jm'2). 
Then the cover was replaced and cells were allowed to grow at 30°C for 48 
hours and photographed after this period. This method was used for colony 
screening to get an initial indication of UV sensitivity. For more accurate
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analysis of UV sensitivity, a UV survival assay was employed, involving 
plating irradiated cells and counting surviving colonies, performed in triplicate.
4.2.3 Analysis of Gene Expression Using qPCR
Total mRNA was extracted using the hot phenol method (Chapter 2.5), then 
reverse-transcribed into cDNA (Bio-Rad iScript cDNA Synthesis kit). This 
cDNA was then used for 20jnl qPCR reactions, using SYBR green labelling 
buffer (Bio-Rad), and was run and analysed using the iCycler iQ qPCR 
Detection System (Bio-Rad). Each sample was conducted in triplicate, and a 
standard curve was prepared for each 96 well plate. qPCR data is displayed 
in Appendix VII.
4.2.4 Methods Pertaining to Microarray Preparation, RNA Submission 
and Analysis
4.2.4.1 Preparation of Cells and RNA Extraction
Cells were grown in YPD to late log phase (ODeoo ~ 0.6), then total RNA was 
isolated using the hot phenol method (Schmitt et al. 1990) then run on 
agarose gel to visualise quality. mRNA was isolated from total RNA using 
Qiagen’s Oligotex mRNA kit, and a single round of poly(A)+ mRNA selection 
was performed to obtain optimal yield and purity of mRNA.
4.2.4.2 RNA Quality Controls
To check RNA quality, absorbance was measured at 260 and 280nm using a 
spectrophotometer (DU 800 UVA/isible Spectrophotometer, Beckman Coulter, 
Fullerton, CA) using the convention that 1 absorbance unit at 269nm equals 
40pg RNA per ml. The A260/A280 ratio should be within 1.9 and 2.1 in order to 
be of acceptable quality and purity. If the ratio fell within this range they were 
submitted for microarray expression analysis to the Affymetrix GeneChip 
expression profiling service (CBS, School of Medicine, Cardiff University).
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4.2.4.3 Data Acquisition
Further RNA processing and microarray data acquisition was carried out by 
Affymetrix GeneChip expression profiling, performed at CBS (Cardiff), and 
described in Figure 4.1. The cDNA was hybridised to the Yeast Genome S98 
chip, which represents all known yeast ORFs. Following scanning, microarray 
data was received as Affymetrix cell intensity (.CEL) files, which were then 
processed to obtain a representation of gene expression.
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Figure 4.1 - RNA and Microarray Processing Adapted from Affymetrix 
GeneChip Expression Analysis Technical Manual.
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4.2.4.4 Arrays Quality Assessment
Array quality was assessed using the Bioconductor simpleaffy package within 
R (Team 2010). A quality control (QC) plot was constructed to visualise RNA 
quality. Figure 4.2 shows the QC plot for the psocs/rad23 arrays. In the QC 
plot each array is represented by a horizontal line. The central solid black line 
represents 0 fold-change (fc), and the two dotted black lines depict 3 fold up 
and down regulation. The blue bar shows the region that all arrays have scale 
factors within, over a default 3-fold range. The lines representing the arrays 
begin at the central 0 fc, and end with a dot, which corresponds to their scale 
factor. In Figure 4.2 all lines terminate in the blue region, which confirms their 
scale factors are compatible. The lines are coloured red if they are not 
compatible and blue if they are (all lines are blue).
The circular and triangular points represent the RNA pol III and Actin 3/5 
ratios respectively. The values show the % of genes present (blue), and 
average background (red). It is preferable that the values are similar, which 
constitutes <10% variation in gene presence, and <20 units variation in 
background intensity. Figure 4.2 shows some variation in background 
intensity. This is most probably because the overall signal from the array is 
greater due to different amounts of cRNA present in the hybridisation cocktails 
or because of variations in hybridisation efficiency, thus incorporating different 
amounts of label and altering brightness of the chip (Wilson). The background 
intensity variation forms two groups with limited variation within each group. 
The groups coincide with the two different array sets (pRAD7/psocs (orange) 
and Arad23 pRAD7/psocs (green)) so variation within array sets is not 
significant (Figure 4.2).
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Figure 4.2 - QC Plot of psocs/rad23 Microarray Data Quality of the 30 
psocs/rad23 microarrays was visualised using the Bioconductor R simpleaffy 
package.
4.2.4.5 Quantile Normalisation of Raw Data
Normalisation was also performed in R as part of the gcrma package. 
Quantile normalisation was applied to all data sets, which is visualised by 
boxplots in Figure 4.3. The boxplots show the range of the data (dotted lines), 
interquartile range (box) and the median value (central line through box). 
Quantile normalisation transforms the data to equalise the range, interquartile 
range and median value in order to compare differential expression between 
arrays.
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Figure 4.3 - Quantile Normalisation of psocs/rad23 Microarray Data
Quantile normalisation of the 30 psocs/rad23 microarrays was conducted and 
visualised using the R gcrma package.
4.2.4.6 Quantification of Differential Expression
Relative expression values were obtained using the R Bioconductor gcrma 
package, which produced log2 expression values. Significance testing 
including t-test and FDR correction was performed using GeneSpring 
software, version 7.3 (Agilent Technologies, Stockport, UK). Gene Lists were 
transferred to a Microsoft Excel spreadsheet where further analysis was 
conducted. Mean values of duplicate and triplicate data sets were calculated. 
Fold-change (fc) values were also calculated where appropriate by obtaining 
log ratios, by subtracting WT or untreated values from mutant or UV-treated 
values (loga -  logb = log(a/b)).
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To identify genes that were significantly differentially expressed a t-test was 
applied to the data filtering p=0.05, to test for genes with a significant 
difference in mean value between WT and mutant or untreated and UV- 
treated strains. A false-discovery rate (FDR) correction was also applied to 
control for multiple testing issues. A fc cut off was also employed to find 
significantly differentially expressed genes. In order to produce gene lists of a 
manageable size, a 1.5 fc cut off was employed when investigating variance 
between untreated mutants, and a 2 fc cut off was used to define UV- 
responsive genes.
4.2.4.7 Functional Analysis -  GO Analysis and Clustering
Gene lists were analysed for commonalities and differences using the online 
Venn diagram generator (http://www.panqloss.com/seidel/Protocols/venn.cgi). 
Cluster analysis was performed using Genesis software (Sturn et al. 2002), 
which was also used for visualisation of gene expression using heat-maps. All 
other graphical and statistical analysis was performed in Microsoft Excel. 
Gene Ontology (GO) analysis was performed using the online GO Slim 
Mapper (http://www.veastgenome.org/cgi-bin/GO/qoSlimMapper.pl). This was 
used to identify common pathways and gene functions from a statistically 
obtained gene list. GO and other functional analyses were also performed 
online using the Database for Annotation, Visualisation and Integrated 
Discovery (DAVID), which also proved useful for converting Affymetrix Probe 
IDs to gene symbols and vice versa (Dennis et al. 2003; Huang da et al.
2009).
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4.3 Results
The experiments described in this chapter investigate a role for the Rad4- 
Rad23 complex in DNA damage-responsive gene transcription, with particular 
attention to the role of the Rad7 E3 ligase-dependent Post-UV ubiquitination 
of Rad4. Prior to conducting microarrays, suitable mutant strains were 
constructed and characterised and the process of UV irradiation of cells was 
optimised.
4.3.1 Construction of pRS313-RAD7 and pRS313-socs Strains
Strain background can have a significant impact on experimental accuracy 
and reproducibility. For this reason, mutant strains with EUROSCARF genetic 
background were created, which allowed comparison to previously 
investigated strains. The psocs mutant strains were constructed using 
plasmids based on those described in (Gillette et al. 2006), which were based 
on the pRS314 plasmid (Sikorski and Hieter 1989), containing a TRP1 marker 
gene and the full genomic RAD7 sequence with promoter region. For the 
purposes of this study, the RAD7 and RAD7-socs sequences were inserted 
into the pRS313 vector (Sikorski and Hieter 1989) to allow selection via 
histidine instead of tryptophan, as EUROSCARF strains are TRP+.
The original pRS314-based RAD7 and RAD7-socs plasmids (Gillette et al. 
2006) were digested with Clal/Sacll, which specifically removed the RAD7 
sequences. The pRS314-RAD7, pRS314-socs and pRS313 plasmids were 
digested for 90 minutes at 37°C, using 2pl Clal, 2jnl Sacll, 5pl buffer 4 (NEB) 
with 0.5pl 10mg/ml BSA in 50pl reaction volume. The required DNA fragments 
were recovered from the gel (Qiagen QIAquick Gel Extraction Kit) and then 
ligated to form pRS313-RAD7 and pRS313-socs constructs. Correct ligation 
was confirmed by DNA sequencing, and the various mutations were found to 
be present and correct.
The newly constructed plasmids were transformed into Arad7 EUROSCARF 
cells {BY4742) and transformants were grown on HIS' media. Successful
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transformation was phenotypically checked by examining UV sensitivity using 
a streak test. As expected, the transformed strains had a less severe UV 
sensitivity than the parental BY472strain, due to the reinstated gene
(Figure 4.4).
UV Dose 
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Control Strains
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A rad23
Arad4
Arad7
pRAD7-pRS314
psocs-pRS314
New Strains
m m pRAD7-pRS313
psocs-pRS313
Figure 4.4 - UV Sensitivity Streak Test of New Strains Yeast cell cultures 
were streaked across solid media, then irradiated with 0-100Jm‘2 UV. As can 
be seen, the strains harbouring plasmids containing RAD7 have increased UV 
resistance compared to the Arad7 strain. The control strains show the WT 
strain with normal UV sensitivity, the severely UV-sensitive Arad4 strain, and 
the moderately UV-sensitive Arad23 and Arad7 strains.
In order to assess the transformants, expression of RAD7 transcript and 
protein level was observed by qPCR and Western Blotting. qPCR was 
performed to check RAD7 gene expression levels by detecting mRNA 
concentration (Figure 4.5). Quantification of relative gene expression revealed 
that both pRAD7 and psocs mRNAs were expressed at approximately the 
same level but psocs expression appears to occur at a lower level, however 
this does not affect the UV sensitivity of the strain (Figure 4.7) so will not be 
considered as reason for concern for future experiments.
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Original (pRS314) Strains New (pRS313) Strains
Figure 4.5 - RAD7 Expression in New Strains mRNA was extracted, 
reverse-transcribed into cDNA, and used for qPCR with primers homologous 
to RAD7 ORF. Expression of RAD7 was quantified in newly constructed 
pRS313-RAD7 and pRS313-socs) and control strains (pRS314-RAD7 and 
pRS314-socs) Relative expression values are displayed in Appendix VII.
Rad7 protein expression was deduced using WCE preparation, SDS-PAGE 
and western blotting. The blot was probed using an anti-Rad7 polyclonal 
antibody (Figure 4.6), and revealed Rad7 expression in all strains except 
Arad7, which shows Rad7 is being successfully expressed from the plasmid.
Figure 4.6 - Rad7 Protein Levels in New Strains SDS-PAGE and western 
blotting was performed on WCEs from new strains (pRAD7 and psocs) and 
control strains (WT and Arad7). The western membrane was probed with 
Rad7 antibody to monitor protein levels in newly synthesised strains.
The newly constructed strains were also characterised by comparing their UV 
survival phenotype to those observed in (Gillette et al. 2006), thus displaying
New (pRS313) Strains
Rad7
Loading
Control
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no UV sensitivity in the psocs strain and increased UV sensitivity in the psocs 
Arad23 strain compared to the pRAD7 Arad23 strain. Arad23 strains were 
constructed by replacing the genomic RAD23 sequence with a URA3 marker, 
which was confirmed by PCR.
0.1
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pRAD7 Arad23 
psocs Arad23
0.01 200 5 10
UV dose (Jma)
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Figure 4.7 - UV Survival of pRS313 pRAD7, psocs, pRAD7 Arad23 and 
psocs Arad23 Strains Newly constructed (pRS313 pRAD7, psocs, pRAD7 
Arad23 and psocs Arad23) strains were spread onto minimal media plates in 
triplicate. Following 2 days growth, surviving colonies were counted and % 
survival calculated. Error bars correspond to standard deviation. This figure 
shows the same result as observed in (Gillette et al. 2006). UV survival raw 
data can be found in Appendix II.
The UV sensitivity of the new strains was also confirmed to be the same as 
(Gillette et al. 2006) whereby the psocs Arad23 strain is significantly more UV- 
sensitive than the Arad23 strain, and the strain which only has the psocs 
mutation shows no UV sensitivity (Figure 4.7). These observations confirmed 
that the new strains had the same phenotype as those used previously, so 
future experiments could be compared to the results obtained in (Gillette et al. 
2006).
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4.3.2 Determination of UV-lrradiation Conditions for psocslrad23 Arrays
pRAD7 Cells were grown to 107 cells/ml in HIS' minimal media. 50ml cell 
culture was centrifuged for 3 minutes at 4 000 rpm, and cells were diluted in 
50ml cold PBS. Another 50ml portion of cell culture was also irradiated 
without dilution in PBS. An UV survival assay was conducted using the 
pRAD7 strain in order to compare survival between irradiation in media and 
PBS (Figure 4.8).
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Figure 4.8 - UV Survival of pRAD7 Strain Irradiated in PBS or Minimal 
Media pRAD7 cells were exposed to UV in PBS or minimal media, then 200 
cells were spread onto minimal media plates in triplicate. Following 2 days 
growth, surviving colonies were counted and % survival calculated. Error bars 
correspond to standard deviation.
As displayed in Figure 4.8, UV radiation was found to penetrate PBS more 
effectively thus killing more cells at a lower dose. It is important for the 
purposes of global transcriptional analysis to induce a UV-dependent 
transcriptional response, without causing an unnecessarily high cell death 
rate, which would induce transcription of genes involved in extreme survival or 
programmed cell death and make it more difficult to identify UV-inducible
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genes. It was decided a survival rate of approximately 50% was appropriate to 
invoke a suitable UV response. This equates to a dose of 40Jm'2 in PBS, or 
100Jm"2 in minimal media. A dose of 100Jm'2 in minimal media was applied to 
cells prior to mRNA extraction for use in microarrays.
Two sets of arrays were analysed in order to deduce the role of the Rad4- 
Rad23 complex in DNA damage-responsive global transcription. Firstly, the 
rad4/rad23 used Arad4, Arad23 and Arad4Arad23 strains without UV 
irradiation to identify altered global gene expression in untreated cells. The 
psocs/rad23 microarray set was then conducted, which used the strains 
constructed in this chapter -  the pRAD7, psocs, pRAD7 Arad23 and psocs 
Arad23 mutant strains. These strains were irradiated with UV to identify genes 
regulated by the Rad4-Rad23 complex in response to DNA damage, 
particularly the Rad7 E3 ligase-dependent ubiquitination of Rad4. The psocs 
strain was used instead of a Arad4 strain to deduce the role of the Rad4- 
Rad23 complex in UV-responsive transcription as the Arad4 strain is highly 
UV-sensitive and transcriptional responses caused by the high rate of cell 
death may mask the UV-induced transcriptional response.
4.3.3 Initial Analysis of rad4/rad23 Arrays
The rad4/rad23 arrays were conducted to identify transcriptional targets of the 
Rad4-Rad23 damage recognition complex, which may contribute to its role in 
the DNA damage response. Due to the severe UV sensitivity of the Arad4 
mutant these arrays were conducted in the absence of UV or DNA damaging 
agents. The rad4/rad23 arrays were conducted using a WT strain and strains 
with Arad4, Arad23, or Arad4Arad23 mutations, with three biological repeats 
conducted for each strain. RNA preparation, submission, microarray 
processing and initial data handling including QC and normalisation was 
conducted by Dr J. Smirnova and will not be included in this report. Genes 
with significantly differential expression in the mutant strains compared to WT 
were identified, using a FDR corrected t-test (p<0.05) and a 1.5 fc cut-off. To 
initially assess the transcriptional disruption in the strains, scatter plots were
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created. Figure 4.9 shows mutant gene expression compared to WT, with 
genes identified as expressed at a significantly lower level in the mutant 
highlighted green, and genes identified as expressed at a significantly higher 
level in the mutant highlighted red. Genes that were not significantly 
differentially expressed are shown in grey. Genes which lie on the black y=x 
line exhibit no transcriptional change in the mutant strains.
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Figure 4.9 - Scatter Plots of rad4/rad23 Microarrays Expression values 
were plotted for mutant against WT strains, and significantly differentially 
expressed genes were identified. The scatter plots show genes expressed at 
a significantly lower level in the mutant strain in green and genes expressed 
at a significantly higher level in the mutant strain in red. The numbers 
correspond to the number of significantly up- and downregulated genes in the 
stated strains.
The Arad4 strain has only 5 significantly altered genes compared to the WT, 
and the Arad23 strain also shows a fairly mild phenotype of 44 genes 
significantly altered. A more substantial alteration in gene expression is 
displayed in the double Arad4Arad23 strain, which has 90 significantly 
differentially expressed genes. This initial observation from the data could
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suggest a genetic redundancy for the two genes, whereby the Rad4-Rad23 
complex can still function as a transcription factor if one gene is absent for a 
subset of genes.
A rad4 Arad23
Arad23Arad4
Figure 4.10 - Venn Diagram to Show Overlap Between Different Gene 
Lists Commonly misregulated genes are represented here in the rad4/rad23 
mutant strains using the aforementioned significant gene lists.
The gene lists were also organised into a Venn diagram (Figure 4.10). The 
slight altered transcription of the Arad4 phenotype could be caused by the 
action of the recently characterised Rad4 homologue, Rad34. It has been 
reported that Rad34 can fulfil the role of Rad4 in repair of ribosomal DNA and 
interacts with Rad23. This compensatory function of Rad34 could explain the 
Venn diagram data shown in Figure 4.10 (den Dulk et al. 2005; den Dulk et al. 
2006; Tremblay et al. 2008).
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4.3.4 Cluster Analysis of rad4/rad23 Arrays
In order to obtain manageable gene lists, the conditions were relaxed to omit 
the t-test and just include genes which exhibited a >1.5 fc. This provided a list 
of 205 genes, which was then clustered using average linkage hierarchical 
clustering in order to find similarly expressed genes. Four main clusters were 
found and they are visualised in Figure 4.12. The clusters (from top to bottom) 
represent 1). Genes that are unaffected in single mutants and downregulated 
in the double mutant, 2). Genes that are downregulated in single mutants and 
upregulated in the double mutant, 3). Genes that are downregulated in all 
mutants and 4). Genes that are upregulated in all mutants. In order to assess 
the relevance of these gene lists in response to DNA damage, a list of UV- 
responsive genes in the pRAD7 (WT) strain was compiled.
4.3.5 Compilation of a UV-Responsive Gene List
The threat of DNA damage invokes a vast transcriptional response to 
stimulate DNA repair, stress response and checkpoint pathways, and 
promoting cell cycle arrest. As part of the psocs/rad23 arrays a microarray to 
deduce which genes were significantly up or down regulated in response to 
UV in the pRAD7 WT strain was conducted. Cells were exposed to 100Jm'2 
UV and mRNA was extracted after 15 minutes and 1 hour. Microarrays were 
conducted and expression values were obtained. The log2 untreated values 
were subtracted from log2 UV-treated values, and a FDR corrected t-test 
(p<0.05) was applied to the untreated and UV-treated values to obtain 
significantly differentially expressed genes. A 2 fc cut off was applied to 
identify genes significantly regulated in response to UV. Amalgamating genes 
significantly differentially expressed 15 or 60 minutes after UV produced a list 
of 1360 UV-responsive genes (Figure 4.11). The UV-responsive gene list is 
displayed in the electronic Appendix IV, list 2.
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Figure 4.11 - Venn Diagram to Show Genes Significantly Differentially 
Expressed in Response to UV in the pRAD7 Strain The three gene lists 
shown here were combined to form a list of 1360 UV-responsive genes. This 
gene list is displayed in the electronic Appendix IV, List 2.
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4.3.6 UV-Responsive Genes Affected by the Rad4-Rad23 Complex
The UV-responsive gene list was used in conjunction with the Arad4/Arad23 
gene list (Displayed in Appendix IV, List 1) to identify UV responsive genes 
transcriptionally regulated by the Rad4-Rad23 complex. In the context of the 
previously clustered gene lists, it was deduced which of those genes were 
UV-responsive.
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Figure 4.12 -  Analysis of Arad4/Arad23 Significantly Differentially 
Expressed Gene Lists A: Venn diagram to show proportion of UV- 
responsive genes that are also significantly misregulated in Arad4/Arad23 
strains. B: heatmap of Arad4/Arad23 significantly differentially expressed 
genes hierarchically clustered. Genes were divided into 4 distinct clusters, 
and % values refer to the proportion of UV-responsive genes in each cluster. 
This gene list is displayed in Appendix IV, List 1.
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Figure 4.12A shows that approximately half of the genes significantly 
differentially expressed in Arad4Arad23 mutants are UV responsive in the 
pRAD7 strain. This suggests that the Rad4-Rad23 complex has an important 
role in the transcriptional response to UV. In order to further analyse the UV- 
responsive genes under transcriptional control of Rad4-Rad23, UV- 
responsive genes in individual clusters were investigated. % values in Figure 
4.12 show the UV-responsive proportion of each cluster. The 101 UV 
responsive genes were extracted, and are displayed in the same cluster order 
in Figure 4.13.
101 significant genes pRAD7 Strain
Figure 4.13 - Heatmap of UV-Responsive Arad4/Arad23 Significantly 
Differentially Expressed Genes Untreated mutant strains are shown in the 
first three columns, and the UV-treated pRAD7 strain is shown in the final two 
columns
Comparing the untreated and UV-treated columns in Figure 4.13, an 
interesting observation is how the UV response appears to mimic the 
transcriptional pattern seen in the Arad4Arad23 double mutant. This may 
suggest that removal of the Rad4-Rad23 complex from gene promoters is 
required for UV-responsive transcription.
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The cluster with the largest proportion of UV-responsive genes is the second, 
which will be analysed in further detail. 13/17 genes were found to be UV 
responsive in this cluster and are displayed in Figure 4.14. These genes were 
subjected to analysis to deduce common regulatory pathways. It was found 
that 5 of these genes contain 5’ STRE  sequences, and expression of 2 of the 
genes is controlled by the Crt1 transcription factor. STRE sequences are 
found in several gene promoters and become bound by the Msn2/4 
transcription factors in response to different stresses to induce transcription of 
stress responsive genes. The Crt1 protein was initially discovered as a 
repressor of the RNR pathway, which functions to regulate nucleotide pools in 
the cell. It has been found to affect the transcription of several other genes 
involved in stress response (Zaim et al. 2005). The UV-responsive, Rad4- 
Rad23 regulated genes (Figure 4.13) are mostly misregulated in the same 
direction (up- or down-regulated), but with a smaller magnitude, as the WT UV 
response. This could suggest that the removal, inactivation or destruction of 
the Rad4-Rad23 complex is important for transcription of these UV responsive 
genes.
Figure 4.14 - Genes of Cluster Two -  the genes of cluster two are shown 
with common regulatory elements.
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104
In order to analyse further the role of the Rad4-Rad23 complex in 
transcription, specifically focussing on the role of post-UV Rad4 ubiquitination, 
the untreated psocs/rad23 arrays were analysed.
4.3.7 Initial Analysis of Untreated psocs/rad23 Arrays
The untreated arrays were initially analysed in the same way as the 
rad4/rad23 arrays. Genes with significantly differential expression in the 
mutant strains compared to the pRAD7 strain were identified using a FDR 
corrected t-test (p<0.05) and a 1.5 fc cut-off. To initially assess the 
transcriptional disruption in the strains, scatter plots were created. Figure 4.15 
shows mutant gene expression compared to the pRAD7 strain, with genes 
identified as expressed at a significantly lower level in the mutant highlighted 
green, and genes identified as expressed at a significantly higher level in the 
mutant highlighted red. Genes that were not significantly differentially 
expressed are shown in grey. Genes which lie on the black y=x line exhibit no 
transcriptional change in the mutant strains.
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Figure 4.15 - Scatter Plots of psocs/rad23 Microarrays fc values were 
calculated from the psocs/rad23 expression value microarray data, and 
significantly differentially expressed genes between the mutant and pRAD7 
strains were identified. The scatter plots show genes expressed at a 
significantly lower level in the mutant strain in green and genes expressed at 
a significantly higher level in the mutant strain in red. The numbers 
correspond to the number of significantly up- and downregulated genes in the 
stated strains.
The psocs strain has only 1 significantly altered gene compared to pRAD7, 
which was the RAD7 gene itself. For the purpose of this study, this result will 
be ignored as the plasmids have been sequenced, and RAD7 expression has 
been addressed previously (Section 4.3.1).
The pRAD7 and psocs Arad23 strains exhibit a similar magnitude of 
transcriptional disruption but they exhibit a far greater difference than the 
pRAD7 and psocs RAD23+ strains. This transcriptional variation will be 
considered when progressing to investigate variations in transcriptional 
response to UV.
Commonly misregulated genes in the different strains were determined by 
constructing a Venn diagram (Figure 4.16). This shows that RAD7 was 
significantly misregulated in all strains (the central 1 gene). The Arad23 
strains show an unexpected crossover based on their UV survival phenotype.
It would be predicted that the genes that are misregulated in the pRAD7 
Arad23 strain would be a subset of the genes misegulated in the psocs 
Arad23 strain. Like the data seen in the rad4/rad23 arrays, there is relatively 
little overlap of gene lists. This suggests that Rad4, and its ubiquitination has 
a complex role in global transcription.
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Figure 4.16 - Venn Diagram to Show Overlap Between Different Gene 
Lists Commonly misregulated genes are represented here in the 
psocs/Arad23 mutant strains using the aforementioned significant gene lists.
4.3.8 Cluster Analysis of psocs/Arad23 Untreated Arrays
In order to obtain manageable gene lists, the conditions were relaxed to omit 
the t-test and just include genes which exhibited a >1.5 fc. This provided a list 
of 306 significant genes that were compiled into a list and hierarchically 
clustered, then UV-responsive genes were identified (Figure 4.17). The gene 
list is displayed in Appendix IV, List 3. Hierarchical clustering revealed three 
main clusters. Cluster 1 represents genes that were downregulated in the 
pRAD7 Arad23 and psocs Arad23 strains, Cluster 2 represents genes 
downregulated in the psocs and pRAD7 Arad23 strains, and Cluster 3 
represents genes upregulated in the pRAD7 Arad23 and psocs Arad23 
strains. This shows that in most significantly regulated gene sets the two 
Arad23 strains appear to behave similarly, and the psocs strain behaves as 
the pRAD7 strain. It is therefore of great importance to extract and identify the 
small minority of genes that are differentially expressed between the psocs 
and pRAD7 strains in the presence or absence of Rad23.
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Figure 4.17 -  Analysis of psocs/Arad23 Significantly Differentially 
Expressed Gene Lists A: Venn diagram to show proportion of UV- 
responsive genes that are also significantly misregulated in psocs/Arad23 
strains. B: heatmap of psocs/Arad23 significantly differentially expressed 
genes Hierarchically clustered. Genes were divided into three distinct clusters, 
and % values refer to the proportion of UV-responsive genes in each cluster. 
The gene list is displayed in Appendix IV, List 3.
It appears in Figure 4.17 that genes that are upregulated in the mutants are 
mostly UV-responsive. The rad4/rad23 and psocs/rad23 untreated arrays had 
similar numbers of significantly altered genes (205 and 306), and of these 
genes, approximately half of each are common to the UV-responsive gene 
list. Despite these commonalities, only 43 genes are common to both sets.
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The UV-responsive genes were extracted from the psocs/rad23 significant 
gene list and are displayed in Figure 4.18.
145 significant genes pRAD7 Strain
Figure 4.18 -  Heatmap of UV-Responsive psocs/Arad23 Significantly 
Differentially Expressed Genes Untreated mutant strains are shown in the 
first three columns, and the UV-treated pRAD7 strain is shown in the final two 
columns.
Figure 4.18 shows that some of the untreated mutant strains also mimic the 
UV response without UV treatment compared to the WT, which is most 
evident in the Arad23 strains. GO analysis was performed on the three 
clusters in Figure 4.17. The top 6 GO terms for Clusters 1 and 3 were 
extracted, and are shown in Figure 4.19.
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Figure 4.19 - GO Analysis of psocs/rad23 Significant Genes. GO analysis 
was performed on the genes from the named clusters in Figure 4.17
The top 6 GO terms selected in Figure 4.19 support the idea that the 
transcriptional misregulation in Arad23 mutants without UV treatment mimics 
the W T transcriptional response to UV, as stress response, cell cycle and 
DNA metabolism genes are upregulated, and genes for more general 
housekeeping tasks such as amino acid, lipid and RNA metabolism are 
downregulated.
Further analysis of the upregulated gene lists reveal key genes involved in the 
DNA damage response in the Cluster 3 stress response GO list. These 
include RAD53, the checkpoint kinase, and 2 subunits of RPA (RFA1 and 
R F A 2 ) the ssDNA binding protein involved in the checkpoint response. 
Another checkpoint protein, DDC2 is present in Cluster 2. CLB5 and CLB6 the 
Gi cyclins are present in the cell cycle category from Cluster 3, which promote 
entry into S-phase. Another Gi cyclin, CLB3 is present in Cluster 2 (not shown 
in figure). These observations suggest disruption of the transcriptional
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response to UV in the mutant strains but further analysis must be conducted 
to determine which genes are affected in which mutant, and how these could 
produce the phenotypes shown.
It was seen in the initial analyses of the arrays that the transcription of a large 
proportion of the genome is altered in response to UV in WT cells. It has also 
been shown that the untreated Arad4Arad23, pRAD7 Arad23 and psocs 
Arad23 strains display a similar transcriptional pattern to UV-irradiated cells, 
however the expression changes in untreated mutant cells occur at a lower 
magnitude than the WT UV response.
Having identified misregulated genes in the mutant strains in the absence of 
DNA damage, the study then progressed to identify differentially regulated 
genes in the mutant strains in response to UV radiation in order to identify 
candidate genes whose altered transcription could cause the increased UV- 
sensitivity in the psocs Arad23 strain compared to the pRAD7 Arad23 and 
pRAD7 strains, observed by (Gillette et al. 2006).
4.3.9 Differentially Expressed Genes in Response to UV
The purpose of this investigation was to identify genes and pathways 
responsible for the additional UV sensitivity of the psocs Arad23 strain 
compared to the Arad23 strain, and therefore revealing the role of the Rad4- 
Rad23 complex in global transcription. It is not appropriate to compare 
different UV-treated strains directly, so fc between untreated and UV treated 
arrays for each strain was calculated, and fc difference was compared as a 
measure of differential expression between different mutant strains. A Venn 
diagram displaying differentially expressed genes between the pRAD7 Arad23 
and psocs Arad23 strains is shown in Figure 4.20. A threshold value of 1.5 fc 
difference was employed between the two strains, a suitable cut-off to 
produce manageable gene-lists.
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Figure 4.20 - Venn Diagram to Show Commonly Misregulated Genes in 
the pRAD7 Arad23 and psocs Arad23 Strains Either 15 or 60 Minutes 
Post-UV. Gene lists shown here exhibit >1.5 fc difference between the 
pRAD7 and the pRAD7 Arad23 strains or the pRAD7 and the psocs Arad23 
strains fc in response to UV.
The most likely candidates responsible for the increased UV sensitivity in the 
psocs Arad23 strain are genes that are significantly misregulated in the psocs 
Arad23 strain but not the pRAD7 Arad23 strain. For this reason the 168 gene 
list from Figure 4.20 was extracted, and clustered using a K-Means technique 
to identify genes with a similar expression pattern in response to UV. This 
gene list is displayed in Appendix IV, List 4. Three significant clusters were 
found (Figure 4.21). Cluster 1 had reduced gene activation in the psocs 
Arad23 mutant compared to the pRAD7Arad23 and pRAD7 strain. Cluster 2 
had reduced gene downregulation in the psocs Arad23 strain, and Cluster 3 
had increased gene downregulation in the psocs Arad23 strain, not evident in 
the pRAD7 Arad23 strain or pRAD7 strain (Figure 4.21).
112
<-8 
Cluster 3
Figure 4.21 - K-means Clusters from 168 Gene List. Genes with 
significantly differential expression in response to UV between the pRAD7 
Arad23/psocs Arad23, and pRAD7 strain were extracted (Figure 4.20), and 
168 genes were identified as significantly differentially regulated in the psocs 
Arad23 but not the pRAD7 Arad23 strain. These were subjected to K-Means 
clustering. The 3 clusters that showed the most striking differential expression 
are shown here. The heatmaps show expression values 1 hour after UV in the 
3 strains.
Genes identified in clusters shown in Figure 4.21 include proteasomal 
subunits, RAD7 itself and the RTT109 histone acetyltransferase, which is 
involved in histone modification in response to DNA damage.
Although these clusters revealed a few candidate genes, most genes were 
not significantly differentially expressed in the psocs Arad23 strain compared 
to the pRAD7 Arad23 strain and pRAD7 strain. This occurred because most 
genes were expressed close to the threshold value so did not actually show a 
significant difference between the pRAD7 Arad23 strain and the psocs Arad23 
strain. A more appropriate method was derived whereby the difference in 
expression between the pRAD7, pRAD7 Arad23 and the psocs Arad23 in 
response to UV was taken into account.
This alternative method of identifying misregulated genes was to compare the 
fc difference between the pRAD7 Arad23 and psocs Arad23 strains, and 
extract genes that exhibited a difference in fc of at least 0.2. This produced a
list of 110 genes, which was also hierarchically clustered. The gene list is 
displayed in Appendix IV, List 5. In order to extract the required genes, 
clusters were obtained which showed more extreme or different misregulation 
in the psocs Arad23 strain than the pRAD7 Arad23 strain. This was intended 
to identify likely candidates responsible for the additional UV sensitivity of the 
psocs Arad23 strain, and thus possible targets of transcriptional regulation by 
the Rad4-Rad23 complex.
The clusters selected in Figure 4.22 display a variety of gene misregulation in 
the psocs Arad23 strain compared to other strains. The identified clusters 
were extracted and are displayed as individual genes in Figure 4.23. The 
clusters show genes that are upregulated in pRAD7 and downregulated in 
psocs Arad23 (Cluster 1), not changed in pRAD7 but downregulated in psocs 
Arad23 (Cluster 2), further downregulated in psocs Arad23 than pRAD7 
(Cluster 3) and upregulated in pRAD7 but no change in psocs Arad23 (Cluster 
4). All clustering was performed with regard to expression change 1 hour after 
UV treatment.
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Figure 4.22 - Genes Significantly Differentially Regulated in Response to 
UV in psocs Arad23 Strain. A list of 110 genes that were significantly 
misregulated in response to UV in the psocs Arad23 strain, and >0.2 fc 
different to the pRAD7 Arad23 strain. These 110 genes were hierarchically 
clustered and four biologically interesting clusters have been labelled. Some 
clusters have been merged to amalgamate similarly expressed genes, which 
are shown by the same cluster number. The gene list is displayed in Appendix 
IV, List 5.
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Figure 4.23 - Gene Clusters from Figure 4.22. Gene names are shown for 
the four clusters identified in Figure 4.22. Heatmap values are shown for 
untreated samples in all mutants compared to the W T or pRAD7 strain value 
and expression values 1 hour after UV treatment are compared to the 
corresponding untreated value.
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Further analysis of individual genes from the clusters displayed in Figure 4.23, 
using SGD (www.yeastgenome.org), was conducted in order to reveal genes 
from common pathways or with similar functions. Cluster 1 contains several 
subtelomeric elements (YLL067C, YHL050C and YHR218W) downregulated 
in the psocs Arad23 strain, which although are not well classified ORFs, all 
have similarity to helicases, and are all situated in the telomeric Y’ element. 
They are thought to have a role in chromosome segregation and stability 
(Louis 1995), so down regulation of these elements in the psocs Arad23 
mutant could affect the UV survival. Cluster 1 also contains BFA1, a 
checkpoint gene, which functions as part of the mitotic exit network (MEN) 
inhibitor complex and functions to prevent anaphase onset (de Bettignies and 
Johnston 2003; Geymonat et al. 2003).
Cluster 2 also contains subtelomeric Y’-element helicase-like ORFs (YLL067C 
and YML133C), which are also downregulated in the psocs Arad23 strain. It 
should be noted that the subtelomeric ORFs represented here are located 
across a variety of chromosomes, so it appears to be a genome-wide effect 
and not just localised to one telomere. Cluster 2 also contains the histone 
acetyltransferase RTT109, which acetylates histone H3 during S-phase and in 
response to DNA damage (Han et al. 2007). CDC8 is also in Cluster 2, and is 
a gene involved in dTTP synthesis, an important step in DNA synthesis 
downstream of the RNR pathway. Although CDC8 regulation is not as well 
understood as RNR regulation, downregulating CDC8 may upset nucleotide 
levels, which would affect DNA replication and repair. Reduction of CDC8 
levels is also known to affect telomere length (Toussaint et al. 2005).
Subtelomeric helicases are also found in Cluster 3. YRF1-1 and YRF1-5 are 
highly expressed in cells which lack functional telomerase, however are not 
usually induced in WT cells (Yamada et al. 1998). Misregulation of these 
telomeric elements could affect genome stability and therefore possibly pose 
a threat to cellular integrity and survival.
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Cluster 4 features genes that exhibit failed upregulation in the psocs Arad23 
mutant in response to UV. The most striking feature is the presence of several 
proteasomal subunits (PRE3, PUP1 and RPN13), whose expression is 
controlled by the Rpn4 transcription factor. The proteasome is known to have 
a varied function in the DNA damage response with both proteolytic and non- 
proteolytic regulatory roles. RFA3 is a subunit of RPA, the ssDNA binding 
complex which has a pivotal role in the DNA damage checkpoint response. 
Regulation of transcription of RPA subunits may have an important role in 
DNA damage sensitivity, however there is no evidence of previous research in 
this area. But the identification of other RPA subunits in Section 4.3.8 may 
suggest they are of interest, and a possible regulatory target of the Rad4- 
Rad23 complex. Other genes in Cluster 4 that may affect DNA damage 
sensitivity are ASF1, a nucleosome assembly factor and possible downstream 
target of Rad53, and TOP3, which affects telomere stability.
The Rpn4 transcriptional activator controls transcription of most proteasomal 
subunits and several other genes, most of which are known to be 
proteasome-associated. Due to the apparent over-representation of Rpn4- 
regulated genes in Cluster 4 (PUP1, RPN13 and PRE3), all proteasome 
subunits and several other Rpn4-regulated genes were extracted and are 
displayed in Figure 4.24. It can be seen that the expression levels of most 
proteasome subunits in the Arad23 strains show a uniform lower induction 
than the RAD23+ strains, which does not appear to be a psocs-dependent 
expression change for most genes. RPN4 transcription is not siginificantly 
affected by the mutations, so it may be affected post-transcriptionally by 
Rad23. This may also demonstrate the Rad23 regulatory mechanism 
proposed by (Wade et al. 2009), whereby Rad23 regulates transcription 
independently of Rad4. Although many of the proteasome subunits are less 
upregulated in the Arad23 mutants, the role of proteasomal transcriptional 
upregulation in response to DNA damage is not well studied so it is unknown 
whether DNA damage sensitivity is affected by reduced induction of 
transcription of proteasome subunits.
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Figure 4.24 - Rpn4-Regulated Genes Including All Proteasome Subunits
Rpn4 is a transcription factor that activates transcription of most proteasome 
subunits and other genes shown here, many of which are proteasome-related. 
Expression values represent 1 hour after UV treatment in the different strains.
Another well-represented pathway, identified in several analyses so far is the 
Mec1-Rad53 dependent DNA damage checkpoint pathway. Genes involved in 
this pathway were extracted from the arrays and are displayed in Figure 4.25 
to reveal any common transcriptional misregulation in the mutant strains. 
Genes from pathways commonly induced in response to DNA damage 
(discussed in Section 4.1.4), are also displayed in Figure 4.25 in order to view 
disruption of the well-characterised transcriptional response to UV in the 
mutant strains.
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Figure 4.25 - Genes Involved in the DNA Damage Checkpoint Pathway, 
and Genes Commonly Induced In Response to DNA Damage. Genes 
were extracted from rad4/rad23 and psocs/rad23 microarrays, and expression 
values are displayed as fc values.
Transcription of the RNR pathway shows strong evidence of being regulated 
by the Rad4-Rad23 complex. Basal transcriptional levels are altered in the 
rad4/rad23 mutants for most RNR subunits, and there is reduced expression 
of RNR1-4 in pRAD7 Arad23 and psocs Arad23 strains following UV. This 
reduction in RNR transcription could cause reduced RNR activity, which may
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result in reduced dNTP pools and inefficient repair. DUN1, the RNR activator 
exhibits reduced transcription in the pRAD7 Arad23 and psocs Arad23 
mutants, which could contribute to or cause the reduced RNR transcription. 
RNR transcriptional induction is regulated by the Crt1 repressor. In order to 
test if defective Crt1 activity was responsible for reduced RNR induction, all 
other known Crt1 -regulated genes were extracted. Figure 4.25 illustrates that 
most other Crt1-regulated genes also exhibit reduced expression in the 
pRAD7 Arad23 and psocs Arad23 strains, which could explain the reduced 
expression of RNR.
The DNA damage checkpoint pathway genes also exhibit altered transcription 
in response to UV in the mutant strains. The most striking transcriptional 
alteration appears in RFA3, a subunit of RPA the ssDNA binding factor, which 
appears to lose upregulation in a psocs-dependent manner. RAD53 also 
exhibits altered expression in response to UV in the mutants, which could 
affect coordination of the DNA damage checkpoint response, as Rad53 is a 
central key player in the pathway. The TEL1 pathway shows some Rad23- 
dependent transcriptional misregulation, which would implicate Rad23 in 
affecting the response to more than just NER-repairable lesions as Tell 
responds exclusively to dsb.
The other two pathways mentioned previously to be upregulated in response 
to DNA damage are the PHR1 and MAG1-DDI1 pathways. Figure 4.25 
suggests that UV-induced transcription of the PHR1 photolyase is highly 
dependent on Rad23, but does not show any psocs-dependent variation. 
Every effort was made to keep strains in the dark following UV irradiation, 
however the contribution of photolyase activity to UV sensitivity is not known, 
and reduced PHR1 induction could be a contributor to the Arad23 strains’ 
damage sensitivity. The MAG1/DDI1 pathway shows no significant variation in 
UV-induced transcription between the mutants shown.
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4.4 Discussion
The aim of this chapter was to investigate and identify the role of the Rad4- 
Rad23 complex and particularly the Rad7-dependent ubiquitination of Rad4 in 
DNA damage-responsive global transcriptional control. This was investigated 
based on observations seen by (Gillette et al. 2006) that the Rad7-dependent 
ubiquitination of Rad4 is involved in a component of the NER pathway that 
requires de novo protein synthesis. This provoked the theory that the Rad4- 
Rad23 complex has a role in global transcriptional control in response to DNA 
damage.
Rad23 has been reported previously to have a role in global gene 
transcription, by (Wade et al. 2009). They suggested that Rad23 had a 
regulatory role in global gene transcription, affecting a third of the genome 
dependent on its interaction with the 19S proteasome. They also concluded 
that Rad23’s function in transcriptional regulation did not involve Rad4. The 
analyses undertaken in this chapter aimed to reveal the role of Rad4-Rad23 
as a complex in UV-responsive transcription, and more specifically the 
function of Rad4 post-UV ubiquitination. This may present a role for Rad23 in 
transcription separate to the function observed by (Wade et al. 2009), possibly 
revealing a DNA-damage specific regulatory role of Rad23 in transcription, 
involving Rad4 ubiquitination. Whether the role of Rad23 in transcription 
affects a vast proportion of the genome as suggested in (Wade et al. 2009), or 
affects a smaller range of genes as revealed in this study, it was concluded 
that this represents a separate function of Rad23 in transcriptional control 
than the Rad4-Rad23 complex-dependent UV-responsive transcriptional 
control observed here.
The original rad4/rad23 microarrays identified genes misregulated in 
untreated strains with Arad4, Arad23 or Arad4Arad23 mutations. Genes of 
interest from these arrays included downstream elements of the checkpoint 
pathway including RNR3 and HUG1, and genes with STRE elements in their 
promoter (HSP12, C/A/5, GND2, DDR2 and GPH1). STRE elements bind the 
Msn2-Msn4 transcription factors in order to activate a vast array of genes in
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response to a variety of stresses (Martinez-Pastor et al. 1996). Analysis of the 
rad4/rad23 microarrays suggested a significant role for the Rad4-Rad23 
complex in global transcription, particularly in stress-responsive gene 
expression.
4.4.1 Transcriptional Misregulation of the RNR Pathway and Other 
Factors Involved in dNTP Synthesis
The DNA damage checkpoint pathway presents a highly specialised response 
to DNA damage, featuring the culmination of several effectors with one 
common goal, to protect genomic integrity. Two of the main effects of the 
DNA damage checkpoint response are altered cell cycle control and 
upregulation of dNTP synthesis. The psocs Arad23 mutant strain studied here 
exhibited reduced transcription of genes required for regulation of dNTP levels 
in response to DNA damage (Figure 4.23), including significantly reduced 
induction of RNR3, and increased downregulation of CDC8. RNR3 is a 
subunit of the ribonucleotide reductase (RNR) complex, which catalyses the 
rate limiting step of dNTP synthesis, an essential precursor of DNA synthesis 
(See Chapter 5.1.1). The RNR complex is most active during S-phase and 
following DNA damage, when DNA synthesis is required. There are four RNR 
genes, which encode interchangeable subunits of the RNR complex, but 
RNR3 is the most DNA damage-inducible subunit. RNR subunit composition 
is specific to activity during S-phase or during DNA repair. The reduced 
induction of RNR3 observed here may present a novel regulatory mechanism 
of the DNA damage-dependent RNR subunit specificity.
Whereas the regulation of RNR is fairly well understood, a lot less is known 
about regulation of the second dNTP level-regulatory gene identified by the 
arrays, CDC8. CDC8 is an essential gene in S. cerevisiae, and is a 
thymidylate (and uridylate) kinase required for the conversion of dTMP to 
dTDP (and dUMP to dUDP), an important step in dTTP synthesis (Chien et al. 
2009). A specific balance between the four nucleotides levels in cells is 
essential for accurate DNA synthesis, so impaired synthesis of any dNTP 
could jeopardise genomic integrity and cellular survival. Reduced expression
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of CDC8 in the psocs Arad23 strain could cause reduced dTTP synthesis and 
thus infringe upon genomic integrity.
4.4.2 Altered Expression of Genes Involved in Telomere Maintenance
It has been shown that reduced cellular dNTP levels can cause telomeric 
shortening. This has been displayed in mec1 and rad53 checkpoint mutants, 
which exhibit slightly shortened telomeres, a phenotype enhanced by the 
absence of Sir proteins. The phenotype can be suppressed by deletion of 
SML1 the RNR inhibitor, or RNR overexpression, which suggests that 
shortened telomeres is an effect of inadequate dNTP supply (Longhese et al. 
2000). A shortened telomere phenotype is also evident in cells harbouring a 
temperature sensitive, reduced function mutant cdc8 gene (Adams and Holm 
1996; Flurin et al. 2005). This implies that effective maintenance of cellular 
dTTP level is required for cell survival, and failure to regulate dTTP synthesis 
can impact upon genomic integrity by reducing telomere length. Figure 4.23 
displays increased transcriptional downregulation of CDC8 in the psocs 
Arad23 strain in response to DNA damage, which could reduce Cdc8 levels 
thus decreasing dTTP synthesis, which could cause the shortened telomere 
phenotype observed in the cdc8 mutant strain discussed previously. This 
could result in reduced genome stability, thus contributing to the increased UV 
sensitivity phenotype of the psocs Arad23 strain.
In support of the theory that the psocs Arad23 strain may exhibit shortened 
telomeres, another group of genes involved in telomere maintenance were 
also revealed in the analysis. The organisation of the ends of S. cerevisiae 
chromosomes comprise of -350bp telomeric DNA, containing a simple 
repetitive sequence of (TGi.3)n. These regions of DNA are elongated by 
telomerase to prevent gradual telomeric shortening caused by DNA 
replication. Telomere maintenance is essential for maintaining genomic 
integrity of immortal cells. Proximal to the telomeric sequence exist multiple 
copies of a more complex subtelomeric repeat, known as the Y’ element 
(Zakian 1996). Y’ elements occur in two forms, Y’-L (-6.7 kb) and Y’-S (-5.3 
kb), and are involved in telomere maintenance by homologous recombination
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in telomerase-negative strains. Both varieties of element contain a helicase- 
like ORF, known as the YRF1 gene, encoding Y’-Help1 (Yamada et al. 1998). 
The mechanism of telomerase-independent telomere maintenance is thought 
to involve reverse transcription of Y’ mRNA, then using Y’ cDNA to extend 
telomeres. Significant transcriptional induction of YRF1 has been observed in 
telomerase-negative strains, but has also been observed following exposure 
to the DNA damaging agent enediyne (Watanabe et al. 2002). The 
microarrays performed and analysed here show reduced expression of Y’ 
element transcripts (YRF1-1, YRF1-5, YLL067C, YHL050C, YHR218Wand 
YML133C) in the psocs Arad23 strain in response to DNA damage. Y’ 
element transcription has only been studied as being induced as a backup 
system for telomere maintenance in the absence of telomerase. This is not 
relevant to the arrays performed here as the strains are assumed to have an 
active telomerase. The increased downregulation of Y’ element transcription 
in the psocs Arad23 strain represents lower levels of transcript following DNA 
damage, which could impact on telomere stability, thus affecting genome 
stability and therefore cause or contribute to the increased UV sensitivity 
observed in the psocs Arad23 strain. The altered regulation of Y’ elements 
may be a result of genome instability or may represent a potential regulatory 
target for the Rad4-Rad23 complex.
4.4.3 Transcriptional Changes in Genes That Affect Chromatin 
Structure
Another group of functionally related genes that displayed significantly altered 
transcriptional control in the psocs Arad23 strain is genes involved in 
chromatin modification, particularly the histone acetyltransferase (HAT) 
RTT109, and the nucleosome assembly factor ASF1 (Anti-Silencing Factor 1). 
In order for factors to access DNA to conduct processes such as DNA 
replication, repair and transcription, chromatin modification is required, which 
involves the controlled disassembly of nucleosomes, and the subsequent 
reassembly following the DNA metabolic process. Asf1 is a H3/H4 histone 
chaperone (Tyler et al. 1999), which facilitates nucleosome reassembly, 
observed in vitro using human extracts, following NER (Mello et al. 2002).
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Asf1 facilitates nucleosome assembly via interaction with the chromatin 
assembly factor CAF-1 and promotes heterochromatin formation via 
interaction with Hir1 (Green et al. 2005; Sharp et al. 2001). Genetic studies in 
yeast have deduced that ASF1 is required for RTT109-dependent acetylation 
of Lysine 56 on histone H3 (Recht et al. 2006). Deletion of ASF1 results in 
cells with increased sensitivity to DNA damage (including UV) (Le et al. 1997), 
and increased genomic instability. Asf1 is also known to dynamically interact 
with Rad53 (Emili et al. 2001), which implies that Asf1 has a role in the DNA 
damage response. If reduced ASF1 expression causes reduced Asf1 protein 
levels, it could disrupt DNA damage-dependent chromatin modification, thus 
compromise cellular integrity and could contribute to the increased UV 
sensitivity of the psocs Arad23 strain. These observations suggest that ASF1 
or RTT109 could be a regulatory target of the Rad4-Rad23 complex, 
dependent on Rad7-dependent Rad4 ubiquitination in a Arad23 strain.
Mobilisation of Y’ elements in telomerase-negative strains is mediated by the 
Ty1 retrotransposon. Ty1 facilitates reverse transcription of the subtelomeric 
Y’ element, and promotes cDNA insertion (Maxwell et al. 2004). It has been 
shown that histone modification involving Asf1 and Rtt109 can function to 
protect the genome from Ty1 mediated insertional mutagenesis (Nyswaner et 
al. 2008). These observations could provide a regulatory link to the 
subtelomeric and chromatin modificatory transcripts revealed in this analysis. 
Further work in this area could include observing H3 K56 acetylation levels in 
the psocs Arad23 strain following UV irradiation to assess Asfl and Rtt109 
activity. Telomere length assays could also be performed to observe the 
effects of reduced expression of Y’ elements or reduced expression of dNTP 
level-maintenance genes (RNR and CDC8) in the psocs Arad23 strain. If 
shortened telomeres or altered H3 K56 acetylation levels were observed in 
the psocs Arad23 strain this could suggest a cause of genomic instability in 
the strain.
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4.4.4 Altered Expression of Proteasomal and Proteasome-Associated 
Genes
Multiple proteasomal genes were also shown to be significantly 
downregulated in the psocs Arad23 strain (PUP1, RPN13 and PRE3). The 
proteasome has many complex and essential roles in various cellular 
metabolic processes, therefore it is likely that transcriptional regulation of 
proteasomal subunits is important for cell survival and metabolism. 
Transcription of almost all proteasomal subunits is governed by the 
transcriptional activator protein Rpn4. Rpn4 activity represents an elegant 
negative feedback loop whereby Rpn4 promotes transcription of proteasomal 
subunits, and Rpn4 is subsequently degraded by the proteasome which 
decreases its transcription when sufficient proteasome has been synthesised. 
Rpn4 is not an essential gene, but Arpn4 cells are hypersensitive to a variety 
of stresses including DNA damage, however this stress hypersensitivity may 
not be due to lack of proteasomal upregulation as Rpn4 regulates 
transcription of several other genes, many of which are proteasome- 
associated, including Rad23 (Jelinsky et al. 2000; Ju et al. 2008). These 
genes are displayed in Figure 4.24, which shows a uniform lack of 
upregulation of proteasomal subunits, but also in several other Rpn4- 
dependent genes in pRAD7 Arad23 and psocs Arad23 strains. Rpn4 is 
activated by numerous stress-responsive factors including Hsf1, Pdr1, Pdr3 
and Yap1 (Ju et al. 2008), so it is possible that the other factors such as the 
Rad4-Rad23 complex could transcriptionally activate Rpn4 or Rpn4-regulatory 
factors in response to DNA damage stress.
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4.4.5 Identification of Potential Transcriptional Regulatory Targets of 
the Rad4-Rad23 Complex in the DNA Damage Response
The main goal of this chapter was to explore and identify misregulated genes 
and pathways that could cause or contribute to the UV sensitivity phenotype 
of the psocs Arad23 strain in order to reveal potential transcriptional 
regulatory targets of the Rad4-Rad23 complex in the DNA damage response. 
Four main pathways have been revealed in the final analysis; maintenance of 
dNTP levels (RNR and CDC8), control of proteasomal genes (Rpn4 target 
genes), genome stability-related chromatin modification (RTT109 and ASF1) 
and telomere maintenance (Y’ element transcripts). Links between these 
functional gene groups were also observed, for example the role of Asf1 and 
Rtt109 in preventing insertional mutagenesis involving the Ty1 
retrotransposon, the pathway by which Y’ elements are replicated, and the 
role of dTTP and dNTP levels in telomere maintenance. All genes 
investigated from Figure 4.23 exhibit reduced expression in the psocs Arad23 
strain. Reduced expression of genes that are known to promote genome 
stability and cellular integrity could reduce an organism’s tolerance to cellular 
threats such as DNA damaging agents, which could cause an effect such as 
the phenotype displayed by the psocs Arad23 strain in response to UV 
irradiation, and thus present likely regulatory targets of the Rad4-Rad23 
complex, with regulation dependent of Rad4 ubiquitination.
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The study will now progress to investigate the role of the Rad7 E3 Ligase in 
regulation of the RNR pathway. A recurring theme in these analyses has been 
inappropriate down regulation of genes involved in the maintenance of dNTP 
levels following DNA damage. The RNR pathway is a well-defined pathway 
for regulating dNTP levels. The inappropriate downregulation of genes 
involved in dNTP synthesis in the psocs Arad23 strain could be assumed to 
cause reduced dNTP levels. If dNTP levels were artificially elevated in the 
psocs Arad23 strain by constitutive expression/activation of RNR, and a 
suppressive effect was observed from UV survival data, it would suggest that 
the increased UV sensitive phenotype of the psocs Arad23 strain is caused 
(wholly or partly) by insufficient cellular dNTP supply.
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5 The Rad7 E3 Ligase Regulates the DNA Damage Response 
via the RNR Pathway
The previous chapter employed analysis of global gene expression to identify 
misregulated genes and pathways in the psocs Arad23 strain, in order to 
reveal the function of Rad4 ubiquitination by the Rad7-containing E3 ubiquitin 
ligase in DNA damage-responsive transcription. This followed on from work 
conducted by (Gillette et al. 2006), which identified Rad4 ubiquitination as 
having a possible role in the DNA damage response, particularly in the 
absence of Rad23. One pathway that exhibited significantly altered 
transcription in response to DNA damage in the psocs Arad23 strain was the 
Ribonucleotide Reductase (RNR) pathway, a downstream sub-pathway of the 
Mec1-Rad53 checkpoint response. The RNR pathway modulates cellular 
dNTP levels at specific stages of the cell cycle and in response to DNA 
damage. Genetic analysis will be employed in this chapter to attempt to 
characterise the possible regulatory function of the Rad4-Rad23 complex and 
if and how it regulates the RNR pathway.
5.1 Introduction
Regulation of cellular dNTP pools is of paramount importance for survival and 
genomic stability. During periods of DNA synthesis, during replication and 
repair, nucleotide pools are elevated and balanced between the four 
nucleotide varieties to facilitate efficient DNA synthesis and minimise 
mutagenesis. Although yeast can tolerate variations in dNTP level and still 
maintain cell viability, hyper-recombination but a decreased spontaneous 
point mutation rate have been associated with lower dNTP levels in a dun1 
strain (Datta et al. 2000; Fasullo et al. 1999), and higher than normal dNTP 
levels can result in an increase in spontaneous or DNA damage-associated 
mutagenesis due to encouraged damage bypass by replicative polymerases 
(Sabouri et al. 2008).
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The RNR pathway is the main target for regulation of nucleotide levels, as it is 
responsible for the rate-limiting step of nucleotide synthesis, and thus DNA 
synthesis. dNTP concentration is increased by 6-8 fold in response to DNA 
damage (Chabes et al. 2003).
5.1.1 The RNR Pathway
The rate-limiting step of DNA synthesis is production of deoxyribonucleotides 
(dNTPs) by reduction of ribonucleotides catalysed by the RNR complex. This 
creates increased cellular pools of dNTPs, which are used by the DNA 
polymerase enzyme complex to synthesise DNA. RNR is an a 2p2 holoenzyme 
complex, consisting of 2 large (a) and 2 small (P) subunits. There are 4 RNR 
genes (RNR1-4) of which the highly homologous RNR1 and RNR3 encode 
the a subunits, however only RNR1 is essential for cell viability. RNR1 
transcription fluctuates between 15 and 30 fold during the unperturbed cell 
cycle, with a peak in mRNA concentration during S-phase. It is slightly 
induced by DNA damage by 3-5 fold, whereas RNR3 is minimally expressed 
during the normal cell cycle but is highly induced in response to DNA damage 
by over 100 fold. This DNA damage dependent transcriptional induction of 
RNR3 does not contribute much to the DNA damage response and 
ribonucleotide reduction. Although overexpression of RNR3 can rescue the 
lethality of the mr1 mutant, deletion of RNR3 does not result in increased 
damage sensitivity (Elledge and Davis 1990). RNR2 and 4 encode the p 
subunits and are both essential and DNA damage inducible, however some 
yeast strains appear to be able to survive without RNR4 (Wang et al. 1997a). 
The p2 subcomplex consists of an Rnr2-Rnr4 heterodimer. Only Rnr2 is 
capable of forming the (Fe)2-Y* cofactor, however Rnr4 is required for Rnr2- 
dependent radical formation although it cannot bind iron itself (Perlstein et al. 
2005).
Regulation of RNR activity occurs at several distinct levels. Firstly, the 
transcription of DNA damage-inducible RNR genes is governed by the Crt1 
transcription factor. The RNR complex itself is regulated by allosteric control, 
altered subcellular localisation and by inhibition by the Sml1 peptide.
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Allosteric control of RNR occurs via dATP feedback inhibition. As the level of 
dATP rises by the action of RNR, dATP binds to an allosteric site on the RNR 
a subunit. The a subunit contains two allosteric sites: the activity site that 
monitors dNTP pools based on the dATP:ATP ratio, and the specificity site 
that regulates the balance between the dNTP varieties and can bind ATP, 
dATP, dCTP and dGTP (Reichard et al. 2000). A recent study by (Symington 
et al. 1996) has elegantly revealed the importance of the balance between 
levels of each dNTP. A series of mr1 mutant alleles were constructed, 
containing various point mutations in the allosteric specificity site. It was found 
that specific mr1 point mutations resulted in differentially balanced levels of 
dNTP varieties, which appeared to follow a purine/pyrimidine trend. The mr1 
Y285F and Y285A mutants exhibited dramatically increased pyrimidine dNTP 
(dCTP/dTTP) levels, and the mr1 Q288A mutant exhibited increased purine 
dNTP (dATP/dGTP) levels and reduced pyrimidine dNTP levels. Mutants with 
reduced pyrimidine dNTP levels were also observed to have a prolonged S- 
phase causing slower growth, due to pyrimidines limiting DNA synthesis. The 
reduced dNTP level was also found to activate the S-phase checkpoint, 
detected by increased expression of the RNR2, 3 and 4 subunits, however 
these mutants do not exhibit an increased mutation rate. These observations 
show that excessively high levels of specific dNTPs can increase mutation 
rate but do not affect cell cycle progression, however decreased levels of 
specific dNTPs can limit DNA synthesis and therefore delay cell cycle 
progression (Symington et al. 1996). Despite the conserved allosteric site 
between yeast and mammalian Rnr1, yeast Rnr1 can tolerate far higher levels 
of dATP in vitro before feedback inhibition occurs (Domkin et al. 2002).
5.1.2 Regulation of RNR transcription by the Crt1 repressor
The product of the CRT1 gene regulates the RNR pathway by binding at the 
promoter of various genes. It is known to bind to RNR2, RNR3 and RNR4 
promoters (Huang et al. 1998), and repress transcription under non-inducing 
conditions, when elevation of nucleotide pools is not required. Crt1 becomes
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phosphorylated by active Dun1 kinase and vacates the promoters in response 
to DNA damage to allow RNR transcription and subsequent elevation of 
nucleotide pools (Hao et al. 2009; Huang et al. 1998).
Crt1 has other genetic targets aside from RNR2, 3 and 4. It also binds to its 
own promoter and several other genes, only some of which are known to be 
involved in the DNA damage response. Crt1 recognises a 13bp cis-regulatory 
nucleotide sequence, which shares significant homology with the mammalian 
X-box motif. This motif becomes bound by RFX transcription factors, which 
have a role in regulation of major histocompatability complex genes (Huang et 
al. 1998). Crt1-regulated genes contain variations of the Crt1 binding motif in 
their promoters. Different strong and weak binding sequences have been 
discovered, and variable combinations of the different motifs is thought to 
provide a graded transcriptional response for different genes, as Crt1 
dissociates from weak binding sites before strong when active Crt1 levels 
become progressively depleted (Huang et al. 1998).
Whilst bound to gene promoters, Crt1 interacts with the Tup1-Ssn6 global 
corepressor complex, which negatively regulates many DNA damage- 
inducible genes. Crt1 has 2 repression domains, at residues 1-130 (N- 
terminal repression domain) and 709-811 (C-terminal repression domain).
Crt1 N-terminal repression domain is required forTup1-Ssn6 recruitment to X- 
box-containing promoters. The Crt1-Tup1-Ssn6 repressor complex 
orchestrates a precise nucleosomal array across the promoter that blocks 
access to the TATA box by the transcriptional machinery. DNA damage- 
induced Dun1 dependent Crt1 phosphorylation results in loss of Tup1-Ssn6 
recruitment, chromatin remodelling and derepression of damage-inducible 
genes. Repression by Tup1-Ssn6 is known, at other loci, to occur by HDAC 
recruitment. This could be the case at Crt1-repressed genes, however the 
action of HDACs at these promoters is not well understood (Zhang and Reese 
2005).
The N-terminal repression domain of Crt1 is also known to interact with the 
SWI/SNF and TFIID complexes, which both act as co-activators of damage-
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inducible genes by chromatin remodelling. It has been proposed that Crt1 can 
act as a repressor or activator of transcription depending on the DNA damage 
status (Zhang and Reese 2005).
A novel regulator of Crt1 has been discovered recently. Crt10 was found to 
positively regulate Crt1 transcription. Crt10 was also found to be epistatic to 
Dun1, and induced by Dun1. It is most probable that Crt10 functions in 
checkpoint recovery to reinstate Crt1 levels and repression of damage- 
inducible genes (Fu and Xiao 2006). Another factor thought to influence the 
levels of Crt1 is the mRNA deadenylase Ccr4. It is thought that Ccr4 affects 
Crt1 mRNA stability thus adding an extra level of Crt1 regulation 
(Woolstencroft et al. 2006).
The HUG1 gene, although its function is unknown, is also repressed by Crt1, 
and is transcriptionally induced in response to DNA damage. Several other 
genes have been computationally identified as possible targets of Crt1 
repression, from which three genes have been experimentally confirmed as 
Crt1-regulated. These genes, FSH3, NTH2 and YLR345Whave been 
implicated in regulation of central metabolism in response to stress. This 
suggests Crt1 has a more general role in stress response signalling as a 
downstream effector of the Mec1-Rad53 checkpoint pathway, however the 
abundance of Crt1 binding sites in RNR gene promoters suggest that the 
RNR pathway is the main target of Crt1(Zaim et al. 2005).
5.1.3 Further Transcriptional Regulation of RNR
Transcription of RNR3, the main damage-inducible RNR gene has been 
studied further to reveal additional factors involved in its regulation. The 
transcriptional modulator proteins Wtm1 and Wtm2 also influence RNR3 
transcription. It has been shown that Wtm2 interacts with RNR3’s promoter, 
and is required for RNR3 expression (Tringe et al. 2006). Wtm1 interacts with 
the Rnr2-Rnr4 complex to anchor it to the nucleus under normal conditions.
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This interaction is disrupted following DNA damage, which causes export of 
active Rnr2-Rnr4 to the cytoplasm (Lee and Elledge 2006).
Damage-induced RNR3 transcription also requires histone modification by the 
histone deacetylases (HDAC) Rpd3 and Hos2. Rpd3 has been shown to bind 
to the RNR3 promoter independently of Crt1 or Tup1. The action of both 
HDAC is required for effective RNA polymerase recruitment and RNR3 
transcription (Sharma et al. 2007).
5.1.4 RNR Inhibition by Sml1
Sml1 acts post-translationally upon the RNR tetramer by binding via its C- 
terminal region to the RNR a subunits and inhibiting RNR enzyme action. 
SML1 expression fluctuates throughout the normal cell cycle. During S-phase, 
when dNTPs are in high demand, removal of active Sml1 is essential for cell 
viability. The checkpoint kinase Dun1 is responsible for Sml1 phosphorylation, 
which triggers its subsequent degradation both during S-phase and following 
DNA damage (Zhao and Rothstein 2002). This Dun 1-dependent degradation 
is a downstream event of the Mec1-Rad53 pathway, as Mec1 and Rad53 
proteins are required to alter Sml1 protein levels. Further evidence of the 
involvement of Dun1 in Sml1 protein levels is a prolonged S-phase in Adun1 
cells, which can be suppressed by Sml1 deletion. The Adunl cells do not 
exhibit a slow-growth phenotype as G2/M phase is suitably adjusted so the 
overall cell cycle time remains the same. This prolonged S-phase suggests 
defective DNA repair when Sml1 levels are too high. Deletion of SML1 has 
been shown to increase cell viability compared to WT cells in response to 
DNA damaging agents in some cases. This would suggest that the dNTP 
level that cells normally operate at is not set to allow maximal survival in 
response to damaging agents, but probably to maintain genetic integrity and 
an optimum rate of DNA synthesis. Asml1 cells exhibit 2.5x elevated pools of 
all dNTPs in asynchronous untreated cells (Zhao et al. 1998).
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Figure 5.1 - Regulation of the RNR Pathway The RNR pathway is regulated 
at many different levels. At the transcriptional level the Crt1 repressor vacates 
RNR gene promoters in response to checkpoint activation by phosphorylation 
of Crt1 by activated Dun1 kinase. This also triggers Crt1 transcription which 
provides a feedback loop to rapidly suppress RNR genes when no longer 
required. The Dun1 kinase also phosphorylates the Sml1 RNR inhibitor, which 
activates the RNR complex. The active RNR complex catalyses dNTP 
synthesis thus increasing dNTP levels and DNA synthesis. RNR activity is 
also inhibited by increased nucleotide levels thus providing a further negative 
feedback loop. The upstream factors in the DNA damage checkpoint 
response are displayed in Figure 1.7. This figure was created from multiple 
sources cited in this chapter.
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5.2 Materials and Methods
5.2.1 Yeast Strains Used
Strain Genotype Source
Arad7 BY4742: M ATahis3Al leu2A0 ura3A0 
YJR052W::KanMx4
EUROSCARF
Arad7
Arad23
BY4742 Arad7 Arad23::URA3 This Study
pRAD7 
Arad23 
Asm 11
BY4742 Arad7 Arad23::URA3 Asmll::LEU2 
pRS313-RAD7
This Study
psocs
Arad23
Asmll
BY4742 Arad7 Arad23::URA3 Asmll::LEU2 
pRS313-socs
This Study
pRAD7
Arad23
Acrtl
BY4742 Arad7 Arad23::URA3 Acrtl ::LEU2 
pRS313-RAD7
This Study
psocs
Arad23
Acrtl
BY4742 Arad7 Arad23::URA3 Acrtl::LEU2 
pRS313-socs
This Study
5.2.2 Chromatin Immunoprecipitation (ChIP)
5.2.2.1 Preparation of Chromatin
Cells were grown to mid/late log phase (O.D6oo ~ 1), and 2.8ml of 37% 
formaldehyde was added to 100ml of the culture medium (containing at least 
2 x109 cells). The mixture was incubated at room temperature for 20 mins with 
occasional mixing to allow efficient DNA and protein cross-linking. The cross- 
linking reaction was stopped by adding 5.5ml of 2.5M glycine to a final 
concentration of 0.125M. Cells were collected by centrifugation and then 
washed with ice-cold TBS buffer and ChIP lysis buffer (50mM HEPES-KOH 
pH 7.5, 140mM NaCI, 1mM EDTA, 1% Triton X-100, 0.1% Na-deoxycholate 
1mM PMSF, 1mM Benzamidine, 10pg/ml Aprotinin, l^g/ml Leupeptin, 1 jig/ml 
Pepstatin). Cells were resuspended in 500pl of ChIP lysis buffer 
supplemented with 12.5pl of 20% SDS and 12pl of 100x protease inhibitors. 
After 0.5ml glass beads were added to this solution, the mixture was vortex 
(at the highest speed on a turboMix) at 4°C for 10-15 mins. The cell lysate 
was carefully collected by centrifugation. The cell lysate was sonicated by a
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Diagenode sonication system at the high output rate for 3 mins (6 x  0.5 min 
on/0.5 min off cycle). The sonicated cell lysate was centrifuged at 13 200 rpm 
for 15 mins at 4°C. Supernatant (chromatin extract) was transferred to a clean 
tube and stored at -80°C until further use.
5.2.2.2 Chromatin Immunoprecipitation
Protein A beads were washed twice with ChIP lysis buffer and then 
equilibrated with ChIP lysis buffer supplemented with 0.1% BSA and 40pg/ml 
single strand salmon sperm DNA for 3 hours at 4°C. 50pl of chromatin 
extracts were added to 500pl of ChIP binding buffer (ChIP lysis buffer 
supplemented with 0.25% SDS and 1x protease inhibitors) and then the 
solution was cleaned with the equilibrated Protein A beads. After removal of 
the Protein A beads by centrifugation, the chromatin immunoprecipitation was 
carried out by adding 1-5pl antibody to this solution at 4°C overnight. 20-30pl 
of Protein A beads slurry were washed twice with ChIP lysis buffer, then 
added to the solution and incubated for 2-3 hours at 4°C. The Protein A beads 
were quickly spun down and washed successively with ChIP lysis buffer, ChIP 
lysis buffer with an increased salt concentration (500mM NaCI), LiCI solution 
and TE buffer. The Protein A beads were incubated for 15 minutes at 65°C in 
100pl pronase buffer, supplemented with 5pl pronase to reverse-crosslink and 
elute proteins. This was then centrifugated for 2 mins at 13 000 rpm, then 
supernatent was incubated overnight at 65°C to ensure reverse-crosslinking.
1 pi RNAse was added and incubated at 37°C for 30 mins. DNA was then 
isolated using the QIAquick PCR Purification Kit (Qiagen). The DNA 
suspension was stored at -20°C and used for qPCR, described in Section 
4.2.3.
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5.2.3 Strain Construction
In order to activate RNR activity constitutively throughout the cell cycle and 
following DNA damage, two new strains were constructed. Deletion of the 
Crt1 repressor results in constitutive expression of RNR, and deletion of the 
Sml1 inhibitor results in loss of RNR complex inhibition, thus causing 
constitutive RNR activation.
Using the Arad7 Arad23 strain, the SML1 or CRT1 gene was deleted by 
replacement with a LEU2 marker gene. Marker gene insertion was detected 
by colony PCR and confirmed by DNA sequencing. The pRS313-RAD7 and 
pRS313-socs plasmids were transformed into the Asml1 and Acrt1 strains to 
produce the last four strains displayed in the above Table.
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5.2.4 Northern Expression Analysis
Northern Blotting was performed to ensure SML1 and CRT1 were not being 
expressed in the knockout strains. Total RNA was extracted by the hot phenol 
method, and quality-checked by briefly running an agarose gel. The RNA was 
then used for Northern Blotting, and hybridisation of radiolabelled probe was 
detected.
Arad7 AradY
Arad23 Arad23
A sm ll A c rtl
SML1
ACT1
CRT1
ACT1
Figure 5.2 - Northern Expression Analysis of CRT1 and SML1 in AradY 
and New Strains RNA was extracted from pRADYArad23Asml1 (lane 2), 
psocsArad23Asm/1 (lane 3), pRADYArad23Acrtl (lane 4) psocsArad23Acrt1 
(lane 5) and AradY (lane 1)(CRT1+, SML1+) strains and used for northern 
analysis. The hybridised radiolabelled probe was detected as shown here to 
visualise SML1, CRT1 and ACT1 RNA as a loading control.
The northern blots (Figure 5.2) display clearly that SML1 and CRT1 are not 
being expressed in their respective deletion strains. Lane 1 shows expression 
of both SML1 and CRT1 in the control AradY strain. Lanes 2 and 3 show 
expression of CRT1 but not SML1 in the Asm/1 strains and lanes 4 and 5 
show expression of SML1 but not CRT1 in the Acrtl strains. This confirms 
that strain construction was successful.
mm mm «Mi mm
1 2 3 4 5
140
5.3 Results
It was observed previously that components of the RNR pathway exhibit 
decreased upregulation in response to UV in the psocs Arad23 strain 
(Chapter 4), a strain unable to facilitate Rad4 ubiquitination following UV 
(Gillette et al. 2006). This suggested that ubiquitination of Rad4 has a 
regulatory role in activation of the RNR pathway. In order to investigate the 
role of Rad4 ubiquitination in regulation of the RNR pathway in response to 
DNA damage, the RNR pathway was constitutively upregulated by deletion of 
the negative regulators of the pathway, SMLI1 or CRT1. The effect of RNR 
upregulation was monitored in psocs Arad23 and pRAD7 Arad23 strains with 
respect to their UV sensitivity.
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5.3.1 Constitutive RNR Activation Suppresses the UV Sensitivity of the 
psocs Arad23 Strain
The RNR complex was constitutively activated by deleting the RNR inhibitor 
Sml1. A UV survival assay was conducted in the psocs Arad23 Asmll strain, 
with pRAD7 Arad23 and psocs Arad23 strains as controls (Figure 5.3).
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Figure 5.3 - UV Survival of Asm ll psocs Arad23 strain. The psocs Arad23 
Asmll strain, with the pRAD7, psocs, pRAD7 Arad23 and psocs Arad23 
strains were spread onto minimal media plates in triplicate. Following 2 days 
growth, surviving colonies were counted and % survival calculated. Error bars 
correspond to standard deviation. UV survival raw data can be found in 
Appendix II.
Figure 5.3 shows that constitutive activation of RNR suppressed the additional 
UV sensitivity of the psocs Arad23 strain compared to the pRAD7 Arad23 
strain. The UV resistance appears to be elevated to the pRAD7 Arad23 level, 
which suggests that deletion of SML1, which is reliably assumed to cause 
elevated dNTP pools, can completely suppress the UV sensitivity caused by 
failed Rad4 ubiquitination when RAD23 is deleted.
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5.3.2 Constitutive RNR Activation Does Not Significantly Affect UV 
Sensitivity of the pRAD7 Arad23 Strain
To examine further the suppressive effect of SML1 deletion, a UV survival 
assay was conducted in the pRAD7 Arad23 Asmll strain. If SML1 deletion 
does only suppress the UV sensitivity caused by the psocs mutation as 
suggested previously, then the UV survival curve should not be affected in the 
pRAD7 Arad23 Asmll strain compared to the pRAD7 Arad23 SML1+ strain.
—  — i100*
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Figure 5.4 - UV Survival of Asm ll pRAD7 Arad23 Strain The pRAD7 
Arad23 Asmll strain, with the pRAD7, psocs, pRAD7 Arad23 and psocs 
Arad23 strains were spread onto minimal media plates in triplicate. Following 
2 days growth, surviving colonies were counted and % survival calculated. 
Error bars correspond to standard deviation. UV survival raw data can be 
found in Appendix II
Figure 5.4 shows that deletion of SML1 in the pRAD7 Arad23 strain does not 
significantly suppress its UV sensitivity. Although there appears to be slight 
suppression at lower UV doses, the strains are equally sensitive at 20Jm'2, 
which suggests that an overall suppressive effect is not occurring. This
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suggests that the intermediate UV sensitivity caused by RAD23 deletion is not 
due to insufficient elevation of nucleotide pools following DNA damage- 
induced checkpoint activation. An alternative concusion could be that the 
dNTP levels are insufficiently elevated in the Asmll strains to allow complete 
suppression of UV sensitivity, as Asmll strains are known to elevate dNTP 
levels 2-3 fold, whereas a 6-8 fold increase occurs in a typical WT strain in 
response to DNA damage. This is explored further in the discussion section.
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5.3.3 Constitutive RNR Expression Suppresses the UV Sensitivity of the 
pRAD7 and psocs Arad23 Strain
The Crt1 repressor was deleted in order to constitutively express RNR 
throughout the cell cycle and in response to DNA damage. A UV survival 
assay was conducted in the psocs Arad23 Acrtl strain, with pRAD7 Arad23 
and psocs Arad23 strains as controls (
Figure 5.5).
pRAD7
psocs
pRAD7 Arad23 
psocs Arad23 
Acrtl Arad23 psocs 
Acrtl Arad23 pRAD7
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Figure 5.5 - UV Survival of Acrtl pRAD7 Arad23 and Acrtl psocs Arad23 
Strains The pRAD7 Arad23 Acrtl and psocs Arad23 Acrtl strains, with the 
pRAD7, psocs, pRAD7 Arad23 and psocs Arad23 strains were spread onto 
minimal media plates in triplicate. Following 2 days growth, surviving colonies 
were counted and % survival calculated. Error bars correspond to standard 
deviation. UV survival raw data can be found in Appendix II
Figure 5.5 displays a dramatic increase in UV resistance in strains with CRT1 
deleted. This implies that constitutive upregulation of RNR transcription 
suppresses the UV sensitivity of Arad23 pRAD7 and psocs strains. This 
exhibits a similar effect to the Asmll strains, however whereas in the Asmll
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strains it was only the additional sensitivity of the psocs mutant in the Arad23 
strain that was suppressed,
Figure 5.5 displays further suppression of the UV sensitivity caused by 
deletion of RAD23. This suggests that RNR activation is able to suppress the 
additional UV sensitivity of the psocs Arad23 strain (as shown in Figure 5.3) 
whereas deletion of CRT1 appears to suppress the additional UV sensitivity of 
the psocs Arad23 strain by RNR activation, but can also partly suppress UV 
sensitivity caused by RAD23 deletion, possibly by a function of Crt1 not 
involving RNR.
5.3.4 The Rad4-Rad23 Complex Binds at the DUN1 Promoter
The suppression of UV sensitivity in Asmll and Acrtl strains provide 
phenotypic evidence to suggest that the Rad7 E3 ligase has a role in 
regulation of cellular dNTP levels. In order to characterise this role further the 
regulatory mechanism must be revealed. Following DNA damage, the Dun1 
kinase activates the RNR pathway by inactivating the Sml1 inhibitor and the 
Crt1 repressor (Huang et al. 1998; Zhao and Rothstein 2002). The microarray 
data from Chapter 4 indicated that several RNR pathway genes exhibited 
reduced upregulation in response to DNA damage in the psocs Arad23 strain. 
This may indicate that the Rad4-Rad23 complex is acting on a regulator of the 
RNR pathway, rather than the RNR genes themselves, which presents Dun1 
as a likely candidate to be Rad4-Rad23-regulated. Dun1 also exhibited a 
degree of reduced upregulation in response to UV from the microarray data, 
which was confirmed by northern blot (Z. Zhou, Unpublished Data). In order to 
begin to elucidate the mechanism by which the Rad4-Rad23 complex 
regulates the RNR pathway, ChIP analysis was performed at the DUN1 
promoter to examine Rad4-Rad23 occupancy.
A double-ChIP assay was performed using the pRAD7 and Arad4Arad23 
strains, by first conducting an immunoprecipitation using a Rad23 antibody, 
then immunoprecipitating Rad23-associated chromatin using a Rad4
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antibody. qPCR was then performed on the resulting precipitated chromatin. 
The result of this ChIP assay is displayed in Figure 5.6.
□ pRA D7
mArad4/Arad23
Figure 5.6 - ChIP Assay Detecting Occupancy of the Rad4-Rad23 
Complex at the DUN1 Promoter. Chromatin was extracted from the pRAD7 
and Arad4Arad23 strains, and used to perform a Double IP assay, using a 
Rad23 antibody followed by a Rad4 antibody. Rad4-Rad23 binding at the 
DUN1 promoter was then quantified by qPCR. qPCR data is displayed in 
Appendix VIII.
Figure 5.6 displays the presence of the Rad4-Rad23 complex at DUNVs 
promoter region in untreated cells in a WT (pRAD7) strain. This can be seen 
from the increased IP/Input ratio in the pRAD7 strain compared to the 
Arad4Arad23 strain. This suggests that the Rad4-Rad23 complex affects 
DUN1 transcription, and due to the fact that DUN1 is not significantly 
expressed during the normal cell cycle it could be assumed that the Rad4- 
Rad23 complex acts as a negative regulator of transcription. This result 
demonstrates the potential of this study, and provides further evidence to 
suggest that the Rad4-Rad23 complex acts as a transcriptional regulator.
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5.4 Discussion
The results obtained in this chapter suggest that UV-dependent ubiquitination 
of Rad4 by Rad7’s E3 ligase has a role in regulating cellular dNTP levels via 
altering transcription of the RNR pathway in response to UV-induced DNA 
damage. This is based on the significant suppression of UV sensitivity in the 
psocs Arad23 Asmll strain compared to the psocs Arad23 SML1+strain 
(Figure 5.3), which was an effect not observed in the pRAD7 Arad23 Asmll 
strain compared to the pRAD7 Arad23 SML1+ strain (Figure 5.4). These 
phenotypic observations provide evidence for a role of the Rad7 E3 ligase in 
regulation of the RNR pathway in response to stress. It has also been shown 
that the Rad4-Rad23 complex binds to DUNfs promoter, which could 
represent the regulatory mechanism by which the Rad4-Rad23 complex by 
ubiquitination of Rad4 could be regulating the RNR pathway.
It has been reliably assumed that deletion of SML1 or CRT1 results in 
constitutively elevated dNTP levels in the strains studied here. This prompted 
the theory that the increased UV sensitivity of the psocs Arad23 strain is due 
to improper regulation of dNTP levels via the RNR pathway. Studies to 
determine the dNTP level in logarithmically growing cells have revealed 
previously that dNTPs are elevated by ~2 fold in Asmll cells and ~3-4 fold in 
Acrtl cells (Tang et al. 2009). Although these mutants have increased cellular 
dNTP levels, dNTP levels are generally increased 6-8 fold in response to DNA 
damage (Chabes et al. 2003). It is plausible that the UV survival curves for the 
various mutants could portray incomplete suppression of the psocs Arad23 
strain’s UV sensitivity because dNTP levels are being raised insufficiently.
This raises the possibility that the actual level of dNTPs could relate to UV 
survival in this case, which would also explain the higher level of suppression 
in the Acrtl strain, assuming that deletion of CRT1 results in higher dNTP 
levels than deletion of SML1. It is not being proposed that dNTP levels are 
completely depleted in the psocs Arad23 strain, but that the dNTP levels are 
lowered sufficiently to affect DNA synthesis in response to DNA damage. In 
order to test this theory, direct detection of dNTP levels could be performed 
using an HPLC technique, as employed by (Chabes et al. 2003). This would
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reveal whether cellular dNTP levels are misregulated and therefore lowered in 
the psocs Arad23 strain. This could be conducted following UV treatment to 
reveal whether the psocs Arad23 strain exhibits altered dNTP levels following 
DNA damage. dNTP levels could also be raised higher than the levels 
expected in the Asmll and Acrtl strains using overexpression of the mr1 
D57N mutant strain, a strain that exhibits significantly higher dNTP levels due 
to the Rnr1 protein being insensitive to dATP allosteric feedback inhibition 
(Chabes et al. 2003). This mutant strain could demonstrate further 
suppression of the UV sensitivity in the psocs Arad23 strain if insufficient 
dNTP levels are the cause of the UV sensitivity of psocs Arad23 Asmll/Acrtl 
strains. Higher dNTP levels could also be achieved using an Asmll Acrtl 
double mutant, however the use and viability of this mutant has not been 
reported previously, so it can only be assumed that deleting SML1 and CRT1 
could increase dNTP levels further than the single mutants.
The microarray data in Chapter 4 displayed transcriptional down regulation of 
components of the RNR pathway in the psocs Arad23 strain in response to 
UV, thus presenting potential transcriptional regulatory targets of the Rad4- 
Rad23 complex, and the regulatory function of Rad4 ubiquitination. It was 
proposed that downregulation of the RNR pathway in this strain caused 
decreased elevation of cellular dNTP levels and thus affected DNA synthesis 
following DNA damage. The data obtained in this chapter support the notion 
that dNTP levels are less elevated in the psocs Arad23 strain following DNA 
damage, as constitutive activation or expression of RNR, reliably assumed to 
increase dNTP levels has specifically suppressed the additional UV sensitivity 
of the psocs Arad23 strain compared to the pRAD7 Arad23 strain. The most 
straightforward method to test this theory would be to investigate actual dNTP 
levels in the cell using an HPLC technique, as performed by (Chabes et al. 
2003). This would also provide information regarding the balance of different 
dNTPs, as CDC8, an essential gene involved solely in dTTP synthesis, was 
also identified as a downregulated gene in the psocs Arad23 strain, which 
could upset the cellular dNTP balance.
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dNTP levels must also be increased periodically in an RNR-dependent 
manner for DNA replication during S-phase of the unperturbed cell cycle. Both 
S-phase and DNA-damage dependent RNR activation is dependent upon the 
Mec1-Rad53 checkpoint pathway however it is not fully understood how the 
pathway differentiates between the S-phase and DNA damage response. It is 
possible that the Rad4-Rad23 complex is either affected by the Mec1-Rad53 
checkpoint pathway, or an alternative DNA damage-specific RNR regulatory 
pathway such as those discussed in Section 5.1.3. The regulatory mechanism 
could be probed further using genetic analysis by deleting or using 
functionally defective mutant alleles of the checkpoint response pathway.
The role of the Rad4-Rad23 complex in DNA damage-responsive 
transcription has been investigated further by measuring DNA occupancy of 
the Rad4-Rad23 complex at the DUN1 promoter, which upregulates the RNR 
pathway in response to DNA damage. Figure 5.6 shows that the Rad4-Rad23 
complex binds at the DUN1 promoter, thus suggesting it plays a regulatory 
role in DUN1 transcription. This also supports the theory that the Rad4-Rad23 
complex regulates a subset of DNA damage-inducible genes, and provides 
investigative potential to identify other Rad4-Rad23-regulated genes. Other 
potential Rad4-Rad23 target genes and pathways could be those suggested 
in Chapter 4, such as DDR2, CDC8, ASF1 and RTT109. This could be 
investigated in the absence of DNA damage, and then at specific timepoints 
following UV survival in the pRAD7 Arad23 and psocs Arad23 strains. Rad4- 
Rad23 occupancy could be deduced using ChIP analysis and qPCR. This 
would reveal binding dynamics of Rad4-Rad23 following DNA damage, and 
would thus provide indications of genes being transcriptionally affected by 
post-UV Rad4 ubiquitination. In order to get a more global perpective, ChlP- 
chip analysis could be performed to identify all Rad4-Rad23 target genes, 
using untreated and UV-irradiated strains.
When examining the suppression of UV sensitivity, the effect of SML1 or 
CRT1 deletion in a WT strain must also be considered, to ensure a general 
decrease in UV sensitivity is not observed in all strains where SML1 or CRT1 
are deleted. The Asmll data provide an internal control for this, as the pRAD7
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Arad23 strain does not exhibit significant suppression of UV sensitivity. The 
majority of previous reports assessing DNA damage resistance using Asmll 
or Acrtl strains conclude that the mutations do not cause a generic increase 
in UV resistance, particularly with the relatively low doses of UV used in this 
study (Tang et al. 2009).
The data presented here suggests that the Rad7 E3 ligase functions in 
regulation of the DNA damage checkpoint via the RNR pathway. It remains to 
be speculated which level of regulation the ligase acts upon. The role of the 
Rad4-Rad23 complex in gene transcription has been presented in Chapter 4, 
so it is possible that Rad7-dependent ubiquitination of Rad4 affects Rad4- 
Rad23-mediated transcription, thus regulating the RNR pathway.
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6 The Rad7 E3 Ligase Regulates DNA Damage and Stress 
Responsive Cell Cycle Progression Involving the RNR 
Pathway
6.1 Introduction
Precise regulation of cell cycle progression is essential for successful and 
accurate replication of eukaryotic organisms. Defects in cell cycle regulation 
can result in genomic instability, inappropriate cell division and cell death. 
Upon encountering environmental stresses such as DNA damaging agents, 
the cell cycle must respond by arresting until it is suitable to continue, to avoid 
replication of damaged cellular components. These arrests occur at certain 
cell cycle stages known as checkpoints. Checkpoints are conserved 
throughout evolution from prokaryotes to higher eukaryotes, and they provide 
a successful mechanism to maintain cellular and genomic integrity.
6.1.1 Activation of the DNA Damage Checkpoint Response
DNA damage triggers a complex response involving a kinase cascade 
signalling pathway, resulting in numerous effects such as cell cycle arrest and 
DNA repair. It is thought that the Mec1-Ddc2 complex is able to sense RPA- 
coated ssDNA, resulting from sites of DNA damage processed by DNA repair 
machinery, however the exact mechanism is not clear. This triggers a 
signalling cascade involving the kinases Rad53, Rad9, Chk1 and many other 
downstream effectors. This cascade is able to halt cell cycle progression by 
phosphorylation of the anaphase inhibitor Pds1, which prevents cells from 
progressing through anaphase with damaged DNA, thus creating a G2 cell 
cycle arrest (Harrison and Haber 2006).
DNA damage checkpoint-induced cell cycle arrest can also occur at the G1/S 
cell cycle phase. This occurs by Rad53-dependent phosphorylation of Swi6, 
which inhibits CLN1/2 transcription, thus delaying S-phase onset. The DNA
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damage checkpoint is discussed in detail in Chapter 1.7, and reviewed in 
(Harrison and Haber 2006).
6.1.2 Cell Cycle-Dependent Regulation of dNTP Levels
The Mec1-Rad53 DNA damage checkpoint pathway also activates the Dun1 
kinase, which triggers activation of the RNR pathway, thus upregulating 
cellular dNTP production. This pathway is also required to upregulate dNTP 
production during DNA replication in S-phase. Deletion of members of the 
Mec1-Rad53 pathway render cells inviable, however deletion of the RNR 
inhibitor Sml1 can suppress the lethal phenotype, thus restoring cell viability. 
This observation illustrates the essential nature of elevation of dNTP levels 
during S-phase (Discussed in Chapter 5.1.1 and (Zhao and Rothstein 2002).
6.1.3 The Ubiquitin Proteasome System and Cell Cycle Control
Cell cycle progression relies upon the progressive activation and deactivation 
or removal of regulatory complexes. Proteolysis, largely facilitated by the 
ubiquitin proteasome system (UPS) is required at specific stages to promote 
correct cell cycle progression. The UPS is also responsible for degradation of 
negative regulators of cell cycle progression, therefore it must be tightly 
regulated to balance promotion and inhibition of cell cycle progression 
(Glotzer et al. 1991; Nakayama and Nakayama 2006).
6.1.4 The Current Study
It was proposed in the previous chapters that the Rad7 E3 ligase-dependent 
ubiquitination of Rad4 had a regulatory role in maintenance of cellular dNTP 
levels. dNTP levels are tightly regulated in synchrony with the cell cycle to 
facilitate efficient DNA replication and repair. Altered regulation has been 
shown to cause defective cell cycle progression, as displayed by the dun1 
mutant strain, which exhibited an extended S-phase, a phenotype that could 
be suppressed by deletion of SML1 (Zhao and Rothstein 2002). This 
observation prompted the possibility that the Rad7 E3 ligase-defective psocs
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strains could exhibit altered cell cycle progression. The aim of this chapter 
was to investigate cell cycle progression in the psocs strains in response to 
DNA damage and characterise the observed defects.
6.2 Materials and Methods
6.2.1 Cell Cycle Synchronisation by Centrifugal Elutriation
The process of centrifugal elutriation allows separation of particles according 
to their sedimentation rate, which in the case of most cells is directly related to 
their size. Size-mediated separation is useful in cell cycle studies as the 
smallest cells in an asynchronously growing S. cerevisiae culture are Gi cells. 
Isolation of these cells from the rest of the population provides an effective 
method of cell cycle synchronisation without resorting to more disruptive 
methods such as a-factor pheromone treatment.
The main principle of elutriation uses two opposing forces to create a gradient 
of particles with varying sedimentation rates. Cells are pumped into a 
chamber within a centrifuge rotor at a constant flow rate. The increasing width 
of the chamber causes a decrease in the fluid velocity of the cells as they 
enter, while the centrifugal force acts against the pump and promotes the 
decrease in velocity. Each cell migrates to a position in the chamber relating 
to its sedimentation rate. When constructing the gradient, the pump flow rate 
and centrifuge speed are adjusted so the smallest required cells are retained 
just before the widest part of the chamber (known as the elutriation boundary). 
When cells cross this boundary, which is achieved by increasing the pump 
flow rate or decreasing the centrifugal speed, they leave the chamber and 
proceed to a collecting vessel. Using controlled incremental increases in 
pump flow rate, cell fractions of increasing size can be collected.
6.2.2 Elutriation
Elutriation was conducted using the Beckman JE-5.0 Elutriation System 
(Beckman 1989). 1L of each required culture was grown to late log-phase in
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appropriate media. Cells were harvested by centrifugation at 4 000 rpm for 10 
minutes, and resuspended in 50ml of the same media. The rest of the media 
was retained for use in the elutriator, and will be referred to as “clarified 
media.” Reusing this media minimises cell stress during the procedure.
The elutriation apparatus was assembled as shown in (Beckman 1989) using 
a Masterflex pump (model 900-292) with a Beckman J6-MC centrifuge, with a 
JE-5.0 rotor. The centrifuge temperature was set at RT (23°C), and the 
system was filled with the clarified media using the pump at a setting of 1.30 
(~25ml/min flow rate) until all air had been expelled from the tubes and 
chamber. The tubes were arranged to recycle the clarified media by placing 
the exit tube in the same bottle as the entry tube. The centrifuge was turned 
on at 3 000 rpm, and once the top speed was reached the viewing window 
was adjusted to allow visualisation of the chamber via the synchronised firing 
of the strobe light. The cells were introduced by briefly turning the pump off to 
change from media to cells to prevent introduction of air bubbles. Once almost 
all the cells had entered the system, the tubes were switched back to 
recycling the clarified media (still at pump setting 1.30). The sedimentation 
gradient was allowed to form in the chamber for 5 minutes, with frequent 
visual checks (Figure 6.1 B).
The pump was then increased incrementally by no more than 0.10 units/min 
until the gradient moved to the elutriation boundary and the smallest cells 
began to exit the chamber (Figure 6.1C). At this point the exit tube was placed 
into a clean flask and a 100ml fraction was taken. Cell count and budding 
index was conducted and the pump was adjusted accordingly. At this stage 
the pump speed was increased very gradually, as an excessive increase 
would cause significant amounts of budded cells to exit the chamber. In this 
case, the procedure must be abandoned, the cells flushed out of the system 
and re-harvested, however this could stress the cells and may affect the 
result. Gi cells are unbudded, so the budding index (% budded cells in a 
population) should ideally be as low as possible. The cell count is not as 
crucial, but a count of more than 106 cells/ml is preferential. 5 fractions were
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collected and counted, and suitable fractions were centrifuged at 4 000 rpm 
for 5 minutes to make a resuspension of 107 cells/ml in 50ml minimal media.
A. Filling the Chamber
Asynchronous 
Cells — » 
Pumped in
Clarified Media 
Flows out
Centrifugal Counterflow 
Force
B. Gradient Formation
G,  Cells
C. Elutriation of G1 Cells
Flow Rate 
Increased
G 1 Cells 
Elutriated
Figure 6.1 - Principles of Elutriation. A: Cells were pumped into the 
elutriation chamber, which arrange themselves in a gradient with the smallest 
cells at the elutriation boundary and largest cells at the chamber entrance (B). 
C: Increasing the flow rate causes smallest (Gi) cells to exit the chamber for 
collection. Figure adapted from (Beckman 1989).
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6.2.3 UV Irradiation, Gi Release and Cell Fixation
The elutriated culture was irradiated with 100Jm'2 or 20 Jm'2 UV (254nm bulb, 
delivered at 10 Jm'2s'1) in 25ml portions of minimal media, then centrifuged at 
4 000 rpm for 3 minutes and resuspended in 50ml YPD. The cultures were 
then incubated at 30°C to allow recovery and Gi release. To observe Gi 
release without UV cells were immediately incubated at 30°C for observation 
of cell cycle progression.
In order to monitor cell cycle progression across a time-course, 1ml portions 
of cell culture were removed at suitable times and centrifuged at 10 000 rpm 
for 2 minutes. 700jul of supernatant was removed, and the pellet was 
resuspended in the remaining media. 700pl of 100% ethanol was added while 
vortexing to fix the cells, and cells were stored at 4°C until required.
Timepoints were chosen at appropriate times to observe the G1-S-G2 
transition most effectively, which occurred at 20 minute intervals in untreated 
samples for up to 3-4 hours, and 30-60 minute intervals in UV-treated 
samples for up to 12 hours in some strains. Timepoints were continued until 
the budding index value settled on a constant value, usually ~70%.
6.2.4 Plasmid Stability Assay
Cells were prepared for Gi synchronisation by growth in 1L HIS' media, then 
elutriated and allowed to continue growth in 50ml YPD. When timepoints were 
taken to fix cells for cell cycle analysis, 200 cells were also suspended in 
water and spread onto HIS' and YPD plates in triplicate. Plasmid stability was 
represented as % cells able to grow on HIS' media, using the number of cells 
growing on YPD as 100%, as only cells containing the pRS313 plasmid could 
grow on HIS' media. This was conducted Oh and 4h.
6.2.5 Budding Index Measurement
At each timepoint the cell culture was analysed to measure the proportion of 
budded cells in the culture and thus monitor cell cycle progression. 10pl of cell
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culture was vortexed vigorously to help separate cells, and placed on a 
haemacytometer. Cells were counted, and the percentage of budded cells 
was calculated. At least 200 cells were counted at each time point to obtain 
sufficiently accurate percentage values. Budded cells were defined as cells 
that exhibited a defined bud of any size, but not just an undefined protrusion 
from the cell, known as a schmoo, which would represent an unbudded early 
S-phase cell.
6.2.6 Cell Staining and Flow Cytometry
The cell cycle stage of individual cells in a population was identified using flow 
cytometry. All genomic DNA is replicated once per cell cycle so by quantifying 
cellular DNA using fluorescent staining a 1N state (Gi phase), a 2N state (G2 
phase), or somewhere between (S phase) can be determined.
Fixed cells were centrifuged at 10 000 rpm for 2 minutes, and resuspended in 
200pl Sodium Citrate Buffer (50mM, pH 7.0) then sonicated on low power for 
40 seconds to reduce clumping (Diagenode Bioruptor). 800jnl buffer was 
added and cell count and budding index was performed. Cells were then 
diluted to 1.5 x 106 in 1ml buffer, and treated with 0.25mg/ml RNase A 
overnight at 37°C. Cells were centrifuged at 10 000 rpm for 2 minutes, 
washed once in 1ml buffer, then resuspended in 200pl buffer and re­
sonicated on low power for 40 seconds. Cells were stained by adding 8pg/ml 
Propidium Iodide (Invitrogen), and incubating for 30 mins at RT prior to flow 
cytometric analysis.
20 000 cells for each timepoint were analysed for DNA content using the BD 
FACScalibur (Becton-Dickinson Immunocytometry Systems, San Jose, CA, 
USA) flow cytometer. Parameters were collected using CellQuest software 
(Becton-Dickinson Immunocytometry Systems, San Jose, CA, USA). Data 
analyses were also performed using CellQuest software, and data were gated 
using forward and 90° light scatter were analysed to exclude cell debris.
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6.3 Results
The results obtained in previous chapters have revealed a possible role of the 
Rad7 E3 ligase in the DNA damage response via regulation of the RNR 
pathway. Alterations in dNTP levels can affect cell cycle progression, so this 
chapter will focus on regulation of cell cycle progression in the mutant strains 
constructed in Chapter 4 to identify a possible regulatory role of the Rad7- 
containing E3 ligase in cell cycle control. Cell cycle progression was 
monitored initially by growth analysis, then more specifically by Gi 
synchronisation and flow cytometry. The microarray data from Chapter 4 was 
then examined to attempt to identify genes whose altered transcription could 
cause the observed altered cell cycle progression in the untreated psocs 
strain. The Asmll and Acrtl strains from Chapter 5 were then analysed for cell 
cycle progression.
6.3.1 Growth Defect of psocs Mutant
In order to analyse cell cycle progression in the psocs and psocs Arad23 
strain initially, a standard growth curve was conducted. Growth of pRAD7 and 
psocs strains in HIS" media was monitored over 14 hours, using a visible light 
spectrophotometer to detect cell concentration by optical density (OD6oo)- 
OD6oo was plotted against time to display growth rate (Figure 6.2). It was 
discovered that the psocs strain exhibited a slower growth phenotype, as 
displayed in Figure 6.2. This suggested that the Rad7’s E3 ligase function 
affects cell cycle progression. Without this E3 ubiquitin ligase function {psocs 
strain), the cell cycle appears to have a longer overall duration. However, 
further analysis of the growth curve shows that the psocs strain actually has 
the same population doubling time during logarithmic growth as the pRAD7 
strain of approximately 104 minutes. The average cell doubling time was 
calculated during initial growth (0-8 hours) and during logarithmic growth (9-12 
hours) as a representation of the time taken for cells to complete 1 complete 
cell cycle, assuming that cell concentration correlates to ODeoo in a linear 
fashion between 0.1 and 1 (Table 6.1). It was found that the cause of the 
apparent slow growth phenotype occurred during the initial growth phase
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between 0-8 hours. During this period, the psocs strain had an 8.2% shorter 
doubling time than the pRAD7 strain. This suggests that the E3 ligase function 
of Rad7 has a role in cell cycle progression in initial growth phase, so further 
growth observation and analysis of cell cycle progression was performed.
pRAD7
psocs
Time (Hours)
LOG PHASEINITIAL G RO W TH PHASE
Figure 6.2 - Growth Curve of pRAD7 and psocs Strains Early stationary 
phase cultures were diluted to O D 6oo=0.1 and grown in HIS' media, with 
hourly measurement of cell density. It can be seen that the psocs strain has a 
growth defect compared to the pRAD7 strain.
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Growth
Phase
Time Strain Cell Cycles 
per hour
Cell Cycle 
Time 
(mins)
%
Difference
Initial 0-8h pRAD7 0.39 154 8.2%
psocs 0.36 167
Log 9-12h pRAD7 0.57 105 1.3%
psocs 0.58 104
Table 6.1 - Variations in Cell Cycle Time Between pRAD7 and psocs 
Strains Average cell cycle time was calculated in the initial growth phase (0-8 
hours) and logarithmic growth phase (9-12 hours) using time taken for ODeoo 
to double. The difference in cell cycle time is represented by the percentage 
change in the psocs strains, using the pRAD7 value as 100%.
The growth curve data displayed in Figure 6 .2  represents diluted cultures that 
were grown overnight, so the cells would have entered early stationary phase, 
and then growth was monitored. It was proposed that the slower initial growth 
rate of the psocs strain could be due to delayed re-entry into the normal cell 
cycle from a partially stationary state. Budding yeast cultures tend to slow 
replicative growth when they reach O D 6oo~4, when nutrient resources become 
a limiting factor. Cells enter a quiescent state, known as Go, whereby they halt 
growth until nutrient availability changes. Cells undergo several physical 
changes as they enter stationary phase, including shutting off biochemical 
pathways required for growth and replication, and as they progress to later 
stages of stationary phase the cell wall structure becomes altered, 
transcription decreases, cells become more thermotolerant and storage 
carbohydrates accumulate (Werner-Washburne et al. 1 993 ; Werner- 
Washburne et al. 1 9 9 6 ). To eliminate the influence of stationary phase 
recovery from the growth curve, strains were diluted once from early 
stationary phase to O D 6oo=0.1, then allowed to grow to O D 6oo~0.5-0 .8 , then 
rediluted to O D 6oo=0.1 and growth monitored as before. The results of this 
growth curve are displayed in Figure 6 .3 .
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Figure 6.3 - Growth Curve of pRAD7 and psocs Strains Logarithmically 
growing cultures were diluted to OD6oo=0.1 and grown in HIS' media, with 
hourly measurement of cell density. It can be seen that the psocs strain grows 
at an identical rate compared to the pRAD7  strain.
The identical pRAD7 and psocs strains’ growth curves observed in Figure 6.3 
suggest that the psocs strain does exhibit delayed exit from stationary phase, 
but does not exhibit altered regulation of the unperturbed cell cycle during 
logarithmic growth phase.
Although the psocs strain does not appear to exhibit alterations in cell cycle 
time compared to the pRAD7 (WT) strain, it may still display a phenotype 
sim ilar to the dun1 mutant strain reported by (Zhao and Rothstein 2002), 
which exhibited a delayed S-phase but the same overall cell cycle length. In 
order to characterise cell cycle progression in the psocs strain further, Gi 
synchronisation and flow cytometry was employed.
6.3.2 Altered Cell Cycle Progression in psocs Strain
Logarithmically growing cells were synchronised in Gi phase using centrifugal 
elutriation, which separates cells on the basis of size, a reliable marker of cell 
cycle stage. Cell cycle synchronisation was employed instead of pheromone-
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induced cell cycle arrest as it is a less invasive technique to monitor the cell 
cycle, so more subtle variations in cell cycle regulation could be identified.
Gi cells were elutriated, counted and checked for contamination by budded 
cells, then the concentration was adjusted to 107 cells/ml in fresh media. They 
were then allowed to continue growing at 30°C, whilst regular samples were 
taken and fixed, and were used for flow cytometric analysis.
Initially, Gi cells were allowed to grow in HIS' minimal media, to retain the 
pRAD7 and psocs plasmids. However, this resulted in poor sustained 
synchronisation following Gi exit. This was due to an extended Gi phase in 
daughter cells grown in minimal media. Unlike in complex media (YPD) 
whereby cytokinesis occurs when mother and daughter cells are similarly 
sized, and successive cell cycles can occur in approximate synchrony, in 
minimal media cell division occurs when daughter cells are significantly 
smaller than mother cells in order for the mother cell to conserve energy 
(Carter and Jagadish 1978) (Figure 6.4). This results in highly asymmetric 
division, caused mainly by an extended Gi phase in daughter cells, as they 
must reach critical size before budding can occur, whereas the mother can 
begin budding again almost immediately after division. This produces mother- 
daughter asynchrony, thus creating confusion in cell cycle experiments 
involving a synchronised cell population. This is visualised in Figure 6.4 and 
Figure 6.5 as an increased Gi population.
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Figure 6.4 - Growth in Complex Media vs Minimal Media Cell division in 
minimal media occurs more asymmetrically than in complex media, due to the 
elongated Gi phase in daughter cells grown in minimal media.
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Figure 6.5 - Cells Grown, Elutriated, then Continued to Grow in Minimal 
Media Exhibiting a Disproportionately High Gi Population Following Gi 
exit, cells should remain synchronised for the next cell cycle, however in 
minimal media daughter cells remain in Gi significantly longer than mother 
cells, thus resulting in a higher overall G i population.
An alternative strategy was devised which produced more interpretable 
results. Cells were grown and elutriated in minimal media, then, following 
adjustment of cell concentration, resuspension and cell growth was performed 
in complex medium (YPD). Initial growth in minimal media allows more 
efficient elutriation of small, unbudded Gi cells as they are more common, 
which is advantageous for isolation of Gi cells. To assess plasmid loss during 
growth in complex media, a plasmid stability assay was employed. This 
showed that there was not significant plasmid loss after 4 hours, to represent 
the time course being monitored because the Oh and 4h timepoints only show 
~20% variation in HIS+ colonies (Table 6.2). The plasmid stability was 
concluded to be acceptable after 4h growth, so the method was adopted of
165
growing and elutriating cells in HIS* media, then allowing synchronised growth 
to occur in YPD.
Oh 4h
pRAD7 86.3% 59.3%
psocs 80.9% 67.4%
Table 6.2 - Plasmid Stability of pRS313-RAD7/socs Following Growth in
YPD Cells were grown and elutriated in HIS* media, then switched to YPD. 
200 cells were removed and spread onto triplicate HIS* and YPD plates at 0 
hours and after 4 hours, and % HIS+ cells were deduced, and are displayed in 
the table. Plasmid Stability data is displayed in Appendix VI.
The elutriation procedure was repeated with cells grown in HIS* media, then 
counted and allowed to grow synchronously in YPD. Cell samples were then 
fixed and cell cycle stage analysed by flow cytometry (Figure 6.6).
The flow cytometry data shows phenotypic variation between the pRAD7 and 
psocs strain. The psocs strain exits Gi synchrony approximately 20 minutes 
earlier than the WT (pRAD7) strain. This observation is rather unexpected, as 
the growth curve data shows a slower growth phenotype in the psocs strain, 
in the initial growth period, however this may suggest delayed progression of 
a later cell cycle phase. Both strains exhibit an elongated Gi phase following 
synchronisation, which differs from many similar flow cytometric experiments 
in the literature, which exhibit complete passage to G2 within 60 minutes of 
growth. This is most probably due to growing the pre-elutriated culture in 
minimal media. Gi cells in minimal media range from small daughter cells 
which have just undergone cytokinesis to much larger mother and daughter 
cells which have undergone cell growth, reached critical mass and are soon to 
begin budding (Carter and Jagadish 1978). The process of elutriation will first 
isolate the smallest daughter cells, then proceeding fractions will contain the 
larger Gi cells, however the vast majority would be smaller cells. The 
extended Gi phase is most likely due to cell growth of the more immature 
daughter cells. It should also be noted that growth in YPD reduced the initial 
Gi phase compared to minimal media in Figure 6.5.
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Figure 6.6 - Gi Exit and Cell Cycle Progression of pRAD7 and psocs 
Strains pRAD7 and psocs strains were G i-synchronised by elutriation, then 
allowed to continue growth in YPD. Cell samples were taken at the stated 
timepoints and analysed by flow cytometry. Budding index data for this 
progression is displayed in Appendix III (A3.1).
To account for the extended Gi phase observed here it is possible that the 
psocs strain can increase cell mass faster than the pRAD7, thus reaching 
critical mass sooner and allowing earlier S-phase entry. Another possibility is 
that the psocs strain begins S-phase at a smaller critical mass, or that cell 
division occurs when daughter cells are larger. These explanations would 
require less increase in cell mass from cytokinesis to onset of S-phase, and 
would therefore require a shorter Gi growth phase. It could also be 
speculated that an intra-Gi or G i/S  checkpoint response becomes activated 
during the elutriation process, thus instigating a cell cycle arrest cascade, 
which is switched off with variable efficiency in the different strains when 
normal growth conditions are reinstated.
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This shortened Gi phenotype of the psocs strain is the opposite of what was 
anticipated from the delayed stationary exit phenotype observed in the growth 
curve data. This could be due to an extension of another cell cycle phase in 
the initial growth stages, which would mask the reduced Gi phase observed in 
Figure 6.6. It is most likely that a checkpoint pathway is responsible for the 
phenotype, as it is only visible during the initial growth phase when a stress- 
induced checkpoint response could be activated, and not during logarithmic 
growth.
Once cells enter S-phase, both strains take approximately 40 minutes for the 
majority of cells to be in G2 phase, however this is more clearly visible in the 
psocs strain. The pRAD7 strains exhibits a relatively high proportion of Gi 
cells throughout the time course, which resembles the growth pattern 
observed in minimal media. A constantly elevated Gi population in the pRAD7 
strain suggests that Gi phase is shorter in the psocs strain, as fewer cells 
remain in Gi, and cell synchrony is maintained for a full cell cycle.
The premature Gi exit of the psocs strain is a subtle phenotypic difference 
compared to Gi exit in the pRAD7 strain. Previous work has identified that the 
Rad7 E3 ligase functions in one of two separate components of the NER 
pathway. It was found that deletion of RAD23 in a psocs strain results in 
increased UV sensitivity, compared to the pRAD7 Arad23 strain (Gillette et al. 
2006). In the case of UV sensitivity, removing the Rad23-dependent 
component of the NER pathway exposed the phenotype caused by the psocs 
mutation. If the premature Gi exit phenotype observed here is caused by the 
same defect that causes increased UV sensitivity, then it was hypthesised 
that deletion of RAD23 could characterise the Gi exit phenotype further. 
pRAD7 Arad23 and psocs Arad23 cells were grown, elutriated and allowed to 
exit Gi as performed previously (Figure 6.7). It has been shown previously 
that deletion of Rad23 does not affect Gi exit in pheromone-arrested Gi cells, 
so any visible phenotypic difference between pRAD7 Arad23 and psocs 
Arad23 cells would most likely be an effect of the defective E3 ligase (Wade et 
al. 2009).
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Figure 6.7 - Gi Exit and Cell Cycle Progression of pRAD7 Arad23 and 
psocs Arad23 Strains pRAD7 Arad23 and psocs Arad23 strains were G r  
synchronised by elutriation, then allowed to continue growth in YPD. Cell 
samples were taken at the stated timepoints and analysed by flow cytometry. 
Budding index data is displayed in Appendix III (A3.2).
Figure 6.7 shows that in the absence of Rad23 the psocs strain still exits Gi 
sooner than the pRAD7 strain. There is also a reduced population of cells in 
Gi in the psocs strain, which suggests that the strain still exhibits the shorter 
Gi phenotype. This implies that the Rad7 E3 ligase function in cell cycle 
regulation occurs independently of Rad23, however this will be discussed 
later.
A further observation of the Arad23 elutriation was that it was far more difficult 
to isolate Gi cells in Arad23 cells w ithout elutriating budded cells. This would 
either suggest that there were fewer G i cells in Arad23 populations, or that Gi 
cells were unusually large, so were therefore difficult to distinguish from 
budded cells. Although the elutriation was not completely effective in this 
case, samples were obtained with the same levels of G2 cell contamination 
(visible G2 peaks at time = 0, Figure 6.7) so it is assumed the two strains are
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still comparable. This is also represented by budding index analysis in 
Appendix III.
6.3.3 The Rad7 E3 Ligase Function Affects Cell Cycle Progression in 
Response to DNA Damage
Having established that the Rad7 E3 ligase affects cell cycle progression 
through and beyond Gi phase independently of Rad23, it was next examined 
whether altered checkpoint response signalling was involved. Similar 
experiments were conducted, but following isolation of Gi cells they were 
exposed to 100Jm'2 UV (254nm). This dose was intended to invoke a DNA 
damage checkpoint response without resulting in high levels of cell death or 
permanent cell cycle arrest. This was first conducted in the pRAD7 and psocs 
strains. Timepoints were taken for 8 hours after elutriation (Figure 6.8).
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Figure 6.8 - Gi Exit and Cell Cycle Progression Following UV Irradiation 
of pRAD7 and psocs Strains pRAD7 and psocs strains were G i- 
synchronised by elutriation, irradiated in clarified media with 100Jnrf2 UV, then 
allowed to continue growth in YPD. Cell samples were taken at the stated 
timepoints and analysed by flow cytometry. Budding index data is displayed in 
Appendix III (A3.3).
Following irradiation the G i/S  checkpoint response would be triggered to 
maintain genomic integrity prior to DNA replication. Figure 6.8 shows a UV- 
induced Gi arrest lasting for 1-2 hours in the pRAD7 strain, and a further 2 
hours pass before the majority of cells are in G2 phase (4 hour timepoint). The 
Gi arrest period has a similar duration to the untreated sample, which arrests 
for 60-80 minutes. However the untreated sample reaches a G2 majority at 2 
hours, whereas the UV-irradiated sample requires an additional 2 hours in S- 
phase to contend with the damage.
The psocs strain behaves in a sim ilar manner to the untreated sample in 
regard to Gi release and initial cell cycle progression. Cells begin to enter S- 
phase after 1 hour, and a G2 majority is reached at the 2 hour timepoint. It 
then appears that the cells arrest in G2, and unlike pRAD7, the Gi population
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is almost completely diminished. The shortened S-phase could suggest 
hyperactivation of the postreplication checkpoint, which allows the cell cycle to 
bypass damage using alternative DNA polymerases, without the use of DNA 
repair processes. This process can cause increased mutagenenic DNA 
replication (Friedberg 2005a). This could lead to accumulation of damage, 
which may explain the extended G2 arrest in the psocs strain. Another 
unusual observation from the psocs data is the presence of peaks greater 
than G2 DNA levels between 3-6 hours, which is not apparent after 7-8 hours. 
Although the presence of these peaks has not been documented previously, it 
is plausible that the suspected accumulation of damage from the rapid S- 
phase progression could cause further disruption to cell cycle progression.
The Arad23 strains were also subjected to UV radiation, and cell cycle 
progression was analysed. The strains were also treated with 100Jrrf2 UV, 
however this was found to activate a seemingly indefinite Gi arrest (Figure 
6.9).
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Figure 6.9 - Gi Exit and Cell Cycle Progression Following 100Jm'2 UV 
Irradiation of pRAD7 Arad23 and psocs Arad23 Strains pRAD7 Arad23 
and psocs Arad23 strains were G i-synchronised by elutriation, irradiated in 
clarified media with 100Jm'2 UV, then allowed to continue growth in YPD. Cell 
samples were taken at the stated timepoints and analysed by flow cytometry.
This experiment was repeated using a lower dose of UV to provide a situation 
whereby a temporary arrest was invoked, and Gi exit could be analysed. This 
was achieved using a dose of 20Jm '2 (Figure 6.10), which appeared to induce 
the postreplicative checkpoint rather than a G i/S  arrest from which the Arad23 
strains cannot recover.
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Figure 6.10 - G<\ Exit and Cell Cycle Progression Following 20Jm'2 UV 
Irradiation of pRAD7 Arad23 and psocs Arad23 Strains pRAD7 Arad23 
and psocs Arad23 strains were G i-synchronised by elutriation, irradiated in 
clarified media with 20Jm '2 UV, then allowed to continue growth in YPD. Cell 
samples were taken at the stated timepoints and analysed by flow cytometry. 
Budding index data is in Appendix III (A3.4).
This lower dose of UV induces a response sim ilar to Figure 6.8, whereby Gi 
arrest is shorter, and therefore S-phase entry is sooner in the psocs strain, 
however it appears that a degree of indefinite Gi arrest is occurring in the 
pRAD7 strain. This suggests Arad23 cells can reach a damage threshold 
before indefinitely arresting in G i, so some cells in the population can 
progress through S-phase and some remain arrested in G-i. This either does 
not occur, or occurs to a much lesser extent in the psocs strain, thus 
supporting a role for the Rad7 E3 ligase in Gi progression or exit. This 
suggests a defective G i/S checkpoint response in Arad23 cells that is 
suppressed in psocs Arad23 cells. The psocs Arad23 cells appear to exhibit a 
postreplicative checkpoint response. It also appears that a significant 
proportion of cells have more DNA than G2 cells in both strains. However,
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unlike the previous experiment this does not appear to be properly corrected 
within the 8 hour time frame of the experiment.
6.3.4 The Role of the 19S Proteasome Interaction with Rad23 in Cell 
Cycle Control
The 19S proteasome sug2-1 mutant, which contains a point mutation in the 
Sug2 AAA 19S subunit, has been shown to suppress the UV-sensitivity of the 
pRAD7 Arad23 and psocs Arad23 mutants. This is thought to be caused by 
the 19S proteasome having an inhibitory effect on the NER pathway via its 
interaction with Rad23. This explains the defective NER in Arad23 mutants, 
and the suppression of this defect by mutating the 19S proteasome (Gillette et 
al. 2001; Gillette et al. 2006). It was proposed that the cell cycle phenotype 
observed here could also be affected by the 19S proteasome, thus 
introducing the sug2-1 mutation could influence the phenotype. Cell cycle 
synchronisation and Gi release were conducted with the pRAD7 Arad23 
sug2-1 and psocs Arad23 sug2-1 strains using untreated cells (Figure 6.11).
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Figure 6.11 - Gi Exit and Cell Cycle Progression of pRAD7 Arad23 sug2- 
1 and psocs Arad23 sug2-1 Strains pRAD7 Arad23 sug2-1 and psocs 
Arad23 sug2-1 strains were G i-synchronised by elutriation, then allowed to 
continue growth in YPD. Cell samples were taken at the stated timepoints and 
analysed by flow cytometry.
The psocs Arad23 sug2-1 strain in Figure 6.11 shows no suppression of the 
psocs-related phenotype of faster Gi release, however the sug2-1 mutation 
appears to alleviate the disproportionately large Gi population, a trait present 
in most previous samples. This could be due to more symmetrical growth 
caused by a shorter daughter Gi phase, possibly a result o f differences in 
strain background. The sug2-1 strains were those used in (Gillette et al.
2006), which were not EUROSCARF-based so may show phenotypic 
variance not related to the sug2-1 mutation. It does however appear that G2 
phase is extended, as cells delay returning to Gi in the pRAD7 strain, and do 
not significantly return to Gi over the 3 hour timecourse in the psocs strain. 
This Gi depletion is also evident in the asynchronous (AS) cell sample. This 
result suggests that neither Rad23 nor interaction with the 19S proteasome
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affect the defective Gi progression phenotype resulting from the psocs 
mutation.
The Rad7 E3 ligase has been found to affect cell cycle progression. It was 
suggested in Chapter 4 that Rad7 E3 ligase-mediated ubiquitination of Rad4 
affects transcription of a subset of genes involved in the DNA damage 
response. The global gene expression data used in Chapter 4 was also 
examined to identify misregulated genes involved in cell cycle progression.
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6.3.5 A Transcriptional Role of the Rad7 E3 Ligase in Cell Cycle Control
The Rad7 E3 ligase has been discovered to affect cell cycle progression. The 
psocs/rad23 microarrays used in Chapter 4 were utilised to detect 
misregulation of genes known to be involved in cell cycle control, or known to 
be transcribed periodically throughout the cell cycle in order to reveal potential 
target of the Rad4-Rad23 complex. The pRAD7 strain was compared to the 
psocs strain, as the defective cell cycle progression phenotype was observed 
between these two strains. Genes were identified using SGD GO Slim 
Mapper (www.yeastgenome.org) for cell cycle-related genes, and the list of 
800 cell cycle-differentially expressed genes from (Spellman et al. 1998).
The observed psocs premature Gi exit phenotype can be seen in the psocs 
strain compared to the pRAD7 strain independently of Rad23. For this reason 
transcriptional changes between the pRAD7 and psocs RAD23+ strains will be 
compared. Using significance testing (FDR corrected t-test (p<0.05) and a 1.5 
fc cut-off), no genes could be identified as differentially expressed between 
the pRAD7 and psocs strains. It should also be noted that genes involved in 
cell cycle may be more up or down regulated at a particular cell cycle stage 
than is visible in the data due to the use of asynchronous cells. Instead of 
lowering the stringency for significance testing, the top 100 differentially 
expressed genes were extracted, and were subjected to hierarchical 
clustering to find similarly expressed genes (This gene list is displayed in 
Appendix IV, List 6). GO analysis of these 100 genes showed that 6 out of 
100 genes were involved in cell cycle progression (Figure 6.12). It was also 
suggested that the premature Gi exit seen in the psocs strain was due to a 
checkpoint response to stress caused by centrifugation. GO analysis also 
identified 7 genes involved in stress response, which may contribute to the 
psocs Gi phenotype.
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Figure 6.12 - GO Analysis of Top 100 psocs vs pRAD7 Differentially 
Expressed Genes The top 100 psocs gene list was input into the GO Slim 
Mapper, which identified 94 known ORFs. Genes were allocated to functional 
pathways, and the top 17 GO terms are displayed here. Genes involved in cell 
cycle progression account for 6/94 genes, and genes involved in stress 
response account for 7/94 genes. The gene list is displayed in Appendix VI, 
List 6.
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Figure 6.13 - Cell Cycle and Stress Response Genes Identified by GO 
Analysis Using the psocs top 100 gene list, 6/94 genes were identified to be 
involved in cell cycle progression, and 7/94 genes were identified to have a 
role in response to stress. Gene lists are taken from the GO analysis in Figure
The gene lists obtained from GO analysis represent the most likely candidates 
from known ORFs, which could contribute to the premature Gi exit phenotype 
seen in the psocs strain, assuming the phenotype is due to altered 
transcription (Figure 6.13). The pRAD7 Arad23 strain does not exhibit the 
same premature Gi exit phenotype as the psocs or psocs Arad23 strains. For 
this reason, the expected expression pattern of the responsible genes would 
be an elevated or decreased expression level in the psocs and psocs Arad23 
strains, and WT expression level in the pRAD7 Arad23 strain. This would 
indicate that the expression is only dependent on the psocs mutation. The 
only gene that fits these criteria from Figure 6.13 is PRM7, which is a poorly 
characterised pheromone-responsive membrane protein, possibly controlled 
by the Gcn4 transcription factor. Gcn4 is thought to bind to 1% of all gene 
promoters, and stimulates transcription of genes involved in amino acid and 
nucleotide metabolism. Other genes from the list that show suitable 
downregulation in the psocs strain, but inappropriate expression levels for the 
observed phenotype are RSC3, a chromatin remodelling factor that can cause 
cell cycle arrest when repressed, CDC48, which is involved in shuttling
6 . 12.
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ubiquitinated proteins to the proteasome for degradation and exhibits cell 
cycle arrest when repressed, and CDC37, a co-chaperone that is essential for 
progression through cell cycle START. All these genes affect the cell cycle by 
arresting it when repressed and are downregulated in the array, which does 
not correspond to the psocs Gi phenotype.
Another method of identifying cell cycle regulated target genes is to use the 
gene list devised in (Spellman et al. 1998). Global studies were performed by 
(Spellman et al. 1998) to identify genes that were temporally differentially 
expressed during the cell cycle. A list of 800 genes was compiled, and they 
were ordered according to their chronological order of peak expression during 
the cell cycle. Five cell cycle phase groups were devised to categorise the 
genes: M/Gi, Gi, S, S/G2 and G2/M. For the purpose of this study, this list will 
be referred to as the Spellman 800 list. Although all genes in the Spellman 
800 list do not necessarily have a role in cell cycle control, and many are 
probably only upregulated to perform cell cycle phase-specific activities. 
These genes may have an indirect function in cell cycle progression. The 
Spellman 800 list was extracted from the psocs/rad23 untreated microarrays 
and is displayed in Figure 6.14.
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Figure 6.14 - The Spellman 800 Gene List -  Genes from the Spellman 800 
list (Spellman et al. 1998) were extracted from the psocs/rad23 microarrays, 
and arranged into chronological order of expression.
The entire Spellman 800 gene list (Figure 6.14) shows some variation in 
expression, however differences may have been more evident if synchronised 
cells were used. Genes that were most misregulated in the psocs strain were 
identified from the Spellman 800 list (The gene list is displayed in Appendix 
IV, List 7), which was then edited further to reveal genes which showed a 
difference in psocs vs pRAD7 expression, and also showed a difference in 
pRAD7 Arad23 and psocs Arad23 expression. This formed a list of 8 genes 
(Figure 6.15).
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Figure 6.15 - psocs Differentially Expressed Genes from Spellman 800 
List A. Genes extracted from Figure 6.14 that were differentially expressed in 
the psocs strain compared to the pRAD7 strain. This gene list is displayed in 
Appendix IV, List 7. B. Genes extracted from (A) that showed an expression 
pattern that could explain the psocs Gi phenotype.
The gene list in Figure 6.15B displays genes temporally transcriptionally 
regulated in a cell cycle dependent manner, which are misregulated in the 
psocs mutant. None of these 8 genes have been previously implicated in cell 
cycle control, however some genes (SPI1 and YOR052C) have been found to 
be stress induced. SPI1 is regulated by Msn2/4, which bind to STRE elements 
to induced genes in response to a variety of stresses. STRE-responsive 
genes were also identified as significantly misregulated in the rad4/rad23 
mutants (4.3.6), so it is possible that STRE-responsive genes are regulated 
by the Rad4-Rad23 complex in order to alter cell cycle progression.
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6.3.6 The Role of the Rad7-Containing E3 Ligase in Cell Cycle 
Progression via the RNR Pathway
It has been identified previously in this study that the Rad7-containing E3 
ligase has a role in regulating genes involved in dNTP synthesis, including the 
RNR pathway. Although analysis of microarray data did not identify any 
suitable targets known to be involved in cell cycle progression (Chapter 6.3.5), 
it is possible that misregulated dNTP levels could also be the cause of the 
defective cell cycle progression observed in psocs strains. If this is the case, 
then elevation of dNTP levels by constitutive activation or expression of the 
RNR pathway could affect the defective cell cycle progression observed in 
psocs strains. The Asml1 and Acrt1 strains constructed in Chapter 5 were 
used for cell cycle analysis, regarding stationary phase recovery, and cell 
cycle progression following Gi synchronisation.
6.3.6.1 Constitutive Activation of RNR Restores Normal Exit from Early 
Stationary Phase in psocs Strain
A growth defect of the psocs strain was observed previously when cells were 
re-introduced to logarithmic growth following early stationary phase entry. The 
psocs strain exhibited slower re-entry to logarithmic growth from early 
stationary phase. This phenotype was alleviated by diluting logarithmically 
growing strains into fresh media (Section 6.3.1). It was proposed that 
defective regulation of cellular dNTP levels could delay cellular recovery and 
re-entry into logarithmic growth. A growth curve was conducted for the pRAD7 
and psocs Arad23 Asml1 and Acrt1 strains to monitor recovery from early 
stationary phase (Figure 6.16).
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Figure 6.16 - Growth Curve of RNR-Activated Strains Early stationary 
phase cultures were diluted to OD6oo=0.1 and grown in HIS' media, with 
hourly measurement of cell density. OD6oovalues are displayed in Appendix V.
The growth curve in Figure 6.16 demonstrates suppression of the psocs 
delayed exit from early stationary phase phenotype. It appears that 
constitutive activation of RNR causes the psocs strain to exit early stationary 
phase at the same rate as the pRAD7 strain. This occurs to same extent in 
Asmll and Acrtl strains, which could provide evidence that insufficient dNTP 
levels are the cause of the defect in the psocs strains. This observation 
suggests that the Rad7 E3 ligase has a role in elevating dNTP levels following 
early stationary phase entry caused by a period of nutrient starvation.
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6.3.6.2 Constitutive RNR Activation Suppresses Premature Gi Exit 
Phenotype in psocs Strains
Mins After 
G, Release
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pRad7 Arad23 Asmll psocs Arad23 Asmll
Figure 6.17 - Gi Exit and Cell Cycle progression of Asmll Arad23 pRAD7 
and psocs Strains Strains were Gi-synchronised by elutriation, then allowed 
to continue growth in YPD. Cell samples were taken at the stated timepoints 
and analysed by flow cytometry. Budding index data is displayed in Appendix 
III (A3.5).
Gi exit and cell cycle progression appear identical in the two strains displayed 
in Figure 6.17. The strains both appear to exit Gi at the 60 minute timepoint, 
and reach a G2 majority at 100 minutes. A Gi exit after 60 minutes was 
observed previously for the psocs strain, however the elutriation was more 
successful in the psocs strain, which would affect apparent cell cycle 
progression as there was a lower proportion of non-Gi cells in the 0 timepoint. 
Evidence of this effect can be seen in the pRAD7 and psocs Arad23 strains 
(Figure 6.7), which proved difficult to isolate purely Gi cells from and therefore 
exhibited an apparent accelerated Gi exit. Taking this into account, the Asmll 
strains in Figure 6.17 display a cell cycle progression that reflects the psocs 
strain but could also reflect progression of the pRAD7 Arad23 strain if quality 
of elutriation is considered.
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The most significant observation from Figure 6.17 is that both strains exhibit 
identical cell cycle progression and it is most likely that deletion of SML1 
causes suppression of the psocs phenotype, therefore delaying Gi exit to the 
pRAD7 (WT) strain time.
Gi exit and cell cycle progression was also investigated in pRAD7 Arad23 
Acrtl and psocs Arad23 Acrtl strains and the flow cytometry results are 
displayed in Figure 6.18.
Mins After 
G, Release
180
160
140
-2C
100
v
AS
psocs Arad2 3 AcrtlpRad7 Arad23 Acrtl
Figure 6.18 - Gi Exit and Cell Cycle progression of A crtl Arad23 pRAD7 
and psocs Strains Strains were G i-synchronised by elutriation, then allowed 
to continue growth in YPD. Cell samples were taken at the stated timepoints 
and analysed by flow cytometry. Budding index data is displayed in Appendix 
III (A3.6).
The Acrtl strains in Figure 6.18 show the same pattern of Gi exit and cell 
cycle progression as the Asmll strains in Figure 6.17. This suggests that 
elevating dNTP levels abolishes the premature Gi exit phenotype of the psocs 
strain as both strains exit Gi at the same (80 minutes) timepoint, and progress 
to a G2-majority at 120 minutes. This pattern of cell cycle progression 
suggests that the psocs Gi exit phenotype is being suppressed to the pRAD7 
Gi exit time.
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It has been identified that the Rad7 E3 ligase affects cell cycle progression in 
two ways, by promoting exit from stationary phase and by preventing 
premature progression to S phase following stress- or DNA damage-induced 
checkpoint arrest. The complete suppression of these phenotypes by 
increasing cellular dNTP levels suggests that the defective cell cycle 
progression is due to misregulation of dNTP levels in the psocs mutant 
strains.
6.4 Discussion
The results presented in this chapter have identified a role of the Rad7- 
containing E3 ligase complex in cell cycle progression. It has been shown that 
the psocs mutant exhibits delayed exit from early stationary phase, and 
premature exit from Gi phase in Gi-synchronised cells, in response to 
centrifugal stress and UV irradiation, however this was not thought to be 
caused by misregulation of the unperturbed cell cycle. This phenotype was 
also found to occur irrespective of Rad23 or its interaction with the 19S 
proteasome. Global analysis of gene expression in the psocs strain could not 
identify misregulated genes known to be involved in cell cycle progression, 
thus causing the observed phenotypes. It was suggested previously that the 
Rad7 E3 ligase has a role in regulating cellular dNTP levels via the RNR 
pathway, which could affect cell cycle progression if misregulated. In order to 
examine the effect of elevating dNTP levels in the psocs strain, the Acrtl and 
Asmll mutants were analysed with regard to cell cycle progression. Both 
Asm/7 and Acrtl strains were found to suppress both delayed stationary 
phase exit and premature Gi exit phenotypes of the psocs strain. This 
suggests the effect on cell cycle progression of the psocs mutation is a result 
of misregulated dNTP levels.
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6.4.1 The psocs Strain Exhibits a Delayed Stationary Phase Exit 
Phenotype
It has been shown that the psocs strain exhibits slower recovery from early 
stationary phase than the pRAD7 strain (Figure 6.2). This suggests that the 
Rad7-containing E3 ligase functions to promote cell cycle progression 
following a period of nutrient starvation. It has been observed that the psocs 
strain does not exhibit an elongated overall cell cycle time during logarithmic 
growth. This implies that the Rad7-containing E3 ligase functions in stress 
responsive regulation, and not in a general cell cycle regulatory role. The work 
conducted in Chapter 4 suggested that the Rad4-Rad23 complex regulated 
transcription of a subset of DNA damage-responsive genes, and that the 
Rad7-dependent Rad4 ubiquitination has a role in this regulatory activity. The 
observed psocs delayed stationary phase phenotype may suggest that the 
ubiquitination of Rad4 may have a more general role in response to stress, 
and not just DNA damage.
6.4.2 The Rad7 E3 Ligase Affects Gi/S Phase Progression
It has also been shown that the Rad7-containing E3 ligase defective psocs 
mutant displays altered cell cycle regulation from a population of G r 
synchronised cells. The psocs cell population appears to progress out of Gi 
sooner than the pRAD7 cell population. It is most likely that this a defect in 
stress response, and not misregulation of the unperturbed cell cycle because 
the effect is only visible following the initial Gi exit of the synchronised cells, 
following which the psocs strain appears to continue the cell cycle at the same 
rate as the pRAD7 strain. The psocs strain does not appear to exhibit a 
generally shorter Gi phase, only in the initial Gi phase following synchrony. 
The process of elutriation is thought to evoke a checkpoint mediated stress 
response due to centrifugation and changing media. A centrifugation-induced 
stress response has been well documented in the fission yeast S. pombe, 
which identify activation of Spc1 following centrifugation which triggers a 
MAPK stress response pathway (Petersen and Hagan 2005; Shiozaki et al. 
1998; Soto et al. 2007). The S. cerevisiae homologue of Spc1 is Hog1, which 
is activated in response to a variety of stresses. Defective activation of stress
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response pathways could be responsible for the psocs premature exit from Gi 
synchrony. These genes could also provide potential regulatory targets of the 
Rad4-Rad23 complex if it is involved in general stress-responsive 
transcription and not just DNA damage-responsive transcription.
The Rad7 E3 ligase functions in one of two separate components of the NER 
pathway. It was found that deletion of RAD23 in a psocs strain results in 
increased UV sensitivity, compared to the pRAD7 Arad23 strain (Gillette et al. 
2006). A UV-sensitive phenotype of the psocs strain is only apparent when 
RAD23 is deleted and the UV-sensitive phenotype is suppressed by mutation 
of the 19S proteasome, a negative regulator of NER (Gillette et al. 2006). 
Deletion of RAD23 in pRAD7 and psocs strains appears to have no effect on 
the previously observed cell cycle phenotype. The psocs strain still exhibits a 
premature exit from Gi phase to the same extent as observed in RAD23+ 
strains. This is also the case in pRAD7 and psocs Arad23 sug2-1 strains. This 
shows that neither Rad23 nor its interaction with the 19S proteasome affect 
the Rad7-containing E3 ligase role in cell cycle progression, which therefore 
may suggest that the defective E3 ligase is affecting cell cycle progression by 
a different mechanism to the mechanism promoting UV survival, as the psocs 
strain is not significantly UV sensitive. An alternative conclusion is that the 
disrupted cell cycle progression in psocs strains is a result of the same 
misregulated pathway(s) as for the UV survival, however the UV sensitivity 
may be cell cycle phase-specific. If Gi cells are affected more severely by UV, 
then the cell cycle defect observed in psocs strains could affect their UV 
survival. This could be investigated by performing a UV survival assay on Gi 
synchronised psocs cells and comparing it to the UV survival curve of 
asynchronous psocs cells. If Gi cells are more sensitive to UV it could 
suggest that the cell cycle defect does affect UV sensitivity. This could be due 
to increased activation of pathways such as damage bypass or translesion 
synthesis (TLS) in psocs strains, thus avoiding repair pathways, which could 
lead to potentially harmful mutagenesis. However this effect could be masked 
in asynchronous psocs cell populations, thus explaining the lack of UV 
sensitivity of the psocs strain.
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In order to analyse further the psocs Gi-exit phenotype, and its potential role 
in maintenance of stress-induced cell cycle arrest, cells were treated with UV 
to evoke a more significant stress-induced arrest, and to observe how the 
mutant strains respond to DNA damage. The psocs strain compared to the 
pRAD7 strain exhibited the same phenotype as observed in untreated strains, 
with the psocs strain exhibiting a premature Gi exit, however the pRAD7 and 
psocs strains exhibited a greater difference in S-phase progression. Whereas 
the pRAD7 strain exhibited delayed progression through S-phase then normal 
cell cycle progression, the psocs strain appeared to progress through S-phase 
much faster and accumulate in G2 , then a significant amount of particles with 
a >2N DNA content were visible. This could suggest genome instability in the 
psocs strain. It is possible that the faster progression through S-phase in the 
psocs strain is due to increased dependency and activation of the TLS 
pathway, which could bypass damage without activation of repair pathways. 
This process may be mutagenic and cause accumulation of DNA damage, 
which would explain the extended arrest in G2 . The pattern of cell cycle 
progression also suggests that Gi psocs cells may be more vulnerable to 
DNA damage than other cell cycle phases, due to the rapid progression 
through S-phase. This could be determined by conducting a UV survival 
assay on psocs Gi cells. The involvement of the TLS pathway could also be 
investigated in cell cycle progression and UV survival in the psocs strain. This 
could be accomplished using genetic analysis, by knocking out components of 
the TLS pathway, such as the alternative replicative polymerase RAD30, or 
the ubiquitin processing factors RAD5 or RAD18, and identifying mutant 
phenotypes. Knocking out these factors may alter cell cycle progression or UV 
survival differently in the psocs strain compared to the pRAD7 strain, which 
could help reveal the regulatory mechanism of TLS vs NER and the 
involvement of the Rad7 E3 ligase.
The psocs strain is known to exhibit UV sensitivity when RAD23 is deleted, 
however it has been shown that Rad23 does not affect the psocs Gi-exit 
phenotype in untreated cells, so cell cycle progression in the psocs strain with 
RAD23 deleted following UV irradiation was observed. Arad23 cells proved
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more difficult to test for post-UV cell cycle phenotype as they exhibit a 
reduced UV survival, unlike the psocs strain. This resulted in apparent 
indefinite Gi arrest after exposing to 100Jm'2 UV. After lowering the UV dose 
from 100Jm'2 to 20Jm'2, a similar phenotype was observed as seen in pRAD7 
and psocs RAD23+ cells. The psocs Arad23 strain exhibited faster Gi exit, 
although S-phase progression did not occur as quickly as seen for the psocs 
strain, however extensive G2 arrest and particles with >2N DNA content were 
observed. The S-phase progression still appears to be faster than the pRAD7 
Arad23 strain, however the lower UV dose may affect this progression. This 
could be due to differential regulation of the TLS pathway as discussed 
previously.
It has been assumed in this chapter that the psocs cell cycle phenotype is due 
to misregulation of a stress-induced cell cycle arrest. In order to confirm this 
theory, unstressed cells would have to be tested for cell cycle progression. 
The process of elutriation is the least invasive technique for cells to obtain a 
synchronised Gi population. An alternative method is a-factor 
synchronisation, which involves exposing cells to a mating factor, thus 
inducing Gi arrest. Although this omits the mechanical stress the cells must 
undergo during elutriation, the induced cell cycle arrest causes cells to enter a 
stationary phase-like Gi arrest. Observing recovery from a-factor-induced Gi 
arrest may help reveal the cell cycle progression occurring in psocs cells 
when recovering from stationary phase. Another method of observing the 
unperturbed cell cycle in psocs strains could be time-lapse microscopy, which 
would provide detailed monitoring of single cell cycle progression. Although 
flow cytometric data cannot be obtained to produce a true representation of 
the unperturbed cell cycle in psocs strains, the growth curve presents 
evidence to suggest that the psocs strain does not exhibit significant 
misregulation of the unperturbed cell cycle.
Considering the two phenotypes observed in the psocs strain relating to cell 
cycle progression, it appears the Rad7-containing E3 ligase has a potentially 
complex role in stress-responsive cell cycle control. It suggests that cell cycle
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regulation by the ligase is dependent on the type of stress the cell encounters. 
This is visualised in Figure 6.19.
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Figure 6.19 -  Overview of Observed Phenotypes of psocs Strain with 
Regard to Cell Cycle Progression in Response to Various Stresses.
The different cell cycle phenotypes may suggest that the E3 ligase targets 
different factors in response to different stresses, or possibly just targets 
Rad4, which affects various factors, or transcriptional targets according to the 
type of stress encountered. The control of cell cycle progression by 
proteasomal proteolysis of regulatory factors has been observed in fission 
yeast. The DNA replication-licensing factor Cdt1 was found to be degraded in 
M and Gi phase in response to DNA damage. This occurred in a Rad3 and 
Cds1-independent manner (Mec1 and Rad53 homologues), so the 
degradation was checkpoint-independent. The degradation was dependent 
upon the Cdt2 and Ddb1-containing CUL4 ligase complex, which is 
homologous to the Ddb1-Ddb2 ligase complex in humans. This complex is 
involved in human GG-NER and shares orthologous functions with the S. 
cerevisiae Rad7-Rad16 containing complex. During normal cell cycle 
progression, Cdt1 functions as a replication-licensing factor, so is degraded in 
S-phase following initiation of DNA replication to ensure only one round of 
DNA replication occurs. It was speculated that the degradation of Cdt1 in Gi 
phase could contribute to genome stability by preventing S-phase onset and
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thus reducing the demand on dNTP pools during DNA repair (Ralph et al. 
2006). Although a homologue to Cdt1 does not exist in S. cerevisiae, it is 
possible that a similar mechanism could be occurring whereby the Rad7 E3 
ligase is degrading a factor to postpone S-phase onset thus preventing DNA 
repair and replication happening simultaneously and creating excessive 
demand upon dNTP pools. However in the case of the psocs mutant this 
appears to be a general stress response as opposed to just a response to 
DNA damage.
6.4.3 Identification of Genes Responsible for the Premature Gi Exit of 
psocs Strains
The microarray data obtained in Chapter 4 was examined to identify 
transcriptional misregulation of genes in the psocs strain that could cause or 
contribute to the psocs premature Gi exit cell cycle phenotype. Very few 
genes were transcriptionally altered in the psocs strain, and the potential 
genes extracted in Figure 6.13 or Figure 6.15 as most significantly 
misregulated in the psocs strain were poorly characterised or showed an 
inappropriate expression pattern (not misregulated in a psocs-dependent 
manner). For this reason, it must be concluded that the psocs cell cycle 
phenotype is not a result of altered transcriptional regulation of known cell 
cycle-regulatory genes. If this was to be pursued further, microarrays could be 
performed using synchronised cells. This would provide better clarity in 
revealing cell cycle-specific altered transcription in the psocs strain, which can 
be masked when using asynchronous cells.
6.4.4 Suppression of psocs Cell Cycle Phenotypes by Constitutive 
Activation of RNR
Due to the lack of possible cell cycle-related transcriptional targets identified 
by global analysis, the role of the RNR pathway in cell cycle control was 
investigated. The Rad7 E3 ligase has been shown previously to have a 
possible role in regulating cellular dNTP levels via regulation of the RNR 
pathway. It was considered that the cell cycle defects identified in this chapter
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could be due to misregulation of dNTP levels in psocs cells. Constitutive 
activation of the RNR pathway has been shown previously to suppress the UV 
sensitivity of the psocs Arad23 strain, which appears to occur in a psocs- 
dependent fashion, thus suggesting that the Rad7-containing E3 ligase has a 
regulatory effect on the RNR pathway. If failure to upregulate dNTP pools in 
psocs strains is the cause of the defective cell cycle progression, constitutive 
activation of RNR, and thus elevation of cellular dNTP levels should affect the 
cell cycle defective phenotypes observed in this chapter.
Constitutive activation or expression of the RNR pathway was found to 
completely suppress the defects in cell cycle progression seen in the psocs 
(and psocs Arad23) strains. This suggests that following progression to early 
stationary phase, the psocs strain cannot elevate dNTP levels effectively in 
order to reinstate DNA replication and logarithmic growth phase. This could 
cause the growth defect displayed in Figure 6.16. This could explain how 
upregulation of dNTP synthesis would reinstate normal stationary phase exit.
The results obtained in this chapter also suggest that misregulation of dNTP 
levels are responsible for the premature Gi exit of the psocs (and psocs 
Arad23) strains. Deletion of either SML1 or CRT1 completely suppressed the 
defective Gi exit phenotype. A study performed in S. pombe could provide a 
possible model for the observed psocs Gi phenotype. The DNA replication 
licensing factor Cdt1 was found to be degraded in a UPS-dependent manner 
in response to DNA damage in Gi in order to delay S-phase progression and 
reduce dNTP demand while DNA repair was occurring (Ralph et al. 2006). A 
similar mechanism could be dependent on the Rad7 E3 ligase, whereby 
degradation of a regulatory factor could prevent onset of DNA replication 
following DNA damage. However, the premature Gi exit phenotype is also 
observed in cells that have not been exposed to DNA damage. It is possible 
that S-phase delay is a feature of general stress response, and not just DNA 
damage. The suppression of the premature Gi exit by deletion of SML1 or 
CRT1 suggests that increasing dNTP levels overrides the regulation 
controlling S-phase entry. It remains unclear if the Gi exit is accelerated in
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Asm/7 and Acrtl strains, which would probably be the most plausible 
conclusion, as elevation of dNTP levels would be predicted to promote DNA 
replication. Alternatively, SML1 or CRT1 deletion could restore the delayed S- 
phase entry of the pRAD7 strain when exposed to centrifugal stress.
It has been shown in this chapter that the Rad7-containing E3 ligase affects 
cell cycle progression in response to stress and DNA damage. These defects 
appear to result from defective regulation of cellular dNTP levels as the 
phenotypes are suppressed by constitutive activation of the RNR pathway.
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7 General Discussion and Further Work
The complex co-ordination of different cellular pathways is required to allow 
eukaryotic cells to adapt and respond to DNA damage. S. cerevisiae provides 
an invaluable model to represent the precise mechanism by which eukaryotic 
cells cope with DNA damage, and promote cellular survival. This study has 
revealed new aspects of the complex cellular response to DNA damage 
involving novel regulatory roles of the Rad7, Rad4 and Rad23 NER factors, 
and provides an investigative potential for further studies in this research 
area.
7.1 Evidence of a Functional Interaction Between Abf1 and the 19S 
Proteasome
The initial aim of this study was to reveal a possible functional interaction 
between the 19S regulatory complex of the 26S proteasome and the global 
regulator protein Abf1. It was proposed that the 19S proteasome could be 
responsible for destabilising Abf1 binding to DNA using the same mechanism 
as observed for Gal4 (Archer et al. 2008b). This prompted the theory that 
mutating the proteasome could suppress the DNA binding defect of the abf1-1 
mutant allele (Rhode et al. 1992), thus restoring its activity in such processes 
as DNA replication and NER. A series of experiments were conducted to 
observe the mutant strains’ phenotypes in order to reveal a genetic interaction 
between Abf1 and the 19S proteasome.
A physical interaction between the 19S proteasome and Abf1 was identified 
by Co-IP, however a significant functional interaction could not be observed 
using mutant alleles and phenotypic analysis of cellular growth and UV 
sensitivity. A slight suppression of temperature sensitivity in the sug2-1 abf1-1 
strain compared to the abf1-1 strain might suggest some functional 
interaction, but the strains had identical logarithmic growth rates and UV 
survival curves.
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The physical interaction, and slight suppression of temperature sensitivity 
provides scope for further investigation in this area, which could be conducted 
using alternative Abf1 mutants, such as the C-terminal mutants first 
characterised by (Miyake et al. 2002). The role of the C-terminal domain of 
Abf1 is less understood than the DNA-binding N-terminal region, so although 
C-terminal mutants were not conveniently available at the time of this study, 
AbfTs C-terminal function remains an intriguing and exciting area of research, 
which could potentially expand on the results obtained here and reveal a 
functional interaction with the proteasome. In order to further test the Abf1- 
19S functional interaction, chromatin immunoprecipitation (ChIP) could be 
employed, using the abf1-1/sug2-1 mutants and observing Abf1 binding at 
specific genomic loci. This could be used to determine the function of Abf1 
affected, for example altered binding at ARS could affect its role in DNA 
replication, whereas altered binding at promoter elements of genes could 
affect its role in transcriptional regulation. It would also be of interest to 
analyse the binding dynamics of Abf1 C-terminal mutants as this has not been 
investigated previously, and may help characterise a possible functional 
interaction with the 19S proteasome. ChIP analysis could be performed on 
abfl mutants at a local or global level to obtain a genomic overview of 
differential Abf1 binding, and how it is affected by the 19S proteasome.
An advantage of using genetic techniques with ABF1 and the SUG genes in 
this study is the allele specificity and variability they exhibit. As discussed 
previously, many different characterised functional mutant alleles exist for 
both Abf1 and Sug1/2, which differentially affect distinct cellular processes, 
such as transcription and DNA repair. It is not until a variety of allelic 
combinations of the two genes have been tested that a proper conclusion 
regarding the Abf1-19S proteasome interaction can be drawn. It has been 
shown in this study that combining abf1-1 and sug2-1 in a strain proved to be 
unstable, and combining abf1-1 and sug1-20 appeared to be lethal. Obtaining 
a variety of mutant backgrounds proved more difficult than first presumed, and 
it was soon apparent that the task was beyond the scope of this study. It can 
be seen from the results obtained in Chapter 3 that the abf1-1 sug2-1 mutant 
strain does not produce a significant phenotype using the assays performed,
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however the positive Co-IP and temperature sensitivity results supports the 
speculation that Abf1 does functionally interact with the 19S proteasome. 
Investigation of different combinations of abfl and sug mutant alleles could 
help characterise the possible functional interaction between Abf1 and the 
19S proteasome. Further investigation in this area was not performed in this 
study.
7.2 The Rad4-Rad23 Functions in DNA Damage-Responsive Gene 
Transcription
The role of the Rad4-Rad23 complex in NER has been reported previously in 
the literature, however it has been suggested more recently that the Rad4- 
Rad23 complex has a role in the general DNA damage response (Gillette et 
al. 2006), and that Rad23 has a role in global transcription (Wade et al. 2009). 
The characterisation of an NER regulatory component involving the Rad7- 
containing E3 ubiquitin ligase-dependent ubiquitination of Rad4 that requires 
de novo protein synthesis, coupled with the observation that deletion of 
Rad23 appears to affect RAD4 transcription, prompted the theory that the 
Rad4-Rad23 complex may have a role in DNA damage-responsive gene 
transcription, and that this role was dependent on the Rad7-dependent 
ubiquitination of Rad4 (Gillette et al. 2006). (Wade et al. 2009) also identified 
a possible role for Rad23 in global transcription, however Rad4 was thought 
not to be involved in this function. To investigate the role of the Rad4-Rad23 
complex in UV-responsive transcription, global gene expression studies were 
performed and potential regulatory targets of the Rad4-Rad23 complex were 
identified (Chapter 4).
Using the Rad7 E3 ligase-defective, UV-sensitive psocs Arad23 mutant strain, 
which does not exhibit post-UV Rad7-mediated Rad4 ubiquitination, 
misregulated genes in response to UV were identified by comparing to the 
pRAD7 and pRAD7 Arad23 strains. This comparison was conducted to 
specifically reveal genes affected by Rad4 ubiquitination in response to DNA 
damage in the absence of Rad23. The comparison identified four main
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pathways that exhibited significantly altered transcription; genes involved in 
dNTP synthesis, DNA damage-responsive chromatin remodelling, telomere 
maintenance and proteasome metabolism. All four groups showed 
downregulation of genes that promote cell integrity and genome stability, 
which could impact on UV-sensitivity, thus explaining the additional UV- 
sensitivity of the psocs Arad23 strain compared to the pRAD7 Arad23 strain.
The misregulation of genes involved in regulating cellular dNTP levels was 
considered most striking, thus most likely to impact upon cellular survival in 
response to UV. This pathway is discussed in more detail below, however the 
investigative potential of the other misregulated genes was also considered.
The array data show reduced upregulation of almost all proteasomal subunits 
in the Arad23 mutants, with some pRAD7 vs psocs variation. This observation 
may help to characterise the role of upregulation of proteasomal subunits in 
response to DNA damage. It is known that deletion of RPN4, the 
transcriptional activator of proteasomal and other genes causes increased 
DNA damage sensitivity, however it was not known whether this is due to 
reduced transcription of the proteasome or other targets of Rpn4, such as 
RAD23, that caused the DNA damage sensitivity (Gasch et al. 2001). A study 
was performed using mutants that had defective Rpn4 binding at proteasomal 
genes, which showed that DNA damage-dependent upregulation of 
proteasomal transcription does affect DNA damage sensitivity (Wang et al. 
2008), so therefore reduced transcriptional induction of the proteasomal 
genes as observed in the pRAD7 Arad23 and psocs Arad23 strains could 
cause the observed increased UV sensitivity. These results suggest that 
Rad23 has a regulatory role in proteasomal gene expression, however the 
role of Rad4 ubiquitination does not appear to be significant from comparison 
between the pRAD7 Arad23 and psocs Arad23 strains. The role of Rad23 or 
Rad4 in regulation of proteasomal genes could be examined by ChIP at 
promoters of proteasomal genes, which would determine occupancy of the 
complex at the UAS. It is also possible that Rad4 or Rad23 could affect an 
additional factor, such as Rpn4, so assessment of Rpn4 DNA binding by ChIP
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at proteasomal gene promoters in the psocs/rad23 mutant strains may help 
reveal this regulatory connection. The role of transcriptional regulation of the 
proteasome in response to DNA damage remains an interesting concept, 
which may be regulated by the Rad4-Rad23 complex.
Genes involved in DNA damage response-related chromatin modification 
including ASF1 and RTT109 were also found to exhibit increased 
downregulated in the psocs Arad23 strain in response to UV. Both genes act 
in chromatin modification to facilitate the DNA repair process (Mello et al. 
2002; Recht et al. 2006), and their expression is induced following DNA 
damage in the pRAD7 strain. Reduced transcription could cause reduced 
cellular Asf1/Rtt109, which could result in defects in the DNA damage 
response, thus causing or contributing to the psocs Arad23 UV sensitivity. It is 
known that deletion of ASF 1 causes increased UV sensitivity (Le et al. 1997), 
which suggests it has an important role in the DNA damage response. It 
would be of interest to observe Asf1 protein levels in response to DNA 
damage in the psocs Arad23 strain to deduce whether they are significantly 
lower than the pRAD7 and pRAD7 Arad23 strains, as a result of reduced 
ASF1 transcription in the psocs Arad23 strain. This could help reveal the 
importance of Asf1 upregulation in the DNA damage response. ChIP analysis 
could also be employed to identify if Rad4 or Rad23 bind to the ASF1 or 
RTT109 promoters, and thus affect their DNA damage-responsive 
transcription.
Down regulation of the previously discussed genes involved in chromatin 
modification or dNTP synthesis has been shown to result in telomeric 
shortening (Nyswaner et al. 2008; Toussaint et al. 2005). Other ORFs 
involved in telomere maintenance also exhibited increased downregulated in 
the psocs Arad23 mutant strain, primarily subtelomeric Y’ element ORFs. 
Although the regulatory role of these elements has not been characterised in 
strains with functional telomerase, such as the strains employed in this study, 
it would be of interest to observe the telomeric state of the psocs Arad23 
strain. If shortened telomeres were revealed, it would help explain the
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increased UV-sensitivity of the psocs Arad23 strain. Evidence supporting the 
theory that the psocs Arad23 strain may exhibit telomeric instability includes 
the reduced expression of CDC8 and the RNR pathway, altered regulation of 
subtelomeric Y’ element ORFs, and downregulaiton of ASF1 and RTT109.
The most striking group to exhibit transcriptional misregulation in the psocs 
Arad23 strain was genes involved in dNTP metabolism. This included the 
RNR pathway and the dTTP-specific synthesis pathway. Regulation of cellular 
dNTPs plays an important role in promoting successful DNA synthesis, both 
during DNA replication in S-phase, and DNA repair in response to DNA 
damage. Misregulation of dNTP levels can affect genome stability and cause 
mutagenesis. The RNR genes were found to be expressed at a lower level in 
the psocs Arad23 strain, which could suggest that the strain has lower cellular 
dNTP levels. Reduced expression of the CDC8 gene could also affect dNTP 
levels, by reducing dTTP levels and upsetting the nucleotide balance, thus 
increasing genome instability. This prompted the theory that constitutive 
activation or expression of the RNR pathway with the intention of raising 
cellular dNTP levels could promote genome stability and thus suppress the 
UV sensitivity phenotype of the psocs Arad23 strain.
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7.3 The Rad7 E3 Ligase Activity Has a Role in Regulation of the DNA 
Damage Response via the RNR Pathway
Following the observation that genes involved in dNTP synthesis, particularly 
the RNR pathway, exhibited reduced transcriptional upregulation in response 
to DNA damage in the psocs Arad23 strain, mutants were created with the 
RNR pathway constitutively activated or constitutively expressed. This was 
intended to elevate cellular dNTP pools to an acceptable level to suppress the 
psocs Arad23 strain’s increased UV sensitivity, under the suggestion that 
reduced RNR upregulation in the psocs Arad23 strain caused reduced cellular 
dNTP levels following DNA damage. The repressor of RNR transcription,
Crt1, and the inhibitor of the RNR complex, Sml1, were deleted in separate 
strains. Both mutations have been shown to constitutively elevate cellular 
dNTP levels (Tang et al. 2009).
It has been shown that constitutive activation of RNR in the psocs Arad23 
AsmH strain can suppress the additional UV sensitivity of the psocs Arad23 
strain compared to the pRAD7 Arad23 strain (Chapter 5), however the UV 
sensitivity of the pRAD7 Arad23 strain was not significantly affected by 
deletion of SML1. This suggests that the Rad7 E3 ligase-mediated Rad4 
ubiquitination has a regulatory role in maintenance of cellular dNTP levels. 
Deletion of CRT1 in pRAD7 Arad23 and psocs Arad23 strains also cause 
suppression of UV sensitivity, but to a greater extent than the Asml1 strains, 
and enhanced the UV survival to above the pRAD7 Arad23 level.
The level of suppression of UV-sensitivity varied between RNR mutants, 
which shows that deletion of CRT1 suppressed the UV sensitivity to a greater 
extent than deletion of SML1. This could be a direct result of actual cellular 
dNTP levels, as Asmll strains have been shown to elevate dNTP levels ~2 
fold, whereas Acrtl strains have been documented to elevate dNTP levels 3-4 
fold (Tang et al. 2009). This could explain the increased suppression of the 
Acrtl strains compared to the Asmll strains. The actual dNTP level could also 
explain the incomplete suppression of the UV sensitivity (not suppressed to
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the WT level), because dNTP levels are raised by 6-8 fold in response to DNA 
damage (Chabes et al. 2003). If the psocs Arad23 strain exhibits reduced 
DNA damage-responsive dNTP level increase, then deletion of Crt1 or Sml1 
may be able to suppress the UV sensitivity to a certain extent, but not to the 
UV sensitivity of the pRAD7 or psocs strains as dNTP levels are not elevated 
high enough for efficient DNA repair.
On the other hand, the increased suppression of UV sensitivity in the Acrtl 
strains could suggest an additional regulatory interaction. Whereas the only 
known function of Sml1 is as an inhibitor of RNR, Crt1 is known to repress the 
transcription of several genes, many of which are involved in the DNA 
damage response. This may suggest that the constitutive expression of genes 
other than the RNR pathway may contribute to the increased UV survival in 
Acrtl strains compared to Asmll strains. An example of these additional 
factors could be Hug1, a gene repressed by Crt1 and seen to be misregulated 
in Chapter 4.3.6. Although HUG1 is known to be transcriptionally upregulated 
in response to DNA damage, its function is not yet known (Zaim et al. 2005).
If the Rad7-E3 ligase has a regulatory role in stress/DNA damage-responsive 
dNTP production, it may affect the activity of the Dun1 kinase, which activates 
the RNR pathway in S-phase and in response to DNA damage. Dun1 
regulation by the Rad4-Rad23 complex and the Rad7 E3 ligase could provide 
a stress/DNA damage-specific regulatory aspect of the checkpoint and dNTP- 
regulatory pathway. The Rad4-Rad23 complex has been shown to bind at the 
DUN1 promoter in pRAD7 (WT) cells (Figure 5.6), which suggests that the 
Rad4-Rad23 complex has a role in regulation of DUN1 transcription.
Therefore, increased DUN1 transcription regulated by the Rad4-Rad23 
complex could increase RNR activation and subsequently upregulate dNTP 
synthesis in response to stress. To investigate this role further, Rad4-Rad23 
occupancy could be examined at the DUN1 promoter in response to DNA 
damage, and in the psocs mutant strains. This could reveal a DNA damage- 
dependent regulatory role of the Rad4-Rad23 complex in DUN1 transcription, 
and could reveal the role of Rad4 ubiquitination. To identify other possible
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regulatory gene targets of the Rad4-Rad23 complex, further ChIP studies 
could be conducted at promoters of other candidate genes such as DDR2, 
ASF1, RTT109 and CDC8. In order to obtain a more global perspective and 
thus potentially identify all Rad4-Rad23-regulated genes a ChlP-chip study 
could be performed. This would identify Rad4-Rad23 binding across the 
genome, and if performed in psocs strains could help further characterise the 
role of Rad4 ubiquitination in DNA damage-responsive transcription.
It was suggested from the data presented in Chapter 5 that the Rad7 E3 
ligase has a regulatory role in maintenance of dNTP levels via regulation of 
DNA damage-responsive transcription of genes such as DUN1. This can be 
seen from the suppressed UV sensitivity of the psocs Arad23 strain when 
RNR is constitutively activated or expressed, and the binding of the Rad4- 
Rad23 complex at DUNTs promoter. In order to confirm the data presented 
here, and to investigate further the regulatory mechanism, the cellular dNTP 
levels could be measured directly in response to DNA damage in the psocs 
Arad23 strain compared to the pRAD7 strain using an HPLC technique as 
used in (Chabes et al. 2003). This would unambiguously reveal the role of the 
Rad7 E3 ligase in maintenance of cellular dNTP levels.
7.4 The Rad7 E3 Ligase Has a Regulatory Role in Cell Cycle 
Progression
Under normal growth conditions, dNTP levels are altered in a cell cycle- 
dependent manner. In order to investigate the regulatory role in maintenance 
of dNTP levels of the Rad7 E3 ligase, cell cycle progression was observed in 
pRAD7 and psocs strains. Altered cell cycle progression was initially 
investigated by conducting a growth curve. If the psocs strains exhibit lower 
dNTP levels, it could exhibit delayed cell cycle progression, most likely 
caused by defective DNA replication during S-phase, a phenotype observed 
in a Adun1 strain (Zhao and Rothstein 2002) This was found not to be the 
case, as logarithmically growing psocs and pRAD7 cells exhibited the same 
cell cycle duration.
205
It was observed using cells that had entered early stationary phase, that 
psocs cells exhibit slower growth than pRAD7 cells when placed in fresh 
media to return to logarithmic growth phase. This suggested defective stress 
responsive signalling in the psocs strain, which could be a result of decreased 
dNTP levels. The apparent normal progression of the unperturbed cell cycle 
suggests that this is a defect in response to stress and not in general cell 
cycle regulation. Another explanation could be that S-phase is delayed, but 
the cell cycle ‘catches up’ in other phases, as seen in the dun1 mutant strain 
observed in (Zhao and Rothstein 2002). This defect was suppressed by 
deleting SML1, which suggests it was caused by insufficient dNTP levels. To 
investigate cell cycle progression further, flow cytometric analysis was 
performed on the psocs/rad23 strains, both untreated and in response to DNA 
damage.
Flow cytometric analysis revealed a different defect in psocs strains in cell 
cycle progression. Rather than exhibiting delayed cell cycle progression, the 
psocs strains displayed premature Gi exit in Gi-synchronised cells, which 
only appeared to occur following initial Gi exit, and following cycles occurred 
at the same rate in both psocs and pRAD7 strains, with no visible prolonged 
S-phase. This premature Gi exit was observed the same in pRAD7 Arad23 
and psocs Arad23 strains. Premature Gi exit was also displayed in response 
to UV irradiation, however the psocs strain also exhibited rapid progression 
through S-phase, extended G2 arrest, and the presence of particles with a 
>2N DNA content. This cell cycle progression could indicate that defective 
DNA damage-responsive signalling is occurring in psocs strains. Although the 
psocs strain does not exhibit significant UV sensitivity, it was suggested that 
psocs cells could exhibit UV sensitivity at a certain stage of the cell cycle, for 
example Gi cells, which could be sensitive due to defective S-phase 
progression. In an asynchronous cell population this effect could be masked 
by the majority of the cells not exhibiting UV sensitivity. The apparent 
accelerated S-phase progression in psocs cells could be due to increased 
activation of a pathway such as translesion synthesis (TLS), which would 
promote damage bypass rather than accurate repair, thus leading to damage
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accumulation and genomic instability in certain cells, but not significantly 
affecting UV survival.
An alternative explanation of the psocs premature Gi exit phenotype could be 
the mechanism reported in S. pombe by (Ralph et al. 2006), which identified 
the DNA replication licensing factor Cdt1, that was targeted for ubiquitination 
in order to delay S-phase initiation to reduce the demand on dNTPs whilst 
DNA repair occurred. Failure to ubiquitinate Cdt1 resulted in premature onset 
of S-phase, the phenotype observed in the psocs strains. However, the psocs 
strains also exhibited premature Gi exit in the absence of DNA damage, 
which may suggest that S-phase delay is a general stress response rather 
than a response to DNA damage, possibly to allow dNTP synthesis before 
logarithmic growth phase is resumed. It was assumed that the premature Gi 
exit was caused by misregulation of a general stress response, rather than a 
DNA damage-specific response as it was proposed that non-UV-treated cells 
were still subjected to stress by centrifugation during elutriation, so also 
exhibited a checkpoint response.
It was speculated that decreased levels of cellular dNTPs could be the cause 
of the defective cell cycle progression in psocs strains. It has been shown that 
the Rad7 E3 ligase has a possible role in regulation of cellular dNTP levels via 
the RNR pathway, so misregulation of dNTP synthesis in psocs strains could 
also be the cause of the defective cell cycle progression. Cell cycle 
progression analysis was also performed in the Asmll and Acrtl strains 
constructed in Chapter 5 to deduce whether elevation of dNTP levels could 
suppress the cell cycle progression defects observed in psocs strains. It was 
shown that constitutive activation or expression of RNR, which was reliably 
assumed to elevate cellular dNTP pools, was able to suppress and therefore 
alleviate both observed cell cycle defects in the psocs strain. In the case of 
the delayed exit from stationary phase in the psocs strains, it could be 
accepted that, as suggested previously, psocs strains have a defective ability 
to increase dNTP levels in response to stress/DNA damage, so constitutive 
elevation of dNTP levels could allow normal stationary phase exit of psocs
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strains. The complete suppression of the phenotype by activating the RNR 
pathway suggests that insufficient dNTP pools could be the sole cause of the 
defect.
Suppression of the psocs strains’ premature Gi exit phenotype by activating 
RNR is likely to be a result of elevated dNTP levels. In the case of S. pombe, 
ubiquitination of Cdt1 prevents S-phase onset following DNA damage, thus 
reducing the dNTP demand (Ralph et al. 2006). If dNTP levels are increased 
sufficiently, it could be proposed that there would be no need to delay S- 
phase onset.
The incomplete suppression of the UV sensitivity of pRAD7 Arad23 and psocs 
Arad23 strains by deletion of SML1 or CRT1 was suggested to be due to 
insufficient dNTP levels, as deletion of SML1 is known to increase dNTP 
levels by 2.5 fold, deletion of CRT1 is known to increase dNTP levels by 3-4 
fold, but DNA damage induces a 6-8 fold increase in cellular dNTP levels 
(Chabes et al. 2003). The complete suppression of the cell cycle progression 
defects observed in Asmll and Acrtl cells suggests that the dNTP level 
increase caused by these mutations allows normal cell cycle progression. If 
hyper-activation of a pathway such as TLS is the cause of defective cell cycle 
progression in psocs strains then this could suggest that a threshold dNTP 
level could be required to decide whether TLS or repair will be activated in 
response to DNA damage. This could be investigated by introducing TLS 
pathway mutations into the psocs strains, then observing cell cycle 
progression and dNTP levels in response to DNA damage.
To conclude, the results suggest that the Rad7 E3 ligase has a regulatory role 
in maintenance of stress or DNA damage-responsive cellular dNTP levels.
The psocs strain has exhibited increased UV-sensitivity (when RAD23 is 
deleted), delayed stationary phase exit and premature Gi exit when subjected 
to centrifugal stress or DNA damage. These defects can be suppressed by 
constitutive activation or expression of the RNR pathway, which is reliably 
assumed to elevate cellular dNTP levels, which suggests that the Rad7 E3
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ligase has a role in elevating dNTP pools in response to stress or DNA 
damage. The Rad4-Rad23 complex has been shown to bind to the promoter 
of DUN1, which presents a plausible regulatory mechanism for the Rad7 E3 
ligase and the RNR pathway.
7.5 Possible Further Experiments and Prospects
To confirm and expand on the results obtained in this study, it would be useful 
to view the actual cellular dNTP levels in the psocs Arad23 strain, and 
observe the effects of introducing the Asmll or Acrtl mutations. This could 
confirm the speculated role of the Rad7 E3 ligase in regulation of cellular 
dNTP levels, either in response to DNA damage, other stresses or during 
normal growth. It could also reveal whether there was a uniform decrease in 
dNTP levels, or if the balance of different dNTP was upset, thus resulting in 
increased genomic instability and explaining the UV sensitivity of the strain. 
Disruption of the dNTP balance could suggest that Rad7 E3 ligase affects 
other genes, such as CDC8, which is specific to dTTP production rather than 
general dNTP synthesis.
To characterise further the transcriptional regulatory role of the Rad23-Rad4 
complex, more extensive ChIP experiments could be performed at the DUN1 
promoter, and at other gene promoters identified in Chapter 4. To obtain a 
more global perspective of this transcriptional role, ChlP-chip could be 
performed to analyse Rad4-Rad23 binding across the whole genome. These 
ChIP studies could be performed in response to DNA damage, and in the 
psocs mutant strains in order to detect altered occupancy at gene promoters. 
The Dun1 kinase is known to be activated following DNA damage to activate 
the RNR pathway by inhibiting Sml1 and Crt1 (Zhao and Rothstein 2002), 
therefore if Rad4-Rad23 vacating the promoter causes upregulation of DUN1 
transcription following DNA damage, the RNR complex would be activated 
further, thus promoting dNTP synthesis. If Rad4-Rad23 was acting as a 
transcriptional repressor, Rad4 ubiquitination in response to DNA damage 
could cause a conformational change thus preventing DNA binding of the
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Rad4-Rad23 complex and promoting DUN1 transcription. It is possible that 
this repressor activity of the Rad4-Rad23 complex could occur at other DNA 
damage-responsive genes, such as those identified in Chapter 4. Following its 
ubiquitination, it appears that Rad4 is degraded by the proteasome, however 
this degradation is not required for its function in NER. Degradation of the 
human Rad4 homologue XPC is not observed in response to DNA damage 
(Sugasawa 2006), therefore the role of the degradation of Rad4 remains 
unknown. It is possible that Rad4 degradation occurs in yeast because de 
novo protein synthesis is not as energetically demanding as it is in human 
cells. This would suggest that evolutionary pressure has prevented XPC 
degradation due to energy demands, thus suggesting that Rad4 degradation 
has no significant regulatory function.
It has been reported that DNA damage promotes nuclear localisation of Rad4, 
and without DNA damage it remains dispersed throught the cytosol and 
nucleus (Li et al.). It is plausible that a subset of Rad4-Rad23 in the cell 
remains bound to gene promoters in the nucleus to repress transcription, and 
following DNA damage the remainder of the Rad4-Rad23 could localise to the 
nucleus as observed in (Li et al.), and bind to damaged DNA to recruit NER 
factors.
Post-translational modification of regulatory factors dramatically increases the 
complexity of the proteome, and allows factors to adopt different functions 
without the need for de novo protein synthesis. Rad4 may be subjected to 
post-translational modification to retain the Rad4-Rad23 complex in the 
cytosol in the absence of DNA damage, or it may be the case that post- 
translational modification is required for Rad4 to function as a repair factor or 
transcriptional regulator. It is known that Rad4 becomes ubiquitinated in 
response to DNA damage, however Rad4 may be subjected to other post- 
translational modifications such as phosphorylation or SUMO modification in 
order to participate in specific regulatory tasks. SUMO modification has
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previously been documented to affect subcellular localisation of regulatory 
factors (Hay 2005).
Defective subcellular localisation of Rad4 in the psocs Arad23 mutant may be 
a contributor to its UV sensitivity. It could be conceived that Rad4 
ubiquitination could trigger its nuclear localisation, thus allowing it to function 
in the NER pathway. It is also plausible that Rad23’s UBL domain could 
compensate for the lack of Rad4 ubiquitination in the psocs mutant thus 
suppressing the defect in Rad4 subcellular localisation, and preventing a UV- 
sensitive phenotype in the psocs strain.
The results obtained in this study have further characterised the complex 
regulatory pathways involved in the DNA damage response in S. cerevisiae, 
by identifying a possible role of the Rad4-Rad23 complex in DNA damage- 
responsive transcription involving Rad7-dependent Rad4 ubiquitination. This 
has identified and explored a possible role for the Rad7 E3 ligase in regulation 
of cellular dNTP levels, which has been shown to affect UV sensitivity and cell 
cycle progression. Several other potential regulatory target genes of the 
Rad4-Rad23 complex have been identified, which provides scope for further 
research in this area to further examine and characterise the subset of DNA 
damage-responsive genes regulated by the Rad4-Rad23 complex, and 
implications of their regulation in the DNA damage response.
The participation of NER factors in the overall DNA damage response 
remains a fascinating and intriguing area of research. This continues to reveal 
the responses and adaptations cells undergo to cope with the threat of DNA 
damage, thus maintaining genomic integrity and promoting cell survival. The 
results presented in this thesis provide scope for further investigation in this 
area, regarding the role of the Rad4-Rad23 complex in DNA damage- 
responsive transcription, and as a result of this, regulation of cellular dNTP 
levels.
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Appendix I -  Growth Media, Solutions and Buffers 
Growth Media
All media listed require autoclave sterilisation for 20-30 minutes at 15 psi.
YNDB Minimal Medium (1L)
Yeast Nitrogen Base (without amino acids) -  7.2g 
Glucose -  20g
Bacto-Agar (for solid media) -  20g 
Appropriate Amino Acid Selection Mix -  0.85g 
H2 O to final volume
YPD Complex Medium (1000ml)
Yeast Extract -  10g 
Bacto-Peptone -  20g 
Glucose -  20g
Bacto-Agar (for solid media) -  20g 
H2O to final volume
Amino Acid Dry Mix -  (To Supplement 50L Minimal Media)
Argenine -  1g 
Methionine -  1g 
Tyrosine -  1.5g 
Isoleucine -  1.5g 
Lysine HCI -  1.5g 
Phenylalanine -  2.5g 
Glutamic Acid -  5g 
Aspartic Acid -  5g 
Valine -  7.5g 
Threonine -  10g 
Serine -  20g 
*Tryptophan -  4g 
*Leucine -  5g 
*Adenine -  1g 
*Uracil -  1g 
*Histidine -  3g
*Essential amino acids can be omitted to produce selective media 
Ensure Dry Mix is thoroughly mixed before use.
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Stock Solutions and Buffers
All stock solutions are sterilised by autoclave unless otherwise stated 
SDS-PAGE and Western Blotting
Yeast Dialysis Buffer (1L)
1M Hepes-KOH -  20ml 
0.5M EDTA- 20ml 
MgS04 -  1.2g 
Glycerol -  100ml 
H2O to final volume 
*DTT -  5ml
*Proteinase Inhibitors -  10ml
*Add immediately before use
10x TBST (1L)
1M Tris-Base (pH 8.0) -  100ml 
NaCI -  87.66g 
Tween 20 -  5mI 
H2O to final volume
10x SDS Running Buffer (1L)
Tris-Base -  30.3g 
Glycine -  144.2g 
SDS -  10g 
H2O to final volume
Adjust pH to 8.3
Western Transfer Buffer (2L)
Tris-Base -  6.06g 
Glycine -  22.6g 
SDS -  0.3g 
Methanol -  400ml 
H2O to final volume
Western Membrane Stripping Solution (100ml)
2-Mercaptoethanol -  694jnl 
SDS -  2g
1M Tris-HCI pH 6 .7-62.5m l 
H2O to final volume
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RNA Extraction and Northern Blotting
RNA Lysis Buffer (1L)
Tris-Base -1 .21 g 
0.5M EDTA -  20ml 
SDS -  5g
H2 O to final volume
10x FA Gel Buffer (500ml)
3-[N-Morpholinolpropanesulfonic acid (MOPS) -  20.9g 
3M NaAc -  8.2ml 
0.5M EDTA -  10ml 
RNase-free H20  to final volume 
Adjust pH to 7.0
20x SSC (1L)
NaCI -  175.3g 
Na Citrate.2H20  -  88.2g 
H20  to final volume
Adjust pH to 7.0
2x Binding and Washing (BW) Buffer (100ml)
NaCI -  11.6g 
1M Tris-HCI pH 8 .0 -  1 ml 
0.5M EDTA-0.2ml
Hybridisation Solution (250ml)
BSA -  2.5g
1M Phosphate Buffer -  125ml 
20% SDS -  87.5ml 
0.5M EDTA-0.5ml 
H20  to final volume
1M Phosphate Buffer
71g Na2HP04
(or 89g Na2 HP0 4 .2 H2 0  
or 134g Na2HP04.7 H20)
4ml 85% H3P04 
H20  to final volume
1M DTT (Dithiothreitol) (20ml)
Dissolve 3.09g DTT in 20ml 0.01 M Sodium Acetate (pH 5.2) 
Filter-sterilise (do not autoclave)
231
Chromatin Extraction
ChIP lysis Buffer (1L)
1M HEPES-KOH pH 7.5 -  50ml
5M NaCI -  28ml
0.5 EDTA-2m l
10% Triton X-100-100m l
5% Na-deoxycholate -  20ml
1mM PMSF, 1mM Benzamidine (100x stock)
10jLAg/ml Aprotinin, 1pg/ml Leupeptin (100x stock) 
1pg/ml Pepstatin (100x stock) -  10ml of each 
H2O to final volume
Other Stock Solutions and Buffers
Sodium Citrate Buffer (1L)
Na3Citrate -  12.9g
Adjust pH to 7.0
10x TE (100ml)
1M Tris-HCI pH 7 .5 -10m l 
0.5M EDTA pH 8.0-4 m l 
H20  to final volume
10x LiAc (100ml)
LiAc -  10.9g 
H20  to final volume
Adjust to pH 7.5
Phosphate-Buffered Saline (PBS) (1L)
NaCI -  8g 
KCI -  0.2g 
Na2HP04 -  1.44g
(or Na2HP04.2H20 -1 .8 g )  
H20  to final volume
Adjust pH to 7.4
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DNA Lysis Buffer (1L)
Urea -  240g 
NaCI - 1 1.7g 
EDTA -  5g 
SDS -  5g
H2 O to final volume
50x TAE (1L)
Tris Base-242g 
NaAc.3H20  -  136g 
0.5M EDTA-200ml 
H20  to final volume
Adjust pH to 7.2
0.5M EDTA (Ethylenediaminetetraacetic acid) (1L)
EDTA.Na2.2H20  -  186.7g 
H2O to final volume
Adjust pH to 8.0
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Appendix II -  UV Survival Data
Chapter 2 UV Survival (Figure 3.8)
—v,1 yw ' V 5'
•'" Strain * UV Dose (Jm”2) Count 2
'-X
Count 3. Mean\C6iint
Standard
Deviation % Survival’^
WT 0 271 292 279 280.7 10.6 100.0
10 222 269 245 245.3 23.5 87.4
20 165.5 158.5 187 170.3 14.9 60.7
30 85 73.6 97 85.2 11.7 30.4
40 49.8 51.4 45 48.7 3.3 17.4
80 32 35.1 33.1 33.4 1.6 11.9
abf1-1 0 265 222 245 244.0 21.5 100.0
10 236 204 204 214.7 18.5 88.0
20 122 130.5 124.5 125.7 4.4 51.6
30 52.4 67.4 79.4 66.4 13.5 27.2
40 14.9 15 16.7 15.5 1.0 6.4
80 1.9 2 2.1 2.0 0.1 0.8
abf1-1
sug2-1
0 238 245 240 241.0 3.6 100.0
10 186 175 168 176.3 9.1 73.2
20 112 107 100 106.3 6.0 44.1
30 58.4 52.6 60 57.0 3.9 23.7
40 22.7 20.5 19.2 20.8 1.8 8.6
80 1.7 1.5 1.3 1.5 0.2 0.6
Chapter 4 UV Survival (Figure 4.8)
.Media ,V;
* ' 1
UVDose .Count 1 . Count 2 ; Mean .Count; *
Standard
Deviation
*: % <: 
Survival
PBS 0 100.0 100.0 100.0 0.0 100.0
50 30.0 28.7 29.3 0.8 29.3
100 2.22 6.6 4.4 3.1 4.4
150 0.33 1.0 0.7 0.5 0.7
200 0.00 0.1 0.04 0.1 0.04
Minimal
Media
0 100.0 100.0 100.0 0.0 100.0
50 66.0 63.6 64.8 1.7 64.8
100 42.1 41.1 41.6 0.7 41.6
150 15.2 32.3 23.8 12.1 23.8
200 11.3 15.6 13.4 3.0 13.4
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Chapter 5 UV Survival (Figure 5.3, Figure 5.4 and 
Figure 5.5)
Strain
\;M"1'*\r\
UV Dose , 
(Jm’2) Count 1* ' X
Count 2 .
"
: Count 3 ' Mean Count
_
Standard
Deviation
\ A > ’> *
% x  
Survival
pRAD7 0 256 253 229 246.0 14.8 100.0
5 239 247 267 251.0 14.4 102.0
10 241 234 234 236.3 4.0 96.1
15 221 209 197 209.0 12.0 85.0
20 207 201 244 217.3 23.3 88.3
psocs 0 127 151 132 136.7 12.7 100.0
5 117 145 119 127.0 15.6 92.9
10 123 134 138 131.7 7.8 96.3
15 140 136 148 141.3 6.1 103.4
20 100 102 110 104.0 5.3 76.1
pRAD7 
Arad 23
0 172 158 148 159.3 12.1 100.0
5 70 62 74 68.7 6.1 43.1
10 12 13 9 11.3 2.1 7.1
15 2.05 3 1.98 2.3 0.6 1.5
20 0.989 0.102 0.754 0.6 0.5 0.4
psocs 
Arad 2 3
0 77 93 85 85.0 8.0 100.0
5 14.1 13 30.9 19.3 10.0 22.7
10 2.08 1.25 3.5 2.3 1.1 2.7
15 0.104 0.081 0.085 0.1 0.01 0.11
20 0.0122 0.0148 0.0094 0.0 0.00 0.01
pRAD7
Arad23
AsrnH
0 108 123 104 111.7 10.0 100.0
5 94 58 97 83.0 21.7 74.3
10 17 16 26 19.7 5.5 17.6
15 3.15 4.85 5.1 4.4 1.1 3.9
20 0.257 0.461 0.31 0.3 0.1 0.3
psocs 
Arad23 
Asm 11
0 99 153 104 118.7 29.8 100.0
5 78 74 60 70.7 9.5 59.6
10 3.07 11.1 5.79 6.7 4.1 5.6
15 2.87 1 2.12 2.0 0.9 1.7
20 0.241 0.29 0.44 0.3 0.1 0.3
pRAD7 0 305 278 295 292.7 13.7 100.0
Arad23 5 313 289 281 294.3 16.7 100.6
Acrtl 10 147 139 114 133.3 17.2 45.6
15 39 43 54 45.3 7.8 15.5
20 21 23 15 19.7 4.2 6.7
psocs 0 194 226 216 212.0 16.4 100.0
Arad23 5 131 140 160 143.7 14.8 67.8
Acrtl 10 88 63 84 78.3 13.4 36.9
15 16.2 28 25 23.1 6.1 10.9
20 3.81 8.54 3.3 5.2 2.9 2.5
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Appendix III -  Budding Index Analysis
To be viewed in conjunction with Chapter 0 Flow Cytometry Data
A3.1 pRAD7 (—*"“ ) & psocs ( " * " )  (No UV)
(Figure 6.6)
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A3.2 pRAD7 Arad23 ( - • “ ) & psocs Arad23 ( - * - )  (No UV)
(Figure 6.7)
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A3.3 pRAD7 & psocs ( " • " )  100Jm'2 UV
(Figure 6.8)
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A3.4 pRAD7Arad23(~*~) & p ( “ ■“ ) 20Jm 2 UV
(Figure 6.10)
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A3.5 pRAD7Arad23Asml1 (“ ♦“ ) & psocsArad23Asml1 ( " * “ ) (No UV)
(Figure 6.17)
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A3.6 pRAD7Arad23Acrt1 ( “ ♦“ ) & psocsArad23Acrt1 ( " * " )  (No UV)
(Figure 6.18)
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Appendix IV -  Gene Lists From Microarray Data
(See also electronic Appendix IV CD with full gene lists and .CEL files)
A4.1 rad4-rad23 Significantly Differentially Expressed Genes
(Figure 4.13)
Gene ORF Gene Symbol Arad4IWT(Fold-Change)
Arad23IWT (Fold- 
Change)
Arad4Arad23IWT
(Fold-Change)
YDR345C HXT3 0.02 -5.29 -7.47
YEL037C RAD23 0.11 -5.05 -5.79
YML123C P H 084 0.45 -0.03 -4.41
YAR071W P H 011 0.88 0.35 -1.61
YBR093C P H 0 5 0.67 0.09 -2.00
YJR105W A D 01 0.05 -0.02 -2.64
YAL003W EFB1 0.07 0.10 -2.47
YLR229C CDC42 -0.12 0.02 -2.20
YLR421C RPN13 -0.26 0.00 -1.98
YHR136C SPL2 0.40 0.06 -3.05
YER162C RAD4 -0.54 0.74 -1.64
YLR261C VPS63 0.11 0.24 -1.17
YJR072C NPA3 0.20 0.16 -1.09
YPL019C VTC3 0.14 0.15 -1.11
YLR420W URA4 0.19 0.18 -0.75
YJL193W YJL193W 0.18 0.22 -0.75
YJL131C YJL131C 0.22 0.13 -0.67
YJR003C YJR003C 0.25 0.11 -0.77
YER072W VTC1 0.12 0.01 -0.71
YJL012C VTC4 0.12 -0.02 -0.78
YBL054W YBL054W 0.11 -0.10 -0.73
YNR053C NOG2 0.01 -0.17 -0.78
YLR389C STE23 -0.07 -0.09 -0.75
YHR085W IP 11 -0.07 -0.23 -0.68
YLR451W LEU3 -0.04 -0.23 -0.66
YBR141C YBR141C -0.02 -0.11 -0.60
YLR096W KIN2 -0.11 0.07 -0.80
YLR166C SEC10 -0.08 0.07 -0.91
YNL141W AAH1 -0.18 -0.09 -0.67
YML116W ATR1 -0.14 0.08 -0.65
YOR287C YOR287C -0.12 0.01 -0.66
YLR291C GCD7 0.06 0.10 -1.69
YLR129W DIP2 -0.14 0.12 -1.47
YKL172W EBP2 0.00 0.06 -1.32
YKL143W LTV1 -0.09 0.14 -1.23
YLR325C RPL38 -0.10 0.05 -1.12
YJL096W MRPL49 0.00 0.00 -1.13
YJR104C SOD1 0.04 0.03 -1.18
YKL060C FBA1 -0.14 -0.08 -1.22
YKL207W YKL207W -0.11 -0.04 -1.25
YJL063C MRPL8 0.08 -0.18 -1.56
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Gene ORF Gene Symbol Arad4IWT(Fold-Change)
Arad23fWT (Fold- 
Change)
Arad4Arad23!WT
(Fold-Change)
YLR063W YLR063W -0.01 -0.18 -1.36
YPL263C KEL3 -0.33 0.10 -0.97
YJL062W LAS21 -0.08 -0.24 -1.03
YDR281C PHM 6 -0.15 -0.21 -1.17
YKR067W GPT2 -0.20 -0.06 -1.03
YLR357W RSC2 -0.18 -0.12 -1.04
YML086C A L01 -0.27 -0.14 -1.38
YKR099W BAS1 -0.24 -0.24 -1.28
YKL002W DID4 -0.31 -0.30 -1.24
YPL198W YPL198W -0.42 -0.08 -1.27
YFL014W HSP12 -0.48 -1.72 0.88
YML058W YML058W -0.18 -0.59 1.24
YKL163W PIR3 0.18 -0.11 1.28
YGR043C YGR043C 0.01 -0.22 1.31
YMR196W YM R196W -0.12 -0.27 1.06
YNL160W YGP1 -0.35 -0.37 0.67
YGL121C GPG1 -0.25 -0.32 0.70
YOR202W HIS3 -0.08 -0.30 0.60
YOR028C CIN5 -0.02 -0.23 0.65
YGR256W GND2 -0.13 -0.30 0.71
YJL116C NCA3 -0.47 -0.52 0.64
YOL053C DDR2 -0.59 -0.35 0.75
YIL066C RNR3 -0.17 -0.65 0.40
YPR160W GPH1 -0.73 -0.85 0.44
YER158C YER158C -0.25 -0.70 -0.11
YBR067C TIP1 -0.10 -0.69 -0.11
YJL079C PRY1 -0.31 -0.85 -0.06
YGR032W GSC2 -0.26 -0.69 0.08
YBR282W MRPL27 -0.46 -0.62 -0.14
YDL124W YDL124W -0.70 -0.21 0.14
YCR061W YCR061W -0.62 -0.42 -0.29
YIL162W SUC2 -0.65 -0.39 -0.19
YDR204W COQ4 -0.66 -0.41 -0.20
YPR129W SCD6 -0.71 -0.51 -0.26
YOR253W NAT5 -0.62 -0.33 -0.34
YFL031W HAC1 -0.75 -0.25 -0.38
YDL067C COX9 -0.76 -0.39 -0.39
YCL033C YCL033C -0.67 -0.28 -0.06
YDR007W TRP1 -0.65 -0.22 -0.14
YMR286W MRPL33 -0.61 -0.16 -0.26
YDL125C HNT1 -0.65 -0.17 -0.26
YDL219W DTD1 -0.64 -0.21 -0.25
YPR159W KRE6 -0.75 -0.44 -0.04
YOL058W ARG1 0.06 -1.64 -0.45
YBR072W HSP26 -0.41 -1.59 -0.09
YNL279W PRM1 -0.19 -1.16 -0.22
YBR040W FIG1 -0.16 -1.18 -0.39
YHR018C ARG4 -0.12 -1.06 -0.44
YHL028W WSC4 -0.20 -1.07 -0.46
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Gene ORF Gene Symbol Arad4IWT(Fold-Change)
Arad23tm  (Fold- 
Change)
Arad4Arad23IWT
(Fold-Change)
YJR109C CPA2 0.27 -0.60 -0.05
YCL025C AGP1 0.03 -0.68 -0.11
YER069W ARG5,6 0.11 -0.69 -0.16
YNR044W AGA1 0.10 -0.82 -0.22
YCR089W FIG2 0.06 -0.86 -0.26
YGL117W YGL117W 0.14 -0.73 -0.49
YIL123W SIM1 -0.88 -0.90 -0.75
YOR302W YOR302W -0.47 -0.99 -0.96
YJR147W HM S2 -0.32 -0.54 -0.90
YPL250C ICY2 -0.19 -0.87 -0.83
YAR066W YAR066W -0.15 -0.70 -0.75
YKR093W PTR2 -0.11 -0.60 -0.65
YAR068W YAR068W -0.06 -0.59 -0.69
YGR079W YGR079W -0.11 -0.57 -0.77
YKL029C MAE1 -0.01 -0.34 -0.60
YOR107W RGS2 0.00 -0.47 -0.62
YER056C YER056C -0.29 -0.21 -0.64
YJL078C PRY3 -0.36 -0.26 -0.63
YKL208W CBT1 -0.22 -0.21 -0.74
YOR316C COT1 -0.26 -0.17 -0.82
YLR032W RAD 5 -0.27 -0.26 -0.81
YCL036W GFD2 -0.33 -0.31 -0.84
YNR053C NOG2 -0.36 -0.27 -0.86
YBR267W RE 11 -0.29 -0.34 -0.79
YHR048W YHR048W -0.17 -0.37 -0.64
YHR070W TRM5 -0.36 -0.40 -0.72
YLR073C YLR073C -0.29 -0.42 -0.66
YER119C AVT6 -0.69 -0.65 -0.35
YCR065W HCM1 -0.60 -0.60 -0.33
YPL058C PDR12 -0.56 -0.62 -0.37
YPR034W ARP7 -0.75 -0.55 -0.50
YOR383C FIT3 -0.73 -0.60 -0.52
YLR136C TIS11 -0.67 -0.58 -0.48
YDL222C FMP45 -0.54 -0.82 -0.35
YBR247C ENP1 -0.44 -0.73 -0.56
YER175C TMT1 -0.44 -0.75 -0.42
YML047C PRM6 -0.26 -0.70 -0.39
YDR534C FIT1 -0.32 -0.62 -0.60
YBR157C ICS2 -0.33 -0.67 -0.50
YGL125W M E T 13 -0.39 -0.62 -0.54
YDL170W UGA3 -0.19 -0.69 -0.54
YIL015C YIL014C-A -0.20 -0.55 -0.60
YBL051C PIN4 -0.70 -0.40 -0.54
YFL031W HAC1 -0.64 -0.43 -0.64
YER125W RSP5 -0.63 -0.52 -0.62
YBR145W ADH5 -0.45 -0.49 -0.73
YNL190W YNL190W -0.51 -0.49 -0.71
YBR254C TRS20 -0.45 -0.31 -0.61
YBR105C VID24 -0.40 -0.36 -0.65
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Gene ORF Gene Symbol Arad4lWT(Fold-Change)
Arad23im  (Fold- 
Change)
Arad4Arad23IWT
(Fold-Change)
YDR075W PPH3 -0.52 -0.26 -0.65
YEL017C PM P2 -0.51 -0.37 -0.64
YOR204W DED1 -0.52 -0.32 -0.71
YHR143W YHR 143W -0.51 -0.36 -0.70
YOR315W YOR315W -0.63 -0.31 -0.69
YBR219C YBR219C -0.78 1.48 0.59
YCR021C HSP30 1.08 1.86 0.29
YJL188C BUD19 0.62 0.24 0.21
YKL022C CDC16 0.64 0.21 0.25
YKL025C PAN3 0.75 0.34 0.30
YKL024C URA6 0.74 0.30 -0.04
YMR011W HXT2 0.22 1.30 0.54
YMR081C ISF1 0.66 1.25 0.52
YER067W YER067W 0.73 1.06 -0.07
YMR316W DIA1 0.36 0.91 0.11
YHL036W MUP3 0.40 0.73 0.16
YOL014W YOL014W 0.54 0.98 0.24
YFL067W YFL067W 0.03 0.79 0.21
YBR056W YBR056W-A 0.17 0.74 0.17
YKR075C YKR075C 0.12 0.78 0.15
YJR158W YJR158W 0.23 0.68 0.28
YDR277C MTH1 0.20 0.75 0.31
YAR064W YAR064W 0.28 0.63 0.15
YOR268C YOR268C 0.14 0.60 0.16
YGR142W BTN2 0.73 1.20 1.68
YLR327C RBF9 0.32 1.17 1.56
YKL123W YKL123W 0.55 0.53 0.80
YJL144W YJL144W 0.35 0.67 0.84
YLR264C YLR264C-A 0.56 0.64 0.54
YDL021W GPM2 -0.06 -0.05 0.90
YPL223C GRE1 -0.15 -0.04 1.00
YGR070W R0M 1 0.03 0.15 0.95
YDR070C FMP16 -0.01 0.07 0.78
YMR175W SIP 18 -0.04 0.17 0.82
YMR169C ALD3 0.07 -0.08 0.78
YIL136W OM45 0.03 -0.03 0.64
YBR053C YBR053C 0.10 0.07 0.63
YGR130C YGR130C 0.08 0.06 0.63
YHR087W YHR087W 0.13 0.01 0.64
YER037W PHM8 0.27 0.07 0.63
YBR006W UGA2 0.29 0.14 0.77
YIL101C XBP1 0.15 0.12 0.81
YDR258C HSP78 0.40 0.30 0.64
YIL065C FIS1 0.22 0.23 0.61
YNR002C FUN34 0.25 0.24 0.61
YPL240C HSP82 0.17 0.28 0.66
YGR146C YGR146C 0.21 0.29 0.68
YOR120W GCY1 0.26 0.36 1.11
YKL093W MBR1 0.21 0.34 0.79
242
Gene ORF Gene Symbol Arad4IW T(Fold-Change)
A rad 23W T  (Fold- 
Change)
Arad4Arad23IW T
(Fold-Change)
YLR108C YLR108C 0.18 0.29 0.94
YHL048W COS8 0.11 0.58 0.87
YDR171W HSP42 0.10 0.47 0.79
YHR092C HXT4 0.13 0.65 0.70
YHR054C YHR054C 0.23 0.49 0.64
YDR216W ADR1 -0.15 0.40 0.81
YGR243W FMP43 -0.07 0.63 0.57
YDR342C HXT7 -0.07 0.60 0.69
YHL048W COS8 -0.08 0.46 0.60
YDR034W YDR034W-B 0.01 0.38 0.65
YDL020C RPN4 0.07 0.28 0.71
YDR018C YDR018C 0.00 0.20 0.71
YLL039C UBI4 -0.16 0.22 0.63
YBR183W YPC1 -0.05 0.21 0.61
YDR343C YDR343C -0.05 0.99 0.94
YGL263W COS12 0.15 0.70 1.57
YPR158W YPR158W -0.12 0.41 1.26
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A4.3 psocs-rad23 Significantly Differentially Expressed Genes
(Figure 4.17)
Gene ORF GeneSymbol
psocs un 
fpRAD7 un 
(Fold-Change)
pRAD7Arad23 un 
lpRAD7 un 
(Fold-Change)
psocsArad23 un 
lpRAD7 un 
(Fold-Change)
YEL021W UR A3 - 0.13 4.33 4.10
YEL037C RAD23 - 0.26 - 4.67 - 5.00
YJL153C IN 01 0.25 - 3.24 - 3.10
YOL154W ZPS1 0.14 - 2.99 - 1.67
YJR052W RAD7 - 3.00 - 0.75 - 3.15
YGL258W YGL258W 0.26 - 1.76 - 1.84
YHL016C DUR3 - 0.05 - 1.51 - 1.49
YGL125W M ET13 0.10 - 1.74 - 1.23
YCL025C AGP1 0.03 - 1.75 - 1.31
YGL258W YGL258W 0.38 - 1.55 - 1.55
YOR387C YOR387C 0.30 - 1.51 - 1.47
YDR502C SAM2 0.29 - 2.15 - 0.95
YEL073C YEL073C - 0.21 - 1.74 - 0.85
YBR177C EHT1 - 0.15 - 1.67 - 0.63
YDR497C ITR1 - 0.27 - 1.50 - 0.59
YBR145W ADH5 - 0.21 - 1.41 - 0.72
YJR073C OPI3 0.26 - 1.52 - 0.93
YJL052W TDH1 - 0.01 - 1.12 - 0.86
YJL048C UBX6 0.04 - 1.09 - 0.74
YFL021W GAT1 - 0.08 - 1.30 - 0.81
YER091C MET6 0.03 - 1.22 - 0.74
YNL169C PSD1 0.21 - 1.19 - 0.61
YDL039C PRM 7 - 0.66 - 0.52 - 1.38
YDL038C YDL038C - 0.57 - 0.65 - 1.27
YDL037C BSC1 - 0.54 - 1.25 - 1.19
YGR032W GSC2 - 0.10 - 0.65 - 1.25
YBR105C VID24 - 0.17 - 0.77 - 1.15
YBL042C FUI1 - 0.03 - 0.79 - 1.33
YJL088W ARG3 - 0.36 - 1.00 - 0.84
YHL045W YHL045W - 0.35 - 1.00 - 0.85
YLR237W THI7 - 0.34 - 0.63 - 0.81
YER081W SER3 - 0.31 - 0.78 - 0.91
YKR039W GAP1 - 0.14 - 1.01 - 0.86
YER069W ARG5,6 - 0.10 - 1.09 - 1.04
YPR194C OPT2 - 0.09 - 0.91 - 1.07
YPL277C YO R389W - 0.09 - 0.98 - 0.97
YER073W ALD5 - 0.05 - 0.79 - 0.91
YOR107W RGS2 - 0.14 - 0.81 - 0.84
YGL117W YG L117W 0.05 - 1.33 - 1.19
YGL256W ADH4 0.20 - 1.30 - 1.32
YKL216W URA1 0.02 - 1.10 - 1.28
YOL126C MDH2 - 0.04 - 0.99 ^  - 1.35
YLL053C YLL053C - 0.15 - 1.08 - 1.14
YLL052C AQY2 - 0.13 - 1.09 - 1.19
YOR338W YO R338W - 0.23 - 1.14 - 1.23
YNL142W MEP2 - 0.28 - 1.21 - 1.08
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Gene ORF GeneSymbol
psocs  un 
lpR A D 7  un 
(Fold-Change)
pRAD7Arad23 un 
lpR AD7  un 
(Fold-Change)
psocsArad23 un 
ipR AD7  un 
(Fold-Change)
YER088C DOT6 0.15 -0.40 -0.73
YPL177C CUP9 0.15 -0.47 -0.81
YHR044C DOG1 -0.16 -0.06 -0.76
YNL065W AQR1 0.02 -0.14 -0.61
YKL043W PHD1 -0.41 -0.44 -0.60
YHR049W FSH1 -0.35 -0.52 -0.62
YBR114W RAD16 -0.34 -0.62 -0.55
YPR065W ROX1 -0.23 -0.61 -0.51
YOR306C MCH5 -0.20 -0.53 -0.75
YIL119C RPI1 -0.04 -0.57 -0.68
YOR203W YOR203W -0.04 -0.52 -0.69
YGR108W CLB1 -0.09 -0.45 -0.68
YOL140W ARG8 -0.16 -0.49 -0.61
YNL141W AAH1 -0.19 -0.44 -0.62
YJL056C ZAP1 0.46 -0.64 -0.35
YGR055W MUP1 -0.06 -1.35 -0.31
YGR157W C H 02 0.19 -1.15 -0.22
YHR123W EPT1 0.03 -1.15 -0.19
YGL077C HNM1 -0.05 -1.14 -0.31
YER026C CH01 -0.22 -1.09 -0.40
YPR158W YPR158W -0.24 -0.99 -0.25
YHR123W EPT1 0.02 -0.96 -0.40
YGR254W EN01 -0.02 -0.93 -0.33
YOR375C GDH1 -0.02 -0.87 -0.37
YLR133W CKI1 0.17 -0.95 -0.42
YLR303W MET17 0.10 -0.87 -0.40
YHR067W YHR067W 0.12 -0.84 -0.42
YOR383C FIT3 0.11 -0.83 -0.37
YGR161C RTS 3 -0.03 -0.60 -0.46
YPL264C YPL264C -0.03 -0.61 -0.39
YIR017C MET28 0.04 -0.73 -0.43
YHR094C HXT1 -0.04 -0.72 -0.49
YHL020C OPI1 -0.01 -0.67 -0.47
YOR344C TYE7 0.00 -0.69 -0.51
YLR132C YLR132C 0.23 -0.70 -0.43
YJR008W YJR008W 0.21 -0.72 -0.41
YGL255W ZRT1 0.14 -0.66 -0.45
YBR256C RIB 5 0.12 -0.61 -0.57
YDL198C YDL198C 0.08 -0.61 -0.50
YKL120W OAC1 0.10 -0.63 -0.51
YOL108C IN 04 0.08 -0.64 -0.51
YBR029C CDS1 0.11 -0.72 -0.55
YOR130C ORT1 0.09 -0.67 -0.54
YPR167C MET16 0.10 -0.70 -0.59
YNL104C LEU4 0.12 -0.72 -0.62
YHL040C ARN1 -0.15 -0.83 -0.64
YGR121C MEP1 -0.15 -0.88 -0.52
YOR302W YOR302W -0.10 -0.84 -0.55
YPR138C MEP3 -0.05 -0.75 -0.58
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Gene ORF GeneSymbol
psocs  un 
lpR A D 7  un 
(Fold-Change)
pRAD7Arad23  un 
lpR AD7  un 
(Fold-Change)
psocsArad23 un 
!pRAD7  un 
(Fold-Change)
YGR281W YOR1 -0.08 -0.78 -0.61
YOL058W ARG1 -0.09 -0.79 -0.58
YNL044W YIP3 -0.13 -0.66 -0.63
YOLO59W GPD2 -0.14 -0.64 -0.59
YGR224W AZR1 0.01 -0.64 -0.57
YPR145W ASN1 -0.02 -0.63 -0.55
YOR389W YOR389W -0.04 -0.62 -0.57
YOR202W HIS3 0.01 -0.63 -0.65
YNL129W NRK1 -0.03 -0.65 -0.61
YLR168C YLR168C 0.16 -0.67 -0.75
YJR109C CPA2 0.16 -0.83 -0.77
YER175C TMT1 0.11 -0.90 -0.73
YPL058C PDR12 0.24 -0.84 -0.68
YOL119C MCH4 -0.01 -0.74 -0.77
YOL143C RIB4 -0.06 -0.84 -0.76
YHL022C S P 011 0.07 -0.82 -0.71
YHR071W PCL5 0.02 -0.80 -0.66
YMR246W FAA4 0.00 -0.77 -0.69
YDR123C IN 02 0.12 -0.82 -0.56
YHR018C ARG4 0.04 -0.83 -0.61
YMR062C ECM40 0.05 -0.88 -0.62
YKL158W APE2 0.08 -0.61 0.12
YBR147W YBR147W -0.21 -0.61 0.06
YER056C YER056C -0.31 -0.62 -0.35
YER086W ILV1 -0.27 -0.69 -0.23
YER057C HMF1 -0.37 -0.60 -0.19
YDR499W LCD1 -0.14 -0.61 -0.30
YKL182W FAS1 0.01 -0.68 -0.23
YER185W YER185W -0.05 -0.60 -0.20
YPL231W FAS2 0.00 -0.62 -0.14
YGL184C STR3 0.12 -0.64 -0.26
YJR133W XPT1 0.02 -0.65 -0.36
YMR006C PLB2 0.04 -0.62 -0.29
YIL144W TID3 -0.69 0.07 -0.02
YHR063W YHR063W -0.72 0.05 -0.01
YHR183W GND1 -0.78 0.13 0.23
YDR171W HSP42 -0.52 -0.08 0.65
YDR432W NPL3 -0.64 -1.02 0.14
YDL060W TSR1 -0.80 -0.40 -0.01
YDR075W PPH3 -0.48 -0.68 -0.31
YDR006C SOK1 -0.49 -0.68 -0.25
YDR007W TRP1 -0.58 -0.77 -0.25
YDR238C SEC26 -0.61 -0.67 0.09
YDR172W SUP35 -0.67 -0.54 0.04
YDR399W HPT1 -0.51 -0.62 -0.06
YDL092W SRP14 -0.47 -0.73 -0.02
YDR533C HSP31 -0.51 -0.72 -0.12
YDL155W CLB3 -0.50 -0.72 -0.09
YDR139C RUB1 -0.41 -0.60 0.04
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Gene ORF GeneSymbol
psocs  un 
lpR A D 7  un 
(Fold-Change)
pRAD7Arad23 un 
lpR AD7  un 
(Fold-Change)
psocsArad23 un 
/p R A D 7 un 
(Fold-Change)
YDR333C YDR333C -0.49 -0.63 0.03
YCR077C PAT1 -0.45 -0.61 -0.01
YFL031W HAC1 0.64 0.24 0.19
YKL206C YKL206C 0.31 0.22 -0.64
YGL205W POX1 -0.11 0.70 -0.01
YLR214W FRE1 0.08 1.12 1.03
YHR137W A R 09 0.00 1.28 1.06
YER011W TIR1 -0.04 1.21 0.98
YGL263W COS 12 0.02 1.48 0.87
YDR342C HXT7 -0.03 1.40 1.11
YDR343C YDR343C 0.02 1.54 1.11
YGL037C PNC1 -0.02 1.28 1.30
YFR053C HXK1 -0.05 1.42 1.38
YDR380W ARO10 0.00 1.73 1.42
YMR011W HXT2 -0.19 1.64 1.28
YDR305C HNT2 0.31 0.17 0.69
YCR061W YCR061W 0.08 0.42 0.85
YJL164C TPK1 -0.05 0.36 0.89
YPR160W GPH1 -0.04 0.46 0.87
YPR002W PDH1 -0.15 0.47 0.98
YGR248W S0L4 -0.09 0.42 0.62
YLR149C YLR149C -0.11 0.65 0.72
YER142C MAG1 -0.11 0.63 0.72
YGL047W ALG13 -0.10 0.55 0.63
YEL011W GLC3 -0.15 0.60 0.62
YKR011C YKR011C -0.07 0.52 0.76
YPL240C HSP82 -0.20 0.52 0.72
YDR111C ALT2 0.07 0.57 0.61
YBR183W YPC1 0.05 0.63 0.60
YKL121W YKL121W -0.04 0.61 0.55
YER044C YER044C 0.00 0.60 0.56
YDR358W GGA1 -0.05 0.56 0.62
YOL053C DDR2 -0.03 0.54 0.64
YJL217W YJL217W -0.03 0.59 0.64
YGR008C STF2 -0.03 0.62 0.65
YOL048C YOL048C -0.05 0.62 0.67
YJL212C OPT1 0.11 0.31 0.76
YJL196C EL01 0.16 0.30 0.61
YJL163C YJL163C 0.08 0.32 0.62
YCR061W YCR061W 0.06 0.27 0.64
YNL037C IDH1 0.07 0.27 0.62
YLR270W DCS1 0.18 0.47 0.72
YLR218C YLR218C 0.01 0.39 0.63
YLR258W GSY2 0.08 0.41 0.66
YEL039C CYC7 0.09 0.37 0.69
YKL195W YKL195W 0.10 0.48 0.65
YDL022W GPD1 0.07 0.47 0.62
YLR304C A C 01 0.05 0.52 0.70
YGL104C VPS73 0.02 0.45 0.73
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Gene ORF GeneSymbol
psocs  un 
lpR A D 7  un 
(Fold-Change)
pRAD7Arad23  un 
IpR AD7  un 
(Fold-Change)
psocsArad23  un 
lpRAD7  un 
(Fold-Change)
YMR250W GAD1 0.03 0.49 0.76
YOR374W ALD4 -0.24 0.22 0.65
YDL214C PRR2 -0.02 0.18 0.62
YIL155C GUT2 -0.04 0.30 0.64
YGL010W YGL010W -0.05 0.25 0.70
YMR105C PGM 2 -0.13 0.22 0.70
YHR087W YHR 087W -0.27 0.73 0.74
YPL061W ALD6 -0.45 0.88 0.87
YKL096W YKL096W -0.08 1.01 1.29
YCL042W GLK1 -0.13 0.77 1.39
YCL040W GLK1 -0.19 0.87 1.08
YLL026W HSP104 0.07 0.96 1.02
YDL241W YDL241W 0.09 0.93 0.93
YNR001C c m 0.08 0.89 0.91
YML100W TSL1 0.07 0.83 1.03
YLR267W B 0P 2 -0.03 0.90 1.00
YML128C MSC1 -0.05 0.81 1.06
YKL163W PIR3 0.17 1.12 0.80
YIR043C YIR043C 0.39 1.14 0.82
YGR109C CLB6 0.00 1.09 0.53
YBR040W FIG1 0.01 1.14 0.59
YJR048W CYC1 0.26 0.64 0.92
YOR027W STI1 0.39 0.81 0.94
YLR202C YLR202C 0.23 0.69 0.55
YHL048W C 0S 8 0.25 0.66 0.54
YDR435C PPM1 0.24 0.60 0.56
YKL151C YKL151C 0.17 0.59 0.67
YBR126C TPS1 0.06 0.62 0.71
YBR056W YBR056W 0.10 0.61 0.69
YOR298C MBF1 0.23 0.62 0.71
YOR292C YOR292C 0.28 0.62 0.67
YKR077W YKR077W 0.20 0.79 0.55
YCL061C MRC1 0.17 0.77 0.45
YBR302C C 0S 2 0.12 0.77 0.42
YBR073W RDH54 0.11 0.71 0.38
YOR074C CDC21 0.10 0.73 0.40
YHL035C VMR1 0.20 0.70 0.43
YBR071W YBR071W 0.23 0.68 0.48
YLR130C ZRT2 0.23 0.68 0.35
YDR055W PST1 0.28 0.70 0.37
YNL102W P0L1 0.20 0.74 0.38
YLL039C UBI4 0.00 0.75 0.89
YKL067W YNK1 0.11 0.67 0.83
YHR138C YHR138C -0.04 0.66 0.73
YHL030W ECM29 -0.03 0.70 0.71
YDR516C EMI2 0.02 0.67 0.75
YLR216C CPR6 0.04 0.74 0.76
YJL218W YJL218W -0.01 0.76 0.72
YER067W YER067W -0.01 0.73 0.80
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Gene ORF GeneSymbol
psocsun 
lpRAD7 un 
(Fold-Change)
pRAD7Arad23 un 
lpRAD7 un 
(Fold-Change)
psocsArad23 un 
tpRAD7 un 
(Fold-Change)
YDL130W YDL130W -0.04 0.74 0.79
YDR070C FMP16 -0.14 0.76 0.85
YBL064C PRX1 -0.07 0.81 0.72
YOL014W YOL014W -0.08 0.77 0.77
YOL158C ENB1 -0.04 0.83 0.81
YLR297W YLR297W 0.15 0.86 0.66
YAR007C RFA1 0.13 0.83 0.67
YKR091W SRL3 0.20 0.75 0.70
YBR149W ARA1 0.17 0.79 0.74
YDL018C ERP3 0.15 0.71 0.76
YDL169C UGX2 0.14 0.68 0.70
YPR026W ATH1 0.17 0.67 0.71
YNL115C YNL115C 0.12 0.68 0.67
YOL122C SMF1 0.16 0.95 0.77
YCL064C CHA1 0.08 0.80 0.75
YPL014W YPL014W 0.07 0.86 0.77
YMR145C NDE1 0.09 0.82 0.83
YHR140W YHR140W -0.03 0.84 0.50
YCL024W KCC4 0.07 0.89 0.46
YER015W FAA2 0.02 0.89 0.48
YKL109W HAP 4 0.03 0.91 0.59
YHR092C HXT4 0.05 0.90 0.54
YMR179W SPT21 0.08 0.87 0.54
YLR284C ECU -0.01 0.83 0.66
YGR243W FMP43 -0.04 0.86 0.59
YPR184W GDB1 -0.09 0.74 0.62
YLR056W ERG3 0.00 0.77 0.62
YML075C HMG1 0.03 0.73 0.67
YKL142W MRP8 0.29 0.73 0.26
YJL192C SOP4 0.28 0.75 0.13
YBL035C POL12 0.14 0.64 0.31
YDL110C YDL110C -0.09 0.62 0.46
YCR021C HSP30 -0.18 0.61 0.46
YOR195W SLK19 -0.09 0.63 0.28
YER070W RNR1 -0.03 0.60 0.26
YDL003W MCD1 -0.04 0.62 0.26
YDR097C MSH6 -0.04 0.65 0.29
YOR144C ELG1 -0.02 0.62 0.32
YDL164C CDC9 -0.10 0.67 0.39
YOR074C CDC21 -0.03 0.63 0.37
YOL123W HRP1 -0.06 0.63 0.34
YIL160C P 0T1 -0.02 0.74 0.25
YMR199W CLN1 0.01 0.66 0.25
YOL090W MSH2 0.01 0.70 0.38
YFL062W COS4 0.04 0.67 0.31
YNL202W SPS19 0.03 0.67 0.36
YNL336W YNL336W 0.03 0.64 0.37
YMR101C SRT1 0.03 0.63 0.34
YPR120C CLB5 0.05 0.70 0.35
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Gene ORF GeneSymbol
psocs un 
!pRAD7 un 
(Fold-Change)
pRAD7Arad23 un 
lpRAD7 un 
(Fold-Change)
psocsArad23 un 
lpRAD7 un 
(Fold-Change)
YPL153C RAD53 0.07 0.72 0.31
YMR076C PDS5 0.04 0.75 0.29
YER096W SHC1 -0.08 0.75 0.39
YLR103C CDC45 0.00 0.80 0.42
YBR070C ALG14 -0.01 0.76 0.45
YNL082W PMS1 0.03 0.62 0.44
YML059C NTE1 -0.01 0.65 0.42
YDR144C MKC7 0.01 0.71 0.53
YNL312W RFA2 0.03 0.69 0.55
YBR041W FAT1 0.01 0.70 0.55
YMR119W ASI1 0.01 0.69 0.54
YLR183C TOS4 0.05 0.72 0.47
YML132W YML132W 0.08 0.72 0.51
YNL280C ERG24 0.02 0.68 0.47
YLR454W FMP27 0.06 0.66 0.46
250
A4.4 Significantly Differentially Expressed Genes in Response to UV, ONLY in psocs Arad23 Strain
(Figure 4.20 and Figure 4.21)
fc fc fc fc
pRAD760 psocs 60 pRAD7Arad23 60 psocsArad23 60
lpRAD7 un Ipsocs un lpRAD7Arad23 un lpsocsArad23 un
-0.17 0.01 0.01 0.48
0.29 0.12 -0.09 -0.32
0.55 0.45 0.67 -0.10
3.26 3.38 2.78 3.53
3.26 3.37 2.89 3.64
1.17 1.14 0.00 0.03
-0.30 -0.33 0.01 0.31
0.29 0.15 -0.17 -0.33
0.29 -0.04 -0.29 -0.48
-0.29 -0.33 0.18 0.38
-0.23 -0.24 -0.67 -0.90
0.60 0.53 0.35 -0.11
0.03 -0.07 -0.05 -0.59
-0.11 0.03 0.31 0.69
0.48 0.63 1.01 1.16
-0.02 0.09 0.00 -0.77
0.00 -0.24 -0.39 -0.63
-1.28 -1.29 -0.94 -1.45
1.31 1.30 1.71 1.97
0.73 1.10 1.06 1.78
-0.10 -0.07 0.35 0.72
-0.45 -0.65 -0.47 -1.39
1.22 1.17 0.86 1.83
1.22 1.11 1.18 2.01
-1.01 -1.09 -1.46 -0.66
1.84 1.79 0.55 0.50
fc fc fc fc
pRAD7 15 psocs15 pRAD7Arad2315 psocsArad2315
lpRAD7 un Ipsocs un lpRAD7Arad23 un lpsocsArad23 un
-0.08 0.20 0.10 0.14
-0.40 -0.41 -0.42 -0.54
-0.28 -0.23 -0.17 -0.56
2.14 2.21 1.61 1.48
2.23 2.22 1.68 1.62
0.45 0.51 0.03 -0.19
0.19 -0.04 0.00 0.44
-0.08 -0.03 0.09 -0.05
-0.23 -0.13 -0.22 -0.30
0.40 0.15 0.24 0.66
-0.39 -0.26 -0.26 -0.38
0.07 0.01 0.17 -0.14
-0.14 0.09 -0.19 0.01
0.25 0.17 0.10 0.58
0.31 0.32 0.18 0.29
-0.30 -0.21 -0.17 -0.38
0.01 0.06 -0.03 -0.04
-1.32 -1.26 -0.79 -0.66
0.55 0.40 0.61 0.71
0.65 0.87 0.33 0.80
0.00 -0.09 -0.10 0.61
-0.71 -0.69 -0.22 -0.90
0.62 0.38 0.25 0.97
0.60 0.17 0.37 1.31
-0.38 -0.47 -0.40 0.26
0.28 0.16 -0.28 -0.39
Probe ID Gene ORF GeneSymbol
fc
psocs un 
lpRAD7 un
fc
pRAD7Arad23 un 
lpRAD7 un
fc
psocsArad23 un 
lpRAD7 un
5724 at YEL021W URA3 -0.18 0.29 0.08
5753 at YEL037C RAD23 0.08 0.17 0.18
11185 at YJL153C IN01 0.05 0.14 0.29
8726 at YOL154W ZPS1 -0.06 0.15 0.08
10981 at YJR052W RAD7 -0.04 0.13 0.09
5255 s at YGL258W YGL258W 0.01 0.39 0.63
4546 at YHL016C DUR3 0.19 0.18 -0.26
5117 at YGL125W MET13 0.11 0.07 0.27
6907 at YCL025C AGP1 0.00 0.77 0.62
5254 i at YGL258W YGL258W 0.19 0.39 -0.06
00 £ l“* CD YOR387C YOR387C -0.13 0.04 0.22
5971 at YDR502C SAM2 0.06 -0.15 0.20
5811 at YEL073C YEL073C -0.01 0.05 0.23
7179 at YBR177C EHT1 0.08 0.18 -0.21
5966 at YDR497C ITR1 -0.05 -0.23 -0.24
7236 at YBR145W ADH5 0.02 -0.37 -0.14
10957 at YJR073C OPI3 0.07 0.21 0.23
11060 at YJL052W TDH1 0.14 -0.30 -0.51
11065 at YJL048C UBX6 0.03 0.04 0.00
5409 at YFL021W GAT1 -0.17 0.05 -0.39
5620 at YER091C MET6 0.14 0.38 -0.31
9044 at YNL169C PSD1 0.08 -0.61 0.12
6513 at YDL039C PRM7 0.22 0.54 -0.14
6514 at YDL038C YDL038C 0.31 0.22 -0.64
6515 at YDL037C BSC1 0.08 0.40 -0.38
4959 at YGR032W GSC2 0.10 0.48 0.65
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fc fc fc fc
pRAD760 psocs 60 pRAD7Arad23 60 psocsArad23 60
lpRAD7 un Ipsocs un lpRAD7Arad23 un lpsocsArad23 un
0.78 0.69 0.29 0.11
-1.52 -1.77 -2.06 -2.13
-0.33 -0.44 -0.67 -0.98
-0.08 0.06 2.01 1.02
0.54 0.32 0.20 -0.15
1.22 0.97 0.76 0.54
-0.10 0.04 1.91 0.90
0.42 0.24 -0.58 0.37
0.53 -0.03 0.07 -0.72
0.57 0.34 0.21 -0.32
1.70 1.59 1.37 0.96
1.69 1.64 1.46 0.87
1.36 1.36 0.97 0.68
0.87 0.82 0.36 0.19
-0.39 -0.46 -0.43 0.23
0.02 -0.25 -0.35 -0.73
-0.84 -1.08 -1.30 -1.53
-0.31 -0.34 -0.64 -0.07
-0.44 -0.36 -0.84 -1.11
-0.20 -0.20 -0.60 -0.92
-0.02 -0.19 -0.10 -0.65
0.13 -0.12 -0.47 -0.54
2.46 2.46 1.95 1.79
0.32 0.22 -0.24 -0.49
0.79 0.59 0.74 0.13
-0.41 -0.73 -0.52 -1.60
0.45 0.45 0.07 -0.27
-0.02 -0.12 0.15 -0.81
-0.21 -0.21 0.25 -1.05
1.64 1.71 1.24 0.93
fc fc fc fc
pRAD7 15 psocs15 pRAD7Arad23 15 psocsArad23 15
lpRAD7 un Ipsocs un lpRAD7Arad23 un lpsocsArad23 un
0.00 0.02 -0.13 -0.08
-0.75 -0.60 -0.40 -0.63
-0.64 -0.51 -0.21 -0.44
0.95 0.95 0.58 0.34
-0.45 -0.43 -0.41 -0.79
0.40 0.29 0.15 -0.13
0.46 0.16 0.70 1.12
0.08 -0.05 -0.04 0.88
-0.50 -0.42 -0.25 -0.35
0.06 0.08 0.26 0.03
0.27 0.22 0.51 0.24
0.61 0.40 0.74 0.26
0.24 0.33 0.39 0.17
0.30 0.34 0.54 0.31
0.02 -0.15 -0.05 0.28
-0.07 0.01 -0.08 -0.19
-0.17 -0.14 0.34 -0.05
-0.28 -0.26 -0.43 0.46
-0.77 -0.65 -0.65 -0.91
-0.35 -0.35 -0.24 -0.47
-0.07 0.04 0.20 -0.06
-0.12 -0.17 0.11 -0.10
1.48 1.29 1.06 0.90
-0.69 -0.55 -0.73 -0.85
0.31 0.25 0.44 0.15
-0.70 -0.74 -0.70 -0.86
-0.13 -0.08 0.04 -0.14
-0.43 -0.36 -0.12 -0.61
-0.29 -0.24 -0.09 -0.41
0.71 0.94 0.40 0.06
Probe ID Gene ORF GeneSymbol
fc
psocs un 
lpRAD7 un
fc
pRAD7Arad23 un 
lpRAD7 un
fc
psocsArad23 un 
lpRAD7 un
7241 at YBR105C VID24 0.07 0.27 0.37
7410 at YBL042C FUI1 0.06 -0.09 0.07
11114 at YJL088W ARG3 0.06 -0.44 0.05
3193 at YHL045W YHL045W -0.18 -0.16 0.11
10085 at YLR237W THI7 0.07 -0.14 0.25
5654 at YER081W SER3 0.09 -0.25 0.09
10511 at YKR039W GAP1 0.26 -1.52 -0.93
5642 at YER069W ARG5.6 0.15 0.38 -0.32
7546 at YPR194C OPT2 -3.00 -0.75 -3.15
8019 s at YPL277C YOR389W 0.03 0.08 0.34
5646 at YER073W ALD5 0.03 -0.05 0.36
8444 at YOR107W RGS2 0.09 -0.31 0.28
5125 at YGL117W YGL117W -0.01 -0.01 0.32
5257 at YGL256W ADH4 0.02 0.05 0.35
10796 at YKL216W URA1 0.12 -0.11 -0.29
8663 at YOL126C MDH2 0.05 0.37 0.39
10377 at YLL053C YLL053C -0.02 -0.23 0.05
10378 at YLL052C AQY2 0.09 0.25 -0.39
8228 at YOR338W YOR338W 0.02 -0.09 0.08
9026 at YNL142W MEP2 0.15 -0.51 -0.12
5617 at YER088C DOT6 -0.09 0.01 0.25
7938 at YPL177C CUP9 0.09 -0.14 0.05
4473 i at YHR044C DOG1 0.08 0.32 0.62
8923 at YNL065W AQR1 0.02 0.06 0.29
10609 at YKL043W PHD1 0.16 0.30 0.61
4478 at YHR049W FSH1 0.11 0.31 0.76
7250 at YBR114W RAD16 -0.03 -0.07 0.04
7685 at YPR065W ROX1 0.11 -0.41 0.09
8241 at YOR306C MCH5 0.07 -0.21 0.28
4192 at YIL119C RPI1 -0.10 0.27 0.57
252
fc
pRAD760 
lpRAD7 un
fc
psocs 60 
Ipsocs un
fc
pRAD7Arad23 60 
lpRAD7Arad23 un
fc
psocsArad23 60 
lpsocsArad23 un
1.65 1.69 1.22 0.98
1.06 1.02 1.28 0.44
0.22 0.18 -0.20 -0.73
0.79 0.60 0.34 0.17
-0.41 -0.55 -0.89 -1.25
0.10 -0.05 -0.10 -0.77
0.01 -0.20 -0.05 -0.64
0.85 0.69 0.36 -0.73
-0.06 0.12 0.42 0.54
0.74 0.69 0.28 0.03
-0.39 -0.61 -0.61 -1.40
-0.28 -0.39 -0.06 -1.04
-0.29 -0.27 -0.66 -1.24
-0.04 -0.17 0.03 -0.65
2.42 2.60 2.15 3.12
-0.60 -0.51 -0.16 0.02
1.35 1.42 1.77 2.00
-1.02 -0.77 -0.66 -0.31
0.71 0.83 0.31 0.08
2.75 2.90 1.92 2.12
0.89 0.99 1.48 1.54
2.11 2.19 2.06 2.81
1.06 1.15 0.57 0.41
-0.37 -0.12 -0.02 0.25
-0.04 0.20 0.47 0.57
0.42 0.66 0.93 1.05
-0.86 -0.80 -1.35 -1.46
-0.76 -0.83 -0.17 -0.12
0.04 0.20 0.36 0.80
1.70 1.94 -2.12 -0.45
fc fc fc fc
pRAD715 psocs15 pRAD7Arad23 15 psocsArad2315
lpRAD7 un Ipsocs un lpRAD7Arad23 un lpsocsArad23 un
0.73 0.90 0.36 0.10
0.41 0.31 0.55 0.03
-0.73 -0.60 -0.53 -0.84
0.20 0.13 0.27 0.19
-0.66 -0.70 -0.68 -0.72
-0.36 -0.33 0.03 -0.60
-0.12 -0.27 0.10 -0.23
-0.40 -0.58 -0.11 -0.49
0.16 0.21 0.24 0.35
0.05 -0.08 0.04 0.15
-0.64 -0.72 -0.31 -0.75
-0.82 -0.72 -0.25 -0.99
-0.51 -0.50 -0.12 -0.72
-0.57 -0.60 -0.39 -0.68
0.91 0.90 1.01 0.93
-0.66 -0.75 -0.86 -0.70
1.23 0.97 0.87 1.06
-0.11 -0.05 -0.42 -0.16
0.53 0.47 0.56 0.51
1.27 0.82 0.83 0.53
0.44 0.33 0.40 0.50
0.65 0.68 0.54 0.75
0.21 0.14 -0.08 -0.07
-0.07 0.16 0.16 -0.02
0.14 0.30 0.31 0.31
-0.04 0.04 0.06 -0.01
-1.03 -0.90 -0.67 -1.06
0.10 0.00 0.08 0.12
0.21 0.28 0.40 0.76
-0.64 0.11 -0.32 0.12
Probe ID Gene ORF GeneSymbol
fc
psocs un 
lpRAD7 un
fc
pRAD7Arad23 un 
lpRAD7 un
fc
psocsArad23 un 
lpRAD7 un
8360 at YOR203W YOR203W -0.03 0.34 0.56
4898 at YGR108W CLB1 0.10 -0.20 0.43
8694 at YOL140W ARG8 -0.04 -0.33 0.02
9027 at YNL141W AAH1 0.10 0.17 0.25
11101 at YJL056C ZAP1 0.06 -0.06 0.06
4936 at YGR055W MUP1 0.01 -0.36 0.22
4858 at YGR157W CH02 0.12 -0.13 0.11
4416 at YHR123W EPT1 0.23 -0.34 0.21
5074 at YGL077C HNM1 -0.03 -0.06 -0.12
5681 at YER026C CH01 0.17 0.10 0.21
7602 at YPR158W YPR158W 0.27 -0.37 0.15
4417 at YHR123W EPT1 0.16 -0.52 0.28
4729 i at YGR254W EN01 0.03 -0.44 0.13
8174 at YOR375C GDH1 0.18 -0.17 0.11
10207 at YLR133W CKI1 0.01 0.15 0.25
10018 at YLR303W MET17 0.01 0.14 -0.08
4448 at YHR067W YHR067W -0.01 0.30 0.08
8182 at YOR383C F1T3 -0.04 -0.57 -0.68
4862 at YGR161C RTS3 0.04 -0.01 0.17
8031 at YPL264C YPL264C -0.04 0.30 0.64
4098 at YIR017C MET28 0.00 -0.05 -0.06
4430 at YHR094C HXT1 -0.10 0.40 0.05
4542 at YHL020C OPI1 0.00 0.16 0.26
8188 at YOR344C TYE7 -0.10 -0.21 -0.06
10206 at YLR132C YLR132C -0.06 -0.04 0.07
11030 at YJR008W YJR008W -0.20 -0.06 -0.12
5258 at YGL255W ZRT1 -0.04 -0.72 -0.49
7121 at YBR256C RIB5 0.06 0.08 0.01
6665 at YDL198C YDL198C -0.04 -0.26 -0.44
10709 at YKL120W OAC1 0.28 -0.01 -0.57
253
Probe ID Gene ORF GeneSymbol
fc
psocs un 
lpRAD7 un
fc
pRAD7Arad23 un 
lpRAD7 un
fc
psocsArad23 un 
lpRAD7 un
fc
pRAD715 
lpRAD7 un
fc
psocs15 
Ipsocs un
fc
pRAD7Arad23 15 
lpRAD7Arad23 un
fc
psocsArad2315 
lpsocsArad23 un
8680 at YOL108C IN 04 0.03 0.22 -0.10 0.57 0.36 0.31 0.58
7342 at YBR029C CDS1 -0.11 0.36 0.39 0.50 0.49 0.03 0.08
8422 at YOR130C ORT1 0.03 -0.05 0.39 0.71 0.55 0.39 0.09
7565 at YPR167C MET16 -0.01 -0.02 -0.18 0.06 -0.05 0.02 0.11
8973 at YNL104C LEU4 -0.02 0.18 0.15 0.74 0.73 0.62 0.80
4568 at YHL040C ARN1 -0.11 0.30 0.38 0.43 0.42 0.12 0.17
4866 at YGR121C MEP1 -0.10 0.13 0.02 0.41 0.46 0.40 0.49
8236 at YOR302W YOR302W -0.01 -0.23 0.09 0.84 0.62 0.56 0.20
7626 at YPR138C MEP3 0.26 -1.76 -1.84 -0.53 -0.49 0.06 0.18
4711 at YGR281W YOR1 0.14 -0.66 -0.45 -0.97 -0.82 -0.32 -0.35
8593 at YOL058W ARG1 -0.04 0.24 0.48 0.34 0.28 0.12 -0.06
3949 i at YNL044W YIP3 -0.06 -0.28 -0.09 -0.02 0.13 -0.19 -0.09
8592 at YOL059W GPD2 -0.14 0.34 -0.22 -0.17 -0.13 -0.31 0.10
4790 at YGR224W AZR1 -0.14 0.04 0.59 0.82 0.60 0.57 0.13
7588 at YPR145W ASN1 0.08 0.07 0.49 -0.33 -0.37 -0.36 -0.66
8144_g_at YOR389W YOR389W -0.31 0.22 -0.14 -0.30 -0.32 -0.35 -0.20
8359 at YOR202W HIS3 -0.19 -0.30 0.21 -0.25 -0.18 -0.10 -0.56
8993 at YNL129W NRK1 0.17 0.35 0.08 0.32 0.14 0.03 0.40
10148 at YLR168C YLR168C -0.06 0.12 0.12 -0.10 -0.03 -0.19 -0.18
10902 at YJR109C CPA2 0.09 0.37 0.69 4.06 3.72 3.51 3.28
5523 at YER175C TMT1 -0.01 0.01 -0.30 0.20 0.28 0.25 0.47
7831 _at YPL058C PDR12 -0.16 -0.34 -0.29 -0.53 -0.38 -0.37 -0.46
8669 at YOL119C MCH4 -0.04 -0.41 0.01 -0.41 -0.17 -0.13 -0.68
8691 at YOL143C RIB4 0.31 0.17 0.69 0.79 0.17 0.29 0.05
4540 at YHL022C SP011 -0.20 -0.18 0.39 0.76 0.70 0.69 0.26
4452 at YHR071W PCL5 -0.11 0.28 -0.20 -0.13 -0.11 -0.18 0.11
9386 at YMR246W FAA4 -0.07 0.09 -0.04 0.39 0.35 0.24 0.43
6358 at YDR123C IN02 -0.03 0.34 0.34 0.34 0.42 0.00 0.08
4537 at YHR018C ARG4 -0.66 -0.52 -1.38 -2.60 -1.71 -1.53 -1.16
9592 at YMR062C ECM40 -0.21 -0.14 -0.27 0.36 0.41 0.03 0.21
fc fc fc fc
pRAD760 psocs 60 pRAD7Arad23 60 psocsArad23 60
lpRAD7 un Ipsocs un lpRAD7Arad23 un lpsocsArad23 un
0.77 0.76 0.90 1.42
1.47 1.61 0.91 0.79
1.84 1.76 0.72 0.65
-0.67 -0.62 -0.16 -0.03
0.89 0.92 1.27 1.50
1.33 1.35 0.73 0.70
0.77 1.02 1.01 1.46
0.77 0.84 1.20 1.20
-1.53 -1.74 0.57 0.54
-0.81 -1.14 -1.30 -1.67
1.39 1.41 0.86 0.67
-0.67 -0.62 -0.35 0.21
-0.61 -0.31 -0.92 r  0.13
1.76 1.75 1.17 0.91
0.05 0.00 0.10 -0.59
-1.78 -1.70 -1.29 -1.08
0.34 0.28 -0.08 -0.36
-0.02 0.01 0.38 0.60
0.78 0.85 0.29 0.12
4.90 4.67 4.84 5.26
0.25 0.45 0.46 0.97
-0.84 -0.71 -1.17 -1.61
0.47 0.80 0.06 -0.48
1.14 0.79 0.64 0.40
1.88 1.74 1.36 1.19
-0.73 -0.61 -0.14 0.00
0.35 0.58 0.84 1.06
1.55 1.47 0.98 0.94
-2.72 -2.12 -3.02 -1.86
0.26 0.26 0.84 0.98
254
fc
pRAD7 60 
lpRAD7 un
fc
psocs 60 
Ipsocs un
fc
pRAD7Arad23 60 
lpRAD7Arad23 un
fc
psocsArad23 60 
lpsocsArad23 un
-0.62 -0.41 -0.03 0.00
0.23 0.14 -0.29 -0.38
2.08 2.17 1.33 1.38
-1.33 -1.33 -3.16 -1.96
3.86 3.83 1.18 3.21
0.82 0.91 0.24 -0.01
0.63 0.53 0.13 -0.21
3.22 3.16 2.00 1.45
2.79 2.79 1.30 1.38
0.21 0.32 -0.86 -0.75
0.29 0.26 0.87 1.29
1.68 2.04 1.29 2.84
0.31 0.59 0.29 1.05
0.02 0.07 0.44 0.64
0.40 0.93 1.89 1.33
-0.04 0.23 -0.43 0.66
-0.25 -0.41 -0.71 -1.30
2.39 2.43 1.87 1.75
0.48 0.58 1.08 1.09
0.49 0.58 1.18 0.75
1.48 1.36 1.98 2.75
0.48 0.39 0.36 -0.20
1.41 1.40 0.89 0.72
-0.19 -0.10 0.10 0.49
1.30 1.43 1.83 2.01
0.13 0.05 -0.03 -1.09
-0.40 -0.33 -1.00 -1.02
-0.30 -0.35 -0.84 -0.94
1.93 2.05 1.34 1.30
-0.37 -0.27 -0.74 -1.18
fc fc fc fc
pRAD7 15 psocs15 pRAD7Arad2315 psocsArad2315
lpRAD7 un Ipsocs un lpRAD7Arad23 un lpsocsArad23 un
-0.19 -0.07 0.08 0.17
-0.34 -0.14 -0.30 -0.27
1.27 1.28 0.81 0.10
-0.78 -0.65 -0.38 -0.18
1.45 1.38 0.91 0.81
-0.07 -0.28 -0.24 -0.40
-0.14 -0.10 -0.12 -0.35
0.67 0.56 0.10 -0.07
0.56 0.52 0.16 -0.04
-0.79 -0.40 -1.07 -1.53
0.22 0.24 0.27 0.21
0.49 0.53 0.66 0.84
0.75 1.06 -0.40 0.64
0.19 0.16 0.24 0.04
1.38 1.14 1.03 0.74
-0.93 -0.65 -0.42 -0.07
-0.53 -0.52 -0.52 -0.71
1.10 0.82 0.60 0.75
0.34 0.27 0.25 0.43
-0.04 0.07 0.02 -0.73
0.40 0.33 0.27 0.23
-0.03 -0.05 0.05 -0.28
0.48 0.51 0.16 0.05
0.09 0.15 -0.11 0.20
0.34 0.47 0.40 0.42
-0.58 -0.70 -0.39 -0.93
-0.27 -0.14 -0.26 -0.50
0.19 0.13 0.00 0.14
1.50 1.67 1.00 0.88
-0.42 -0.25 -0.23 -0.76
Probe ID Gene ORF GeneSymbol
fc
psocs un 
lpRAD7 un
fc
pRAD7Arad23 un 
lpRAD7 un
fc
psocsArad23 un 
lpRAD7 un
10715 at YKL158W APE2 -0.12 -0.02 -0.21
7193 at YBR147W YBR147W -0.06 0.34 0.32
5669 g at YER056C YER056C -0.37 -0.31 0.53
5614 at YER086W ILV1 0.01 -0.07 -0.19
5672 at YER057C HMF1 -0.08 -0.08 0.19
5968 at YDR499W LCD1 0.11 -0.19 0.09
10781 at YKL182W FAS1 0.03 -0.17 0.07
5534 at YER185W YER185W 0.08 0.42 0.85
7973 at YPL231W FAS2 0.06 0.27 0.64
5196 at YGL184C STR3 -0.35 0.20 0.48
10881 at YJR133W XPT1 0.07 -0.02 0.07
9628 at YMR006C PLB2 -0.09 -0.19 -0.14
4257 at YIL144W TID3 -0.21 -0.06 -0.04
4330 at YHR063W YHR063W -0.08 -0.18 -0.03
4343 at YHR183W GND1 -0.21 -0.61 0.06
6317 at YDR171W HSP42 -0.17 -0.77 -1.15
6038 at YDR432W NPL3 0.01 0.07 0.30
6538 at YDL060W TSR1 0.23 0.33 0.40
6399 at YDR075W PPH3 0.02 -0.19 -0.21
6467 at YDR006C SOK1 -0.24 -0.43 0.12
6468 at YDR007W TRP1 0.14 0.30 0.33
6249 at YDR238C SEC26 0.15 -0.14 0.33
6318 at YDR172W SUP35 -0.07 0.35 0.40
6050 at YDR399W HPT1 -0.08 0.06 -0.14
6594 at YDL092W SRP14 -0.13 -0.16 -0.15
5957 at YDR533C HSP31 0.13 -0.21 0.30
6620 at YDL155W CLB3 -0.16 -0.01 0.17
6330 at YDR139C RUB1 0.08 0.13 -0.09
6119 at YDR333C YDR333C -0.25 0.03 0.25
6818 at YCR077C PAT1 -0.15 0.47 0.98
255
fc fc fc fc
pRAD7 60 psocs 60 pRAD7Arad23 60 psocsArad23 60
lpRAD7 un Ipsocs un !pRAD7Arad23 un lpsocsArad23 un
-2.04 -1.87 -1.03 -0.94
-0.38 -0.45 0.17 0.24
-0.09 -0.31 -0.97 -1.43
1.75 1.04 1.37 1.24
0.13 -0.33 1.16 0.35
1.22 1.15 0.63 0.59
2.25 1.67 2.46 2.25
3.04 2.73 2.38 2.59
-0.17 -0.52 -0.44 -1.21
1.19 0.91 0.98 0.47
1.19 1.00 0.61 0.51
0.70 0.46 0.36 -0.21
2.44 2.54 2.03 1.86
1.07 0.83 0.63 0.31
0.87 0.50 1.17 0.96
0.46 0.04 0.57 0.04
2.70 2.84 2.76 3.35
-0.56 -0.86 -0.75 -1.21
-0.34 -0.35 -0.76 -0.96
0.67 0.79 0.39 -0.02
-0.51 -0.48 -0.13 0.60
1.69 1.63 1.83 2.30
0.03 0.11 0.62 0.63
-1.93 -2.22 -2.25 -2.80
-0.86 -0.97 -0.26 -0.24
0.25 0.30 -0.34 -0.40
-0.74 -1.00 -1.20 -1.40
1.32 1.29 1.49 1.26
-0.22 -0.26 -0.80 -0.91
1.38 1.15 0.67 0.33
fc fc fc fc
pRAD715 psocs 15 pRAD7Arad23 15 psocsArad2315
lpRAD7 un Ipsocs un lpRAD7Arad23 un lpsocsArad23 un
-0.48 -0.59 -0.03 0.36
-0.11 -0.16 0.09 0.28
-0.98 -0.75 -1.25 -1.90
0.76 0.70 0.31 0.03
0.58 0.44 0.21 -0.07
0.31 0.20 -0.12 -0.05
1.45 1.43 0.98 0.84
0.91 0.80 0.51 0.27
0.04 0.03 -0.10 -0.21
0.45 0.33 -0.08 -0.35
0.19 0.23 0.16 0.07
-0.36 -0.24 -0.07 -0.56
1.66 1.89 1.14 0.87
0.31 0.35 0.12 -0.28
0.72 0.69 0.22 -0.01
0.27 0.07 0.01 -0.34
2.68 2.71 2.05 2.17
-0.55 -0.28 -0.63 -0.93
-0.17 -0.14 -0.01 -0.47
-0.45 -0.37 -0.52 -0.57
-0.35 -0.21 -0.82 -0.52
0.00 -0.20 0.23 0.23
0.28 0.22 0.12 0.32
-1.92 -1.82 -1.60 -1.86
0.17 0.15 0.23 0.32
0.46 0.35 0.28 0.35
-0.51 -0.55 -0.29 -0.63
1.03 0.92 0.73 0.37
-0.21 -0.15 -0.46 -0.38
0.64 0.70 0.38 -0.01
Probe ID Gene ORF GeneSymbol
fc
psocs un 
lpRAD7 un
fc
pRAD7Arad23 un 
lpRAD7 un
fc
psocsArad23 un 
lpRAD7 un
3942 at YFL031W HAC1 0.21 0.40 -0.03
10760 at YKL206C YKL206C -0.04 -0.29 -0.24
5220 at YGL205W POX1 -0.22 -0.31 0.34
10106 at YLR214W FRE1 0.12 0.28 0.55
4386 at YHR137W A R 09 0.02 0.15 0.37
5711 at YER011W TIR1 0.09 0.42 0.43
5297 at YGL263W COS12 0.04 0.06 0.27
6128 f at YDR342C HXT7 -0.05 0.19 0.42
6129 f at YDR343C YDR343C -0.02 -0.25 0.15
5025 at YGL037C PNC1 0.00 -0.01 0.42
5307 at YFR053C HXK1 -0.04 0.18 0.31
6077 at YDR380W ARO10 -0.02 -0.28 0.21
9633 at YMR011W HXT2 -0.25 0.02 0.25
6182 f at YDR305C HNT2 0.09 -0.08 0.25
6846 at YCR061W YCR061W -0.04 0.14 0.26
11174 at YJL164C TPK1 0.01 -0.30 0.04
7604 at YPR160W GPH1 0.06 0.33 0.29
7754 at YPR002W PDH1 -0.10 -0.25 0.13
4768 at YGR248W SOL4 -0.01 -0.07 0.35
10179 at YLR149C YLR149C -0.01 -0.18 -0.06
5582 at YER142C MAG1 -0.04 -0.99 -1.35
5060 at YGL047W ALG13 0.06 0.25 0.19
5735 at YEL011W GLC3 0.02 -0.17 -0.13
10574 at YKR011C YKR011C -0.09 -0.04 -0.16
8010 i at YPL240C HSP82 -0.04 0.06 -0.05
6346 at YDR111C ALT2 0.11 0.16 0.14
7184 at YBR183W YPC1 0.10 -0.07 0.06
10708 at YKL121W YKL121W -0.06 0.18 0.51
5699 at YER044C YER044C -0.04 0.15 0.21
6099 at YDR358W GGA1 -0.19 -0.34 0.12
256
fc fc fc fc
pRAD760 psocs 60 pRAD7Arad23 60 psocsArad23 60
lpRAD7 un Ipsocs un lpRAD7Arad23 un lpsocsArad23 un
3.86 3.72 3.46 3.84
2.38 2.01 2.46 2.08
4.08 3.96 3.73 3.21
1.12 0.70 0.85 0.50
0.17 -0.10 0.20 -0.44
2.00 2.09 1.55 1.35
-1.33 -1.55 -0.76 -0.69
-1.75 A l l -1.22 -1.05
0.96 0.84 0.67 0.26
0.55 0.56 0.12 -0.13
0.00 -0.27 -0.59 -0.77
1.03 1.05 1.38 1.69
0.68 0.71 0.32 -0.13
0.16 -0.04 0.39 -0.49
-1.16 -1.17 -1.21 -1.01
-1.82 -1.95 -1.82 -2.53
1.20 1.06 1.25 0.49
0.47 0.45 0.10 -0.32
-0.57 -0.88 -0.94 -1.27
5.21 5.53 4.71 6.16
fc fc fc fc
pRAD715 psocs15 pRAD7Arad2315 psocsArad2315
lpRAD7 un Ipsocs un lpRAD7Arad23 un lpsocsArad23 un
1.91 1.97 1.51 1.28
1.46 1.39 1.11 0.69
0.43 0.37 0.25 0.28
0.41 0.44 0.26 0.14
-0.23 -0.12 -0.12 -0.46
1.63 1.51 1.02 1.05
-0.13 -0.08 -0.06 -0.09
-0.30 -0.29 -0.37 -0.11
-0.11 -0.07 -0.14 -0.37
0.21 0.11 -0.02 0.12
-0.30 -0.31 -0.35 -0.49
0.36 0.25 -0.01 0.35
0.04 0.20 0.22 -0.05
-0.53 -0.55 -0.33 -0.61
-1.79 -1.48 -1.27 -1.18
-1.18 -1.27 -1.00 -1.16
0.54 0.52 0.47 0.22
-0.16 -0.01 -0.28 -0.40
-1.31 -1.32 -1.05 -1.26
4.20 3.98 3.40 3.66
Probe ID Gene ORF GeneSymbol
fc
psocs un 
lpRAD7 un
fc
pRAD7Arad23 un 
lpRAD7 un
fc
psocsArad23 un 
lpRAD7 un
8599 at YOL053C DDR2 0.11 -0.01 0.21
11255 at YJL217W YJL217W 0.08 0.18 0.48
4980 at YGR008C STF2 0.01 0.44 0.30
8604 at YOL048C YOL048C -0.06 0.05 0.33
11260 at YJL212C OPT1 -0.02 -0.05 0.19
11230 at YJL196C EL01 0.18 0.29 0.45
11175 at YJL163C YJL163C 0.00 0.00 -0.13
6847 g at YCR061W YCR061W -0.03 -0.09 -0.19
8904 at YNL037C IDH1 0.00 0.05 0.27
10075 at YLR270W DCS1 0.12 0.10 0.24
10110 at YLR218C YLR218C 0.11 -0.10 0.16
10060 at YLR258W GSY2 0.16 0.39 0.09
5751 at YEL039C CYC7 -0.07 -0.01 0.26
10767 at YKL195W YKL195W 0.15 -0.20 0.19
6485 at YDL022W GPD1 -0.17 -0.15 -0.41
10019 at YLR304C AC01 -0.16 -0.60 -0.55
5093 at YGL104C VPS73 -0.03 -0.06 0.40
9388 at YMR250W GAD1 0.05 0.09 0.32
8173 at YOR374W ALD4 0.15 -0.51 -0.22
6694 at YDL214C PRR2 -0.05 0.38 0.15
257
A4.5 More Severely Differentially Expressed Genes in Response to UV in psocs Arad23 Strain (compared to pRAD7 Arad23 
strain) (Figure 4.22 and Figure 4.23)
Probe ID Gene ORF GeneSymbol
fc
psocs un 
lpRAD7 un
fc
pRAD7Arad23 
un lpRAD7 un
fc
psocsArad23 un 
lpRAD7 un
6915 at YCL064C CHA1 0.08 0.80 0.75
3834 s at YLL067C YBL111C 0.24 -0.31 0.28
3187 s at YHL050C YBL111C 0.23 -0.34 0.21
11260 at YJL212C OPT1 0.11 0.31 0.76
7666 at YPR090W YPR089W 0.00 0.08 0.04
10716 at YKL157W APE2 0.00 0.06 0.20
3646 s at YNL339C YNL339C 0.27 -0.37 0.15
10981 at YJR052W RAD7 -3.00 -0.75 -3.15
7058 at YBR285W YBR285W -0.09 -0.19 -0.14
8400 at YOR153W PDR5 -0.02 -0.25 0.15
7422 at YBL075C SSA3 0.14 0.30 0.33
10760 at YKL206C YKL206C 0.31 0.22 -0.64
8663 at YOL126C MDH2 -0.04 -0.99 -1.35
5654 at YER081W SER3 -0.31 -0.78 -0.91
7130_g_at YBR220C YBR219C -0.01 -0.08 -0.10
10447 s at YKL198C PTK1 0.02 -0.37 -0.14
10653 at YKL086W SRX1 -0.17 0.05 -0.39
9904 at YLR413W YLR413W -0.16 -0.60 -0.55
10982 at YJR053W BFA1 0.01 -0.44 0.04
11360 at YAL048C YAL048C 0.01 -0.36 0.22
9912 at YLR421C RPN13 -0.03 -0.06 0.40
4324 s at YHR218W YBL111C 0.13 -0.27 0.23
4287 s at YHR209W YHR209W -0.10 0.40 0.05
3183 f at YIL177C YBL113C 0.04 0.14 -0.19
9108 at YNL241C ZWF1 0.14 -0.13 0.33
11298 at YAR042W SWH1 0.11 -0.41 0.09
fc fc fc fc
pRAD715 psocs15 pRAD7Arad2315 psocsArad2315
lpRAD7 un Ipsocs un lpRAD7Arad23 un lpsocsArad23 un
0.59 0.01 -0.73 -0.62
-0.57 -0.66 -0.34 -0.82
-0.40 -0.58 -0.11 -0.49
-0.70 -0.74 -0.70 -0.86
-0.11 -0.06 -0.09 -0.01
0.09 0.15 0.25 0.12
-0.64 -0.72 -0.31 -0.75
-0.50 -0.42 -0.25 -0.35
0.49 0.53 0.66 0.84
0.04 0.03 -0.10 -0.21
0.40 0.33 0.27 0.23
0.60 0.17 0.37 1.31
-0.35 -0.21 -0.82 -0.52
0.93 0.85 1.10 1.45
0.02 0.03 0.09 0.23
-0.30 -0.21 -0.17 -0.38
0.65 0.87 0.33 0.80
-1.18 -1.27 -1.00 -1.16
-0.41 -0.47 -0.55 -0.96
-0.36 -0.33 0.03 -0.60
0.54 0.52 0.47 0.22
-0.17 -0.36 0.16 -0.41
0.65 0.68 0.54 0.75
0.70 0.30 0.07 0.50
0.36 0.20 0.26 -0.08
-0.43 -0.36 -0.12 -0.61
fc fc fc fc
pRAD7 60 psocs 60 pRAD7Arad23 60 psocsArad23 60
lpRAD7 un Ipsocs un lpRAD7Arad23 un lpsocsArad23 un
-0.35 -0.42 -1.00 -2.36
0.49 0.35 -0.17 -1.33
0.85 0.69 0.36 -0.73
-0.41 -0.73 -0.52 -1.60
-0.27 -0.34 -0.85 -0.56
0.25 0.12 -0.02 0.10
-0.39 -0.61 -0.61 -1.40
0.53 -0.03 0.07 -0.72
1.68 2.04 1.29 2.84
-0.17 -0.52 -0.44 -1.21
1.48 1.36 1.98 2.75
1.22 1.11 1.18 2.01
-0.51 -0.48 -0.13 0.60
0.28 0.71 1.79 2.53
-0.92 -0.74 -0.86 -0.69
-0.02 0.09 0.00 -0.77
0.73 1.10 1.06 1.78
-1.82 -1.95 -1.82 -2.53
0.67 0.50 -0.42 -1.12
0.10 -0.05 -0.10 -0.77
1.20 1.06 1.25 0.49
0.73 0.70 -0.05 -0.70
2.11 2.19 2.06 2.81
0.53 0.60 -0.43 0.10
1.50 1.22 0.78 0.16
-0.02 -0.12 0.15 -0.81
258
fc fc fc fc
pRAD760 psocs 60 pRAD7Arad23 60 psocsArad23 60
lpRAD7 un Ipsocs un lpRAD7Arad23 un lpsocsArad23 un
0.79 0.59 0.74 0.13
-0.11 -0.10 0.31 -0.25
2.70 2.84 2.76 3.35
-0.39 -0.46 -0.43 0.23
1.70 1.59 1.37 0.96
0.05 0.00 0.10 -0.59
-0.28 -0.39 -0.06 -1.04
-0.47 -0.48 -0.80 -0.45
0.17 -0.10 0.20 -0.44
0.44 0.12 -0.13 0.20
0.48 0.39 0.36 -0.20
-2.72 -2.12 -3.02 -1.86
-0.17 -0.10 -0.02 0.28
-0.02 -0.19 -0.10 -0.65
2.79 2.79 1.30 1.38
-0.29 -0.27 -0.66 -1.24
-2.01 -2.33 -2.39 -2.46
0.03 -0.07 -0.05 -0.59
0.52 0.78 -1.17 -0.40
0.11 0.22 0.11 -0.44
0.12 0.04 -0.92 -0.29
0.57 0.34 0.21 -0.32
-0.04 -0.17 0.03 -0.65
0.55 0.45 0.67 -0.10
4.08 3.96 3.73 3.21
0.77 0.76 0.90 1.42
-0.03 -0.03 -0.11 -0.63
-0.69 -0.79 -0.70 -1.21
1.19 0.91 0.98 0.47
0.25 0.45 0.46 0.97
fc fc fc fc
pRAD715 psocs 15 pRAD7Arad2315 psocsArad2315
lpRAD7 un Ipsocs un lpRAD7Arad23 un lpsocsArad23 un
0.31 0.25 0.44 0.15
0.06 -0.03 0.05 -0.17
2.68 2.71 2.05 2.17
0.02 -0.15 -0.05 0.28
0.27 0.22 0.51 0.24
-0.33 -0.37 -0.36 -0.66
-0.82 -0.72 -0.25 -0.99
0.24 0.15 -0.02 0.14
-0.23 -0.12 -0.12 -0.46
-0.03 0.10 -0.14 -0.09
-0.03 -0.05 0.05 -0.28
-2.60 -1.71 -1.53 -1.16
-0.12 0.10 -0.10 -0.14
-0.07 0.04 0.20 -0.06
0.56 0.52 0.16 -0.04
-0.51 -0.50 -0.12 -0.72
-1.33 -1.14 -1.07 -1.16
-0.14 0.09 -0.19 0.01
-0.41 -0.20 -0.54 -0.34
0.00 -0.04 -0.04 -0.08
-0.07 -0.17 -0.24 0.16
0.06 0.08 0.26 0.03
-0.57 -0.60 -0.39 -0.68
-0.28 -0.23 -0.17 -0.56
0.43 0.37 0.25 0.28
0.57 0.36 0.31 0.58
0.08 0.00 0.07 -0.48
-0.21 0.01 -0.12 -0.45
0.45 0.33 -0.08 -0.35
0.20 0.28 0.25 0.47
Probe ID Gene ORF GeneSymbol
fc
psocs un 
lpRAD7 un
fc
pRAD7Arad23 
un lpRAD7 un
fc
psocsArad23 un 
lpRAD7 un
11230 at YJL196C EL01 0.16 0.30 0.61
11366 at YAL043C PTA1 0.02 -0.14 0.14
8575 at YOL032W YOL032W 0.06 0.33 0.29
11026 at YJR004C SAG1 0.12 -0.11 -0.29
11020 i at YJL001W PRE3 0.03 -0.05 0.36
5608 at YER123W YCK3 0.08 0.07 0.49
3736 s at YLR467W YLR467W 0.16 -0.52 0.28
7298 at YBR075W YBR074W -0.07 0.58 0.26
9335 at YMR286W MRPL33 -0.02 -0.05 0.19
8470 at YOR088W YVC1 -0.07 0.00 0.00
7423 at YBL074C AAR2 0.15 -0.14 0.33
6513 at YDL039C PRM7 -0.66 -0.52 -1.38
5421 i at YFL067W YFL067W -0.17 -0.21 -0.19
11136 at YJL111W CCT7 -0.09 0.01 0.25
6847_g_at YCR061W YCR061W 0.06 0.27 0.64
3737 s at YLR467W YLR467W 0.03 -0.44 0.13
8811 at YNR053C NOG2 -0.09 0.12 -0.20
10341 at YLL002W RTT109 -0.01 0.05 0.23
5988 at YDR474C JIP4 0.04 0.04 0.01
10446 s at YKL199C YKL199C 0.07 -0.36 -0.29
11322 at YAL001C TFC3 0.14 0.35 0.00
11013 at YJL008C CCT8 0.03 0.08 0.34
3791 s at YLL067C YBL111C 0.18 -0.17 0.11
10081 at YLR234W TOP3 0.05 0.14 0.29
9293 at YML058W HUG1 0.01 0.44 0.30
4892 at YGR102C YGR102C 0.03 0.22 -0.10
5576 at YER135C YER135C 0.01 0.10 0.51
7822 at YPL067C YPL067C 0.02 -0.33 0.02
8404 at YOR157C PUP1 0.00 -0.01 0.42
5775 at YEL059C SOM1 I -0.01 0.01 -0.30
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fc
pRAD760 
lpRAD7 un
fc
psocs 60 
Ipsocs un
fc
pRAD7Arad23 60 
lpRAD7Arad23 un
fc
psocsArad23 60 
lpsocsArad23 un
-0.10 0.00 -0.18 -0.67
-0.16 -0.35 0.04 -0.18
0.95 0.61 0.99 0.42
0.33 0.30 0.20 0.07
-0.27 -0.19 -0.28 -0.75
1.69 1.63 1.83 2.30
-0.78 -1.29 -0.87 -1.34
-1.37 -1.55 -1.46 -1.92
0.60 0.53 0.35 -0.11
-0.17 0.01 0.01 0.48
-0.09 -0.31 -0.97 -1.43
-0.56 -0.86 -0.75 -1.21
0.41 0.50 0.40 0.72
-0.09 0.03 0.05 0.50
0.90 0.71 0.92 0.43
0.11 0.15 0.10 -0.35
1.58 1.68 1.58 2.03
0.59 0.76 0.74 1.19
0.77 1.02 1.01 1.46
0.68 0.71 0.32 -0.13
5.21 5.53 4.71 6.16
0.73 0.53 0.74 0.28
2.42 2.60 2.15 3.12
0.11 -0.15 0.12 0.12
-0.84 -0.71 -1.17 -1.61
-0.37 -0.27 -0.74 -1.18
-0.61 -0.31 -0.92 0.13
0.43 0.45 0.53 0.97
0.28 0.05 0.18 -0.25
0.86 0.84 -0.27 -0.25
fc fc fc fc
pRAD7 15 psocs15 pRAD7Arad2315 psocsArad2315
lpRAD7 un Ipsocs un lpRAD7Arad23 un lpsocsArad23 un
-0.48 -0.29 -0.15 -0.86
-0.56 -0.64 0.17 -0.37
0.45 0.30 0.67 0.37
0.21 0.05 -0.11 0.02
-0.37 -0.37 -0.37 -0.54
0.00 -0.20 0.23 0.23
-0.08 -0.06 0.05 -0.14
-0.99 -0.85 -0.55 -0.81
0.07 0.01 0.17 -0.14
-0.08 0.20 0.10 0.14
-0.98 -0.75 -1.25 -1.90
-0.55 -0.28 -0.63 -0.93
0.46 0.34 0.42 0.47
-0.01 0.10 0.05 0.15
0.03 0.09 -0.02 -0.22
-0.19 -0.35 -0.09 -0.27
0.25 0.44 0.41 0.03
-0.02 0.09 0.09 0.01
0.41 0.46 0.40 0.49
0.04 0.20 0.22 -0.05
4.20 3.98 3.40 3.66
0.36 0.30 0.65 0.33
0.91 0.90 1.01 0.93
0.03 0.03 0.07 0.21
-0.53 -0.38 -0.37 -0.46
-0.42 -0.25 -0.23 -0.76
-0.17 -0.13 -0.31 0.10
0.35 0.30 0.12 0.48
-0.03 0.08 0.28 -0.17
0.06 -0.14 0.01 -0.08
Probe ID Gene ORF GeneSymbol
fc
psocs un 
lpRAD7 un
fc
pRAD7Arad23 
un lpRAD7 un
fc
psocsArad23 un 
lpRAD7 un
6619 at YDL156W YDL156W 0.05 -0.09 0.30
3184 s at YIL177C YRF1-1 0.08 -0.53 -0 22
11210 at YJL173C RFA3 0.08 0.29 0.50
9873 at YLR426W YLR426W 0.14 0.30 0.26
7394 at YBL013W FMT1 0.10 -0.22 0.03
8724 at YOL155C YOL155C 0.06 0.25 0.19
10717 at YKL156W RPS27A 0.03 0.02 0.16
11348 at YAL019W FUN30 -0.07 -0.04 0.05
10299 at YLR047C YLR047C 0.06 -0.15 0.20
10022 at YLR307W CDA1 -0.18 0.29 0.08
8030 at YPL265W DIP5 -0.22 -0.31 0.34
8610 at YOL042W NGL1 -0.10 -0.25 0.13
7549 g at YPR196W MAL33 0.12 0.16 0.02
8303 at YOR237W HES1 -0.15 0.09 -0.04
11134 at YJL115W ASF1 0.07 0.40 0.46
3948 s at YKL198C PTK1 -0.01 -0.34 -0.15
10181 at YLR151C PCD1 -0.14 0.17 0.19
6690 at YDL218W YDL218W -0.02 -0.06 0.17
5188 at YGL191W COX 13 -0.10 0.13 0.02
9711 at YML088W UF01 -0.07 -0.01 0.26
9996 at YLR327C RBF9 -0.05 0.38 0.15
11221 at YJL206C NCE101 0.04 -0.03 0.18
4075 at YIR039C YPS6 0.01 0.15 0.25
4725 f at YGR122C YGR122C 0.17 -0.03 -0.06
5789 at YEL046C GLY1 -0.16 -0.34 -0.29
7754 at YPR002W PDH1 -0.15 0.47 0.98
5536 at YER187W YER187W -0.14 0.34 -0.22
10750 at YKL169C YKL169C 0.03 0.16 -0.17
10986 at YJR057W CDC8 -0.04 0.17 0.41
11046 at YJL021C BBC1 0.11 0.17 0.31
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fc
pRAD7 60 
lpRAD7 un
fc
psocs 60 
Ipsocs un
fc
pRAD7Arad23 60 
lpRAD7Arad23 un
fc
psocsArad23 60 
lpsocsArad23 un
-0.06 -0.05 0.02 -0.56
-0.47 -0.28 -0.43 0.00
0.02 -0.47 -0.02 -0.44
1.05 1.19 1.17 1.59
0.16 -0.04 0.39 -0.49
0.18 0.19 0.17 -0.25
0.47 0.45 0.10 -0.32
0.10 0.17 0.46 0.40
0.29 0.26 0.87 1.29
-0.44 -0.47 -0.47 -0.89
0.16 0.22 0.21 0.62
0.67 0.79 0.39 -0.02
0.46 -0.27 0.62 -0.11
1.04 1.40 1.13 1.54
-0.78 -0.85 -0.79 -1.20
-0.11 0.04 -0.21 -0.62
-0.29 -0.45 -0.26 0.15
1.69 1.64 1.46 0.87
0.96 0.84 0.67 0.26
1.43 1.53 1.24 1.93
0.08 0.03 0.00 -0.40
0.90 0.51 0.73 0.33
0.00 0.31 0.13 0.53
fc fc fc fc
pRAD715 psocs15 pRAD7Arad23 15 psocsArad23 15
lpRAD7 un Ipsocs un lpRAD7Arad23 un lpsocsArad23 un
-0.61 -0.36 -0.15 -0.45
-0.12 0.09 -0.30 0.12
0.05 0.04 -0.23 -0.43
0.61 0.49 0.42 0.47
-0.53 -0.55 -0.33 -0.61
-0.16 -0.14 -0.27 -0.53
-0.16 -0.01 -0.28 -0.40
0.19 0.00 -0.01 0.16
0.22 0.24 0.27 0.21
-0.25 0.02 0.15 -0.35
0.01 -0.06 -0.03 0.12
-0.45 -0.37 -0.52 -0.57
0.37 0.32 0.37 0.04
0.31 0.40 0.24 0.09
-0.81 -0.55 -0.51 -0.60
-0.15 -0.04 -0.24 -0.43
0.19 0.15 0.11 0.49
0.61 0.40 0.74 0.26
-0.11 -0.07 -0.14 -0.37
0.30 0.46 0.31 0.26
-0.39 -0.34 0.10 0.10
0.39 0.38 0.48 0.19
0.30 0.48 0.27 0.53
Probe ID Gene ORF GeneSymbol
fc
psocs un 
lpRAD7 un
fc
pRAD7Arad23 
un lpRAD7 un
fc
psocsArad23 un 
lpRAD7 un
10856 at YJR154W YJR154W 0.02 -0.34 -0.02
10621 at YKL031W YKL031W -0.07 -0.07 -0.32
8679 at YOL109W ZE01 -0.02 0.19 0.30
7812 at YPL078C ATP4 0.00 0.18 0.01
9800 s at YML133C YBL111C 0.15 -0.20 0.19
9180 at YNL304W YPT11 -0.12 -0.02 0.18
9928 at YLR393W ATP 10 0.05 0.09 0.32
6961 g at YCL065W YCL065W 0.00 0.05 -0.20
6934 at YCL041C YCL041C 0.07 -0.02 0.07
7807 at YPL036W PMA2 -0.16 -0.54 -0.07
6054 at YDR403W DIT1 0.00 0.02 -0.14
8630 at YOL067C RTG1 -0.01 -0.18 -0.06
11351 at YAL016W TPD3 0.13 0.02 0.37
7789 at YPL054W LEE1 -0.07 0.00 0.13
10624 at YKL072W STB6 -0.06 -0.12 0.01
10651 at YKL088W YKL088W 0.01 -0.30 0.02
7488 at YBL098W BNA4 0.16 0.49 0.18
11021 f at YJL001W PRE3 0.09 -0.31 0.28
9624 at YMR002W YMR002W 0.00 0.05 0.27
4212_g_at YIL099W SGA1 -0.05 0.22 0.14
8021 at YPL274W SAM3 0.08 -0.54 -0.09
9392 at YMR253C YMR253C 0.06 -0.23 0.06
10532 at YKR061W KTR2 -0.15 0.09 -0.30
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A4.6 Top 100 Differentially Regulated Genes in psocs Untreated 
Strain (Figure 6.12 and Figure 6.13)
Probe ID Gene ORF GeneSymbol
fc
psocs un 
JpRAD7 un
fc
pRAD7Arad23 un 
lpRAD7 un
fc
psocsArad23 un 
lpRAD7 un
10981_at YJR052W RAD7 -3.00 -0.75 -3.15
6538 at YDL060W TSR1 -0.80 -0.40 -0.01
4343 at YHR 183W GND1 -0.78 0.13 0.23
4330 at YHR 063W YHR 063W -0.72 0.05 -0.01
4257 at YIL144W TID3 -0.69 0.07 -0.02
6318 at YDR 172W SUP35 -0.67 -0.54 0.04
6513 at YDL039C PRM7 -0.66 -0.52 -1.38
3942 at YFL031W HAC1 0.64 0.24 0.19
6038 at YDR 432W NPL3 -0.64 -1.02 0.14
6249 at YDR238C SEC26 -0.61 -0.67 0.09
6468 at YDR007W TRP1 -0.58 -0.77 -0.25
6025 at YDR465C RMT2 -0.58 -0.50 -0.09
6514 at YDL038C YDL038C -0.57 -0.65 -1.27
6395 at YDR071C PAA1 -0.56 -0.27 0.09
6535 at YDL063C YDL063C -0.55 -0.39 -0.28
6455 s at YDR039C ENA2 -0.55 -0.25 0.08
4399 at YHR149C SKG6 -0.55 0.33 0.18
6958 s at YCL067C HMLALPHA2 -0.55 -0.50 0.01
6316 at YDR170C SEC7 -0.55 -0.45 0.01
6515 at YDL037C BSC1 -0.54 -1.25 -1.19
4342 at YHR182W YHR 182W -0.54 0.03 0.03
4978 at YGR052W FMP48 -0.54 -0.51 -0.53
4187 at YIL077C YIL077C -0.54 0.19 0.01
6537 f at YDL061C RPS29B -0.53 -0.60 -0.03
4199 at YIL112W HOS4 -0.53 0.00 -0.07
6827 at YCR037C P H 087 -0.52 -0.24 -0.09
6317 at YDR171W HSP42 -0.52 -0.08 0.65
6120 at YDR334W SWR1 -0.51 -0.48 0.07
6107 at YDR365C ESF1 -0.51 -0.60 -0.20
6050 at YDR399W HPT1 -0.51 -0.62 -0.06
6329 at YDR139C RUB1 -0.51 -0.42 -0.02
5957 at YDR533C HSP31 -0.51 -0.72 -0.12
6178 at YDR304C CPR5 -0.51 -0.53 0.25
6049 at YDR398W UTP5 -0.50 -0.45 -0.18
6618 at YDL157C YDL157C -0.50 -0.24 0.27
6620 at YDL155W CLB3 -0.50 -0.72 -0.09
6456 at YDR041W RSM10 -0.50 -0.41 0.08
5965 at YDR496C PUF6 -0.49 -0.27 -0.13
6467 at YDR006C SOK1 -0.49 -0.68 -0.25
6119 at YDR333C YDR333C -0.49 -0.63 0.03
5685 at YER030W YER030W -0.49 -0.51 0.02
6399 at YDR075W PPH3 -0.48 -0.68 -0.31
6396 at YDR072C IPT1 -0.48 -0.39 -0.20
6521 at YDL031W DBP10 -0.47 -0.01 -0.24
6594 at YDL092W SRP14 -0.47 -0.73 -0.02
5668 at YER056C YER056C -0.47 -0.38 -0.33
262
Probe ID Gene ORF GeneSymbol
fc
psocs un 
lpRAD7 un
fc
pRAD7Arad23 un 
lpRAD7 un
fc
psocsArad23 un 
!pRAD7 un
6245 at YDR 234W LYS4 -0.47 -0.31 -0.23
6246 at YDR 235W PRP42 -0.47 -0.23 -0.01
11101 at YJL056C ZAP1 0.46 -0.64 -0.35
6094 at YDR397C NCB2 -0.46 -0.36 -0.12
6760_g_at YCL057C YCL057C-A -0.46 -0.31 0.10
6176 at YDR 302W GPU 1 -0.45 -0.34 0.14
6523 at YDL029W ARP2 -0.45 -0.39 0.16
6818 at YCR077C PAT1 -0.45 -0.61 -0.01
7828 at YPL061W ALD6 -0.45 0.88 0.87
6244 at YDR233C RTN1 -0.45 0.04 0.01
6313 at YDR 167W TAF10 -0.45 -0.01 -0.04
6175 at YDR 301W CFT1 -0.44 -0.35 -0.08
6886 at YCR009C RVS161 -0.44 -0.55 0.05
6327 at YDR 137W RGP1 -0.44 -0.14 0.03
6604 at YDL126C CDC48 -0.44 -0.17 0.24
6325 at YDR135C YCF1 -0.44 0.32 0.20
6454 g at YDR038C ENA5 -0.43 -0.20 0.10
6177 at YDR303C RSC3 -0.43 -0.48 -0.15
6314 at YDR168W CDC37 -0.43 0.02 0.10
6092 at YDR395W SXM1 -0.43 0.01 -0.02
6173 at YDR299W BFR2 -0.43 0.12 -0.10
6248 at YDR237W MRPL7 -0.42 -0.41 0.04
7041 s at YBR267W REI1 -0.42 -0.25 -0.24
6673 at YDL190C UFD2 -0.42 -0.29 0.08
6381 at YDR101C ARX1 -0.42 -0.03 -0.33
6688 at YDL219W DTD1 -0.42 -0.51 0.21
11133 at YJL116C NCA3 -0.42 0.49 0.12
6315 at YDR169C STB3 -0.42 -0.40 -0.10
8018 i at YPL277C YPL277C 0.41 -0.07 -0.03
6330 at YDR139C RUB1 -0.41 -0.60 0.04
7888 at YPL137C YPL137C -0.41 0.05 0.12
5752 at YEL038W UTR4 -0.41 -0.26 0.12
6323 at YDR133C YDR133C -0.41 0.14 0.18
10609 at YKL043W PHD1 -0.41 -0.44 -0.60
6605 at YDL125C HNT1 -0.41 -0.34 0.14
6398 at YDR074W TPS2 -0.40 -0.25 0.50
7459 s at YBL083C ALG3 -0.40 -0.26 0.00
6591 at YDL095W PMT1 -0.40 -0.08 0.09
5813 at YEL071W DLD3 -0.40 -0.19 0.37
6174 at YDR300C PR01 -0.40 0.17 0.11
6033 at YDR427W RPN9 -0.40 0.24 0.34
6451 at YDR036C EHD3 -0.39 0.15 0.16
6190 at YDR270W CCC2 -0.39 -0.49 0.04
9885 at YLR438W CAR2 0.39 -0.02 0.16
8545 at YOR027W STI1 0.39 0.81 0.94
6102 at YDR361C BCP1 -0.39 0.09 -0.10
5616 at YER087C SBH1 -0.39 -0.49 0.04
5969 at YDR500C RPL37B -0.39 -0.49 0.03
4078 i at YIR043C YIR043C 0.39 1.14 0.82
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Probe ID Gene ORF GeneSymbol
fc
psocs un 
lpRAD7 un
fc
pRAD7Arad23 un 
lpRAD7 un
fc
psocsArad23 un 
fpRAD7 un
6522 at YDL030W PRP9 -0.39 -0.21 -0.09
6466 at YDR005C MAF1 -0.38 -0.43 -0.04
4411 at YHR118C ORC6 -0.38 0.03 -0.18
6606 at YDL125C HNT1 -0.38 -0.31 0.14
A4.7 Significantly Differentially Expressed Genes from Spellman 
800 List In psocs Untreated Strain (Figure 6.14 and Figure 6 15)
Probe ID Gene ORF Gene Symbol
fc
psocs un 
IpRAD7 un
fc
pRAD7Arad23 un 
!pRAD7 un
fc
psoc$Arad23 un 
lpRAD7 un
8988 at YNL134C YNL134C 0.21 0.51 0.60
6424 at YDR 055W PST1 0.28 0.70 0.37
8480 at YOR052C YOR052C -0.25 0.02 0.25
7321 at YBR053C YBR053C 0.23 0.33 0.40
5750 at YEL040W UTR2 -0.31 -0.15 -0.01
8779 at YNR067C DSE4 0.21 0.25 0.45
5544 at YER150W SPI1 -0.35 -0.01 0.40
10078 at YLR273C PIG1 0.29 0.48 0.49
3646 s at YNL339C YNL339C 0.27 -0.37 0.15
3792 s at YLL066C YBL113C 0.08 0.21 0.10
3834 s at YLL067C YBL111C 0.24 -0.31 0.28
6603 at YDL127W PCL2 -0.22 -0.15 0.04
3187 s at YHL050C YBL111C 0.23 -0.34 0.21
3184 s at YIL177C YRF1-1 0.08 -0.53 -0.22
6462 at YDR001C NTH1 -0.37 0.31 0.05
10502 at YKR077W YKR077W 0.20 0.79 0.55
4399 at YHR149C SKG6 -0.55 0.33 0.18
7294 at YBR071W YBR071W 0.23 0.68 0.48
5952 at YDR528W HLR1 -0.26 0.10 -0.01
8975 at YNL102W POL1 0.20 0.74 0.38
7832 at YPL057C SUR1 0.25 0.26 0.26
6591 at YDL095W PMT1 -0.40 -0.08 0.09
6593 at YDL093W PMT5 -0.38 -0.41 0.11
9044 at YNL169C PSD1 0.21 -1.19 -0.61
5546 at YER152C YER152C -0.21 -0.33 0.04
5746 at YER001W MNN1 0.20 0.32 0.00
5602 at YER118C SH01 -0.27 -0.31 0.13
6618 at YDL157C YDL157C -0.50 -0.24 0.27
6171 at YDR297W SUR2 -0.33 -0.02 -0.26
4257 at YIL144W TID3 -0.69 0.07 -0.02
7999 at YPL250C ICY2 0.34 -0.53 -0.21
6008 at YDR448W ADA2 -0.33 -0.10 -0.06
5748 at YEL042W GDA1 -0.31 0.13 -0.03
11097 at YJL060W BNA3 0.27 0.28 0.17
6176 at YDR302W GPU 1 -0.45 -0.34 0.14
4396 at YHR146W CRP1 -0.20 -0.06 -0.12
10977 at YJR048W CYC1 0.26 0.64 0.92
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7400 at YBL052C SAS3 -0.26 -0.60 -0.10
4884 i at YG R138C T P 0 2 0.28 -0.01 -0.57
8030 at YPL265W DIP5 -0.22 -0.31 0.34
8543 at YO R025W HST3 0.25 -0.13 -0.16
7614 at YPR128C ANT1 -0.25 -0.13 0.22
9885 at YLR438W CAR2 0.39 -0.02 0.16
5216 at YGL209W MIG2 0.36 -0.18 -0.20
7831 at YPL058C PDR12 0.24 -0.84 -0.68
6038 at YDR 432W NPL3 -0.64 -1.02 0.14
10609 at YKL043W PHD1 -0.41 -0.44 -0.60
8249 at YOR313C SPS4 0.22 -0.02 0.13
8684 at YOL150C YOL150C -0.20 -0.37 -0.49
6894 at YCL038C ATG22 -0.22 0.15 0.15
10608 at YKL044W YKL044W -0.30 -0.57 -0.45
7840 at YPL095C YPL095C 0.21 0.40 -0.03
6513 at YDL039C PRM7 -0.66 -0.52 -1.38
6515 at YDL037C BSC1 -0.54 -1.25 -1.19
5585 at YER145C FTR1 -0.28 0.26 0.13
7828 at YPL061W ALD6 -0.45 0.88 0.87
6602 at YDL128W VCX1 -0.33 -0.22 0.01
6830 at YCR042C TAF2 -0.33 -0.51 -0.13
7322 at YBR054W Y R 0 2 0.36 -0.03 -0.42
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Appendix V -  Growth Curve Optical Density (OD600) Values
Growth Curve Data From Chapter 3 (Figure 3.7)
Figure 3.7 1. Growth at 25°C
Time
(Hours) WT abf1-1
abf1-1
sug2-1 sug2-1
0 0.100 0.100 0.100 0.100
1 0.143 0.113 0.137 0.135
2 0.191 0.122 0.156 0.164
3 0.256 0.143 0.177 0.238
4 0.302 0.184 0.186 0.282
5 0.390 0.197 0.224 0.371
6 0.461 0.224 0.248 0.446
7 0.541 0.269 0.267 0.519
8 0.599 0.289 0.289 0.572
Figure 3.7 2. Growth at 30°C
Time
(Hours) WT abf1-1
abf1-1
sug2-1 sug2-1
0 0.100 0.100 0.100 0.100
1 0.116 0.133 0.118 0.166
2 0.168 0.153 0.133 0.236
3 0.269 0.159 0.151 0.341
4 0.372 0.190 0.186 0.429
5 0.440 0.215 0.204 0.525
6 0.519 0.220 0.221 0.585
7 0.558 0.250 0.243 0.649
8 0.609 0.284 0.252 0.713
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Figure 3.7 3. Growth at 37°C
Time
(Hours) WT abf1-1
abf1-1
sug2-1 sug2-1
0 0.100 0.100 0.100 0.100
1 0.184 0.099 0.117 0.161
2 0.251 0.101 0.092 0.203
3 0.391 0.079 0.119 0.328
4 0.525 0.104 0.113 0.401
5 0.624 0.086 0.107 0.463
6 0.755 0.107 0.116 0.523
7 0.860 0.112 0.110 0.602
8 0.924 0.110 0.110 0.663
Growth Curve Data From Chapter 6
(Figure 6.2, Figure 6.3 and  Figure 6.16)
Figure 6.2 -  Growth From Early Stationary Phase Cultures
Time
(Hours) pRAD7 psocs
0 0.100 0.100
1 0.102 0.108
2 0.130 0.129
3 0.194 0.187
4 0.255 0.232
5 0.311 0.269
6 0.505 0.405
7 0.650 0.530
8 0.813 0.735
9 1.330 0.874
10 2.580 1.777
12 4.360 3.367
13 4.950 4.027
14 5.190 4.427
Figure 6.3 -  Growth From Logarithmic Phase Cultures
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Time
(Hours) p R A D 7 p s o c s
0 0.100 0.100
1 0.102 0.102
2 0.115 0.116
3 0.158 0.153
4 0.217 0.210
5 0.320 0.304
6 0.468 0.454
7 0.685 0.661
8 0.943 0.917
9 1.965 1.899
10 2.735 2.669
12 3.415 3.329
13 3.815 3.729
Figure 6.16 -  Growth From Early Stationary Phase Cultures
Time
(Hours)
p R A D 7  
A r a d 2 3  
A s m  11
p s o c s  
A r a d 2 3  
A s m  11
p R A D 7
A r a d 2 3
A c r t l
p s o c s
A r a d 2 3
A c r t l
0 0.100 0.100 0.100 0.100
1 0.090 0.097 0.104 0.117
2 0.128 0.131 0.146 0.167
3 0.211 0.210 0.224 0.222
4 0.303 0.277 0.29 0.290
5 0.389 0.338 0.386 0.378
6 0.595 0.559 0.604 0.586
7 0.761 0.677 0.753 0.739
8 1.166 0.921 1.071 1.316
9 1.386 1.218 1.461 1.376
10 2.926 2.598 2.821 2.626
12 4.506 4.388 4.391 4.186
13 4.856 4.828 4.881 4.786
14 4.906 4.878 4.931 4.866
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Appendix VI -  Plasmid Stability Data
(Table 6.2) 
Cell Counts on YPD and HIS- plates 
pRAD7 Strain
v O h  t, 4h
YPD - 1 191 418
YPD -2 185 451
YPD-3 208 305
Mean 194.7 391.3
HIS - 1 165 248
HIS -2 154 223
HIS-3 185 225
Mean 168.0 232.0
% HIS 86.3 59.3
psocs Strain
YPD - 1 372 1089
YPD -2 408 1106
YPD - 3 567 999
Mean 449.0 1064.7
HIS - 1 347 734
HIS -2 385 731
HIS - 3 358 689
Mean 363.3 718.0
% HIS 80.9 67.4
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Appendix VII -  qPCR Data
Figure 4.5 
Number of qPCR Cycles Shown for RAD7 and ACT1 (control) 
Relative Expression Values calculated using:
2 ((ACT1 mean cycles) -  (RAD7 mean cycles)),
RAD7 :
pRS314- 
"■ n' socs % 'A
- p RS313- 
RAD7
A0*  ^ '!<a
pRS313~
SO C S ; _
ACT1 - 1 25.6 26.5 25.0 24.9
ACT1 -2 25.2 25.3 25.0 25.0
ACT1-  3 25.5 26.0 25.0 24.8
Mean 25.4 25.9 25.0 24.9
RADI  - 1 18.6 20.3 18.8 19.3
RADI  - 2 18.7 20.4 18.9 19.4
R A D I - Z 18.5 19.8 18.7 19.2
Mean 18.6 20.2 18.8 19.3
" Relative - 
, Expression 
Values
7*114.0;
.. V V '7"....^
, •:v 5 4 ;^ :,;;v ; 73.5 • *
.“"1........ .... ..
. 48.5 .
' • ’ 1 'V-' . 0.48 . 1 k 0.66
Figure 5.6 
Number of qPCR Cycles Shown for DUN1 Promoter Input and IP. 
Ratio Values calculated using: IP mean / Input mean
pRAD7
Arad4Arad23
input ip input.Mean
IP
Mean
Input
Adjusted
/' / ;IP: a' 
Adjusted IP/Input SD
4.95E-03 2.85E-04 5.40E-03 2.42E-04 0.488 1.938 3.972 1.715
5.31 E-03 2.41 E-04
5.95E-03 1.98E-04
1.11E-02 1.34E-04 1.11 E-02 1.25E-04 1 1 1
1.14E-02 1.15E-04
1.08E-02
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Appendix VIII - PCR Primers
All oligonucleotide primers were synthesised by Eurofins MWG Operon 
(Germany).
Chapter 3.2.2 (Figure 3.3)
Primers to Amplify pRS306 URA3 gene, with homology to ABF1 3’ 
Region (Bold indicates homology to pRS306 plasmid)
F GCA ATT GCG CCA ACG TAA CGA CGT TAC CAA TGG GCA AGT CTA CGA AGA 
AGC GCA GAT TGT ACT GAG AGT GC
R CCA TAA TGA ACC ACA TCA AAA GCC TGA CTT CTA TTG GCG GGG TAA GTA 
ACC CCT GAT AGA CGG TTT TTC G
Primers to Amplify ABF1 Gene, Including 5’ and 3’ UTRs
F GGA TGG ACA AAT TAG TCG TG
R CTT CAA ACC CGA ACC CTT G
Primers to Amplify 388bp Region Incorporating abf1-1 Mutation Site
F GGA TGG ACA AAT TAG TCG TG
R GCT AAC CTT ATT ATT ACT GCC
Primers to Amplify sug2-1 Mutation Site
F CTC CAG CGT CTG GTA TTG TGG
R CG GCC TCA TTT GGC AAT GGG
271
Chapter 5.2.4 (Figure 5.2)
Primers to Amplify 252bp region of SML1 ORF for Northern Analysis
F (5’ Biotin-Labelled) CAA CAA CAA GCC CCT TCC AC
R CGA CCT TAC CCT GGT TGA AC
Primers to Amplify 419bp region of CRT1 ORF for Northern Analysis
F (5’ Biotin-Labelled) GGT CCA AGT AAC GGA TCT TC
R GGT ATT GGT ACG TTT GGC AG
Chapter 5.3.4 (Figure 5.6)
Primers to Amplify Promoter region of DUN1 for ChIP
F (5’ Biotin-Labelled) AAAAAA CAG GAT GAA TCC AAA GCT CTA
R AAA CGC TGC AAT TCT AAT GAG
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